<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>GNews Health</title><link>https://news.google.com/</link><description></description><generator>rfeed v1.1.1</generator><docs>https://github.com/svpino/rfeed/blob/master/README.md</docs><item><title>25%的男性前列腺增大50 ：现在可以做些什么来预防它-印度时报</title><link>https://timesofindia.indiatimes.com/life-style/health-fitness/25-of-men-will-have-an-enlarged-prostate-by-50-what-can-be-done-now-to-prevent-it/photostory/124256849.cms</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="COQxt" data-ua-type="1"&gt;&lt;p&gt;A healthy lifestyle, and hearty diet goes a long way in preventing &lt;a href="https://www.urologyhealth.org/urology-a-z/b/benign-prostatic-hyperplasia-(bph)%5B10"&gt;prostate&lt;/a&gt;. However, this must be adapted at a young age, since the condition cannot be reversed per se. Physical exercise helps maintain blood circulation and hormone equilibrium, which helps control prostate enlargement. A balanced weight achieved through proper eating habits decreases insulin resistance and inflammation, which are linked to BPH development. The reduction of caffeine and alcohol consumption together with spicy food intake, helps reduce urinary symptoms. Drinking enough water throughout the day helps control nighttime urination, but avoid drinking too much before bedtime. The management of stress together with sufficient sleep duration plays essential roles in maintaining prostate health. Basic changes in daily habits, create an effective method to protect prostate health naturally.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Times of India</author><pubDate>Wed, 01 Oct 2025 23:30:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMi_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</guid></item><item><title>食用油：我应该用橄榄油煎炸吗？如何选择合适的瓶子- BBC</title><link>https://www.bbc.com/news/articles/cj3y7j2dz44o</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;article&gt;&lt;p data-component="headline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h1 class="sc-f98b1ad2-0 jRDKjj"&gt;Should I use olive oil for frying? How to choose the right cooking oil&lt;/h1&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 ERpRj"&gt;&lt;div data-testid="hero-image" class="sc-5340b511-1 ilsLtA"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250919-090805-05e5ba0164-web-2.30.1-2/grey-placeholder.png" class="sc-5340b511-0 hagXkB hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp" loading="eager" alt="Getty Images Assorted healthy vegetable oil bottle collection on wooden table in a old fashioned kitchen with low key illumination: Olive oil, hazelnut oil, almond oil, coconut oil and sesame oil" class="sc-5340b511-0 bGQwLJ"&gt;&lt;span class="sc-5340b511-2 lha-dta"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Supermarket shelves are packed with oils from budget bottles of sunflower and vegetable oil to pricier olive, avocado and coconut oils claiming health benefits.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Oils and fats have been at the centre of nutritional debate for years and to understand why it matters, it helps to look at the different types of fat they contain.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Not all fats behave the same way in the body - some raise cholesterol while others help lower it. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Cholesterol is a natural fatty substance produced in the liver and can also be found in some of the foods we eat. Too much bad cholesterol can lead to a build-up of fatty deposits inside the walls of blood vessels, causing them to become narrowed or blocked. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;With so many shifting messages, knowing which product to pick can often feel overwhelming.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Nita Forouhi, Professor of Population Health and Nutrition at the University of Cambridge, &lt;a target="_self" href="https://www.bbc.co.uk/programmes/articles/5d6Xw8BbzfGb2s3SMJDdFMd/which-oils-should-we-be-using-for-cooking" class="sc-f9178328-0 jZoZnB"&gt;tells the BBC's Sliced Bread podcast&lt;/a&gt; that no single oil holds the magic key to health and debunks three common myths about cooking oils.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;1. Use sunflower and vegetable oil for cooking&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 jHorPx"&gt;&lt;div data-testid="image" class="sc-5340b511-1 ilsLtA"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250919-090805-05e5ba0164-web-2.30.1-2/grey-placeholder.png" class="sc-5340b511-0 hagXkB hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp" loading="lazy" alt="Getty Images Close-up of a shopper holding a bottle of cooking oil in a supermarket aisle, focusing on food choices, daily shopping, and consumer lifestyle." class="sc-5340b511-0 bGQwLJ"&gt;&lt;span class="sc-5340b511-2 lha-dta"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p data-component="caption-block" class="sc-3b6b161a-0 etSgSK"&gt;&lt;figcaption class="sc-536eff7b-0 jFVvLh"&gt;Vegetable and sunflower oil is also a good budget option, costing around £2 a litre &lt;/figcaption&gt;&lt;/p&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Rapeseed oil (commonly sold as vegetable oil) and sunflower oils often get bad press with some claiming they are ultra-processed and can cause inflammation which can be damaging to cardiovascular health.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;But, there isn't evidence to back this up. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;In fact, these oils contain a low amount - 5-10% -  of unhealthy saturated fats and are high in healthier mono- and polyunsaturated fats. Polyunsaturated fats (including omega-3 and omega-6) are essential for brain and heart health.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Forouhi says that these oils are "absolutely good for us".&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;She explains that they can offer a reduction in disease risk "when saturated fats [which can raise bad cholesterol] like butter, lard or ghee are replaced with these oils".&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;At around £2 per litre in most supermarkets it's also a more budget friendly option  for cooking at home.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;2. Margarine can help reduce bad cholesterol&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 jHorPx"&gt;&lt;div data-testid="image" class="sc-5340b511-1 ilsLtA"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250919-090805-05e5ba0164-web-2.30.1-2/grey-placeholder.png" class="sc-5340b511-0 hagXkB hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp" loading="lazy" alt="Getty Images Stock photo shows a close up image of a knife running through margarine with a spot of sunlight pouring in." class="sc-5340b511-0 bGQwLJ"&gt;&lt;span class="sc-5340b511-2 lha-dta"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p data-component="caption-block" class="sc-3b6b161a-0 etSgSK"&gt;&lt;figcaption class="sc-536eff7b-0 jFVvLh"&gt;Modern day margarines have close to zero amounts of trans fats in&lt;/figcaption&gt;&lt;/p&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Margarine has had a bad reputation for years and many of us believe we should steer clear of it. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;That's because it used to contain harmful trans fats which are strongly linked with cardiovascular disease but modern day margarines "have close to zero amounts of trans fats" according to Forouhi. "So it can actually be part of a healthy diet and reduce the bad cholesterols."&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Butter also isn't off the menu entirely. "If you love butter, for instance on your toast, by all means have it," says Forouhi. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;You can use both margarine and butter for cooking, but Forouhi recommends sometimes swapping them out for oil instead which has less saturated fat in. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;UK health guidelines advise to keep your saturated fat intake below 10% of calories and this is easier to do if you're using oil to cook with instead of butter.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;3. Olive oil isn't suitable for deep frying &lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 jHorPx"&gt;&lt;div data-testid="image" class="sc-5340b511-1 ilsLtA"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250919-090805-05e5ba0164-web-2.30.1-2/grey-placeholder.png" class="sc-5340b511-0 hagXkB hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp" loading="lazy" alt="Getty Images A stock photo shows a woman pouring a big bottle of sunflower oil into a deep wok pan on an electric hob with cooking ingredients all around her and her kitchen cabinets and oven in the background." class="sc-5340b511-0 bGQwLJ"&gt;&lt;span class="sc-5340b511-2 lha-dta"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p data-component="caption-block" class="sc-3b6b161a-0 etSgSK"&gt;&lt;figcaption class="sc-536eff7b-0 jFVvLh"&gt;Use sunflower or vegetable oil if you're deep frying food &lt;/figcaption&gt;&lt;/p&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Oils behave differently when heated which makes some of them unsuitable for frying.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Extra virgin olive oil, for example, is packed with antioxidants and beneficial compounds but its low smoke point means it is better for salad dressings or drizzling over food rather than deep frying.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;A smoke point is the point at which the fats in the oil start to break down and nasty compounds are released which can make the oil taste bitter, burnt or unpleasant. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Restaurateur Tim Hayward says for shallow frying he uses a basic olive oil.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;But for deep frying something like chips or battered fish, vegetable or sunflower oil is best as they withstand higher temperatures without breaking down. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Some studies have also shown that oils heated to above their smoke point release toxic chemical by-products. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;But Professor Forouhi says that type of cooking in the home is not very common and that long-term health studies still show that vegetable oils "without exception are related with better outcomes for chronic diseases."&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;Which oils should I be using? &lt;/h2&gt;&lt;/p&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;If you're looking for a simple kitchen strategy:&lt;/p&gt;&lt;ul class="sc-6f869981-0 bYhyhr"&gt;&lt;li class="sc-734a601e-0 NnDUj"&gt;For everyday cooking: Sunflower or rapeseed oil are affordable, healthy, and versatile. You could also use a basic olive oil&lt;/li&gt;&lt;/ul&gt;&lt;ul class="sc-6f869981-0 bYhyhr"&gt;&lt;li class="sc-734a601e-0 NnDUj"&gt;For salads and finishing dishes: Extra virgin olive oil adds flavour and health benefits&lt;/li&gt;&lt;/ul&gt;&lt;ul class="sc-6f869981-0 bYhyhr"&gt;&lt;li class="sc-734a601e-0 NnDUj"&gt;For deep frying: Stick with a high smoke point oil like vegetable or sunflower&lt;/li&gt;&lt;/ul&gt;&lt;ul class="sc-6f869981-0 bYhyhr"&gt;&lt;li class="sc-734a601e-0 NnDUj"&gt;For flavour variety: While they may not have the same health benefits as olive oil, you could use sesame, coconut or avocado oils for cold dishes if you like the flavour&lt;/li&gt;&lt;/ul&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Overall, Professor Forouhi says it is better to look at your whole diet rather than obsess over which bottle to buy. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;"I would recommend going with what taste and cost considerations you have and experiment with different types of oil that will bring you some health benefits," she explains. &lt;/p&gt;&lt;/div&gt;&lt;figure&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;&lt;a target="_self" href="https://www.bbc.co.uk/newsletters/zyxfdnb" class="sc-f9178328-0 jZoZnB"&gt;Sign up here&lt;/a&gt; to receive our weekly newsletter highlighting uplifting stories and remarkable people from around the world.&lt;/p&gt;&lt;/div&gt;&lt;/article&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>BBC</author><pubDate>Wed, 01 Oct 2025 23:06:27 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiWkFVX3lxTE5tVHI1Rmhkbzk3V0JYem5PM01rMVBBZnNsc2F2LXNNZ01jOVlkZ204Um9wZVBMYkhwUUlkczJzbU1pdUJ5U2lHWmZXSE52aXdLa0w0UnpQeWk2Z9IBX0FVX3lxTE55dDVfT0JGZjZWNkMzOUdqYU4zMFprbW52VDVfWEhWd1Vxa1RleWxfVF80LU9PVXZ3UU1MQnM2WURpMEttMTNsRVF0NnVXNVhqSjJKbk9iaDA5NDVZemVF</guid></item><item><title>我应该使用橄榄油油炸吗？如何选择合适的食用油- BBC</title><link>https://www.bbc.com/news/articles/cj3y7j2dz44o</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;article&gt;&lt;p data-component="headline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h1 class="sc-f98b1ad2-0 jRDKjj"&gt;Should I use olive oil for frying? How to choose the right cooking oil&lt;/h1&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 ERpRj"&gt;&lt;div data-testid="hero-image" class="sc-5340b511-1 ilsLtA"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250919-090805-05e5ba0164-web-2.30.1-2/grey-placeholder.png" class="sc-5340b511-0 hagXkB hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/cecb/live/f253c650-9dea-11f0-b3aa-f94b46cdf49f.jpg.webp" loading="eager" alt="Getty Images Assorted healthy vegetable oil bottle collection on wooden table in a old fashioned kitchen with low key illumination: Olive oil, hazelnut oil, almond oil, coconut oil and sesame oil" class="sc-5340b511-0 bGQwLJ"&gt;&lt;span class="sc-5340b511-2 lha-dta"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Supermarket shelves are packed with oils from budget bottles of sunflower and vegetable oil to pricier olive, avocado and coconut oils claiming health benefits.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Oils and fats have been at the centre of nutritional debate for years and to understand why it matters, it helps to look at the different types of fat they contain.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Not all fats behave the same way in the body - some raise cholesterol while others help lower it. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Cholesterol is a natural fatty substance produced in the liver and can also be found in some of the foods we eat. Too much bad cholesterol can lead to a build-up of fatty deposits inside the walls of blood vessels, causing them to become narrowed or blocked. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;With so many shifting messages, knowing which product to pick can often feel overwhelming.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Nita Forouhi, Professor of Population Health and Nutrition at the University of Cambridge, &lt;a target="_self" href="https://www.bbc.co.uk/programmes/articles/5d6Xw8BbzfGb2s3SMJDdFMd/which-oils-should-we-be-using-for-cooking" class="sc-f9178328-0 jZoZnB"&gt;tells the BBC's Sliced Bread podcast&lt;/a&gt; that no single oil holds the magic key to health and debunks three common myths about cooking oils.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;1. Use sunflower and vegetable oil for cooking&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 jHorPx"&gt;&lt;div data-testid="image" class="sc-5340b511-1 ilsLtA"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250919-090805-05e5ba0164-web-2.30.1-2/grey-placeholder.png" class="sc-5340b511-0 hagXkB hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/7744/live/e1651960-9deb-11f0-b3aa-f94b46cdf49f.jpg.webp" loading="lazy" alt="Getty Images Close-up of a shopper holding a bottle of cooking oil in a supermarket aisle, focusing on food choices, daily shopping, and consumer lifestyle." class="sc-5340b511-0 bGQwLJ"&gt;&lt;span class="sc-5340b511-2 lha-dta"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p data-component="caption-block" class="sc-3b6b161a-0 etSgSK"&gt;&lt;figcaption class="sc-536eff7b-0 jFVvLh"&gt;Vegetable and sunflower oil is also a good budget option, costing around £2 a litre &lt;/figcaption&gt;&lt;/p&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Rapeseed oil (commonly sold as vegetable oil) and sunflower oils often get bad press with some claiming they are ultra-processed and can cause inflammation which can be damaging to cardiovascular health.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;But, there isn't evidence to back this up. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;In fact, these oils contain a low amount - 5-10% -  of unhealthy saturated fats and are high in healthier mono- and polyunsaturated fats. Polyunsaturated fats (including omega-3 and omega-6) are essential for brain and heart health.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Forouhi says that these oils are "absolutely good for us".&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;She explains that they can offer a reduction in disease risk "when saturated fats [which can raise bad cholesterol] like butter, lard or ghee are replaced with these oils".&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;At around £2 per litre in most supermarkets it's also a more budget friendly option  for cooking at home.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;2. Margarine can help reduce bad cholesterol&lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 jHorPx"&gt;&lt;div data-testid="image" class="sc-5340b511-1 ilsLtA"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250919-090805-05e5ba0164-web-2.30.1-2/grey-placeholder.png" class="sc-5340b511-0 hagXkB hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/204f/live/dcc67a60-9ef0-11f0-928c-71dbb8619e94.jpg.webp" loading="lazy" alt="Getty Images Stock photo shows a close up image of a knife running through margarine with a spot of sunlight pouring in." class="sc-5340b511-0 bGQwLJ"&gt;&lt;span class="sc-5340b511-2 lha-dta"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p data-component="caption-block" class="sc-3b6b161a-0 etSgSK"&gt;&lt;figcaption class="sc-536eff7b-0 jFVvLh"&gt;Modern day margarines have close to zero amounts of trans fats in&lt;/figcaption&gt;&lt;/p&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Margarine has had a bad reputation for years and many of us believe we should steer clear of it. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;That's because it used to contain harmful trans fats which are strongly linked with cardiovascular disease but modern day margarines "have close to zero amounts of trans fats" according to Forouhi. "So it can actually be part of a healthy diet and reduce the bad cholesterols."&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Butter also isn't off the menu entirely. "If you love butter, for instance on your toast, by all means have it," says Forouhi. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;You can use both margarine and butter for cooking, but Forouhi recommends sometimes swapping them out for oil instead which has less saturated fat in. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;UK health guidelines advise to keep your saturated fat intake below 10% of calories and this is easier to do if you're using oil to cook with instead of butter.&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;3. Olive oil isn't suitable for deep frying &lt;/h2&gt;&lt;/p&gt;&lt;figure&gt;&lt;div data-component="image-block" class="sc-3b6b161a-0 jHorPx"&gt;&lt;div data-testid="image" class="sc-5340b511-1 ilsLtA"&gt;&lt;img src="https://static.files.bbci.co.uk/bbcdotcom/web/20250919-090805-05e5ba0164-web-2.30.1-2/grey-placeholder.png" class="sc-5340b511-0 hagXkB hide-when-no-script" aria-label="image unavailable"&gt;&lt;img sizes="(min-width: 1280px) 50vw, (min-width: 1008px) 66vw, 96vw" srcset="https://ichef.bbci.co.uk/news/240/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 240w,https://ichef.bbci.co.uk/news/320/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 320w,https://ichef.bbci.co.uk/news/480/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 480w,https://ichef.bbci.co.uk/news/640/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 640w,https://ichef.bbci.co.uk/news/800/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 800w,https://ichef.bbci.co.uk/news/1024/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 1024w,https://ichef.bbci.co.uk/news/1536/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp 1536w" src="https://ichef.bbci.co.uk/news/480/cpsprodpb/4198/live/01c15600-9ef1-11f0-92db-77261a15b9d2.jpg.webp" loading="lazy" alt="Getty Images A stock photo shows a woman pouring a big bottle of sunflower oil into a deep wok pan on an electric hob with cooking ingredients all around her and her kitchen cabinets and oven in the background." class="sc-5340b511-0 bGQwLJ"&gt;&lt;span class="sc-5340b511-2 lha-dta"&gt;Getty Images&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p data-component="caption-block" class="sc-3b6b161a-0 etSgSK"&gt;&lt;figcaption class="sc-536eff7b-0 jFVvLh"&gt;Use sunflower or vegetable oil if you're deep frying food &lt;/figcaption&gt;&lt;/p&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Oils behave differently when heated which makes some of them unsuitable for frying.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Extra virgin olive oil, for example, is packed with antioxidants and beneficial compounds but its low smoke point means it is better for salad dressings or drizzling over food rather than deep frying.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;A smoke point is the point at which the fats in the oil start to break down and nasty compounds are released which can make the oil taste bitter, burnt or unpleasant. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Restaurateur Tim Hayward says for shallow frying he uses a basic olive oil.&lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;But for deep frying something like chips or battered fish, vegetable or sunflower oil is best as they withstand higher temperatures without breaking down. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Some studies have also shown that oils heated to above their smoke point release toxic chemical by-products. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;But Professor Forouhi says that type of cooking in the home is not very common and that long-term health studies still show that vegetable oils "without exception are related with better outcomes for chronic diseases."&lt;/p&gt;&lt;/div&gt;&lt;p data-component="subheadline-block" class="sc-3b6b161a-0 bPbmDW"&gt;&lt;h2 class="sc-f98b1ad2-0 fsBZby"&gt;Which oils should I be using? &lt;/h2&gt;&lt;/p&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;If you're looking for a simple kitchen strategy:&lt;/p&gt;&lt;ul class="sc-6f869981-0 bYhyhr"&gt;&lt;li class="sc-734a601e-0 NnDUj"&gt;For everyday cooking: Sunflower or rapeseed oil are affordable, healthy, and versatile. You could also use a basic olive oil&lt;/li&gt;&lt;/ul&gt;&lt;ul class="sc-6f869981-0 bYhyhr"&gt;&lt;li class="sc-734a601e-0 NnDUj"&gt;For salads and finishing dishes: Extra virgin olive oil adds flavour and health benefits&lt;/li&gt;&lt;/ul&gt;&lt;ul class="sc-6f869981-0 bYhyhr"&gt;&lt;li class="sc-734a601e-0 NnDUj"&gt;For deep frying: Stick with a high smoke point oil like vegetable or sunflower&lt;/li&gt;&lt;/ul&gt;&lt;ul class="sc-6f869981-0 bYhyhr"&gt;&lt;li class="sc-734a601e-0 NnDUj"&gt;For flavour variety: While they may not have the same health benefits as olive oil, you could use sesame, coconut or avocado oils for cold dishes if you like the flavour&lt;/li&gt;&lt;/ul&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;Overall, Professor Forouhi says it is better to look at your whole diet rather than obsess over which bottle to buy. &lt;/p&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;"I would recommend going with what taste and cost considerations you have and experiment with different types of oil that will bring you some health benefits," she explains. &lt;/p&gt;&lt;/div&gt;&lt;figure&gt;&lt;/figure&gt;&lt;div data-component="text-block" class="sc-3b6b161a-0 jdlrvG"&gt;&lt;p class="sc-9a00e533-0 bJoRPJ"&gt;&lt;a target="_self" href="https://www.bbc.co.uk/newsletters/zyxfdnb" class="sc-f9178328-0 jZoZnB"&gt;Sign up here&lt;/a&gt; to receive our weekly newsletter highlighting uplifting stories and remarkable people from around the world.&lt;/p&gt;&lt;/div&gt;&lt;/article&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>BBC</author><pubDate>Wed, 01 Oct 2025 23:06:27 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiWkFVX3lxTE5tVHI1Rmhkbzk3V0JYem5PM01rMVBBZnNsc2F2LXNNZ01jOVlkZ204Um9wZVBMYkhwUUlkczJzbU1pdUJ5U2lHWmZXSE52aXdLa0w0UnpQeWk2Zw</guid></item><item><title>明尼苏达州报告了另外13例麻疹病例，将2025年的总数提高到18例- Star Tribune</title><link>https://www.startribune.com/minnesota-reports-13-more-measles-cases-raising-2025-total-to-18/601484655</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div data-testid="article-body-item" class="rt-Box  pb-5 article-body-rich-text"&gt;&lt;div class="rt-Box w-full"&gt;&lt;p class="rt-Text"&gt;“They did not travel together in a group or tour or anything like that,” she said. &lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div data-testid="article-body-item" class="rt-Box  pb-5 article-body-rich-text"&gt;&lt;div class="rt-Box w-full"&gt;&lt;p class="rt-Text"&gt;Griffith encouraged people to seek testing if they develop fevers and other measleslike symptoms after exposure to people who have the disease, or if they develop the infection’s characteristic rash. &lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div data-testid="article-body-item" class="rt-Box  pb-5 article-body-rich-text"&gt;&lt;div class="rt-Box w-full"&gt;&lt;p class="rt-Text"&gt;Unvaccinated people exposed to measles are generally asked to stay home from work and public indoor places for 21 days to prevent further spread of the infection. The measles virus is one of the most infectious agents on the planet, capable of lingering in the air and spreading to others for two hours after sick people have left the area.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div data-testid="article-body-item" class="rt-Box  pb-5 article-body-rich-text"&gt;&lt;div class="rt-Box w-full"&gt;&lt;p class="rt-Text"&gt;A two-dose vaccine is 97% effective at preventing measles, but the infectious disease is making a comeback in the United States as parents decline the shots for their children. The 1,500 U.S. cases this year represent the highest total since 1992.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div data-testid="article-body-item" class="rt-Box  pb-5 article-body-rich-text"&gt;&lt;div class="rt-Box w-full"&gt;&lt;p class="rt-Text"&gt;Minnesota had one of the best measles vaccination rates in the nation a decade ago, when 94% of children had received the shots in time for kindergarten. However, the state had the sixth-worst rate, 87%, at the start of the 2022-23 school year. &lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div data-testid="article-body-item" class="rt-Box   article-body-rich-text"&gt;&lt;div class="rt-Box w-full"&gt;&lt;p class="rt-Text"&gt;Three children in the recent Minnesota clusters were hospitalized, Griffith said. &lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Star Tribune</author><pubDate>Wed, 01 Oct 2025 22:26:34 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMipAFBVV95cUxPY1RleEJXVzEtN3U3S1VyTDBlZ2dELV9sOVpzenlBUlRkRDVFZnNJODMzUHNzMzZTY3NqNy1Nb3ItVWpON2F1d2RadVV1V3BNcHh1bG1IdEVBZWNLNDB1SDlCM1U3U2NaVVZGOHdkSXo1eHladGJWZ3JOUGJpc0xRQTFPZGVRWEVKMnlVTTM2UC1pUFlaaDdiWUw1U3JQRk1nUnhMVA</guid></item><item><title>亚利桑那州犹他州公共卫生协调麻疹疫情应对-德撒律新闻</title><link>https://www.deseret.com/lifestyle/2025/10/01/utah-measles-case-count-keeps-rising-health-department/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="dn-article-body mt-4"&gt;&lt;div class="dn-article-body__key-points-list col-12"&gt;&lt;div class="key-points-list-content"&gt;&lt;ul&gt;&lt;li&gt;Utah confirmed 44 measles cases in 2025 compared to zero in 2024.&lt;/li&gt;&lt;li&gt;Most cases are in southwest Utah near Arizona's ongoing measles outbreak.&lt;/li&gt;&lt;li&gt;Measles vaccine exemption rates for Utah kindergartners exceed 10%.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;p class="c-paragraph"&gt;Utah has 44 confirmed measles cases so far in 2025, according to the &lt;a href="https://epi.utah.gov/measles-response/" target="_blank" rel="" title="https://epi.utah.gov/measles-response/"&gt;weekly update&lt;/a&gt; of the Utah Department of Health and Human Services measles dashboard.&lt;/p&gt;&lt;p class="c-paragraph"&gt;No cases were confirmed in 2024.&lt;/p&gt;&lt;p class="c-paragraph"&gt;According to the counts as of September 30, the majority of Utah cases — 30 — were in the southwest region near Arizona, a state that’s had 59 cases. The &lt;a href="https://www.azdhs.gov/preparedness/epidemiology-disease-control/measles/index.php" target="_blank" rel="" title="https://www.azdhs.gov/preparedness/epidemiology-disease-control/measles/index.php"&gt;Arizona Department of Health&lt;/a&gt; reports an ongoing outbreak of measles, with all but four of its cases in Mohave County.&lt;/p&gt;&lt;p class="c-paragraph"&gt;The outbreak spanning northern Arizona and southwest Utah is among the largest in the U.S. at the moment.&lt;/p&gt;&lt;p class="c-paragraph"&gt;Utah’s other 14 cases include four in northern Utah, three in southeast Utah and seven in Utah County. Measles detection in wastewater samples found virus shed in the same areas, but it doesn’t say how many people in each area had measles. The water detection result is the same for 1 or 100. &lt;/p&gt;&lt;h3 id="Exposure-then-symptom-watch" class="dn-article-body__h3"&gt;Exposure then symptom watch&lt;/h3&gt;&lt;p class="c-paragraph"&gt;There are three active symptom watch periods, but they’re nearly over. People might have been exposed to measles at the Budge Clinic in Logan if they were there Sept. 15 between 3 p.m. and 6:30 p.m. The last day to watch for symptoms from that is Oct. 6.&lt;/p&gt;&lt;p class="c-paragraph"&gt;Someone with measles was at Water Canyon High School in Hildale on Sept. 12, so others there at the same time have risk of exposure. That symptom watch ends Oct. 3.&lt;/p&gt;&lt;p class="c-paragraph"&gt;Finally, folks at Chick-fil-A in Providence, Utah, Sept. 11 between 6:30 p.m. and 9:30 p.m. can stop checking for symptoms after Oct. 2.&lt;/p&gt;&lt;p class="c-paragraph"&gt;Eight other exposures are no longer being watched as enough time has passed.&lt;/p&gt;&lt;h3 id="About-measles" class="dn-article-body__h3"&gt;About measles&lt;/h3&gt;&lt;p class="c-paragraph"&gt;Measles symptoms typically include a high fever (101°F or more), along with cough, runny nose, watery eyes and rash that starts at the hairline most of the time and then spreads down. &lt;/p&gt;&lt;p class="c-paragraph"&gt;The viral illness can cause complications, some very serious. Those include pneumonia, hospitalization, brain swelling that can lead to deafness and other problems, pregnancy complications, seizures and a weakened immune system that can linger for a long time and increase the risk of infections. Some people die.&lt;/p&gt;&lt;p class="c-paragraph"&gt;There’s no specific treatment for measles; rather, symptoms are managed.&lt;/p&gt;&lt;h3 id="The-national-count" class="dn-article-body__h3"&gt;The national count&lt;/h3&gt;&lt;p class="c-paragraph"&gt;As of Sept. 30, the &lt;a href="https://www.cdc.gov/measles/data-research/index.html" target="_blank" rel="" title="https://www.cdc.gov/measles/data-research/index.html"&gt;Centers for Disease Control and Prevention&lt;/a&gt; reports 1,544 cases nationally. The CDC said it is also aware of probable cases, but its count only includes those that have been lab confirmed. In 2024, there were 285 cases of measles nationwide.&lt;/p&gt;&lt;p class="c-paragraph"&gt;Of the 2025 measles cases, 21 were among international visitors. The other 1,523 cases were found in 42 jurisdictions: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Missouri, Montana, Nebraska, New Jersey, New Mexico, New York City, New York State, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Wisconsin and Wyoming.&lt;/p&gt;&lt;p class="c-paragraph"&gt;The CDC said 4% of cases involved those who’d had one dose of measles, mumps, rubella (MMR) vaccine, and similarly, 4% were individuals who’d had both recommended doses. The other 92% were unvaccinated or their status wasn’t known. Nearly 40% of the cases were in the age 5 to 19 (school age) population, while 27% were in children younger than 5. &lt;/p&gt;&lt;p class="c-paragraph"&gt;Twelve percent were hospitalized because of their measles symptom severity and three deaths have been attributed to measles this year.&lt;/p&gt;&lt;h3 id="Vaccination-among-Utah-school-kids" class="dn-article-body__h3"&gt;Vaccination among Utah school kids&lt;/h3&gt;&lt;p class="c-paragraph"&gt;Federal officials are urging parents to have their children vaccinated against measles. “Vaccines not only protect individual children from measles, but also contribute to community immunity,” acting CDC director Jim O’Neill said. He is also deputy secretary of the Department of Health and Human Services.&lt;/p&gt;&lt;p class="c-paragraph"&gt;According to the Utah Department of Health and Human Services, during the 2024-25 school year:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;About 10% of in-person kindergarten students in Utah had an exemption for the MMR vaccine or were missing documentation to show they were vaccinated against measles.&lt;/li&gt;&lt;li&gt;9.0% of in-person kindergarten students in Utah had an exemption to any school-required vaccine.&lt;/li&gt;&lt;li&gt;10.1% of all students in Utah had an exemption to any school-required vaccine, including students in online schools.&lt;/li&gt;&lt;/ul&gt;&lt;p class="c-paragraph"&gt;&lt;a href="https://www.nbcnews.com/health/health-news/measles-outbreak-utah-arizona-vaccines-data-schools-rcna232399" target="_blank" rel="" title="https://www.nbcnews.com/health/health-news/measles-outbreak-utah-arizona-vaccines-data-schools-rcna232399"&gt;NBC News and Stanford&lt;/a&gt; looked at vaccine rates for communicable diseases like measles. NBC reported that in Washington County, Utah, near the Arizona border, about 79% of kindergartners are vaccinated against measles — just a bit higher than the rate in Gaines County, Texas, which was the heart of the 2025 outbreak earlier this year. To get herd immunity protection, 95% need to be vaccinated. &lt;/p&gt;&lt;p class="c-paragraph"&gt;“I’ve worked for this health department for about 18 years, and we’ve never seen a case of measles that I know of up until this point,” David Heaton, the public information officer for the Southwest Utah Public Health Department, told NBC. “We are just at that low rate of (vaccine) uptake that does leave us open for this kind of an outbreak.”&lt;/p&gt;&lt;p class="c-paragraph"&gt;Arizona and Utah health officials are reportedly working collaboratively to respond to the outbreak.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Deseret News</author><pubDate>Wed, 01 Oct 2025 21:06:39 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiogFBVV95cUxQWjkwdWhBMUZBNGwzNWV4d2pWSVk3SUJJejJvaGYzM2JmdHJBTkZ3OEhiaDRBRG15MDhqeTNsdVpQanRMSUktT1lySUFqVTlRWUhxOWRvTFNLRy1ER2hLQUQ3X0xYeGc3Q1MyaElNRm1lYzZrb3dxYXJuUHpsN3dBcVVpM0wzdl9nZFQ1YTZyRFlUcEtZbmI2T09NVURDZXRNakE</guid></item><item><title>卫生部长警告性传播疾病和糖尿病发病率上升--特立尼达和多巴哥新闻日</title><link>https://newsday.co.tt/2025/10/01/tha-health-secretary-warns-of-rise-in-stis-diabetes/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;article class="article-content"&gt;


	&lt;a class="article-category" href="https://newsday.co.tt/category/news"&gt;News&lt;/a&gt;
&lt;header&gt;
	&lt;h1&gt;THA health secretary warns of rise in STIs, diabetes&lt;/h1&gt;
&lt;/header&gt;



&lt;address class="article-author"&gt;
	&lt;a rel="author" href="https://newsday.co.tt/reporter/newsday_reporter"&gt;
		Newsday Reporter								
	&lt;/a&gt;
&lt;/address&gt;



&lt;time class="date-time" pubdate datetime="2025-10-01" title="Wednesday 1 October 2025"&gt;5 Hrs Ago&lt;/time&gt;

&lt;figure id="article-featured-image" class="article-featured-image"&gt;&lt;img fetchpriority="high" src="https://newsday.co.tt/wp-content/uploads/2025/10/23227615.jpg" alt="THA Health Secretary Dr Faith Brebnor - "&gt;&lt;figcaption&gt;THA Health Secretary Dr Faith Brebnor - &lt;/figcaption&gt;&lt;/figure&gt;



&lt;p&gt;THA Secretary of Health, Wellness and Social Protection has reported an increase in sexually transmitted infections (STIs) and diabetes cases on the island.&lt;/p&gt;
&lt;p&gt;At the launch of a health and wellness campaign titled “Play Mas, Live Well” on September 29 at the Hochoy Charles Administrative Complex in Calder Hall, Dr Faith Brebnor made the startling revelation as she encouraged people to take charge of their health.&lt;/p&gt;
&lt;p&gt;“This was a good opportunity to say to the people of Tobago, to the people of TT, that we need us – all of us – to really be healthy – head to toe, and head to toe includes those...private parts.”&lt;/p&gt;
&lt;p&gt;She said before becoming health secretary, she along with others spoke publicly on the issue of contracting HIV and being able to live a long, healthy life with medication.&lt;/p&gt;
&lt;p&gt;“We really are seeing increased rates of almost all of the STIs throughout the island.&lt;/p&gt;
&lt;p class="ad-manager-half-page-mobile-ad-300x600 ad-space-centered" id="div-gpt-ad-1550239531467-0"&gt;
&lt;/p&gt;
&lt;p&gt;"So way back when, when we started talking about HIV and the thing that we were looking at, or the images that we looked at included people looking very sick, and then we went through that wave and then we recognised that there was medication that was available for us and that you did not have to die from HIV but you could live a very long, healthy life with HIV, and then somehow we stopped talking.”&lt;/p&gt;
&lt;p&gt;She noted that with these concerning statistics will be addressed in the “Play Mas, Live Well” campaign and accompanying initiatives.&lt;/p&gt;
&lt;p&gt;“We stopped talking about STIs and we stopped talking about all of the other things, about consent and those areas, and we decided that this was a great opportunity because those things, we are seeing the numbers raised again. This was a good opportunity to say to the people of Tobago, to the people of Trinidad and Tobago, that we really need all of us to be healthy.”&lt;/p&gt;
&lt;p&gt;Using information shared by a health practitioner, she said people in their thirties are reporting HbA1c (blood glucose) readings over 14 per cent. Readings below 5.7 per cent are considered normal, while prediabetes is between 5.7 per cent and 6.4 per cent. Diabetes is diagnosed with readings 6.5 per cent or higher.&lt;/p&gt;
&lt;p&gt;“We now have significantly younger people who are having long-term (diabetes), because HbA1c is not because you drank something and your sugar is high now, it is because you have had uncontrolled high sugar, in essence, in your system for a long time.&lt;/p&gt;
&lt;p&gt;"So this means we have increased numbers of young people (with diabetes), because this used to be what happened to the older people who are treating with these issues.”&lt;/p&gt;
&lt;p&gt;The launch ended with the first aerobic burnout session.
&lt;/p&gt;&lt;/article&gt;



&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Trinidad and Tobago Newsday</author><pubDate>Wed, 01 Oct 2025 19:29:40 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijgFBVV95cUxPUEt0QzQxMm5zeTBjR2JYM1RtdkYzM1RKU2s2VXdXeTNjNmpHa2lKRkxzUnB3T3NRXzB0LWlyUnJHMWhRcmJxcDktU3VvdU1OVFlYOEZuRTJIWUw5R3p6V0FCQnB4WUZMVVZ5T0ttS2tyZFF2blVtcjVxQUNWby1MdGI1U0ltaFk5c3RiS213</guid></item><item><title>长寿研究：饮食压力支持健康衰老- Medical Xpress</title><link>https://medicalxpress.com/news/2025-10-longevity-dietary-stress-healthy-aging.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="mt-4 article-main"&gt;
									    
&lt;div class="article-gallery lightGallery"&gt;
    &lt;div data-thumb="https://scx1.b-cdn.net/csz/news/tmb/2025/longevity-research-die.jpg" data-src="https://scx2.b-cdn.net/gfx/news/hires/2025/longevity-research-die.jpg" data-sub-html="A balanced diet keeps the nematode C. elegans (pictured) fit and healthy in old age. Credit: Jachen Solinger, Biozentrum, University of Basel"&gt;
        &lt;figure class="article-img"&gt;
            &lt;img src="https://scx1.b-cdn.net/csz/news/800a/2025/longevity-research-die.jpg" alt="Longevity research: Dietary stress supports healthy aging" title="A balanced diet keeps the nematode C. elegans (pictured) fit and healthy in old age. Credit: Jachen Solinger, Biozentrum, University of Basel"&gt;
             &lt;figcaption class="text-darken text-low-up text-truncate-js text-truncate mt-3"&gt;
                A balanced diet keeps the nematode C. elegans (pictured) fit and healthy in old age. Credit: Jachen Solinger, Biozentrum, University of Basel
            &lt;/figcaption&gt;        &lt;/figure&gt;
    &lt;/div&gt;
&lt;/div&gt;&lt;p&gt;Certain nutrients in food can trigger a mild stress response in nematodes. But instead of making them sick, this actually helps them stay healthier as they age, according to researchers at the University of Basel, Switzerland.&lt;/p&gt;

                                        
                                                                                &lt;p class="w-100 my-4 d-print-none"&gt;
     
     
     &lt;ins class="adsbygoogle" data-ad-layout="in-article" data-ad-format="fluid" data-ad-client="ca-pub-0536483524803400" data-ad-slot="7587637799"&gt;&lt;/ins&gt;
     
&lt;/p&gt;  
                                         

                                                                                                                                    &lt;p&gt;The results of their study have been &lt;a href="https://www.nature.com/articles/s41467-025-63987-x" target="_blank"&gt;published&lt;/a&gt; in &lt;i&gt;Nature Communications&lt;/i&gt;.&lt;/p&gt;
&lt;p&gt;People are living longer than ever, but a &lt;a href="https://medicalxpress.com/tags/long+life/" rel="tag" class="textTag"&gt;long life&lt;/a&gt; doesn't necessarily mean a healthy one. For many, the question isn't so much "How old do I want to get?" but rather "How do I want to get old?" While lifespan refers to the years we live from birth to death, "healthspan" describes the number of years we spend in good health.&lt;/p&gt;
&lt;p&gt;Healthy aging is also a question of diet. It's long been known that not just the quantity, but also the individual nutrients impact how we age. Using the tiny worm Caenorhabditis elegans, corresponding author Anne Spang's team has now demonstrated that certain RNA molecules in food have a positive effect on the worm's fitness in old age.&lt;/p&gt;
&lt;p&gt;"These molecules prevent the formation of harmful protein aggregates that are typically linked with aging and disease," says Spang.&lt;/p&gt;
&lt;h2&gt;How diet shapes aging&lt;/h2&gt;
&lt;p&gt;With age, the body becomes less efficient at removing altered and damaged proteins. These can accumulate and form harmful protein aggregates in cells. Such protein aggregates are considered drivers of aging and are associated with multiple &lt;a href="https://medicalxpress.com/tags/age-related+diseases/" rel="tag" class="textTag"&gt;age-related diseases&lt;/a&gt; including muscular and &lt;a href="https://medicalxpress.com/tags/neurodegenerative+diseases/" rel="tag" class="textTag"&gt;neurodegenerative diseases&lt;/a&gt; such as Alzheimer's and Parkinson's disease.&lt;/p&gt;
&lt;p&gt;The researchers have discovered that a &lt;a href="https://medicalxpress.com/tags/balanced+diet/" rel="tag" class="textTag"&gt;balanced diet&lt;/a&gt; promotes healthspan, and specific components in the nematode's diet exert a protective effect. The &lt;a href="https://medicalxpress.com/tags/worms/" rel="tag" class="textTag"&gt;worms&lt;/a&gt; feed mainly on bacteria that contain double-stranded RNA molecules.&lt;/p&gt;
&lt;p&gt;"These dietary RNAs are absorbed in the gut and activate quality-control mechanisms to protect from &lt;a href="https://medicalxpress.com/tags/cellular+stress/" rel="tag" class="textTag"&gt;cellular stress&lt;/a&gt;," explains Emmanouil Kyriakakis, the study's first author. "This low-level stress essentially trains the body to cope with protein damage more effectively."&lt;/p&gt;

                                                                                                        
    &lt;p class="w-100 mb-4 ads"&gt;
          
        
        &lt;ins class="adsbygoogle" data-ad-layout="in-article" data-ad-format="fluid" data-ad-client="ca-pub-0536483524803400" data-ad-slot="7099578867"&gt;&lt;/ins&gt;
        
    &lt;/p&gt;
                                                                                                                                                                                                &lt;h2&gt;Diet-dependent mechanisms slow cellular aging&lt;/h2&gt;
&lt;p&gt;Diet activates autophagy—a cellular cleanup process that degrades and recycles damaged proteins. This mechanism reduces harmful protein aggregation and thus slows down cell aging.&lt;/p&gt;
&lt;p&gt;"We were surprised to find that the gut communicates with other organs," says Kyriakakis. "We observed protective effects not only locally, but also in muscles and throughout the whole organism."&lt;/p&gt;
&lt;h2&gt;Healthier aging—even in worms&lt;/h2&gt;
&lt;p&gt;Overall, the worms exposed to a balanced diet were more active and healthier in old age.&lt;/p&gt;
&lt;p&gt;"The dietary-RNA species elicit a systemic stress response that protects the worms from &lt;a href="https://medicalxpress.com/tags/protein/" rel="tag" class="textTag"&gt;protein&lt;/a&gt; aggregation during aging," says Kyriakakis, "thereby extending their healthspan."&lt;/p&gt;
&lt;p&gt;The findings confirm that diet strongly influences health in old age.&lt;/p&gt;
&lt;p&gt;"Specific food components can stimulate the body's own protective mechanisms," adds Spang. "So, a little stress can be good for you."&lt;/p&gt;
&lt;p&gt;Whether individual nutrients can also spark beneficial effects in humans—and potentially help prevent age-related diseases—remains to be investigated. But it's certainly conceivable. What is clear already: What we eat can shape the way we age.&lt;/p&gt;

                                                                                                                                    
                                                                                
                                        											&lt;div class="article-main__more p-4"&gt;
												                                                    &lt;p&gt;&lt;strong&gt;More information:&lt;/strong&gt;
                                                    Emmanouil Kyriakakis et al, Bacterial RNA promotes proteostasis through inter-tissue communication in C. elegans, &lt;i&gt;Nature Communications&lt;/i&gt; (2025). &lt;a data-doi="1" href="https://dx.doi.org/10.1038/s41467-025-63987-x" target="_blank"&gt;DOI: 10.1038/s41467-025-63987-x&lt;/a&gt;
																								
																								&lt;/p&gt;
																							&lt;/div&gt;
                                        											
																					
                                                                                                                        
                                        
                                        &lt;div class="d-none d-print-block"&gt;
                                            &lt;p class="mb-4"&gt;
                                                 &lt;strong&gt;Citation&lt;/strong&gt;:
                                                 Longevity research: Dietary stress supports healthy aging (2025, October 1)
                                                 retrieved 2 October 2025
                                                 from https://medicalxpress.com/news/2025-10-longevity-dietary-stress-healthy-aging.html
                                            &lt;/p&gt;
                                            &lt;p class="border text-muted p-3"&gt;
                                            This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
                                            part may be reproduced without the written permission. The content is provided for information purposes only.
                                            &lt;/p&gt;
                                        &lt;/div&gt;
                                        
									&lt;/div&gt;
								&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Medical Xpress</author><pubDate>Wed, 01 Oct 2025 19:10:01 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiigFBVV95cUxQZFdPOFB5T1N4WkJmeFVkLXhXeno5YV9sQ2EwVkR5ZGEySVBhZGJKUnJZMEVuZTZ6NmpGUWV4Y3VaYXk2akJPVTFRM0JGNWEwV2s3TG1VU1RxMzk3cjlxU2lHSUk5TGZaazZxdEkzdmRmbHR1OHBOMnpRblIxem5iVWE1SnVWUk1fNHc</guid></item><item><title>科学家研究了自我诊断患有多动症的人。他们的发现揭示了什么- Gizmodo</title><link>https://gizmodo.com/scientists-studied-people-with-self-diagnosed-adhd-what-they-found-was-revealing-2000666179</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="entry-content prose dark:prose-invert lg:prose-xl "&gt;
        &lt;p&gt;New research out today shows that there are key differences between people who self-diagnose themselves with attention-deficit/hyperactivity disorder and those diagnosed by a doctor.&lt;/p&gt; &lt;p&gt;Scientists at Michigan State University examined hundreds of thousands of Reddit posts from users of a forum dedicated to ADHD. Among other things, they found that self-diagnosed individuals were more likely to have a negative self-image than people clinically diagnosed with ADHD; they also tended to seek out validation online and from their loved ones more often.&lt;/p&gt;&lt;p class="not-prose my-8 -mx-5 xs:max-w-xs xs:mx-auto"&gt;&lt;/p&gt; &lt;p&gt;The findings suggest it’s important to recognize how people’s identity surrounding ADHD can be shaped by the origin of their diagnosis, the researchers say.&lt;/p&gt; &lt;h2&gt;A Reddit analysis&lt;/h2&gt; &lt;p&gt;The study authors initially analyzed over 450,000 posts on the subreddit r/ADHD, made over a 14-year span between 2009 and 2023.&lt;/p&gt; &lt;p&gt;They ultimately studied a subset of 211,000 posts, made by 15,432 unique users, that clearly indicated a person’s diagnosis status. In one example of self-diagnosis cited by the authors, the user stated that they were “undiagnosed but suspecting things.” They analyzed the language of these posts, looking for signs of validation-seeking, negative self-image, and internalized stigma (one example of the latter: “I avoided treatment for years because of the shame of the source”).&lt;/p&gt;

  &lt;p class="not-prose"&gt;&lt;/p&gt; &lt;p&gt;All in all, they found that people with self-diagnosed ADHD were more likely to look down on themselves and to express internalized stigma in these posts than those with clinically diagnosed ADHD. They were also more likely to express wanting validation of their condition, both social (from their real-life peers) and media (from mass media portrayals or large online communities like r/ADHD).&lt;/p&gt;

 &lt;p&gt;At the same time, having social validation was associated with people having both negative and positive self-images. And while people with clinically diagnosed ADHD sought validation less often, the link between validation and a person’s self-image and internalized stigma was actually stronger in this group than in people with self-diagnosed ADHD.&lt;/p&gt;

 &lt;h2&gt;What to take away&lt;/h2&gt; &lt;p&gt;The findings appear to reaffirm a concept in psychology known as &lt;a href="https://psycnet.apa.org/record/2011-21802-002"&gt;self-verification theory&lt;/a&gt;, the researchers say, which argues that we prefer other people to see us the same way as we see ourselves.&lt;/p&gt; &lt;p&gt;In this particular case, they argue, people with self-diagnosed ADHD are more motivated to seek confirmation of their issues in online communities like Reddit since they lack formal recognition from a doctor. But while being validated might improve a person’s outlook in some ways, it can also reinforce a person’s negative self-perceptions and belief in stereotypes associated with having that condition, which then contributes to internalized shame and stigma.&lt;/p&gt;

  &lt;p class="not-prose"&gt;&lt;/p&gt; &lt;p&gt;The major, if perhaps obvious, takeaway here is that online communities and social media can greatly shape how individuals with ADHD view themselves, the researchers say. And ideally, these communities should share accurate information about the condition that can support a positive self-image and reduce stigma.&lt;/p&gt;

 &lt;p&gt;“Collaboration with mental health organizations is essential to ensure the dissemination of evidence-based content, which can strengthen social support networks and promote positive mental health outcomes for the ADHD community,” the authors wrote in their paper, &lt;a href="http://plos.io/4plEDJz"&gt;published&lt;/a&gt; Wednesday in PLOS-One.&lt;/p&gt; &lt;p&gt;Unfortunately, that might be easier said than done. Other studies have suggested that misinformation about ADHD is rampant online. A study this past March, for instance, found that nearly half of the most popular ADHD-related videos on TikTok &lt;a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0319335"&gt;contained&lt;/a&gt; misleading claims about the condition; the researchers also noted that the more people watched this kind of content, the more likely they were to overestimate how many Americans are thought to have ADHD (it’s estimated about 6% of adults and 11% of children are &lt;a href="https://chadd.org/about-adhd/general-prevalence/"&gt;currently diagnosed&lt;/a&gt; with ADHD).&lt;/p&gt;

 &lt;p&gt;It’s also worth noting that even experts in the field are still &lt;a href="https://gizmodo.com/why-are-adhd-rates-so-much-higher-in-the-u-s-2000595804"&gt;debating&lt;/a&gt; over just how common ADHD truly is among the general public.&lt;/p&gt;      &lt;/div&gt;
    &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Gizmodo</author><pubDate>Wed, 01 Oct 2025 18:00:46 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMisAFBVV95cUxNTW10bEVGc25ZSFJ6WFdsU2dESmNNSlFDUVpKNHdZV2p4cVJtSS1USGtFMWJvLXo5R3hYZ05KYkViczdaNTVqWFVkRjROQWZDbUd0U3U4anRzaTJSTnpOUXJ0VDhWUmZCSG1odEVTbFJnSTBRaDBSQ3hyZmdjUDROYVluWXpOa0tnbnpvZTdHWEktV1RPUzJlekVZejFFbUctQ0g0WjhmejNRRzZEYWRMYQ</guid></item><item><title>州警方称146号公路的所有车道都开放- WJAR</title><link>https://turnto10.com/news/local/crashes-disrupting-traffic-on-route-146-north-and-south</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="index-module_storyColumn__EZ7G" id="js-Story-Content-0"&gt;&lt;p class="StoryTags-module_tagWrapperLine__Jfav"&gt;&lt;/p&gt;&lt;div class="StoryText-module_storyText__FWhP"&gt;&lt;p&gt;Rhode Island State Police said Wednesday that both directions of Route 146 were open again.&lt;/p&gt;&lt;p&gt;The highway was shut down earlier north of Route 99 because of low-hanging power lines.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;Earlier, the Rhode Island Department of Transportation reported that two separate crashes were disrupting traffic on Route 146 in Lincoln and North Smithfield.&lt;/p&gt;&lt;p&gt;RIDOT said on X at about 2:15 p.m. that a crash had been cleared from Route 146 north at Interstate 295 in Lincoln.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;In a separate post, RIDOT said a second crash was cleared from the travel lanes of Route 146 south at Sayles Hill Road in North Smithfield.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;No additional information was immediately available.&lt;/p&gt;&lt;p&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;br&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>WJAR</author><pubDate>Wed, 01 Oct 2025 17:26:54 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMikAFBVV95cUxNTnE2a2RLZXFzZTdvMWlFTGpTSHg1dkRrWXB2cUczN3JrUWZySUZ6LVB5V25KWldocC1ySGxGTkFTUFZRamxRNkh5Z1RXeGRTcG5Sb2Z6UHVUY0F2c0RRbmRXeWxwTTROZkRvLXlqVUZ1YzhyM0hVT2tVZnJLWXBpUnF2ZTJDYWhzM3F6RTdMaHQ</guid></item><item><title>心脏病专家揭示了实际有效的降低胆固醇的3个简单变化-印度时报</title><link>https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/cardiologist-reveals-3-simple-changes-to-lower-cholesterol-that-actually-work/photostory/124263476.cms</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="COQxt" data-ua-type="1"&gt;&lt;p&gt;Patients who show up with stubbornly high cholesterol usually expect a genetic explanation. Dr. Shailesh Singh, an interventional cardiologist, cuts through that expectation on Twitter: “Your cholesterol isn't high because of genetics. It's high because you eat like s***, don't move, and pretend you'll 'start Monday.'” He goes on to name three repeatable choices that, he says, drive most of what he treats in clinic. The claim is blunt, but it’s worth asking whether the evidence lines up with the bluntness.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Times of India</author><pubDate>Wed, 01 Oct 2025 16:44:03 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">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</guid></item><item><title>自闭症的特征可以影响诊断年龄–基因也可以-自然</title><link>https://www.nature.com/articles/d41586-025-03180-8</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article__teaser" data-test="access-teaser"&gt; &lt;figure class="figure"&gt;&lt;picture class="embed intensity--high"&gt;&lt;source type="image/webp" srcset="//media.nature.com/lw767/magazine-assets/d41586-025-03180-8/d41586-025-03180-8_51508972.jpg?as=webp 767w, //media.nature.com/lw319/magazine-assets/d41586-025-03180-8/d41586-025-03180-8_51508972.jpg?as=webp 319w" sizes="(max-width: 319px) 319px, (min-width: 1023px) 100vw,  767px"&gt;&lt;/source&gt;&lt;img class="figure__image" alt="A top-down view of three young children playing with colourful plastic bears in a classroom" loading="lazy" src="//media.nature.com/lw767/magazine-assets/d41586-025-03180-8/d41586-025-03180-8_51508972.jpg"&gt;&lt;figcaption&gt;&lt;p class="figure__caption u-sans-serif"&gt;&lt;span class="mr10"&gt;Children diagnosed with autism before the age of six tend to have different traits to those who are diagnosed later in life.&lt;/span&gt;&lt;span&gt;Credit: Matt Roth for The Washington Post/Getty&lt;/span&gt;&lt;/p&gt;&lt;/figcaption&gt;&lt;/picture&gt;&lt;/figure&gt;&lt;p&gt;The age at which a person is diagnosed with&lt;a href="https://www.nature.com/articles/d41586-025-03173-7" data-track="click" data-label="https://www.nature.com/articles/d41586-025-03173-7" data-track-category="body text link"&gt; autism&lt;/a&gt; is sometimes linked to their genetic make-up and their risk of developing &lt;a href="https://www.nature.com/articles/d41586-020-00922-8" data-track="click" data-label="https://www.nature.com/articles/d41586-020-00922-8" data-track-category="body text link"&gt;mental-health conditions&lt;/a&gt;, according to an analysis of behavioural and genetic data&lt;sup&gt;&lt;a href="#ref-CR1" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;1&lt;/a&gt;&lt;/sup&gt;. Children who are diagnosed early — typically before six years old — are more likely to experience social and behavioral challenges during infancy and early childhood, whereas those who are diagnosed later experience higher rates of conditions such as &lt;a href="https://www.nature.com/articles/d41586-025-01575-1" data-track="click" data-label="https://www.nature.com/articles/d41586-025-01575-1" data-track-category="body text link"&gt;attention deficit hyperactivity disorder&lt;/a&gt; (ADHD) and depression.&lt;/p&gt;&lt;p&gt;Differences in genetic profiles seem to account for about 11% of this distinction. The findings, published today in &lt;i&gt;Nature&lt;/i&gt;, counter previous assumptions that later diagnoses mainly occurr in children who exhibit milder autistic traits overall, or experience delays in diagnosis owing to social factors, such as access to health care, says Varun Warrier, who studies neurodevelopment at the University of Cambridge, UK, and is a lead author on the study.&lt;/p&gt;&lt;p&gt;&lt;article class="recommended pull pull--left u-sans-serif" data-label="Related"&gt;&lt;a href="https://www.nature.com/articles/d41586-025-03024-5" class="u-link-inherit" data-track="click" data-track-label="recommended article"&gt;&lt;img class="recommended__image" alt="" src="//media.nature.com/w400/magazine-assets/d41586-025-03180-8/d41586-025-03180-8_51500828.jpg"&gt;&lt;p class="recommended__title u-serif"&gt;Gestational diabetes linked to autism in study: what scientists say&lt;/p&gt;&lt;/a&gt;&lt;/article&gt;&lt;/p&gt;&lt;p&gt;But the results do not mean that autistic people fall neatly into two categories, he adds. “What we are looking at are the averages underlying these groups,” he says. And the age at diagnosis is still only an imperfect proxy for the developmental and genetic differences the study found: factors such as delays in accessing health care can still exert a big effect.&lt;/p&gt;&lt;p&gt;The findings could spark further research to improve diagnoses and better &lt;a href="https://www.nature.com/articles/d41586-025-01575-1" data-track="click" data-label="https://www.nature.com/articles/d41586-025-01575-1" data-track-category="body text link"&gt;personalize support for autistic people&lt;/a&gt;, Warrier adds. “The more you understand about a condition and what gives rise to the risk for it, the better your understanding of how to diagnose it and how to treat it,” says Elliot Tucker-Drob, who studies developmental psychology at the University of Texas at Austin.&lt;/p&gt;&lt;h2&gt;No single cause&lt;/h2&gt;&lt;p&gt;Autism is a complex condition that affects&lt;a href="https://www.nature.com/immersive/d41586-024-03425-y/index.html" data-track="click" data-label="https://www.nature.com/immersive/d41586-024-03425-y/index.html" data-track-category="body text link"&gt; brain development&lt;/a&gt; and can cause repetitive behaviours and difficulties with social communication. &lt;a href="https://www.nature.com/articles/d41586-025-02876-1" data-track="click" data-label="https://www.nature.com/articles/d41586-025-02876-1" data-track-category="body text link"&gt;There is no single cause of autism&lt;/a&gt;. Last week, US health secretary Robert F. Kennedy Jr called the search for genetic drivers of the condition “entirely fruitless”, but, in fact, researchers have found the heritabilty of autism to be about 80%.&lt;/p&gt;&lt;p&gt;Those genetic factors, and the traits that they influence, are extraordinarily diverse. “It’s been such a challenge to really parse the genetics of autism,” says Natalie Sauerwald, who studies genomics at the Flatiron Institute in New York City. In one study published this year, for example, Sauerwald and her colleagues incorporated data on nearly 240 characteristics of autism, including behavioural traits&lt;sup&gt;&lt;a href="#ref-CR2" data-track="click" data-action="anchor-link" data-track-label="go to reference" data-track-category="references"&gt;2&lt;/a&gt;&lt;/sup&gt;. “It’s not exactly a two-question questionnaire,” she says.&lt;/p&gt;&lt;h2&gt;Diagnostic patterns&lt;/h2&gt;&lt;p&gt;Warrier’s research into this complexity began with a simple question: why are some children diagnosed with autism at a young age, and others diagnosed later, sometimes well into adolescence or beyond?&lt;/p&gt;&lt;p&gt;&lt;article class="recommended pull pull--left u-sans-serif" data-label="Related"&gt;&lt;a href="https://www.nature.com/articles/d41586-023-01549-1" class="u-link-inherit" data-track="click" data-track-label="recommended article"&gt;&lt;img class="recommended__image" alt="" src="//media.nature.com/w400/magazine-assets/d41586-025-03180-8/d41586-025-03180-8_51510916.jpg"&gt;&lt;p class="recommended__title u-serif"&gt;‘I am not a broken version of normal’ — autistic people argue for a stronger voice in research&lt;/p&gt;&lt;/a&gt;&lt;/article&gt;&lt;/p&gt;&lt;p&gt;This has often been attributed to social factors, such as cultural stigmas around autism or a lack of access to care, that delays diagnosis, says Warrier. Another explanation has been that early diagnoses might occur in people whose autistic traits are more pronounced, whereas later diagnoses could reflect milder challenges that are not noticed as quickly.&lt;/p&gt;&lt;/div&gt;
                        &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 01 Oct 2025 16:07:05 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTFBNa1F1SFF6N3hsSERpUVpDbjM4UWczekg3NmFaTFl6X3o0RHBJb04tZWZPcUw2SWR5NVktQTdNWW9OZ2FsRFhHVW9hX2JBR1lzYzRqbzJxRXNTVW1ZT1lF</guid></item><item><title>解释为什么你和某些人一起点击的科幻假设- Big Think</title><link>https://bigthink.com/mini-philosophy/the-sci-fi-hypothesis-that-explains-why-you-click-with-certain-people/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div x-data="prose" class="mb-8 prose  with-dropcap"&gt;

                    
&lt;div class="bt-block bt-block--margin-exclude bt-inp mb-8"&gt;
    &lt;div class="bg-gray-100 dark:bg-gray-800 text-black dark:text-white p-5 lg:p-6 xl:p-7 2xl:p-8"&gt;
        &lt;div class="mb-3.5"&gt;
                            &lt;p class="font-headline-xsmall md:font-headline-small mb-1"&gt;
                    Sign up for the Mini Philosophy newsletter                &lt;/p&gt;
                                            &lt;p class="font-utility-subtitle-small md:font-utility-subtitle-medium"&gt;
                    A place to pause and reflect on life’s bigger questions, with Big Think’s Jonny Thomson.                &lt;/p&gt;
                        &lt;/div&gt;

                        
                &lt;p&gt;

                &lt;/p&gt;
                    &lt;/div&gt;
&lt;/div&gt;
&lt;p&gt;Not all conversations are the same.&lt;/p&gt;&lt;p&gt;Sometimes, you can be talking to someone for hours, and it feels like only a few minutes. You natter and natter without ever having to think of what to say or cringe through any awkward silence. There’s a gentle sway to things — you listen, they speak, they listen, you speak. The chat dances to the easy and comfortable rhythm of the conversational tide.&lt;/p&gt;&lt;p&gt;At other times, a conversation can feel like medieval torture. One-word answers litter the path toward your desperate, fumbling attempt to get away. You’ve already used the toilet excuse, you’ve got a full drink, so you’re stuck in your chatless hell with Captain Boring.&lt;/p&gt;&lt;p&gt;“So, how often do you feed your dog?” you ask.&lt;/p&gt;&lt;p&gt;“It depends.”&lt;/p&gt;&lt;p&gt;Silence.&lt;/p&gt;&lt;p&gt;In this week’s &lt;em&gt;Mini Philosophy&lt;/em&gt; interview, the neuroscientist &lt;a href="https://www.penguinrandomhouse.com/books/761227/why-brains-need-friends-by-ben-rein-phd/"&gt;Ben Rein&lt;/a&gt; takes us inside the brain of a good conversation. And what he has to say gives a whole new weight to the expression, “We’re on the same wavelength.”&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-nice-to-meet-your-brain"&gt;Nice to meet your brain&lt;/h2&gt;&lt;p&gt;There is nothing concrete about human psychology. As a discipline, psychology suffers a &lt;a href="https://bigthink.com/neuropsych/replication-crisis/"&gt;replication crisis&lt;/a&gt;, and even when it comes to “pretty certain” things, there are likely to be several million exceptions at either end of the bell curve. Neuroscience is a bit better. Biology deals with data and observable phenomena, but here the problem is one of complexity. There’s just too much going on to say this or that has to be the case.&lt;/p&gt;&lt;p&gt;Social psychology is no different. A lot of the “why” behind a good conversation is lost in the untrackable murk of our environment. Maybe your parents taught you a lot about David Bowie, your friends taught you to enjoy Pokémon cards, and too many late hours on Reddit taught you about Doomsday prepping. And so, when you spend ten minutes rattling off the first-generation Pokémon evolutions to someone in a Ziggy Stardust outfit and with a homesteader’s calloused hands, you’re surprised how easy the conversation went.&lt;/p&gt;&lt;p&gt;But, as with everything, it’s not all about our environment. Our genetics, and especially our brain, might have something to say. This is what Rein taught me:&lt;/p&gt;&lt;p&gt;“Research shows that people who are better friends show more similar brain structures in these social brain areas. And so, it’s possible — and this is called homophily — that people like people who are like them. It’s this idea of ‘self-other overlap.’ So it’s probably a stretch to say definitely, but it’s possible that when we meet people we are really connecting with, and when it’s just a great relationship, we have similar brain structures. And, you know, if you have similar brain functions, that may kind of help us get onto the same wavelength.”&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-interbrain-connectivity"&gt;Interbrain connectivity&lt;/h2&gt;&lt;p&gt;So, if you really get on with someone, it might be that you have similar-looking or similar-working brains. The next time you find yourself laughing and enjoying someone’s company, pause to say, “Hey, I like how your brain works.”&lt;/p&gt;&lt;p&gt;Rein admits that this kind of homophily is an educated speculation at the moment — we don’t have enough data to prove the point conclusively. But we do have more data to point out something else he taught me, and that’s about how our brains will tend to behave similarly to others we’re bonding with. As Rein put it:&lt;/p&gt;&lt;p&gt;“There’s also something else called interbrain synchrony, which is just unbelievable. It sounds like a sci-fi thing, and it is what it sounds like. It’s that when two people are interacting or working together or sharing an experience, their brain activity can synchronize, and not in the way of telephone wires sprouting from our heads. There’s no signal that’s synchronizing; it’s not like that.&lt;/p&gt;&lt;p&gt;But if you were to have those two people in a brain scanner at the same time, they would be showing nearly identical patterns of brain activity in that moment. And this interbrain synchrony — which only occurs in certain brain areas, not the whole brain — seems to support things like teamwork. So it’s possible that when you get on with someone, you’re literally syncing up with someone else’s brain and just making it easy to understand one another.”&lt;/p&gt;&lt;h2 class="wp-block-heading" id="h-the-antisocial-brain"&gt;The antisocial brain&lt;/h2&gt;&lt;p&gt;There are implications to both of these points.&lt;/p&gt;&lt;p&gt;First, get yourself on the same wavelength. If you want less stilted chat and more flow, do things that literally pull your brains into step: face each other, hold eye contact, and share a concrete task or story. These “neural coupling” techniques might lead to better conversations. We know that when people do the same task — at the same time, and in the same way — their brains activate similar parts. Get on the same wavelength, and hope you stay there.&lt;/p&gt;&lt;p&gt;Second, don’t beat yourself up about it. There isn’t anything mystical about “clicking” with someone; it’s likely just neurological. It’s very tempting to ask, “Am I the problem?” or “Am I just bad at chatting?” when it’s possible that it’s simply a case of brain incompatibility. It might even be incompatibility at this moment. Perhaps you’re tired, or you haven’t eaten enough, or your brain is still trying to process that long magazine article you read at lunch.&lt;/p&gt;&lt;p&gt;So, the next time you feel you’ve “clicked” with someone, remember that you’re likely not just imagining it. Your neural activity could be syncing up in real time with another human brain, and it might be that the feeling of a great connection is an invisible biological dance.&lt;/p&gt;

&lt;div class="bt-block bt-block--margin-exclude bt-inp mb-8"&gt;
    &lt;div class="bg-gray-100 dark:bg-gray-800 text-black dark:text-white p-5 lg:p-6 xl:p-7 2xl:p-8"&gt;
        &lt;div class="mb-3.5"&gt;
                            &lt;p class="font-headline-xsmall md:font-headline-small mb-1"&gt;
                    Sign up for the Mini Philosophy newsletter                &lt;/p&gt;
                                            &lt;p class="font-utility-subtitle-small md:font-utility-subtitle-medium"&gt;
                    A place to pause and reflect on life’s bigger questions, with Big Think’s Jonny Thomson.                &lt;/p&gt;
                        &lt;/div&gt;

                        
                &lt;p&gt;

                &lt;/p&gt;
                    &lt;/div&gt;
&lt;/div&gt;

                &lt;/div&gt;
                
            &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Big Think</author><pubDate>Wed, 01 Oct 2025 16:04:08 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiqwFBVV95cUxQR01ja1FqcFMtbUZfYVNJRDNkMUtXYlNGb0dMRkczSk5QclBTVGRaOEYwbXBSMV9FYkp0NE5kbjlscnJGUFNJcFFFZkp3dDFKWlFqUnRBR2FvWkdFQ3MwTjZwZjQ4RUJYcUlMRW5Ub3Q3eTZPZEFyZ0k4NlJxbWJxdXhtYTRMRHdJdjl0QnlldW5zUGhlYkZPcTQzY0hBMWVVSU9vOE9MdDhwcVk</guid></item><item><title>纽约市中心EEE的受害者是健康、狂热的户外运动员、长期志愿消防员- Syracuse.com</title><link>https://www.syracuse.com/news/2025/10/central-nys-victim-of-eee-was-healthy-avid-outdoorsman-long-time-volunteer-firefighter.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="entry-content   "&gt;&lt;p class="article__paragraph article__paragraph--left" id="6BOFIYDCWJDAXEAJDWMNVVRLVY"&gt;Sullivan, N.Y. - At 79 years old, George Caswell Baker Jr. was in great shape for his age, his family said.&lt;/p&gt;&lt;p id="inarticle-1" data-gaid="inarticle-1"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="Q445X7MNZJC67HWUF6F5ZO5NPY"&gt;He was completing half-marathons into his 70s and could still run a few miles.&lt;b&gt; &lt;/b&gt;He even started training to try to run in the Utica Boilermaker next summer.&lt;b&gt; &lt;/b&gt;An avid outdoorsman, he was also gearing up for the hunting season.&lt;/p&gt;&lt;p id="inarticle-2" data-gaid="inarticle-2"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="VHAF73WM5ZEYHFPV57TNUXMCNI"&gt;Living in Central New York, he was aware of the risks of mosquito-borne viruses like eastern equine encephalitis. His son, George Baker III, said he always warned him and his siblings to wear long sleeves and use bug spray. There’s even a can of bug repellent by the door in his Baker Jr’s house according to his son.&lt;/p&gt;&lt;p id="inarticle-3" data-gaid="inarticle-3"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="XOTPWF4ZRBAKNL7CUBPEU5JOT4"&gt;George Baker Jr., of Sullivan, &lt;a href="https://www.syracuse.com/health/2025/09/central-ny-man-with-eee-dies-first-eee-related-death-here-since-2015.html" target="_blank" rel="" title="https://www.syracuse.com/health/2025/09/central-ny-man-with-eee-dies-first-eee-related-death-here-since-2015.html"&gt;died on Saturday&lt;/a&gt; after contracting EEE earlier this month, according to his family.&lt;/p&gt;&lt;p id="inarticle-4" data-gaid="inarticle-4"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="3MHBNT6P2ZFJ3HQK2R2L3LFL6U"&gt;He’s the first person in Central New York to die of the mosquito-borne illness in 10 years. Only seven people have died from the virus in New York state since 2000 according to the State Department of Health.&lt;/p&gt;&lt;p id="inarticle-5" data-gaid="inarticle-5"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="6KOTTSEXMNDSTFPWWEIFE37XLU"&gt;EEE is a rare and serious virus. About one-third of people who get the virus die from the disease and most survivors suffer brain damage.&lt;b&gt; &lt;/b&gt;It has no vaccine or cure.&lt;/p&gt;&lt;p id="inarticle-6" data-gaid="inarticle-6"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="5WXPOCEHLNBLVEDDGFCS3TMNDI"&gt;The virus is transmitted from birds to mosquitoes, which can then infect horses and humans through bites.&lt;/p&gt;&lt;p id="inarticle-7" data-gaid="inarticle-7"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="ZDYQ4R7ZH5E6VFU7Z4FNNJZWBI"&gt;Baker, an Army veteran, was a selfless “anchor” in the community, his family and friends said Tuesday. He was a volunteer firefighter for decades and active in community events, coaching youth wrestling and volunteering for youth cross-country and track for years. &lt;/p&gt;&lt;p id="inarticle-8" data-gaid="inarticle-8"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="SXM2ZN6COBDKDPBQDLQUBORKMI"&gt;Baker spent over 50 years volunteering for the Chittenango Fire Department. He served as the department chaplain for the last 30 years.&lt;/p&gt;&lt;p id="inarticle-9" data-gaid="inarticle-9"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="TQOQIGWRIJHRVM4BEBJIDC7Z4I"&gt;“He had an old school sense of duty,” said Erick Haas, the president of the fire department. “He worked hard trying to continue these traditions, encouraging younger members to step up and do things they may not have seen as relevant.”&lt;/p&gt;&lt;p id="inarticle-10" data-gaid="inarticle-10"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="4S7LMNYGENEZFKT7DRMZWADKAI"&gt;Even just a few days before Baker Jr. began to really feel the effects of the virus, he delivered a powerful speech at the fire department’s 9/11 memorial, his son said.&lt;/p&gt;&lt;p id="inarticle-11" class="middleParagraph" data-gaid="inarticle-11"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="QFPPDEPS6NCUBAL3PZX7WB5NVU"&gt;The long-time volunteer would often represent the fire department at community events, Haas said. He and his wife Donna for years ran the pizza stand at the fire department’s annual field days. &lt;/p&gt;&lt;p id="inarticle-12" data-gaid="inarticle-12"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="ASSUDOI6CZBUJOE2Z2J6NWC6M4"&gt;On the scene of a fire, he would help with organization and safety issues, the president said.&lt;/p&gt;&lt;p id="inarticle-13" data-gaid="inarticle-13"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="E5O4LRDWPZFYFHSGXOY5AJRBUI"&gt;“He was at every meeting, and he was coming with us to emergencies right up until shortly before his passing,” Haas said. &lt;/p&gt;&lt;p id="inarticle-14" data-gaid="inarticle-14"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="QZUBZHW7LBBWLECWL6C6PPZXWQ"&gt;Even though Baker stopped going into the fires themselves a few years ago, he still felt obligated to contribute on scene as much as he could, said his son.&lt;/p&gt;&lt;p id="inarticle-15" data-gaid="inarticle-15"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="WGESGQH4NZHOXMVOWS4MYGLULI"&gt;Baker was a teacher who was always interested in hearing someone’s story or offering them advice, according to his son and Haas.&lt;/p&gt;&lt;p id="inarticle-16" data-gaid="inarticle-16"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="CYA4FORJGFEATJ46RLMOCRABZA"&gt;He served in the Army in the 60s where he was a radio repairman and communication specialist, his son said. He was largely stationed in Germany.&lt;/p&gt;&lt;p id="inarticle-17" data-gaid="inarticle-17"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="4G5PR3A3ZFC2RNPPO7OWIGUZTY"&gt;After serving, Baker started repairing computers and eventually ran his own computer business.&lt;/p&gt;&lt;p id="inarticle-18" data-gaid="inarticle-18"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="RAWPANDPGNCN7DFKEUWKORKPDA"&gt;Baker is survived by three children and six grandsons. &lt;/p&gt;&lt;p id="inarticle-19" data-gaid="inarticle-19"&gt;&lt;/p&gt;&lt;p class="article__paragraph article__paragraph--left" id="V335MIRODRHQXJOLTB5KDITQLA"&gt;Calling hours will be held from 4 to 7 p.m. Monday at the Zimmer Funeral Home in Chittenango, according to &lt;a href="https://obits.syracuse.com/us/obituaries/syracuse/name/george-baker-obituary?id=59632793" target="_blank" rel="" title="https://obits.syracuse.com/us/obituaries/syracuse/name/george-baker-obituary?id=59632793"&gt;his obituary&lt;/a&gt;. A funeral will be held at 11 a.m. Tuesday at the First Presbyterian Church Chittenango.&lt;/p&gt;&lt;p id="inarticle-20" data-gaid="inarticle-20"&gt;&lt;/p&gt;&lt;p id="fusion-static-enter:23QSJTFGCRBHLEDUS2Z3SNCL2A" data-fusion-component="23QSJTFGCRBHLEDUS2Z3SNCL2A"&gt;&lt;/p&gt;&lt;p id="fusion-static-exit:23QSJTFGCRBHLEDUS2Z3SNCL2A" data-fusion-component="23QSJTFGCRBHLEDUS2Z3SNCL2A"&gt;&lt;/p&gt;&lt;p id="inarticle-21" data-gaid="inarticle-21"&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="article__paragraph article__paragraph--center skimlinks"&gt;If you purchase a product or register for an account through a link on our site, we may receive compensation.&lt;span&gt; By using this site, you consent to our &lt;a href="https://www.advancelocal.com/advancelocalUserAgreement/user-agreement.html" target="_blank" rel="noopener noreferrer"&gt;User Agreement&lt;/a&gt; and agree that your clicks, interactions, and personal information may be collected, recorded, and/or stored by us and social media and other third-party partners in accordance with our &lt;a href="https://www.advancelocal.com/advancelocalUserAgreement/privacy-policy.html" target="_blank" rel="noopener noreferrer"&gt;Privacy Policy.&lt;/a&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Syracuse.com</author><pubDate>Wed, 01 Oct 2025 16:01:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiyAFBVV95cUxOd01OVl9CbEF6a2pUcXFvWWF2bFlNQUIydmw1RkFvQTcydFFNYXNmMVROLTNVcmtOZk5xeTJSTXVqemNZaVdPeVV3VHJ5M0E4SWZWZ1RHRVFLMmQzaDBIMW83Z3BIWUVRLWhmazlhUk5HQzhvQXlpNFlvMVhaYlowQUE1WUJYZVEybDdrUHp1Vkc0QWc3Qlk4MXpDai02Q3NDcmhuc0Q3cW5wREJBdmRCc3UtemFhZnpzVERENUVpNUVHelVjR1Zpc9IB3AFBVV95cUxNQ1ppWjVYSDViN0J3VnlzTXI5Uk1aakYzNWFONnlGaDhyNkhHWi0wdWdycnB1b3hYMmJoMVAwQ2xSUE0yTVN4dlNpMnpQa0RiV2tOQVZLQTFVdzFlZVhNNWZCa25EMXhkYkliY2FBNmVTeElodkRrRnZBb05kN0VfQWhWWTUzZlV4b0tNZUNnV1JBVFp0T1FHT0xaVFNGemZrWEFKTnNGY2NUWHJlSFBoMkMtS09WTUVIc1BfN1J5WlBEb2owU3pQVDZtZVNmTmQ4M3BqOXotZEtRdHdo</guid></item><item><title>我丈夫发誓，他在网上对其他女人的所作所为是无害的。It's Tearing Me Apart. - Slate</title><link>https://slate.com/advice/2025/10/sex-advice-husband-women-online.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article__content" itemprop="mainEntityOfPage"&gt;
          &lt;p class="slate-paragraph slate-graf" data-word-count="18" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t3ikq001k6pm7ccjwmxpz@published"&gt;&lt;em&gt;How to Do It is Slate’s sex advice column. &lt;/em&gt;&lt;strong&gt;&lt;em&gt;Have a question? &lt;/em&gt;&lt;/strong&gt;&lt;a href="https://docs.google.com/forms/d/e/1FAIpQLSdx34-uOijrCIKqMdw5hnyYahSJBKa4AaSzDCu1nfcpmd3IjA/viewform"&gt;&lt;strong&gt;&lt;em&gt;Send it to Jessica and Rich here&lt;/em&gt;&lt;/strong&gt;&lt;/a&gt;&lt;strong&gt;&lt;em&gt;.&lt;/em&gt;&lt;/strong&gt;&lt;em&gt; It’s anonymous!&lt;/em&gt;&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="5" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t5q9j001h3b7akppgq4yc@published"&gt;&lt;strong&gt;Dear How to Do It, &lt;/strong&gt;&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="19" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t5bxu00123b7a2hxd6d17@published"&gt;My husband likes to view porn and will often make comments on women’s nudes. During the pandemic, this worsened.&lt;/p&gt;



  &lt;p class="slate-paragraph slate-graf" data-word-count="107" data-uri="slate.com/_components/slate-paragraph/instances/cmg7374ij000e3b7ayc1bwlwq@published"&gt;He would be looking at posts of women and commenting on them while sitting right next to me. He would also engage in kinky chats with them. I blew up at him when I noticed him messaging during a family function. I told him how much it hurts me to see him messaging strangers how beautiful they are, but not saying the same things to me. He told me that he’s helping these women with their self-esteem, but these women have OnlyFans and other pay site pages on their profiles. He also says it’s just a fantasy and has no bearing on what he feels for me.&lt;/p&gt;

  

  &lt;p class="slate-paragraph slate-graf" data-word-count="72" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t5bzu00133b7a22ktvj6h@published"&gt;We are going to both individual and couples counseling, and my husband was diagnosed with ADHD, which can affect impulse control. He told me he would pursue these sites less and hasn’t done so when I’m around, but I know he’s still texting women because I have caught him messaging on Instagram and Reddit. Do I ignore the chats since we have made improvements in our marriage overall? I still feel inadequate.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="6" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t5c2500143b7atun5h4zv@published"&gt;—Sitting Next to You Yet Alone&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="7" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t5c6l00153b7apy7fju5g@published"&gt;&lt;strong&gt;Dear Sitting Next to You Yet Alone,&lt;/strong&gt;&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="55" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t5c8l00163b7af7avx3px@published"&gt;Before I dive in, I recommend you read &lt;a href="https://lauriepenny.substack.com/p/is-he-autistic-or-is-he-just-an-asshole"&gt;this essay from Laurie Penny on the different phenomena of autism and assholery&lt;/a&gt;. Autism and ADHD are two different (though often co-occurring) diagnoses, but I still think this might offer some valuable insight—namely, that neurodiversity does not preclude a person from sometimes also simply being a jerk.&lt;/p&gt;

  


  


  


  


  &lt;p class="slate-paragraph slate-graf" data-word-count="94" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t5cag00173b7angwjidui@published"&gt;While difficulties with impulse control are often a part of ADHD, there’s more going on here. Your husband says he’s helping these women with their self-esteem. That’s either an outrageous amount of ego on his part or a marketing tactic on the part of these women. OK, maybe it’s the latter case, and he’s very naive. But he also claims it’s just “fantasy,” which indicates that if this self-esteem nonsense &lt;em&gt;is&lt;/em&gt; a marketing maneuver, he’s well aware of it—so then why is he reaching for an aspect of their roleplay as his first justification?&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="107" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t5cce00183b7a3x0qyv3k@published"&gt;I do believe that your husband’s interest in porn, commenting on women’s posts, and engaging in erotic chats with them is separate from his feelings for and attraction to you. What is absolutely not separate, though, is doing all of this during time with you, including &lt;em&gt;at a family function,&lt;/em&gt; or &lt;em&gt;after you’ve made it clear to him that you’re uncomfortable with it&lt;/em&gt;. I’m also less than enthused by the fact that he reserves his positive commentary for other women and doesn’t extend the same appreciative language to you. Do you not also have self-esteem, which could be boosted by hearing that your husband finds you attractive?&lt;/p&gt;

  


  

  &lt;p class="slate-paragraph slate-graf" data-word-count="110" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t5ceg00193b7aw0ehcq6x@published"&gt;To circle back to the “at family gatherings” and “despite having agreed to slow down” aspects of the issue, yes, this could be due to having a hard time controlling his impulses. That’s something a professional can help with. Some people find that medication works well for them, while others prefer to rely on building skills. You can inquire whether he’s working on this in individual therapy, let him know that help is possible, and even, if he wants, text him a helpful reminder to bring this up as he’s walking into his next session, but it’s up to him to follow through. Do not become his nagging neurodiversity nanny.&lt;/p&gt;

  


  &lt;p class="slate-paragraph slate-graf" data-word-count="69" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t5cgv001a3b7aas4i54s4@published"&gt;As for whether to ignore the chats, it seems like the agreement was for him to reduce the amount of time he spends engaging in these activities, and it sounds like he has done so. More importantly, though, is the question of whether the two of you can tackle the contradictory ways he dismisses your feelings and concerns around this, and the absence of praise for your own beauty.&lt;/p&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="1" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t74ib001o3b7ayc0hquwd@published"&gt;&lt;span class="slate-paragraph--tombstone"&gt;—Jessica&lt;/span&gt;&lt;/p&gt;

  &lt;h3 class="subhead subhead--none" data-uri="slate.com/_components/subhead/instances/cmg6t7clq00243b7a2vgwdkf8@published"&gt;
&lt;p class="subhead__marker"&gt;
&lt;/p&gt;
More Advice From Slate

&lt;/h3&gt;

  &lt;p class="slate-paragraph slate-graf" data-word-count="36" data-uri="slate.com/_components/slate-paragraph/instances/cmg6t7abm001w3b7aifyy7wl9@published"&gt;My husband has a sexual superpower, and it is exhausting. He has no refractory period after having an orgasm. He prefers three-plus orgasms during a sexual encounter with me, &lt;a href="https://slate.com/human-interest/2023/04/husband-sex-multiple-orgasms-advice.html"&gt;ideally, five, but will settle for two.&lt;/a&gt;&lt;/p&gt;

  &lt;section class="newsletter-signup   " data-list="Advice" data-uri="slate.com/_components/newsletter-signup/instances/cmg6t3ikq001n6pm72awhbzew@published"&gt;


    &lt;p class="newsletter-signup__intro"&gt;
        &lt;svg class="newsletter-signup__arrow"&gt;
          &lt;use xlink:href="/media/components/newsletter-signup/sprite.svg#arrow"&gt;&lt;/use&gt;
        &lt;/svg&gt;
&lt;h1 class="newsletter-signup__headline"&gt;Never miss new Advice columns&lt;/h1&gt;
      &lt;span class="newsletter-signup__description"&gt;The latest sex, parenting, and money advice from our columnists delivered to your inbox three times a week.&lt;/span&gt;
    &lt;/p&gt;
    



&lt;/section&gt;

  

&lt;/div&gt;

      &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Slate</author><pubDate>Wed, 01 Oct 2025 16:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMieEFVX3lxTE9ZUlVES24wcFA5dVdXUHB2T3E0WlI1MV9GSkd1d0o2WkNSaVg2ckd0aTBQZXRjckdRX05JX19Ra3poQllaQ2ppMFd3aUhSR3QwUHJuaV94ZElzUjIxR1lCN3NvSjFXck5Jd0pibTVldjVrNGFUMlZaTg</guid></item><item><title>类杆菌群外膜蛋白生物发生的新范式-自然</title><link>https://www.nature.com/articles/s41586-025-09532-8</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec8-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec9"&gt;Bacterial strains and growth conditions&lt;/h3&gt;&lt;p&gt;All strains and plasmids used in this work are listed in Supplementary Tables &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09532-8#MOESM1"&gt;2&lt;/a&gt; and &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09532-8#MOESM1"&gt;3&lt;/a&gt;. &lt;i&gt;F. johnsoniae&lt;/i&gt; was routinely cultured aerobically in Casitone yeast extract (CYE) medium&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="McBride, M. J. &amp;amp; Kempf, M. J. Development of techniques for the genetic manipulation of the gliding bacterium Cytophaga johnsonae. J. Bacteriol. 178, 583–590 (1996)." href="/articles/s41586-025-09532-8#ref-CR45" id="ref-link-section-d148898233e2180"&gt;45&lt;/a&gt;&lt;/sup&gt; at 30 °C with shaking. For some physiological studies the cells were cultured in PY2 medium&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Agarwal, S., Hunnicutt, D. W. &amp;amp; McBride, M. J. Cloning and characterization of the Flavobacterium johnsoniae (Cytophaga johnsonae) gliding motility gene, gldA. Proc. Natl Acad. Sci. USA 94, 12139–12144 (1997)." href="/articles/s41586-025-09532-8#ref-CR46" id="ref-link-section-d148898233e2184"&gt;46&lt;/a&gt;&lt;/sup&gt; as indicated below. For experiments testing growth on complex sugars cells were cultured in a 96-well plate in a CLARIOstarPlus plate reader using modified minimal A medium&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Martin, H. et al. Metabolism of hemicelluloses by root-associated Bacteroidota species. ISME J. 19, wraf022 (2024)." href="/articles/s41586-025-09532-8#ref-CR27" id="ref-link-section-d148898233e2189"&gt;27&lt;/a&gt;&lt;/sup&gt; and containing 0.25% (w/v) of either carob galactomannan (Megazyme, 11078-30-1) or tamarind xyloglucan (Megazyme, 37294-28-3) as the sole carbon source. &lt;i&gt;E. coli&lt;/i&gt; strains were routinely grown aerobically in LB medium at 37 °C with shaking, or on LB agar plates. Where required, 100 µg ml&lt;sup&gt;−1&lt;/sup&gt; erythromycin was used in the growth medium for &lt;i&gt;F. Johnsoniae&lt;/i&gt;. 100 µg ml&lt;sup&gt;−1&lt;/sup&gt; ampicillin or 50 µg ml&lt;sup&gt;−1&lt;/sup&gt; kanamycin were used in the growth medium for &lt;i&gt;E. coli&lt;/i&gt;. aTC (CAY10009542-50 mg, Cambridge Bioscience) was used as a final concentration of 0.2 µg ml&lt;sup&gt;−1&lt;/sup&gt; (liquid culture) and 2 µg ml&lt;sup&gt;−1&lt;/sup&gt; (agar plates).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec10"&gt;Genetic constructs&lt;/h3&gt;&lt;p&gt;Plasmids were constructed by Gibson cloning&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009)." href="/articles/s41586-025-09532-8#ref-CR47" id="ref-link-section-d148898233e2221"&gt;47&lt;/a&gt;&lt;/sup&gt; using the primers and target DNA in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09532-8#MOESM1"&gt;4&lt;/a&gt;. Suicide and expression plasmids were introduced into the appropriate &lt;i&gt;F. johnsoniae&lt;/i&gt; background strain by triparental mating as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Agarwal, S., Hunnicutt, D. W. &amp;amp; McBride, M. J. Cloning and characterization of the Flavobacterium johnsoniae (Cytophaga johnsonae) gliding motility gene, gldA. Proc. Natl Acad. Sci. USA 94, 12139–12144 (1997)." href="/articles/s41586-025-09532-8#ref-CR46" id="ref-link-section-d148898233e2231"&gt;46&lt;/a&gt;&lt;/sup&gt;. Chromosomal modifications were introduced using the suicide vector pYT313 harbouring the counter-selectable &lt;i&gt;sacB&lt;/i&gt; gene as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Hennell James, R. et al. Structure and mechanism of the proton-driven motor that powers type 9 secretion and gliding motility. Nat. Microbiol. 6, 221–233 (2021)." href="/articles/s41586-025-09532-8#ref-CR48" id="ref-link-section-d148898233e2239"&gt;48&lt;/a&gt;&lt;/sup&gt;. All plasmid constructs and chromosomal modifications were confirmed by sequencing.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec11"&gt;Construction of a tightly regulated gene expression system for &lt;i&gt;F. johnsoniae&lt;/i&gt;
                     &lt;/h3&gt;&lt;p&gt;The aTC-inducible systems for the depletion of essential Bam&lt;sub&gt;&lt;i&gt;FJ&lt;/i&gt;&lt;/sub&gt; components (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09532-8#Fig12"&gt;7a&lt;/a&gt;) were based on the native &lt;i&gt;F. johnsoniae&lt;/i&gt; &lt;i&gt;ompA&lt;/i&gt; and &lt;i&gt;fjoh_0824&lt;/i&gt; promoters and contain the 100 bp upstream of &lt;i&gt;ompA&lt;/i&gt; or &lt;i&gt;fjoh_0824&lt;/i&gt;. Guided by the observations of Lim et al.&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Lim, B., Zimmermann, M., Barry, N. A. &amp;amp; Goodman, A. L. Engineered regulatory systems modulate gene expression of human commensals in the gut. Cell 169, 547–558.e15 (2017)." href="/articles/s41586-025-09532-8#ref-CR49" id="ref-link-section-d148898233e2278"&gt;49&lt;/a&gt;&lt;/sup&gt;, a&lt;i&gt; tetO2&lt;/i&gt; site (TetR binding site) was inserted upstream of the conserved −33 motif in these promoters and another &lt;i&gt;tetO2&lt;/i&gt; site downstream of the conserved −7 motif generating the synthetic promoters &lt;i&gt;P&lt;/i&gt;&lt;sub&gt;&lt;i&gt;ompAinduc&lt;/i&gt;&lt;/sub&gt; and &lt;i&gt;P&lt;/i&gt;&lt;sub&gt;&lt;i&gt;fjoh_0824induc&lt;/i&gt;&lt;/sub&gt; (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09532-8#Fig12"&gt;7b&lt;/a&gt;). The constructs also contain &lt;i&gt;tetR&lt;/i&gt; under the control of an additional copy of the constitutive &lt;i&gt;F. johnsoniae ompA&lt;/i&gt; promoter. The final inducible systems containing the gene to be induced were integrated into the chromosome at an assumed phenotypically neutral site&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Baez, W. D. et al. Global analysis of protein synthesis in Flavobacterium johnsoniae reveals the use of Kozak-like sequences in diverse bacteria. Nucleic Acids Res. 47, 10477–10488 (2019)." href="/articles/s41586-025-09532-8#ref-CR26" id="ref-link-section-d148898233e2311"&gt;26&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Kulkarni, S. S., Johnston, J. J., Zhu, Y., Hying, Z. T. &amp;amp; McBride, M. J. The carboxy-terminal region of Flavobacterium johnsoniae SprB facilitates its secretion by the type IX secretion system and propulsion by the gliding motility machinery. J. Bacteriol. 201, e00218-19 (2019)." href="/articles/s41586-025-09532-8#ref-CR36" id="ref-link-section-d148898233e2314"&gt;36&lt;/a&gt;&lt;/sup&gt; by replacing &lt;i&gt;fjoh_4538&lt;/i&gt; to &lt;i&gt;fjoh_4540&lt;/i&gt;.&lt;/p&gt;&lt;p&gt;The designed inducible systems were validated using strains in which a NanoLuc reporter gene&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="Hall, M. P. et al. Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem. Biol. 7, 1848–1857 (2012)." href="/articles/s41586-025-09532-8#ref-CR50" id="ref-link-section-d148898233e2327"&gt;50&lt;/a&gt;&lt;/sup&gt; was placed under the control of the chromosomally integrated aTC-inducible systems (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09532-8#Fig12"&gt;7c&lt;/a&gt;). Overnight cultures of these strains were diluted 1:100 into fresh CYE medium in the absence or presence of 0.2 µg ml&lt;sup&gt;−1&lt;/sup&gt; aTC and cultured for 6 h to mid-exponential phase (OD&lt;sub&gt;600&lt;/sub&gt; ~ 0.6). Cells were collected and resuspended in PY2 medium to OD&lt;sub&gt;600&lt;/sub&gt; = 0.6. A volume of 50 µl of cell resuspension was mixed with 50 µl of reaction solution (48 µl PY2 medium supplemented with 2 µl of furimazine (Promega)) in a 96-well plate and the luminescence signal measured in a CLARIOstar&lt;sup&gt;Plus&lt;/sup&gt; plate reader.&lt;/p&gt;&lt;p&gt;Strains to enable the depletion of the essential BAM&lt;sub&gt;&lt;i&gt;Fj&lt;/i&gt;&lt;/sub&gt; subunits were constructed by introducing a copy of the target gene under the control of the designed inducible system into the chromosome at the phenotypically neutral site. The native copy of the target gene was then deleted in the presence of aTC to allow expression of the introduced copy of the gene.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec12"&gt;Purification of BAM&lt;sub&gt;&lt;i&gt;Fj&lt;/i&gt;&lt;/sub&gt; and SusCDE complexes&lt;/h3&gt;&lt;p&gt;To purify complexes containing Twin-Strep tagged BamA, the relevant strain was cultured for 22 h in CYE medium using 1 l culture volume in 2.5 l flasks. A total culture volume of 12 l was used for sample preparations for structure determination, and 4 l of culture was used for analytical purifications of BAM&lt;sub&gt;&lt;i&gt;Fj&lt;/i&gt;&lt;/sub&gt; variants. Cells were collected by centrifugation at 12,000&lt;i&gt;g&lt;/i&gt; for 30 min and stored at −20 °C until further use. All purification steps were carried out at 4 °C. Cell pellets were resuspended in buffer W (100 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA) containing 30 μg ml&lt;sup&gt;−1&lt;/sup&gt; DNase I, 400 μg ml&lt;sup&gt;−1&lt;/sup&gt; lysozyme and 1 mM phenylmethylsulfonyl fluoride (PMSF) at a ratio of 5 ml of buffer to 1 g of cell pellet. Cells were incubated on ice for 30 min with constant stirring before being lysed by two passages through a TS series 1.1 kW cell disruptor (Constant Systems) at 30,000 PSI. Unbroken cells were removed by centrifugation at 20,000&lt;i&gt;g&lt;/i&gt; for 20 min. The supernatant was recovered and total membranes were collected by centrifugation at 230,000&lt;i&gt;g&lt;/i&gt; for 75 min. Membranes were resuspended in buffer W to a protein concentration of 6.5 mg ml&lt;sup&gt;−1&lt;/sup&gt; and solubilized by incubation with 1% (w/v) lauryl maltose neopentyl glycol (LMNG, Anatrace) for 2 h. Insoluble material was removed by centrifugation at 230,000&lt;i&gt;g&lt;/i&gt; for 75 min. Endogenous biotin-containing proteins were masked by addition of 1 ml BioLock solution (IBA Lifesciences) per 100 ml of supernatant and incubation for 20 min with constant stirring. The solution was then circulated through a Strep-TactinXT 4Flow High Capacity column (IBA Lifesciences) overnight. The column was washed with 10 column volumes of buffer W containing 0.01% LMNG (buffer WD) and bound proteins were eluted with 6 column volumes Strep-TactinXT BXT buffer (IBA Lifesciences) containing 0.01% LMNG. The eluate was concentrated to 500 μl using a 100-kDa molecular weight cut-off (MWCO) Amicon ultra-15 centrifugal filter unit (Merck) and then injected onto a Superose 6 Increase 10/300 GL column (Cytiva) previously equilibrated in buffer WD. Peak fractions were collected and concentrated using a 100-kDa MWCO Vivaspin 500 column (Sartorius).&lt;/p&gt;&lt;p&gt;Purification of SusCDE complexes with a N-terminal Twin-Strep tag on SusC was carried out by the same protocol.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec13"&gt;Peptide mass fingerprinting&lt;/h3&gt;&lt;p&gt;Samples were excised from Coomassie-stained gels. For whole sample proteomic analysis, SDS–PAGE was carried out only until the sample had fully entered the gel and the protein smear at the top of the gel was excised. Samples were subject to in-gel trypsin digestion and electrospray mass spectrometry at the Advanced Proteomics Facility (University of Oxford, UK).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec14"&gt;Immunoblotting&lt;/h3&gt;&lt;p&gt;Immunoblotting was carried out as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Lauber, F. et al. Structural insights into the mechanism of protein transport by the type 9 secretion system translocon. Nat. Microbiol. 9, 1089–1102 (2024)." href="/articles/s41586-025-09532-8#ref-CR19" id="ref-link-section-d148898233e2406"&gt;19&lt;/a&gt;&lt;/sup&gt;. Antibodies against BAM&lt;sub&gt;&lt;i&gt;Fj&lt;/i&gt;&lt;/sub&gt; subunits, Sus proteins and SkpA were raised in rabbits against His-tagged recombinant proteins produced using the plasmids listed in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09532-8#MOESM1"&gt;3&lt;/a&gt;. Antiserum against OmpA&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Shibata, S. et al. Filamentous structures in the cell envelope are associated with bacteroidetes gliding machinery. Commun. Biol. 6, 94 (2023)." href="/articles/s41586-025-09532-8#ref-CR34" id="ref-link-section-d148898233e2417"&gt;34&lt;/a&gt;&lt;/sup&gt; was provided by S. Shibata and antiserum against SprF&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Kulkarni, S. S., Johnston, J. J., Zhu, Y., Hying, Z. T. &amp;amp; McBride, M. J. The carboxy-terminal region of Flavobacterium johnsoniae SprB facilitates its secretion by the type IX secretion system and propulsion by the gliding motility machinery. J. Bacteriol. 201, e00218-19 (2019)." href="/articles/s41586-025-09532-8#ref-CR36" id="ref-link-section-d148898233e2421"&gt;36&lt;/a&gt;&lt;/sup&gt; by M. McBride. The following commercial antisera were used: anti-Strep-tag (34850 Qiagen), anti-GroEL (G6532 Merck), anti-ALFA-Tag (N1582 Synaptic Systems GmbH), anti-His-tag (H1029-100UL Merck Life Science), anti-HA-tag (26183 Thermo Fisher Scientific), anti-mouse IgG peroxidase conjugate (A4416 Merck) and anti-rabbit IgG peroxidase conjugate (31462 Pierce). Antibodies were used at the following dilutions: anti-His-tag and anti-HA-tag, 1:1,000; anti-SprF, 1:2,500; anti-BamH, anti-BamM, anti-BamP, anti-SusC, anti-SusD, anti-SusE, anti-SkpA, anti-Strep-tag and anti-ALFA-tag, 1:3,000; anti-OmpA and anti-GroEL, 1:50,000.&lt;/p&gt;&lt;p&gt;Original uncropped gels and immunoblots are shown in Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09532-8#MOESM3"&gt;2&lt;/a&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec15"&gt;Darobactin inhibition experiments&lt;/h3&gt;&lt;p&gt;&lt;i&gt;E. coli&lt;/i&gt; or &lt;i&gt;F. johnsoniae&lt;/i&gt; strains were cultured, respectively, in LB and CYE medium (supplemented with erythromycin if carrying p&lt;sup&gt;TS&lt;/sup&gt;BamP or p&lt;sup&gt;TS&lt;/sup&gt;BamP4 plasmids). Five-millilitre starter cultures were grown aerobically overnight at 30 °C, then diluted into 5 ml fresh medium to OD&lt;sub&gt;600&lt;/sub&gt; = 0.02 and then grown to OD&lt;sub&gt;600&lt;/sub&gt; between 0.6 to 0.8. The cultures were then diluted with fresh medium to OD&lt;sub&gt;600&lt;/sub&gt; = 0.006. Fifty microlitre aliquots were transferred into a 96-well plate and mixed with 50 µl of the required concentration of darobactin solution in growth medium. The minimum inhibitory concentration (MIC) for darobactin was assessed after overnight incubation at 30 °C in a CLARIOstarPlus plate reader.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec16"&gt;BamP pull-downs&lt;/h3&gt;&lt;p&gt;Strains with pCP11-derived plasmids expressing N-terminal Twin-Strep-tagged BamP or BamP4 under the control of a &lt;i&gt;remA&lt;/i&gt; promoter were grown aerobically overnight at 30 °C in erythromycin-supplemented CYE medium. The culture was diluted into 100 ml fresh medium to OD&lt;sub&gt;600&lt;/sub&gt; = 0.02 and grown to an OD&lt;sub&gt;600&lt;/sub&gt; = 0.8–1.0. Cells were then collected by centrifugation at 8,000&lt;i&gt;g&lt;/i&gt; for 10 min and resuspended in 3 ml of buffer W containing 30 µg ml&lt;sup&gt;−1&lt;/sup&gt; DNase I, 400 µg ml&lt;sup&gt;−1&lt;/sup&gt; lysosome and 1 mM PMSF. The cells were incubated for 30 min at 4 °C, and then lysed by sonication for 3 min on ice using a Sonics Vibra Cell Ultrasonic Processor VCX 130 with a 6 mm probe at 40% amplitude, with a 10 s on to 10 s off cycle. Unbroken cells were removed by centrifugation at 20,000&lt;i&gt;g&lt;/i&gt; for 20 min. The supernatant fraction was then centrifuged at 200,000&lt;i&gt;g&lt;/i&gt; for 1 h to pellet total membranes. The membrane pellets were resuspended to a protein concentration of 6.5 mg ml&lt;sup&gt;−1&lt;/sup&gt; with buffer W and solubilized by incubation with 1% (w/v) LMNG for 2 h. Insoluble material was removed by centrifugation at 230,000&lt;i&gt;g&lt;/i&gt; for 1 h, and the recovered supernatant supplemented with 1% BioLock solution before mixing with 50 µl Strep-TactinXT 4Flow lbeads (IBA Lifesciences) that had been equilibrated in buffer WD. Samples were rotated slowly at 4 °C for 2 h and then transferred into Mini Bio-Spin Chromatography columns (Bio-Rad, 7326207), and centrifugation at 100&lt;i&gt;g&lt;/i&gt; for 1 min. The beads were washed 3 times with 250 µl buffer WD and bound proteins then eluted with 150 µl of 1× Strep-TactinXT BXT buffer containing 0.01% LMNG. The elute was concentrated to 30 µl using a 10 kDa MWCO Vivispin500 centrifugal concentrator (VS0102, Sartorius).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec17"&gt;BAM&lt;sub&gt;&lt;i&gt;Fj&lt;/i&gt;&lt;/sub&gt; subunit depletion experiments&lt;/h3&gt;&lt;p&gt;The desired depletion strain was grown overnight in CYE medium supplemented with 0.2 µg ml&lt;sup&gt;−1&lt;/sup&gt; aTC. Cells from 1 ml of the overnight culture were collected, washed once in 1 ml CYE, and resuspended in 1 ml of CYE medium. Cells from this sample were then used to inoculate 15 ml of CYE medium, either with or without 0.2 µg ml&lt;sup&gt;−1&lt;/sup&gt; aTC, to OD&lt;sub&gt;600&lt;/sub&gt; = 0.02. The cells were then cultured aerobically at 30 °C and cell samples collected into SDS sample buffer every 2 h for subsequent analysis by immunoblotting. Samples for imaging or membrane preparation were collected and analysed as detailed below.&lt;/p&gt;&lt;p&gt;To purify BamA complexes after depleting the essential BamG or BamH subunits, a 200 ml overnight culture of the appropriate strain grown in the presence of 0.2 µg ml&lt;sup&gt;−1&lt;/sup&gt; aTC was collected and resuspended in the same volume of fresh CYE medium without aTC. This sample was used to inoculation 8 l of CYE without aTC to OD&lt;sub&gt;600&lt;/sub&gt; = 0.1 which was then cultured aerobically at 30 °C for 6 h. Cells were collected and BamA complexes processed for purification as described above.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec18"&gt;Microscopic analysis of cells during BAM subunit depletions&lt;/h3&gt;&lt;p&gt;Live cells were imaged directly in growth medium by spotting samples taken from depletion cultures onto a 1% agarose pad prepared in PY2 medium. Phase contrast images were acquired on an inverted fluorescence microscope (Ti-E, Nikon) equipped with a perfect focus system, a 100× NA 1.4 oil immersion objective, a motorized stage, and a sCMOS camera (Orca Flash 4, Hamamatsu).&lt;/p&gt;&lt;p&gt;For transmission electron microscopy, cells were collected at the required time points during depletion by centrifugation at 8,000&lt;i&gt;g&lt;/i&gt; for 5 min. After carefully removing the supernatant, cell pellets were gently resuspended in 1 ml of fixative solution (2.5% glutaraldehyde, 4% formaldehyde in 0.1 M PIPES buffer, pH 7.4) and incubated at room temperature for 1 h. Following fixation cells were washed with TEM buffer (100 mM PIPES NaOH pH 7.2), treated with TEM buffer containing 50 mM glycine, washed again in TEM buffer, and then subjected to secondary fixation with TEM buffer containing 1% (w/v) osmium tetroxide and 1.5% (w/v) potassium ferrocyanide. Samples were then washed extensively with Milli-Q water, stained with aqueous 0.5% (w/v) uranyl acetate overnight, then washed again with Milli-Q water. The samples were dehydrated through an ethanol series and infiltrated with and embedded in TAAB low viscosity epoxy resin ahead of polymerization at 60 °C for 24 h. Sections of 90 nm were cut from the resin blocks using a Leica UC7 Ultramicrotome and collected onto 3 mm copper grids. The sections were then post-stained with lead citrate and imaged using a JEOL Flash 120 kV TEM equipped with a Gatan Rio camera.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec19"&gt;Whole-membrane proteomics&lt;/h3&gt;&lt;p&gt;Fifteen millilitres of cells at the 6 h time point of the standard depletion experiment were collected by centrifugation at 8,000&lt;i&gt;g&lt;/i&gt; for 5 min at 4 °C. The cells were resuspended in 1 ml of buffer W and lysed on ice using a probe sonicator (Sonics Vibra Cell, probe 630-0422) at 40% power by 12 repeats of a 10 s on/10 s off pulse cycle. After lysis, the samples were centrifuged at 20,000&lt;i&gt;g&lt;/i&gt; for 20 min at 4 °C to remove cell debris. The supernatant was then centrifuged at 135,000&lt;i&gt;g&lt;/i&gt; for 45 min at 4 °C to pellet the membranes. The membranes were resuspended in buffer W and the protein contents of the samples normalized by A&lt;sub&gt;280 nm&lt;/sub&gt;. The samples were run together on SDS–PAGE gels and stained with Coomassie Blue (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09532-8#Fig12"&gt;7i&lt;/a&gt;) to confirm that normalization had been correctly implemented. Statistical methods were not used to determine sample size. Randomization and blinding were not used.&lt;/p&gt;&lt;p&gt;Membrane fractions were resuspended in lysis buffer containing 1% SDS, 0.1 M ammonium bicarbonate pH 8.0. Samples were sonicated for 5× 15 s in a water bath with 15 s incubations on ice between each pulse cycle. The samples were clarified by centrifugation at 17,500&lt;i&gt;g&lt;/i&gt; for 30 min and 50 µg of total protein lysate was taken for analysis. Samples were reduced for 30 min using 10 mM tris(2-carboxyethyl)phosphine (TCEP) followed by alkylation for 30 min in the dark using 2-chloroacetamide. SpeedBeads Magnetic Carboxylate Modified Particles (GE Healthcare) were mixed with the sample in a 10 volumes beads: 1 volume sample ratio and the samples shaken for 10 min at 1,000 rpm. The beads were then washed twice with 70% ethanol followed by 100% acetonitrile. This procedure was repeated 8 times. 100 mM ammonium bicarbonate was added to the washed beads and pre-digestion with endoprotease LysC (Wako; 1:100) was carried out at 37 °C for 2 h. This was followed by 16 h digestion with trypsin (Promega, 1:40) at 37 °C. The supernatant was collected and any remaining bound peptides were eluted from the beads using 2% dimethyl sulfoxide (DMSO). Digested peptides were loaded onto C18 stage tips, pre-activated with 100% acetonitrile and 0.1% formic acid and centrifuged at 4000 rpm. The tips were then washed with 0.1% formic acid and eluted in 50% acetonitrile/0.1% formic acid. Eluted peptides were dried in a speed-vac.&lt;/p&gt;&lt;p&gt;Peptide analysis employed a Thermofisher Scientific Ultimate RSLC 3000 nano liquid chromatography system coupled in-line to a Q Exactive mass spectrometer equipped with an Easy-Spray source (Thermofisher Scientific). Peptides were separated using an Easy-Spray RSLC C18 column (75 µm internal diameter, 50 cm length, Thermofisher Scientific) using a 60 min linear 15% to 35% solvent B (0.1% formic acid in acetonitrile) gradient at a flow rate 200 nl min&lt;sup&gt;−1&lt;/sup&gt;. The raw data were acquired on the mass spectrometer in a data-dependent acquisition (DDA) mode. Full-scan mass spectra were acquired in the Orbitrap (Scan range 350–1,500 &lt;i&gt;m&lt;/i&gt;/&lt;i&gt;z&lt;/i&gt;, resolution 70,000, AGC target 3 × 10&lt;sup&gt;6&lt;/sup&gt;, maximum injection time 50 ms). The 10 most intense peaks were selected for higher-energy collision dissociation (HCD) fragmentation at 30% of normalized collision energy. HCD spectra were acquired in the Orbitrap at resolution 17,500, AGC target 5 × 10&lt;sup&gt;4&lt;/sup&gt;, maximum injection time 120 ms with fixed mass at 180 &lt;i&gt;m&lt;/i&gt;/&lt;i&gt;z&lt;/i&gt;.&lt;/p&gt;&lt;p&gt;Mass spectrometry data were analysed using MaxQuant 2.5.1.0 as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Cox, J. &amp;amp; Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008)." href="/articles/s41586-025-09532-8#ref-CR51" id="ref-link-section-d148898233e2586"&gt;51&lt;/a&gt;&lt;/sup&gt; to obtain label-free quantification values that were then used for data processing in Perseus 2.1.3.0&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016)." href="/articles/s41586-025-09532-8#ref-CR52" id="ref-link-section-d148898233e2590"&gt;52&lt;/a&gt;&lt;/sup&gt;. Label-free quantification values were log&lt;sub&gt;2&lt;/sub&gt;-transformed and categorically grouped by replicates. Rows were filtered based on two valid values in each group and then missing values were replaced using a normal distribution with a width of 0.3 and down shift of 1.8 (default values). Then, dataset was normalized by subtracting the medians of each sample. After visually verifying a normal distribution and a linear correlation, sample pairs were subjected to a two-tailed &lt;i&gt;t&lt;/i&gt;-test using a false discovery rate (FDR) of 0.1 and a &lt;i&gt;S&lt;/i&gt;&lt;sub&gt;0&lt;/sub&gt; of 0.1 to define a threshold of statistical significance. Proteins were represented in a volcano plot, according to the log&lt;sub&gt;2&lt;/sub&gt; of their enrichment and the −log&lt;sub&gt;10&lt;/sub&gt; of the &lt;i&gt;t&lt;/i&gt;-test &lt;i&gt;P&lt;/i&gt; value.&lt;/p&gt;&lt;p&gt;An ANOVA test was carried out for indicated groups of proteins using the Benjamini–Hochberg method with a FDR of 0.05 for truncation. Then, a post hoc Tukey’s honest significant difference test for one-way ANOVA using a FDR of 0.05 was carried out. Proteins were then filtered by ANOVA significance and by category to represent in a heat map their honest significant difference scores, as indicated.&lt;/p&gt;&lt;p&gt;A batch normalization using empirical Bayes method was carried out with the ComBat script&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Behdenna, A. et al. pyComBat, a Python tool for batch effects correction in high-throughput molecular data using empirical Bayes methods. BMC Bioinformatics 24, 459 (2023)." href="/articles/s41586-025-09532-8#ref-CR53" id="ref-link-section-d148898233e2621"&gt;53&lt;/a&gt;&lt;/sup&gt; for PerseusR package 0.3.4&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Rudolph, J. D. &amp;amp; Cox, J. A network module for the Perseus software for computational proteomics facilitates proteome interaction graph analysis. J. Proteome Res. 18, 2052–2064 (2019)." href="/articles/s41586-025-09532-8#ref-CR54" id="ref-link-section-d148898233e2625"&gt;54&lt;/a&gt;&lt;/sup&gt; to make the heat map for all depletions (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09532-8#Fig13"&gt;8&lt;/a&gt;). Then, samples were subjected to the statistical test previously described.&lt;/p&gt;&lt;p&gt;The proteins obtained from the mass spectrometry experiments were categorized as follows. Proteins with signal peptides or lipoprotein signal peptides were first extracted using SignalP 6.0&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Teufel, F. et al. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat. Biotechnol. 40, 1023–1025 (2022)." href="/articles/s41586-025-09532-8#ref-CR55" id="ref-link-section-d148898233e2635"&gt;55&lt;/a&gt;&lt;/sup&gt; to obtain datasets containing only OM plus periplasmic proteins, or lipoproteins, respectively. Proteins were then manually sorted to the categories OMP or SLP. This sorting was carried out using Uniprot entry data that included AlphaFold&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024)." href="/articles/s41586-025-09532-8#ref-CR23" id="ref-link-section-d148898233e2639"&gt;23&lt;/a&gt;&lt;/sup&gt; models. Lipoproteins were only classified as SLPs if they were either SusD homologues or if they were found at a locus coding SusCD systems.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec20"&gt;Determination of cell surface exposure of SusE&lt;/h3&gt;&lt;p&gt;The strain for analysis was transformed with plasmid pXL184 which expresses His-tagged SusE. The cells were then grown overnight in CYE supplemented with erythromycin, and for BAM subunit depletion strains with 0.2 µg ml&lt;sup&gt;−1&lt;/sup&gt; aTC. Cells were collected, resuspended in CYE medium, and then used to inoculate 10 ml of erythromycin-containing CYE medium to OD&lt;sub&gt;600&lt;/sub&gt; = 0.02, supplementing with 0.2 µg ml&lt;sup&gt;−1&lt;/sup&gt; aTC as required. The cells were cultured for 6 h before being collected by centrifugation and resuspended in phosphate buffered saline (PBS) containing 10 mM MgCl&lt;sub&gt;2&lt;/sub&gt; to a total volume of 80 µl and OD&lt;sub&gt;600&lt;/sub&gt; = 1. Samples were supplemented as appropriate with 200 μg ml&lt;sup&gt;−1&lt;/sup&gt; proteinase K (Thermo Fisher) and 1% (v/v) Triton X-100 (Merck) and incubated for 20 min at room temperature. Reactions were stopped by the addition of 5 mM PMSF (ITW Reagents) followed by incubation at 100 °C for 5 min, addition of SDS–PAGE sample buffer, and further incubation at 100 °C for 5 min before analysis by immunoblotting.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec21"&gt;Isolation of outer membrane vesicle fraction&lt;/h3&gt;&lt;p&gt;The isolation of outer membrane vesicles (OMVs) was performed essentially as in ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Mikheyeva, I. V., Sun, J., Huang, K. C. &amp;amp; Silhavy, T. J. Mechanism of outer membrane destabilization by global reduction of protein content. Nat. Commun. 14, 5715 (2023)." href="/articles/s41586-025-09532-8#ref-CR38" id="ref-link-section-d148898233e2672"&gt;38&lt;/a&gt;&lt;/sup&gt;. In brief, cells were separated from culture supernatant by centrifugation at 8,000&lt;i&gt;g&lt;/i&gt; for 5 min and the pellets reserved as the whole-cell fraction. Culture supernatant from the equivalent of 2 ml of culture at OD&lt;sub&gt;600&lt;/sub&gt; = 1 was filtered through a 0.2 µm filter (MilliporeSigma, SLGPR33RB) and concentrated using a 100 kDa molecular weight cut-off Amicon Ultra-4 centrifugal filter (MilliporeSigma, UFC810096) to produce the OMV fraction. Samples were adjusted to equal volume before analysis by immunoblotting.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec22"&gt;Isolation of a spontaneous suppressor of BamH depletion&lt;/h3&gt;&lt;p&gt;The BamH depletion strain XLFJ_1140 was grown overnight in CYE medium supplied with aTC. One millilitre of cells was collected by centrifugation at 8,000&lt;i&gt;g&lt;/i&gt; for 3 min, washed once with CYE and then diluted to a starting OD&lt;sub&gt;600&lt;/sub&gt; = 0.2 in 10 ml fresh CYE medium without aTC. After culturing for 6 h, cells were diluted 1:200 into fresh CYE medium without aTC and cultured for a further 2 days before plating on CYE agar to obtain single colonies. Individual clones were cultured in parallel with and without aTC in CYE and the expression of BamH analysed by whole-cell immunoblotting. Clones that grew without aTC but still expressed BamH only following aTC induction (showing that they were not constitutively de-repressed for BamH synthesis) were subjected to genome sequencing (Plasmidsaurus). This identified the potential suppressor mutation &lt;i&gt;bamA&lt;/i&gt;&lt;sup&gt;&lt;i&gt;Q801K&lt;/i&gt;&lt;/sup&gt;, which was introduced into a BAM wild-type background, followed by successive deletions of &lt;i&gt;bamH&lt;/i&gt; and &lt;i&gt;bamH2&lt;/i&gt; to produce the &lt;i&gt;bamH&lt;/i&gt;&lt;sup&gt;&lt;i&gt;sup&lt;/i&gt;&lt;/sup&gt; strain XLFJ_1198.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec23"&gt;Cryo-EM sample preparation and imaging&lt;/h3&gt;&lt;p&gt;Four microlitres of either fraction A (for the BAM&lt;sub&gt;&lt;i&gt;Fj&lt;/i&gt;&lt;/sub&gt; complex, 1.3 mg ml&lt;sup&gt;−1&lt;/sup&gt;) or fraction B (for the BamAP complex, 1.3 mg ml&lt;sup&gt;−1&lt;/sup&gt;) of the BAM&lt;sub&gt;&lt;i&gt;Fj&lt;/i&gt;&lt;/sub&gt; preparation (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09532-8#Fig1"&gt;1a&lt;/a&gt;), or of the BamP-deleted BAM complex (ΔBamP complex, 1.2 mg ml&lt;sup&gt;−1&lt;/sup&gt;) was adsorbed onto glow-discharged holey carbon-coated grids (Quantifoil 300 mesh, Au R1.2/1.3) for 10 s. Grids were blotted for 2 s at 10 °C, 100% humidity and frozen in liquid ethane using a Vitrobot Mark IV (Thermo Fisher Scientific).&lt;/p&gt;&lt;p&gt;Movies were collected in counted mode, in Electron Event Representation (EER) format, on a CFEG-equipped Titan Krios G4 (Thermo Fisher Scientific) operating at 300 kV with a Selectris X imaging filter (Thermo Fisher Scientific) and slit width of 10 eV, at ×165,000 magnification on a Falcon 4i direct detection camera (Thermo Fisher Scientific), corresponding to a calibrated pixel size of 0.732 Å. Movies were collected at a total dose ranging between 52.0–60.3 e&lt;sup&gt;−&lt;/sup&gt; Å&lt;sup&gt;−2&lt;/sup&gt; (Extended Data Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41586-025-09532-8#Tab1"&gt;1&lt;/a&gt;), fractionated to ~1.0 e&lt;sup&gt;−&lt;/sup&gt; Å&lt;sup&gt;−2&lt;/sup&gt; per fraction for motion correction.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec24"&gt;Cryo-EM data processing&lt;/h3&gt;&lt;p&gt;Patched motion correction, contrast transfer function (CTF) parameter estimation, particle picking, extraction and initial 2D classification were performed in SIMPLE 3.01&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 56" title="Caesar, J. et al. SIMPLE 3.0. Stream single-particle cryo-EM analysis in real time. J. Struct. Biol. X 4, 100040 (2020)." href="/articles/s41586-025-09532-8#ref-CR56" id="ref-link-section-d148898233e2761"&gt;56&lt;/a&gt;&lt;/sup&gt;. All downstream processing was carried out in cryoSPARC 4.5.3&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 57" title="Punjani, A., Zhang, H. &amp;amp; Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214–1221 (2020)." href="/articles/s41586-025-09532-8#ref-CR57" id="ref-link-section-d148898233e2765"&gt;57&lt;/a&gt;&lt;/sup&gt; or RELION 4.03&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Zivanov, J., Nakane, T. &amp;amp; Scheres, S. H. W. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ 6, 5–17 (2019)." href="/articles/s41586-025-09532-8#ref-CR58" id="ref-link-section-d148898233e2769"&gt;58&lt;/a&gt;&lt;/sup&gt;, using the csparc2star.py script within UCSF pyem 0.5&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Asarnov, D., Palovcak, E. &amp;amp; Cheng, Y. UCSF pyem v0.5. Zenodo 
                https://doi.org/10.5281/zenodo.3576630
                
               (2019)." href="/articles/s41586-025-09532-8#ref-CR59" id="ref-link-section-d148898233e2773"&gt;59&lt;/a&gt;&lt;/sup&gt; to convert between formats. Global resolution was estimated from gold-standard Fourier shell correlations (FSCs) using the 0.143 criterion and local resolution estimation was calculated within cryoSPARC.&lt;/p&gt;&lt;p&gt;The cryo-EM processing workflow for the BAM&lt;sub&gt;&lt;i&gt;Fj&lt;/i&gt;&lt;/sub&gt; complex is outlined in Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09532-8#Fig6"&gt;1&lt;/a&gt;. In brief, particles were subjected to one round of reference-free 2D classification (&lt;i&gt;k&lt;/i&gt; = 200) using a 240 Å soft circular mask within cryoSPARC resulting in the selection of 2,153,927 clean particles. A subset of these particles (180,179) was subjected to multi-class ab initio reconstruction using a maximum resolution cut-off of 7 Å, generating 4 volumes. These volumes were lowpass-filtered to 20 Å and used as references in a heterogeneous refinement against the full 2D-cleaned particle set. Particles (903,299) from the most populated and structured class were selected and non-uniform refined against their corresponding volume lowpass-filtered to 15 Å, generating a 3.0 Å map. Bayesian polishing in RELION followed by duplicate particle removal generated a 2.5 Å map after non-uniform refinement, which could be further improved to 2.3 Å after local and global CTF refinement (fitting beam tilt and trefoil only). These particles were then subjected to heterogeneous refinement against four compositionally distinct volumes previously generated by RELION 3D classification (&lt;i&gt;k&lt;/i&gt; = 8, 3.75° sampling) of a particle subset of pre-polished particles. Particles (274,708) belonging to the class with strong BamD and POTRA densities were selected and non-uniform refined against their corresponding volume, generating a 2.4 Å map. Additional alignment-free 3D classification in RELION was performed (&lt;i&gt;k&lt;/i&gt; = 6) using a soft mask covering BamD and the BamA POTRA domains yielding a class with stronger density. Particles (55,795) from this class were selected and non-uniform refined against a previous volume lowpass-filtered to 15 Å, generating a consensus 2.7 Å volume. Local refinements were performed against the consensus volume (lowpass-filtered to 7 Å) using soft masks covering the BamD/POTRA domains or extracellular density, yielding 3.2 Å and 2.7 Å volumes, respectively. ChimeraX&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 60" title="Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021)." href="/articles/s41586-025-09532-8#ref-CR60" id="ref-link-section-d148898233e2797"&gt;60&lt;/a&gt;&lt;/sup&gt; was used to generate a composite map from the consensus and individual focused maps.&lt;/p&gt;&lt;p&gt;The cryo-EM processing workflow for the BamAP complex is outlined in Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09532-8#Fig11"&gt;6&lt;/a&gt;. Two datasets were collected for this sample. In the first dataset particles were subjected to two rounds of reference-free 2D classification (&lt;i&gt;k&lt;/i&gt; = 200) using a 200 Å soft circular mask resulting in the selection of 979,474 clean particles. These particles were then subjected to multi-class ab initio reconstruction (&lt;i&gt;k&lt;/i&gt; = 4) using a maximum resolution cut-off of 8 Å, generating 4 volumes. Particles (514,326) belonging to the 2 most prominent volumes were combined and non-uniform refined against one of their corresponding volumes, lowpass-filtered to 15 Å, generating a 3.7 Å volume. The second particle dataset underwent four rounds of 2D classification (&lt;i&gt;k&lt;/i&gt; = 200, 200 Å soft circular mask) followed by multi-class ab initio reconstruction using a maximum resolution cut-off of 7 Å, generating 6 volumes. Particles (438,412) from the most populated class were selected and refined against their corresponding volume lowpass-filtered to 15 Å, generating a 3.7 Å volume. Particles from both datasets were independently polished within RELION, combined, and non-uniform refined, fitting per-particle CTF parameters, yielding a 3.5 Å map. Alignment-free 3D classification was subsequently performed within cryoSPARC (&lt;i&gt;k&lt;/i&gt; = 6), using a soft mask covering the full protein density of the complex. Particles (96,076) from the class demonstrating strong density for the N-terminal domain of BamP were selected and non-uniform refined against their corresponding volume, lowpass-filtered to 15 Å, generating a 3.7 Å map.&lt;/p&gt;&lt;p&gt;The cryo-EM processing workflow for the ΔBamP complex is outlined in Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09532-8#Fig10"&gt;5&lt;/a&gt;. In brief, particles were subjected to two rounds of reference-free 2D classification (&lt;i&gt;k&lt;/i&gt; = 200) using a 180 Å soft circular mask within cryoSPARC resulting in the selection of 1,177,554 clean particles. These particles were then subjected to multi-class ab initio reconstruction using a maximum resolution cut-off of 6 Å, generating 6 volumes. Particles from volume classes containing BamA barrels were independently non-uniform refined against their corresponding volume, lowpass-filtered to 15 Å. These particles were subsequently combined and refined against a volume (lowpass-filtered to 15 Å) from the most populated class, generating a 3.6 Å consensus volume. Bayesian polishing in RELION followed by non-uniform refinement and fitting of per-particle CTF parameters plus beam tilt and trefoil generated a 3.5 Å map. Map quality was further improved by non-uniform refinement of a cleaner particle set (534,368 particles) generated by an additional round of 2D classification (&lt;i&gt;k&lt;/i&gt; = 100, 180 Å soft circular mask), despite no increase in nominal resolution. A second β-barrel could be resolved in map density at low contour level (0.08). Attempts to improve map quality for this partner β-barrel, through extensive 3D classification and local refinement schemes, did not improve map quality for this region.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec25"&gt;Model building, structure refinement and figure preparation&lt;/h3&gt;&lt;p&gt;Iterative model building and real-space refinement using secondary structure, rotamer, and Ramachandran restraints was performed in Coot v0.9&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 61" title="Brown, A. et al. Tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions. Acta Crystallogr. D 71, 136–153 (2015)." href="/articles/s41586-025-09532-8#ref-CR61" id="ref-link-section-d148898233e2840"&gt;61&lt;/a&gt;&lt;/sup&gt; and Phenix 1.21&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531–544 (2018)." href="/articles/s41586-025-09532-8#ref-CR62" id="ref-link-section-d148898233e2844"&gt;62&lt;/a&gt;&lt;/sup&gt;, respectively. Validation was performed in Molprobity 4.5.2&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018)." href="/articles/s41586-025-09532-8#ref-CR63" id="ref-link-section-d148898233e2848"&gt;63&lt;/a&gt;&lt;/sup&gt; within Phenix. Cryo-EM data collection, image processing and structure refinement statistics are listed in Extended Data Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41586-025-09532-8#Tab1"&gt;1&lt;/a&gt;. Figures were prepared using UCSF ChimeraX v.1.9&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 60" title="Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021)." href="/articles/s41586-025-09532-8#ref-CR60" id="ref-link-section-d148898233e2855"&gt;60&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec26"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09532-8#MOESM2"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 01 Oct 2025 15:53:24 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE9XMERWNjV2TEFMMEJjSlphc0dkVjk3Wlc3b0htZ3pCV2FQUXpTSFYxSmNwSFhBZDBQczk1bnlUTDRnM3V5dUNZZFkzNFlXUUs5aGJUdy1HaXdNSjdJaEhn</guid></item><item><title>微型CRISPR-Cas10酶通过抑制信号传导赋予免疫力- Nature</title><link>https://www.nature.com/articles/s41586-025-09569-9</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec7-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec8"&gt;Bacterial strains and growth conditions&lt;/h3&gt;&lt;p&gt;Standard bacterial cultures were grown in lysogeny broth (LB Lennox) at 37 °C and 250 rpm except where stated otherwise. When necessary, 34 µg ml&lt;sup&gt;−1&lt;/sup&gt; chloramphenicol (+Ch), +50 µg ml&lt;sup&gt;−1&lt;/sup&gt; kanamycin sulfate (+K) or +50 µg ml&lt;sup&gt;−1&lt;/sup&gt; carbenicillin (+C) was supplemented to media and LB agar plates. For cellular assays, all bacterial strains were stored at −80 °C in 25% glycerol (Sigma) when not in use. Cloning and cellular assays were generally performed in &lt;i&gt;E. coli&lt;/i&gt; DH10b genotype cells (&lt;i&gt;F- mcrA Δ(mrr-hsdRMS-mcrBC) endA1 recA1 ϕ80dlacZΔM15 ΔlacX74 araD139 Δ(ara, leu)7697 galU galK rpsL (StrR) nupG λ-&lt;/i&gt;) (Intact Genomics, NEB). For phage experiments involving G17 or Goslar, &lt;i&gt;E. coli&lt;/i&gt; strain ECOR47 was used&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Ochman, H. &amp;amp; Selander, R. K. Standard reference strains of Escherichia coli from natural populations. J. Bacteriol. 157, 690–693 (1984)." href="/articles/s41586-025-09569-9#ref-CR62" id="ref-link-section-d172089166e1750"&gt;62&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec9"&gt;Phage propagation and scaling&lt;/h3&gt;&lt;p&gt;Phages were propagated using standard protocols. Typically, phage production was performed at 37 °C in LB Lennox media infecting &lt;i&gt;E. coli&lt;/i&gt; BW25113 (&lt;i&gt;F-&lt;/i&gt; &lt;i&gt;DE(araD-araB)567 lacZ4787(del)::rrnB-3 LAM- rph-1 DE(rhaD-rhaB)568 hsdR514&lt;/i&gt;)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="Datsenko, K. A. &amp;amp; Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97, 6640–6645 (2000)." href="/articles/s41586-025-09569-9#ref-CR63" id="ref-link-section-d172089166e1771"&gt;63&lt;/a&gt;&lt;/sup&gt; at an initial MOI of 0.1. Phages G17 and Goslar were propagated on &lt;i&gt;E. coli&lt;/i&gt; ECOR47. Phage titres were determined on their propagation hosts. Bacteriophages used in this study and their sources&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Maffei, E. et al. Systematic exploration of Escherichia coli phage–host interactions with the BASEL phage collection. PLoS Biol. 19, e3001424 (2021)." href="/articles/s41586-025-09569-9#ref-CR35" id="ref-link-section-d172089166e1779"&gt;35&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Korf, I. H. E. et al. Still something to discover: novel insights into Escherichia coli phage diversity and taxonomy. Viruses 11, 454 (2019)." href="/articles/s41586-025-09569-9#ref-CR36" id="ref-link-section-d172089166e1782"&gt;36&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Mutalik, V. K. et al. High-throughput mapping of the phage resistance landscape in E. coli. PLoS Biol. 18, e3000877 (2020)." href="/articles/s41586-025-09569-9#ref-CR51" id="ref-link-section-d172089166e1785"&gt;51&lt;/a&gt;&lt;/sup&gt; have been described at length in Supplementary File &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09569-9#MOESM4"&gt;2&lt;/a&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec10"&gt;Plasmid construction&lt;/h3&gt;&lt;p&gt;Plasmids were assembled using PCR, gel extraction (Zymo) and Golden Gate assembly&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 64" title="Weber, E., Engler, C., Gruetzner, R., Werner, S. &amp;amp; Marillonnet, S. A modular cloning system for standardized assembly of multigene constructs. PLoS ONE 6, e16765 (2011)." href="/articles/s41586-025-09569-9#ref-CR64" id="ref-link-section-d172089166e1800"&gt;64&lt;/a&gt;&lt;/sup&gt; or Gibson Assembly using 25–30 bp of overlapping homology&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 65" title="Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009)." href="/articles/s41586-025-09569-9#ref-CR65" id="ref-link-section-d172089166e1804"&gt;65&lt;/a&gt;&lt;/sup&gt;. For some assemblies, Golden Gate ready DNA was ordered from TWIST BioSciences in lieu of generation by PCR. Native promoter Panoptes includes 300 bp upstream of the gene encoding mCpol and 150 bp downstream of the gene encoding 2TMβ. In general, plasmids were propagated in DH10b genotype &lt;i&gt;E. coli&lt;/i&gt; (Intact Genomics). For G17 and Goslar assays, select plasmids were transferred to &lt;i&gt;E. coli&lt;/i&gt; ECOR47 through electroporation (Intact Genomics) using standard electroporation parameters (2,000 V and 200 Ω). For protein expression and purification, plasmids were transferred into BL21 AI genotype &lt;i&gt;E. coli&lt;/i&gt; (&lt;i&gt;F- ompT hsdSB (rB-mB-) gal dcm araB::T7RNAPtetA&lt;/i&gt;) (Thermo Fisher). For assays involving two plasmids, plasmids were first cloned individually and co-transformed into DH10b genotype &lt;i&gt;E. coli&lt;/i&gt; (Intact Genomics) through electroporation. All plasmids and co-transformations used in this study were sequenced confirmed by full-plasmid sequencing (Plasmidsaurus). To verify co-transformed plasmids, raw reads were mapped against reference plasmid sequences using Geneious. Plasmids used in this study are listed in Supplementary File &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09569-9#MOESM4"&gt;1&lt;/a&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec11"&gt;Phage infection assays&lt;/h3&gt;&lt;p&gt;Phage infection plaque assays were performed via double agar overlay. Overlays were formed by mixing 100 µl of saturated overnight cultures grown at 37 °C at 250 rpm with 5 ml molten LB Lennox agar (0.7% w/v, 60 °C). For G17 and Goslar assays, a lower percentage top agar concentration was used (0.35% w/v). The agar–bacterial mixture was supplemented with kanamycin to a final overlay concentration of 50 µg ml&lt;sup&gt;−1&lt;/sup&gt;. For plaque assays involving crystal violet (Sigma), crystal violet was supplemented to a final overlay concentration as specified. The top agar and bacterial mixture was poured onto a 5 ml LB agar and kanamycin plate and left to dry under microbiological flame for 15 min. Phages were diluted tenfold in SM buffer (Teknova) and 2 μl of each dilution were spotted onto the top agar overlay and dried under microbiological flame. Once dry, plates were incubated at 30 °C for 12–16 h. Plates were scanned in a standard photo scanner (Epson) and PFU were enumerated, keeping note of changes in plaque size relative to a negative control. ‘Lysis from without’&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Abedon, S. T. Lysis from without. Bacteriophage 1, 46–49 (2011)." href="/articles/s41586-025-09569-9#ref-CR66" id="ref-link-section-d172089166e1837"&gt;66&lt;/a&gt;&lt;/sup&gt; phenotypes were interpreted as a lack of productive phage infection and approximated as 1 PFU. Efficiency of plaquing calculations were calculated as mean(PFU in condition)/mean(PFU negative control). The negative control is defined as a strain harbouring a plasmid encoding red fluorescent protein (RFP) instead of Panoptes (pBA1326). All plaque assays were performed in biological triplicate from independent overnight cultures. Visualizations were performed using Seaborn (v0.13.2) in Python.&lt;/p&gt;&lt;p&gt;For plaque assays involving CRISPRi-ART&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Adler, B. A. et al. CRISPRi-ART enables functional genomics of diverse bacteriophages using RNA-binding dCas13d. Nat. Microbiol. 10, 694–709 (2025)." href="/articles/s41586-025-09569-9#ref-CR39" id="ref-link-section-d172089166e1844"&gt;39&lt;/a&gt;&lt;/sup&gt;, experiments were performed with the following modifications. Kanamycin, chloramphenicol and aTc (Sigma) were additionally added to final overlay concentrations of 50 µg ml&lt;sup&gt;−1&lt;/sup&gt;, 34 μg ml&lt;sup&gt;−1&lt;/sup&gt; and 20 nM, respectively, and plated onto a 5-ml LB agar, kanamycin and chloramphenicol plate. The negative control is defined as Panoptes (pBA1751) alongside a CRISPRi-ART vector with an RFP-targeting guide RNA (pBA635)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Adler, B. A. et al. CRISPRi-ART enables functional genomics of diverse bacteriophages using RNA-binding dCas13d. Nat. Microbiol. 10, 694–709 (2025)." href="/articles/s41586-025-09569-9#ref-CR39" id="ref-link-section-d172089166e1852"&gt;39&lt;/a&gt;&lt;/sup&gt;. Guide sequences are listed in Supplementary File &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09569-9#MOESM4"&gt;1&lt;/a&gt;. The positive control is defined as a pJEx vector without Panoptes (pBA1326) alongside a CRISPRi-ART guide RNA targeting a phage not present in the experiment. Titres were calculated as mean (PFU condition). All plaque assays were performed in biological triplicate from independent overnight cultures. Visualizations were performed using matplotlib (v3.7.2) and Seaborn (v0.13.2) in Python. CRISPRi-ART guide RNAs were chosen using gRNA1 and gRNA4 designs as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Adler, B. A. et al. CRISPRi-ART enables functional genomics of diverse bacteriophages using RNA-binding dCas13d. Nat. Microbiol. 10, 694–709 (2025)." href="/articles/s41586-025-09569-9#ref-CR39" id="ref-link-section-d172089166e1860"&gt;39&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec12"&gt;Bacteriophage liquid growth and phage production&lt;/h3&gt;&lt;p&gt;Liquid phage experiments were performed in a Biotek plate reader using LB Lennox + kanamycin media. Strains containing native context Panoptes (pBA1751) or a negative control (pBA1326) plasmid were grown overnight at 37 °C and 250 rpm. Of overnight culture, 8 × 10&lt;sup&gt;6&lt;/sup&gt; CFU were seeded into each well of a 96-well plate (3903, Corning) in 200 µl media. For phage experiments, T4 was diluted in LB + kanamycin media to achieve defined MOIs during infection except for MOI = 0 in which no phage was added. Growth was monitored in a Biotek Cytation 5 plate reader for 12 h at 800 rpm shaking at 30 °C with OD&lt;sub&gt;600&lt;/sub&gt; readings every 5 min. At the end of the experiment, cultures were pelleted and the supernatant from investigated wells was collected. Phage production was estimated via plaque assay (above) on &lt;i&gt;E. coli&lt;/i&gt; harbouring a negative control (pBA1326) plasmid and dividing by the effective titre at time 0. All liquid phage experiments were performed in biological triplicate and replicate conditions from independent overnights. Visualizations were performed using matplotlib (v3.7.2) and Seaborn (v0.13.2) in Python.&lt;/p&gt;&lt;p&gt;Estimation of free phage particle production from a single round of infection was performed in 5 ml cultures. Cultures were inoculated with 2 × 10&lt;sup&gt;8&lt;/sup&gt; CFU &lt;i&gt;E. coli&lt;/i&gt; harbouring native context Panoptes (pBA1751) or a negative control (pBA1326) plasmid in LB + kanamycin media and incubated at 30 °C at 250 rpm for 15 min. Following incubation, approximately 2 × 10&lt;sup&gt;6&lt;/sup&gt; CFU of phage T4 was added for a low MOI infection of approximately 0.01. Infections proceeded at 30 °C at 250 rpm and 200 µl sampled every 30 min for 6.5 h. For each 200 µl sample, remaining cells were pelleted, 100 µl supernatant was extracted and stored on ice until every sample was collected. Phage titres were enumerated via plaque assay on &lt;i&gt;E. coli&lt;/i&gt; harbouring a negative control plasmid (pBA1326). Free phage production was calculated by dividing the sample titre by the number of added phages. Replicates were performed in biological triplicate, sourcing samples from parallel cultures seeded from independent overnights. Visualizations were performed using matplotlib (v3.7.2) and Seaborn (v0.13.2) in Python.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec13"&gt;Panoptes toxin–antitoxin assays&lt;/h3&gt;&lt;p&gt;To test for a potential toxin–antitoxin relationship in Panoptes, we cloned candidate antitoxin mCpol or mCpol D57A under control of the pTet promoter in a p15a-CmR plasmid and candidate toxin 2TMβ under control of the pJex promoter&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Ruegg, T. L. et al. Jungle Express is a versatile repressor system for tight transcriptional control. Nat. Commun. 9, 3617 (2018)." href="/articles/s41586-025-09569-9#ref-CR41" id="ref-link-section-d172089166e1901"&gt;41&lt;/a&gt;&lt;/sup&gt; in a low-copy SC101-KanR plasmid. dCas13d under pTet control on a p15a-CmR plasmid (pBA635)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Adler, B. A. et al. CRISPRi-ART enables functional genomics of diverse bacteriophages using RNA-binding dCas13d. Nat. Microbiol. 10, 694–709 (2025)." href="/articles/s41586-025-09569-9#ref-CR39" id="ref-link-section-d172089166e1905"&gt;39&lt;/a&gt;&lt;/sup&gt; was used as an antitoxin negative control. RFP expressed under pJex control on a SC101-KanR plasmid was used as a toxin negative control. Both sets of plasmids were co-transformed into DH10b &lt;i&gt;E. coli&lt;/i&gt; (Intact Genomics) and sequence verified using whole-plasmid sequencing (Plasmidsaurus), followed by read alignment (Geneious). Sequence-confirmed co-transformants were stored at −80 °C in 20% glycerol (v/v) until further use.&lt;/p&gt;&lt;p&gt;To perform solid agar toxin–antitoxin assays, LB agar plates were freshly poured and dried under flame with the following supplements: 35 µg ml&lt;sup&gt;−1&lt;/sup&gt; chloramphenicol, 50 µg ml&lt;sup&gt;−1&lt;/sup&gt; kanamycin, variable amounts of crystal violet to induce toxin expression and variable amounts of aTc to induce antitoxin expression. For toxin expression conditions, +50 nM crystal violet was added. For antitoxin expression conditions, +2 nM aTc was added. Once the agar was dried, three independent overnight cultures containing candidate toxin and antitoxin plasmids were plated in 10× serial dilutions with 5-µl spots and let dry under flame. Once dried, plates were incubated at 30 °C overnight. To let colonies mature for imaging, plates were transferred to a 37 °C incubator for an additional 24 h. Colonies were imaged and counted.&lt;/p&gt;&lt;p&gt;To perform liquid culture toxin–antitoxin assays, three independent overnight cultures containing candidate toxin and antitoxin plasmids were inoculated in LB media at 8 × 10&lt;sup&gt;6&lt;/sup&gt; CFU in a Corning 3903 plate with the following supplements: 35 µg ml&lt;sup&gt;−1&lt;/sup&gt; chloramphenicol, 50 µg ml&lt;sup&gt;−1&lt;/sup&gt; kanamycin, variable amounts of crystal violet to induce toxin expression and variable amounts of aTc to induce antitoxin expression. For toxin expression conditions, +125 nM crystal violet was used. For antitoxin expression conditions, +20 nM aTc was used. The plate was monitored in a Cytation5 plate reader (Biotek) at 30 °C at 807 rpm and OD&lt;sub&gt;600&lt;/sub&gt; measured every 5 min for 12 h. Data were plotted using the Seaborn (v0.13.2) package in Python.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec14"&gt;Panoptes activator assays&lt;/h3&gt;&lt;p&gt;To test for an activator relationship with Panoptes, we cloned Panoptes in its native context into a p15a-CmR plasmid and candidate activators T4Acb1, T4Acb1(H44A,H113A), T4Acb2, T4Acb2(Y8A) and N4Acb4 under control of the pJex promoter&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Ruegg, T. L. et al. Jungle Express is a versatile repressor system for tight transcriptional control. Nat. Commun. 9, 3617 (2018)." href="/articles/s41586-025-09569-9#ref-CR41" id="ref-link-section-d172089166e1938"&gt;41&lt;/a&gt;&lt;/sup&gt; in a low-copy SC101-KanR plasmid. dCas13d under pTet on a p15a-CmR plasmid (pBA635)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Adler, B. A. et al. CRISPRi-ART enables functional genomics of diverse bacteriophages using RNA-binding dCas13d. Nat. Microbiol. 10, 694–709 (2025)." href="/articles/s41586-025-09569-9#ref-CR39" id="ref-link-section-d172089166e1942"&gt;39&lt;/a&gt;&lt;/sup&gt; was used as the Panoptes negative control. RFP under pJex on a SC101-KanR plasmid was used as an activator negative control.&lt;/p&gt;&lt;p&gt;To perform liquid culture activator assays, three independent overnight cultures containing candidate Panoptes and candidate activator plasmids were inoculated in LB media at 8 × 10&lt;sup&gt;6&lt;/sup&gt; CFU in a Corning 3903 plate with the following supplements: 35 µg ml&lt;sup&gt;−1&lt;/sup&gt; chloramphenicol, 50 µg ml&lt;sup&gt;−1&lt;/sup&gt; kanamycin, variable amounts of crystal violet to induce candidate activator expression and no aTc for Panoptes expression. For candidate activator expression conditions, +125 nM crystal violet was used. The plate was monitored in a Cytation5 plate reader (Biotek) at 30 °C, 807 rpm and OD&lt;sub&gt;600&lt;/sub&gt; measured every 5 min for 12 h. Data were plotted using the Seaborn (v0.13.2) package in Python.&lt;/p&gt;&lt;p&gt;To measure viability from liquid culture activator assays, we used a modified protocol. Three independent overnight cultures containing candidate pTet-native promoter Panoptes or pTet-dCas13d (negative control) and pJEX-T4Acb2 or pJEX-RFP (negative control) were inoculated in LB media at 8 × 10&lt;sup&gt;6&lt;/sup&gt; CFU in a Corning 3903 plate with the following supplements: 35 µg ml&lt;sup&gt;−1&lt;/sup&gt; chloramphenicol, 50 µg ml&lt;sup&gt;−1&lt;/sup&gt; kanamycin and no inducers. Cells were grown for 3 h in a Cytation5 plate reader (Biotek) at 30 °C and 807 rpm (OD&lt;sub&gt;600&lt;/sub&gt; ~ 0.2). At this point (&lt;i&gt;t&lt;/i&gt; = 0), either +125 nM crystal vioelt or +0 nM was supplemented to the cultures to activate or not activate Panoptes and grown for an additional 2 h (&lt;i&gt;t&lt;/i&gt; = 120). At both &lt;i&gt;t&lt;/i&gt; = 0 and &lt;i&gt;t&lt;/i&gt; = 120, 5 µl of cells were sampled, tenfold serially diluted in inducer-free media and spotted on inducer-free LB agar with antibiotics. Plates were incubated overnight at 37 °C and colonies counted to estimate viability from &lt;i&gt;t&lt;/i&gt; = 0 and &lt;i&gt;t&lt;/i&gt; = 120. Data were plotted using the Seaborn (v0.13.2) package in Python.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec15"&gt;Protein expression and purification&lt;/h3&gt;&lt;p&gt;Expression sequences for ECOR31 mCpol were cloned into a custom pET-based vector by Gibson assembly to yield an N-terminal His&lt;sub&gt;10&lt;/sub&gt;-MBP-TEV or C-terminal TEV-MBP-His&lt;sub&gt;10&lt;/sub&gt; construct. Expression plasmids for ECOR31 TM2β residues 72–200 (2TMβ(∆2TM)) were cloned into a pET Duet-1 vector for co-expression of His&lt;sub&gt;6&lt;/sub&gt;-SUMO2-TM2β and MBP-TEV-mCpol constructs.&lt;/p&gt;&lt;p&gt;Proteins were expressed in &lt;i&gt;E. coli&lt;/i&gt; Rosetta 2 (DE3) pLysS by growing cells to an OD&lt;sub&gt;600&lt;/sub&gt; of 0.4–0.6 in 2× yeast extract tryptone (2×YT) medium at 37 °C and induced with 0.5 mM isopropyl β-&lt;span class="u-small-caps"&gt;d&lt;/span&gt;-1-thiogalactopyranoside (IPTG) following a cold shock at 4 °C. After induction, cells expressing each protein were grown overnight at 16 °C. Cells were collected by centrifugation for 20 min at 12,300&lt;i&gt;g&lt;/i&gt; and 4 °C and resuspended in 20 mM Tris-HCl, pH 8.0, 10 mM imidazole, 2 mM MgCl&lt;sub&gt;2&lt;/sub&gt;, 500 mM KCl, 10% (v/v) glycerol, 0.5 mM Tris (2-carboxyethyl) phosphine and Roche protease inhibitor.&lt;/p&gt;&lt;p&gt;Cells were lysed by sonication, and cell lysate was clarified by centrifugation at 17,000&lt;i&gt;g&lt;/i&gt; and 4 °C for 0.5 h. The supernatant was bound to Nickel-NTA affinity resin pre-equilibrated with wash buffer (20 mM Tris-HCl, pH 8.0, 500 mM KCl, 30 mM imidazole, 10% (v/v) glycerol and 0.5 mM Tris(2-carboxyethyl) phosphine (TCEP)) for 1 h at 4 °C. Supernatant was discarded and resin was washed 5 × 30 ml wash buffer (20 mM Tris-HCl, pH 8.0, 500 mM KCl, 30 mM imidazole, 10% (v/v) glycerol and 0.5 mM TCEP). All buffers for the purification of ECOR31 TM2β were additionally supplemented with 1 µM 2′3′-c-di-AMP (BioLog Life Science Institute) in the washing and subsequent steps. Protein was eluted in 5 ml elution buffer (20 mM Tris-HCl, pH 8.0, 500 mM KCl, 300 mM imidazole, 10% (v/v) glycerol and 0.5 mM TCEP). Recombinant TEV protease or SUMO protease 2 (SENP2) with an N-terminal His-tag (BPS Bioscience) was added to the elution for cleavage and dialysed overnight at 4 °C in a 3.5 kDa MWCO dialysis cassette (Thermo Fisher Scientific) with dialysis buffer (20 mM Tris-HCl, pH 8.0, 500 mM KCl, 30 mM imidazole, 10% (v/v) glycerol and 0.5 mM TCEP). The resultant solution was passed over a 5-ml Ni-NTA Superflow cartridge (Cytiva). Flow-through was collected, concentrated to less than 2 ml using a 3 kDa MWCO centrifugal filter (Amicon), and loaded onto a HiLoad 16/600 Superdex 200-pg column (Cytiva). Elution was isocratic (20 mM Tris-HCl, pH 8.0, 500 mM KCl, 10% glycerol and 1 mM TCEP) and monitored by absorbance at 280 nm. Peaks were pooled (approximately 86 ml for ECOR31 TM2β; approximately 83 ml for ECOR31 mCpol), concentrated to 5 mg ml&lt;sup&gt;−1&lt;/sup&gt; (ECOR31 TM2β) or 3 mg ml&lt;sup&gt;−1&lt;/sup&gt; (ECOR31 mCpol) as determined by absorbance at 280 nm, snap frozen and stored at −80 °C.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec16"&gt;Analysis of recombinant protein&lt;/h3&gt;&lt;p&gt;Purified protein was analysed by SDS–PAGE. Samples were prepared in 1X protein loading dye (50 mM Tris-HCl, pH 6.8, 15 mM EDTA, 6% (v/v) glycerol, 10% SDS and bromophenol blue), heated at 95 °C for 3 min, loaded onto a 12% Mini-Protean TGX precast protein gel (Bio-Rad) and run at 125 V until the dye front reached the bottom of the gel. Gels were stained in 30% ethanol, 10% glacial acetic acid in water and 0.1% (w/v) R-250 Coomassie, and destained in 40% ethanol and 10% glacial acetic acid in water.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec17"&gt;Crystallization and structure determination&lt;/h3&gt;&lt;p&gt;Crystals of mCpol bound to a hydrolysis-resistant amine-modified analog of ATP (ApNHpp; NU-449-1, Sapphire North America) were grown at 20 °C using the hanging drop vapour diffusion method. A 1-µl solution of 3 mg ml&lt;sup&gt;−1&lt;/sup&gt; mCpol in 20 mM Tris-HCl, pH 8.0, 500 mM NaCl and 5% glycerol was mixed with 1 µl 0.1 M bicine, pH 8.0, and 15% PEG 1500 and supplemented with 0.2 µl 10 mM MgCl&lt;sub&gt;2&lt;/sub&gt; with 10 mM of ApNHpp. Single crystals appeared within 3 days and were cryoprotected in a solution of mother liquor with 30% glycerol before being flash cooled in liquid nitrogen.&lt;/p&gt;&lt;p&gt;Data for mCpol bound to ApNHpp were collected via fine-phi slicing using 0.2° oscillations at beamline 12-2 at Stanford Synchrotron Radiation Lightsource at SLAC National Accelerator Laboratory. X-ray diffraction data were measured to 2.28 Å resolution.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec18"&gt;Processing and refinement of crystallographic data&lt;/h3&gt;&lt;p&gt;Crystallographic data were processed with the SSRL autoxds script with an I/sigI cut-off ≥ 1.50. Crystals displayed moderate anisotropic X-ray diffraction with some diffraction extending beyond 2.0 Å resolution. However, the resolution was isotropically truncated to 2.28 Å resolution to generate a robust complete dataset. The structure was solved by molecular replacement&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 67" title="McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007)." href="/articles/s41586-025-09569-9#ref-CR67" id="ref-link-section-d172089166e2059"&gt;67&lt;/a&gt;&lt;/sup&gt; using a ColabFold-generated&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods 19, 679–682 (2022)." href="/articles/s41586-025-09569-9#ref-CR68" id="ref-link-section-d172089166e2063"&gt;68&lt;/a&gt;&lt;/sup&gt; model (pLDDT = 95.12) of mCpol with residual residues from the C-terminal cleavage site (mCpol-ENLYFQ) in PHENIX&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 69" title="Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010)." href="/articles/s41586-025-09569-9#ref-CR69" id="ref-link-section-d172089166e2067"&gt;69&lt;/a&gt;&lt;/sup&gt;. Molecular replacement successfully identified the placement of two mCpol monomers as indicated by the log-likelihood gain of 556.03 and the translation-function &lt;i&gt;Z&lt;/i&gt; score of 23.6. The structure was refined using PHENIX&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 70" title="Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D Biol. Crystallogr. 68, 352–367 (2012)." href="/articles/s41586-025-09569-9#ref-CR70" id="ref-link-section-d172089166e2074"&gt;70&lt;/a&gt;&lt;/sup&gt; including simulated annealing, non-crystallographic symmetry and TLS (translation, libration, screw-rotation) parameters. In each protein monomer (chains A and B) residues 121–125 were disordered and thus not included in the model. The model was built and adjusted using COOT&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 71" title="Emsley, P., Lohkamp, B., Scott, W. G. &amp;amp; Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010)." href="/articles/s41586-025-09569-9#ref-CR71" id="ref-link-section-d172089166e2079"&gt;71&lt;/a&gt;&lt;/sup&gt;. The structure was refined to a final &lt;i&gt;R&lt;/i&gt;&lt;sub&gt;free&lt;/sub&gt; and &lt;i&gt;R&lt;/i&gt;&lt;sub&gt;work&lt;/sub&gt; of 24.88% and 22.43%, respectively (Extended Data Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41586-025-09569-9#Tab1"&gt;1&lt;/a&gt;). Extended Data Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41586-025-09569-9#Tab1"&gt;1&lt;/a&gt; shows data processing and model refinement statistics. Atomic coordinates and structure factors have been deposited to the Protein Data Bank.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec19"&gt;Sequence alignment of mCpol domains&lt;/h3&gt;&lt;p&gt;Proteins in the Pfam entry PF18182 ‘minimal CRISPR polymerase domain’ were downloaded and used to create an alignment of 163 mCpol sequences. Sequences were trimmed and aligned using MAFFT alignment with default parameters in Geneious Prime (v2023.2.1).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec20"&gt;TLC of cyclase products&lt;/h3&gt;&lt;p&gt;Recombinant enzymes were assessed for cyclase activity by in vitro reactions with nucleoside triphosphates and analysis by TLC. Cyclase activity assays were initiated by the addition of recombinant enzyme (40 μM final) in reaction buffer (50 mM Tris, pH 8.0, 10 mM MgCl&lt;sub&gt;2&lt;/sub&gt; and 100 mM NaCl) to 5 mM NTP (Thermo Scientific). The reaction mixture was incubated at 37 °C for 18 h and stopped by vortexing for 20 s.&lt;/p&gt;&lt;p&gt;Recombinant enzymes were assessed for cyclic dinucleotide (c-di-AMP) degradation in biochemical reactions containing buffered c-di-AMP and products were analysed by TLC. Reactions were initiated by the addition of recombinant enzyme (40 μM) in reaction buffer (50 mM Tris, pH 8.0, 10 mM MgCl&lt;sub&gt;2&lt;/sub&gt; and 100 mM NaCl) to 1.25 mM c-di-AMP (Biolog or MedChemExpress). The reaction mixture was incubated at 37 °C from 10 min to 18 h and stopped by vortexing for 20 s.&lt;/p&gt;&lt;p&gt;To silica gel 60 matrix TLC plates (5 cm × 10 cm, glass support with fluorescent indicator 254 (Supelco)), was added 2 μl in vitro enzymatic reaction mix. Separation was performed in an eluent of &lt;i&gt;n&lt;/i&gt;-propanol:ammonium hydroxide:water (11:7:2 v/v/v) for 45 min. The plate was allowed to dry fully and visualized with a short-wave ultraviolet light source at 254 nm. Uncropped TLC images are available in Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09569-9#MOESM1"&gt;1&lt;/a&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec21"&gt;S1 nuclease digestion of cyclase products&lt;/h3&gt;&lt;p&gt;To determine the linkage identity of products formed in vitro, cyclase reactions described previously were subjected to digestion by S1 nuclease. To a reaction containing 1X S1 nuclease buffer (40 mM sodium acetate (pH 4.5 at 25 °C) and 300 mM NaCl&lt;sub&gt;2&lt;/sub&gt;), 20 μl of the vortex-inactivated cyclase reaction and 200 U S1 nuclease (Thermo Scientific) were added to a total volume of 40 μl. The reaction was incubated at 37 °C for 4 h and inactivated by the addition of 2 μl of 0.5 M EDTA with heating (70 °C for 10 min).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec22"&gt;Preparation of extracts for mass spectrometry&lt;/h3&gt;&lt;p&gt;mCpol–ATP reactions were diluted 1:2 in deionized H&lt;sub&gt;2&lt;/sub&gt;O, centrifuged at 13,000&lt;i&gt;g&lt;/i&gt; for 15 min and used directly in subsequent analysis. Species identified by TLC were directly analysed by TLC–MS. Silica containing the product was scraped away from the TLC plate and added to 40 μl water. The resultant slurry was vortexed and heated at 30 °C for 10 min and then centrifuged at 13,000&lt;i&gt;g&lt;/i&gt; for 15 min. The supernatant was removed for subsequent analysis.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec23"&gt;Cyclase product analysis by HPLC–MS&lt;/h3&gt;&lt;p&gt;Cyclase product extracts were analysed using a liquid chromatography system (1200 series, Agilent Technologies) that was connected in line with an LTQ-Orbitrap-XL mass spectrometer equipped with an electrospray ionization source (Thermo Fisher Scientific). The liquid chromatography system was equipped with a G1322A solvent degasser, G1311A quaternary pump, G1316A thermostatted column compartment and G1329A autosampler unit (Agilent). The column compartment was equipped with an Ultra C18 column (length of 150 mm, inner diameter of 2.1 mm and particle size of 3 µm; 9174362, Restek). Ammonium acetate (98% or more, Sigma-Aldrich), methanol (Optima LC–MS grade, 99.9% minimum; Fisher) and water purified to a resistivity of 18.2 MΩ cm&lt;sup&gt;−1&lt;/sup&gt; (at 25 °C) using a Milli-Q Gradient ultrapure water purification system (Millipore) were used to prepare mobile-phase solvents. Mobile-phase solvent A was water and mobile-phase solvent B was methanol, both of which contained 10 mM ammonium acetate. The elution program consisted of isocratic flow at 0.5% (v/v) B for 2 min, a linear gradient to 99.5% B over 2 min, isocratic flow at 99.5% B for 4 min, a linear gradient to 0.5% B over 1 min, and isocratic flow at 0.5% B for 21 min, at a flow rate of 100 µl min&lt;sup&gt;−1&lt;/sup&gt;. The column compartment was maintained at 30 °C and the sample injection volume was 1 µl. External mass calibration was performed in the positive ion mode using the Pierce LTQ electrospray ionization positive ion calibration solution (88322, Thermo Fisher Scientific). Full-scan, high-resolution mass spectra were acquired in the positive ion mode over the range of &lt;i&gt;m&lt;/i&gt;/&lt;i&gt;z&lt;/i&gt; = 300–2,000, using the Orbitrap mass analyzer, in profile format, with a mass resolution setting of 60,000 (at &lt;i&gt;m&lt;/i&gt;/&lt;i&gt;z&lt;/i&gt; = 400, measured at full-width at half-maximum peak height). Tandem mass (MS/MS or MS&lt;sup&gt;2&lt;/sup&gt;) spectra were acquired using collision-induced dissociation in the linear ion trap, in centroid format, with the following parameters: isolation width = 3 &lt;i&gt;m&lt;/i&gt;/&lt;i&gt;z&lt;/i&gt; units, normalized collision energy = 28%, activation &lt;i&gt;Q&lt;/i&gt; = 0.25 and activation time = 30 ms. Data acquisition was controlled using Xcalibur software (v2.0.7, Thermo Fisher Scientific).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec24"&gt;Mass spectrometry data processing&lt;/h3&gt;&lt;p&gt;Raw data were converted to mzXML format using msconvert (v3.0.19052.1) from the Galaxy platform&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 72" title="Galaxy Community. The Galaxy platform for accessible, reproducible, and collaborative data analyses: 2024 update. Nucleic Acids Res. 52, W83–W94 (2024)." href="/articles/s41586-025-09569-9#ref-CR72" id="ref-link-section-d172089166e2200"&gt;72&lt;/a&gt;&lt;/sup&gt;. Data were then processed using the open source software MZmine (v3.9.0). Compound identification was performed by differential mass spectrometry of in vitro reactions with active and inactive enzymes, and by comparing retention times and &lt;i&gt;m&lt;/i&gt;/&lt;i&gt;z&lt;/i&gt; with those of chemical standards.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec25"&gt;2′3′-c-di-AMP titration&lt;/h3&gt;&lt;p&gt;Recombinant 2TMβ(∆2TM) was dialysed overnight at 4 °C into SEC buffer (20 mM Tris-HCl, pH 8.0, 500 mM KCl, 10% glycerol and 1 mM TCEP). Protein samples were diluted to 4.75 mg ml&lt;sup&gt;−1&lt;/sup&gt; (323 µM) in SEC buffer with varying concentrations of 2′3′-c-di-AMP (0, 500 µM, 1 mM and 2 mM) and 100 µl was loaded into a Superdex 200 Increase 3.2/300 column (Cytiva). Elution was isocratic in SEC buffer and monitored by A280. Data were visualized in GraphPad Prism (v10.2.2).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec26"&gt;Thermal shift assay of 2TMβ&lt;/h3&gt;&lt;p&gt;Spectra were obtained using a Bio-Rad CFX Connect Real-Time PCR Detection System. Solutions contained 1 μM 2TMβ(∆2TM) in 20 mM Tris-HCl, pH 8.0, 500 mM KCl, 10% glycerol, 1 mM TCEP and 2X SYPRO orange dye with or without 20 μM 2′3′-c-di-AMP. To a 96-well half-skirted clear-bottom PCR plate (Axygen) was added 20 μl of each solution. Wells were sealed with Axyseal sealing film (Axygen). Fluorescence was measured as the solutions were heated from 18 °C to 90 °C at a rate of 2 °C per minute. The fluorescence signal as a function of temperature was plotted, and the background values of buffered solution (with or without 2′3′-c-di-AMP) without protein was subtracted from each sample. Measurements were performed in triplicate and the graph is the average of three replicates ± standard deviation.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec27"&gt;Native PAGE&lt;/h3&gt;&lt;p&gt;Recombinant 2TMβ(∆2TM) was dialysed overnight at 4 °C into 20 mM Tris-HCl, pH 8.0, 500 mM KCl, 10% glycerol and 1 mM TCEP. To 1X native loading buffer (50 mM Tris-Cl, pH 8.0, 0.1% bromophenol blue, 10% glycerol and 100 mM dithiothreitol) 4 μg 2TMβ(∆2TM) was added at 4 °C. The sample was analysed by electrophoresis on an 8% native polyacrylamide gel (5% 29:1 acrylamide:bis solution, 750 mM Tris-Cl, pH 8.8) in Tris-glycine running buffer (1.5% w/v Tris-Cl, pH 8.8, and 9.4% (w/v) electrophoresis grade glycine) at 4 °C and 150 V for 105 min. The gel was stained in 30% ethanol, 10% glacial acetic acid in water and 0.1% (w/v) R-250 Coomassie, and destained in 40% ethanol and 10% glacial acetic acid in water. Uncropped gel images are available in Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09569-9#MOESM1"&gt;1&lt;/a&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec28"&gt;Fluorescence microscopy&lt;/h3&gt;&lt;p&gt;Inducing agents or water were added to 400 µl or 200 µl of log phase cultures at OD&lt;sub&gt;600&lt;/sub&gt; 0.12–0.2 (final concentrations: aTc = 200 nM and crystal violet = 50 nM), which were then incubated in a roller for 50 min at 30 °C. Stains were added to the cultures and incubated, rolling, for an additional 10 min at 30 °C. The final stain concentrations were 4 µg ml&lt;sup&gt;−1&lt;/sup&gt; DAPI and either 2.5 µg ml&lt;sup&gt;−1&lt;/sup&gt; MitoTracker Green FM (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09569-9#Fig3"&gt;3i–k&lt;/a&gt;) or 1 µg ml&lt;sup&gt;−1&lt;/sup&gt; FM4-64 and 2.5 µg ml&lt;sup&gt;−1&lt;/sup&gt; SYTOX Green (Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09569-9#Fig10"&gt;6&lt;/a&gt;). FM4-64 is a membrane stain and was used to verify the presence of membrane lesions in the SYTOX Green staining assay, but is not shown. Of culture, 20 µl was spotted on an agarose imaging pad (25% LB and 1% agarose) in single-well concavity slides for imaging. Cells were imaged at room temperature with eight 0.2-µm slices in the &lt;i&gt;z&lt;/i&gt; axis. Images were collected on a DeltaVision Elite Deconvolution microscope (Applied Precision) using DeltaVision SoftWoRx (v6.5.2) and figure panels were prepared in Adobe Photoshop (v21.2.0) and Adobe Illustrator (v24.2).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec29"&gt;Sequence mining and genomic neighbourhood analysis&lt;/h3&gt;&lt;p&gt;A collection of mCpol encoding genes was curated using the following strategy. First, a DALI search was performed against representatives of the clustered AlphaFold Database (AFDB) using an AlphaFold2 model of the mCpol (A0A426EXS8). After filtering for a &lt;i&gt;Z&lt;/i&gt; score of 12, a structurally informed multiple sequence alignment (MSA) was generated and used for phylogenetic analysis as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 73" title="Yoon, P. H. et al. Structure-guided discovery of ancestral CRISPR–Cas13 ribonucleases. Science 385, 538–543 (2024)." href="/articles/s41586-025-09569-9#ref-CR73" id="ref-link-section-d172089166e2278"&gt;73&lt;/a&gt;&lt;/sup&gt;. The clade containing mCpol representatives (&lt;i&gt;n&lt;/i&gt; = 5) was extracted from the resulting tree, and the selection was then expanded to include all cluster members (&lt;i&gt;n&lt;/i&gt; = 29). A structurally informed MSA was generated from this set and used as input for an HMM search against the NCBI_NR_Aug_2018 database on the MPI Bioinformatics Toolkit website (MSA enrichment iterations using HHblits: 1, &lt;i&gt;e&lt;/i&gt;-value cut-off for reporting: e−10, maximum target hits: 1,000). This set of mCpol candidates (&lt;i&gt;n&lt;/i&gt; = 592) was aligned using MAFFT (v7.490) in Geneious Prime (v2023.0.1; algorithm: E-INS-i, scoring matrix: BLOSUM62 and gap open penalty: 1.3). Fragmented mCpol genes were removed from the alignment, and the remaining genes were used for neighbourhood analysis (&lt;i&gt;n&lt;/i&gt; = 593).&lt;/p&gt;&lt;p&gt;A custom Python script was used to retrieve Genbank files of mCpol-containing loci. Only contigs longer than 20 kb were kept for further analysis (&lt;i&gt;n&lt;/i&gt; = 505). The resultings contigs were converted to FASTA format and deduplicated using mmseqs&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Steinegger, M. &amp;amp; Söding, J. MMseqs2 enables sensitive protein sequence searching for the analysis of massive data sets. Nat. Biotechnol. 35, 1026–1028 (2017)." href="/articles/s41586-025-09569-9#ref-CR74" id="ref-link-section-d172089166e2304"&gt;74&lt;/a&gt;&lt;/sup&gt; easy-cluster (-c 0.5 --min-seq-id 0.5 --dbtype 2 --cluster-mode 2). The final set of sequences (&lt;i&gt;n&lt;/i&gt; = 252) were then subjected to defence association analysis via DefenseFinder Web Service (v2.0.0)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Tesson, F. et al. Systematic and quantitative view of the antiviral arsenal of prokaryotes. Nat. Commun. 13, 2561 (2022)." href="/articles/s41586-025-09569-9#ref-CR46" id="ref-link-section-d172089166e2311"&gt;46&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 75" title="Tesson, F. et al. A comprehensive resource for exploring antiphage defense: DefenseFinder Webservice, Wiki and databases. Peer Commun. J. 4, e91 (2024)." href="/articles/s41586-025-09569-9#ref-CR75" id="ref-link-section-d172089166e2314"&gt;75&lt;/a&gt;&lt;/sup&gt; (&lt;a href="https://defensefinder.mdmlab.fr/"&gt;https://defensefinder.mdmlab.fr/&lt;/a&gt;. The outputs of DefenseFinder were then further processed using a custom Python script to add defence system hit annotations to the Genbank files. This final output was used to investigate co-occurrence of mCpol with CBASS and other types of defence systems.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec30"&gt;Taxonomic analysis of mCpol-encoding genes&lt;/h3&gt;&lt;p&gt;To determine the taxonomic distribution of mCpol homologues, we retrieved the NCBI taxonomic identifier (taxID) associated with each protein sequence. Protein IDs were supplied to a custom script that queries the NCBI Entrez system via E-utilities (esearch, elink, efetch and xtract)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 76" title="Maglott, D., Ostell, J., Pruitt, K. D. &amp;amp; Tatusova, T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 39, D52–D57 (2011)." href="/articles/s41586-025-09569-9#ref-CR76" id="ref-link-section-d172089166e2334"&gt;76&lt;/a&gt;&lt;/sup&gt; to extract both the taxID. For protein IDs that failed automated retrieval, taxonomic information was manually obtained using NCBI’s web interface. For each taxID, we used a separate custom Python script that calls the NCBI Datasets&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 77" title="O’Leary, N. A. et al. Exploring and retrieving sequence and metadata for species across the tree of life with NCBI datasets. Sci. Data 11, 732 (2024)." href="/articles/s41586-025-09569-9#ref-CR77" id="ref-link-section-d172089166e2338"&gt;77&lt;/a&gt;&lt;/sup&gt; command-line tool to obtain taxonomy summaries in JSON format and subsequently parses the taxonomic ranks saved as a tsv. A Jupyter notebook was used to further cross-referenced protein IDs with locus tag information from associated annotation files. Merging and reformatting of the dataset was performed in Python using pandas, yielding a finalized tab-delimited table containing accession IDs, taxonomic lineages and protein identifiers for downstream analysis.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec31"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09569-9#MOESM2"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 01 Oct 2025 15:42:01 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE1CUXZtSHh1UXo1R3pNcGkxOXh2NnVNaktCOFlDeWJnMVBMUTNJd0VxTlJRcExmWFZjU296b2NTcllSSVotRHpNcDFHdWU0U0laN0xQQmNVdjJUZTYyZ2ZB</guid></item><item><title>使用无细胞DNA跟踪卵巢癌治疗期间的克隆进化-自然</title><link>https://www.nature.com/articles/s41586-025-09580-0</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec10-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec11"&gt;Sample collection&lt;/h3&gt;&lt;p&gt;All enrolled patients were consented to an institutional biospecimen banking protocol and MSK-IMPACT testing&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Zehir, A., Benayed, R., Shah, R. H., Syed, A. &amp;amp; Middha, S. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat. Med. 23, 703–713 (2017)." href="/articles/s41586-025-09580-0#ref-CR42" id="ref-link-section-d117199423e2156"&gt;42&lt;/a&gt;&lt;/sup&gt;, and all analyses were performed per a biospecimen research protocol. Eligible patients had International Federation of Gynecology and Obstetrics stage III to IV HGSOC with diagnosis verified through clinicopathological review. All protocols were approved by the Institutional Review Board of the Memorial Sloan Kettering (MSK) Cancer Center. Patients were consented following the Institutional Review Board-approved standard operating procedures for informed consent. Written informed consent was obtained from all patients before conducting any study-related procedures. The study was conducted in accordance with the Declaration of Helsinki and the Good Clinical Practice guidelines. We collected fresh tumour tissues at the time of upfront diagnostic laparoscopy or debulking surgery, as described in ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="McPherson, A. et al. Ongoing genome doubling shapes evolvability and immunity in ovarian cancer. Nature 644, 1078–1087 (2025)." href="/articles/s41586-025-09580-0#ref-CR18" id="ref-link-section-d117199423e2160"&gt;18&lt;/a&gt;&lt;/sup&gt;. Blood collection was carried out longitudinally over a 5-year period (2019–2024). Two Streck tubes for cfDNA were collected in each visit. If possible, blood was collected in the Outpatient Clinic at the MSK Cancer Center. Alternatively, blood samples were collected in the operating room when patients were undergoing debulking surgery or laparoscopy.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec12"&gt;Sample processing&lt;/h3&gt;&lt;p&gt;Streck tubes were submitted to the MSK laboratory medicine facility after collection and processed for plasma and buffy coat separation, as well as DNA extraction&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Rose Brannon, A. et al. Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS. Nat. Commun. 12, 3770 (2021)." href="/articles/s41586-025-09580-0#ref-CR13" id="ref-link-section-d117199423e2172"&gt;13&lt;/a&gt;&lt;/sup&gt; (MagMAX cfDNA isolation kit).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec13"&gt;Clinical data&lt;/h3&gt;&lt;p&gt;In this cohort study, we extracted clinical annotations from electronic health records of 24 patients treated at the MSK Cancer Center for HGSOC. For these patients, we collected contemporaneous longitudinal data from their initial HGSOC diagnosis, as well as historical data, if available. Clinical data included laboratory measurements, surgical procedures and medications. CA-125 measurements were obtained as part of patients’ routine clinical care from blood samples collected at baseline, during therapy and subsequent follow-up visits. All dates are relative to the time of first surgery for each patient: that is, day 0 is the date of primary debulking or laparoscopic biopsy.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec14"&gt;Recurrence data&lt;/h3&gt;&lt;p&gt;Recurrence dates are defined by ‘progression of disease’, a patient without improvement after treatment or while on maintenance therapy based on CT scan. Improvement or lack thereof is determined on the basis of CT scan impressions (for example, an increase in a lymph node or unchanged tumour implants). We define patients as ‘alive with disease’ if they have not achieved remission but have also opted out of new treatment lines and/or are on observation.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec15"&gt;DLP scWGS processing&lt;/h3&gt;&lt;p&gt;The Mondrian scWGS suite of tools and pipeline was used for processing of the scWGS. This scWGS dataset is a subset of the dataset used in ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="McPherson, A. et al. Ongoing genome doubling shapes evolvability and immunity in ovarian cancer. Nature 644, 1078–1087 (2025)." href="/articles/s41586-025-09580-0#ref-CR18" id="ref-link-section-d117199423e2201"&gt;18&lt;/a&gt;&lt;/sup&gt;, see this publication for full details of the data generation and processing. Here we describe the processing in brief. Sequencing reads were aligned to hg19 using BWA-MEM. Read counts were calculated in 500-kb bins across the genome and corrected for GC bias, then these values were input into HMMcopy to infer integer copy number (ranging from 0 to 11). We then applied the cell quality classifier described in ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Laks, E. et al. Clonal decomposition and DNA replication states defined by scaled single-cell genome sequencing. Cell 179, 1207–1221 (2019)." href="/articles/s41586-025-09580-0#ref-CR2" id="ref-link-section-d117199423e2205"&gt;2&lt;/a&gt;&lt;/sup&gt; and removed any cells with quality less than 0.75. In addition, we removed replicating cells, multiplet cells and cells suspected to be the result of multipolar divisions, see ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="McPherson, A. et al. Ongoing genome doubling shapes evolvability and immunity in ovarian cancer. Nature 644, 1078–1087 (2025)." href="/articles/s41586-025-09580-0#ref-CR18" id="ref-link-section-d117199423e2209"&gt;18&lt;/a&gt;&lt;/sup&gt; for a detailed description of the filtering criteria. We then applied SIGNALS v.0.7.6 to infer haplotype specific copy number using default parameters.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec16"&gt;SNV calling in DLP&lt;/h3&gt;&lt;p&gt;To detect SNVs in each dataset, reads from all cells from a patient analysed using DLP+ were merged to form ‘pseudobulk’ bam files. SNV calling was performed on these libraries individually using Mutect2. A panel of normals was constructed by identifying normal cells from every patient, merging them and then running the mutect2 panel of normal option. Mutect2 filter was used to filter variants. We then ran Articull to remove artefacts that are specific to DLP+ due to the shorter than average insert size&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Satas, G., Myers, M. A., McPherson, A. &amp;amp; Shah, S. P. Inferring active mutational processes in cancer using single cell sequencing and evolutionary constraints. Preprint at bioRxiv 
                https://doi.org/10.1101/2025.02.24.639589
                
               (2025)." href="/articles/s41586-025-09580-0#ref-CR43" id="ref-link-section-d117199423e2221"&gt;43&lt;/a&gt;&lt;/sup&gt;. This filtered set of variants were then genotyped in individual cells using cellSNP v.1.2.2 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Huang, X. &amp;amp; Huang, Y. Cellsnp-lite: an efficient tool for genotyping single cells. Bioinformatics 
                https://doi.org/10.1093/bioinformatics/btab358
                
               (2021)." href="/articles/s41586-025-09580-0#ref-CR44" id="ref-link-section-d117199423e2225"&gt;44&lt;/a&gt;&lt;/sup&gt;).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec17"&gt;SV calling in DLP&lt;/h3&gt;&lt;p&gt;To detect SVs in each dataset, we also used the merged pseudobulk bam files. LUMPY&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Layer, R. M., Chiang, C., Quinlan, A. R. &amp;amp; Hall, I. M. LUMPY: a probabilistic framework for structural variant discovery. Genome Biol. 15, R84 (2014)." href="/articles/s41586-025-09580-0#ref-CR45" id="ref-link-section-d117199423e2237"&gt;45&lt;/a&gt;&lt;/sup&gt; and deStruct&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="McPherson, A., Shah, S. &amp;amp; Sahinalp, S. C. deStruct: accurate rearrangement detection using breakpoint specific realignment. Preprint at bioRxiv 
                https://doi.org/10.1101/117523
                
               (2017)." href="/articles/s41586-025-09580-0#ref-CR46" id="ref-link-section-d117199423e2241"&gt;46&lt;/a&gt;&lt;/sup&gt; were run on these pseudobulk libraries. Events were retained if they were detected in deStruct and could be matched in the LUMPY calls. Breakpoint predictions were considered matched if the positions involved were each no more than 200 nucleotides apart on the genome and the orientation was consistent.&lt;/p&gt;&lt;p&gt;SVs called in the pseudobulk library were then genotyped in single cells. To do this we used a modified version of SVtyper&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Chiang, C. et al. SpeedSeq: ultra-fast personal genome analysis and interpretation. Nat. Methods 12, 966–968 (2015)." href="/articles/s41586-025-09580-0#ref-CR47" id="ref-link-section-d117199423e2248"&gt;47&lt;/a&gt;&lt;/sup&gt;. One key modification was rounding the read count up rather down, the read count computation internally in SVtyper are MAPQ scores rather than counts so are non-integers before rounding and outputting to a vcf file. This change is necessary in single cells as typically we observe only a single read supporting a SV. SVtyper computes the number of reads that support the reference (these are reads that directly span the genome reference at the breakpoint locations) and the number of reads that support the alternate allele. Alternate allele counts are either split reads that directly sequence the breakpoint or discordant reads that have larger than expected insert sizes or align to different chromosomes in the case of translocations. Clipped reads that support the breakpoint are also computed, to be more conservative we did not include these reads in the total of SV supporting reads. We made an extra modification requiring split reads to match both sides of the breakpoint to contribute to read counts, in the default version, a split read aligning to one side of the breakpoint would contribute 0.5 counts. This option is available through the –both-sides command line option.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec18"&gt;Phylogenetic inference and clone assignments&lt;/h3&gt;&lt;p&gt;MEDICC2 was used to infer phylogenetic trees using haplotype specific copy number as input, see ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="McPherson, A. et al. Ongoing genome doubling shapes evolvability and immunity in ovarian cancer. Nature 644, 1078–1087 (2025)." href="/articles/s41586-025-09580-0#ref-CR18" id="ref-link-section-d117199423e2260"&gt;18&lt;/a&gt;&lt;/sup&gt; for further details. We then manually identified clades in the tree that were the ancestor of clade specific genomic features of interest. These included whole-genome doubling, whole chromosome and chromosome arm gains or losses and focal amplifications. Clones were then defined as the set of cells that were descendants of each clade of interest. Clones with their genomic features of interest can be found in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09580-0#MOESM1"&gt;5&lt;/a&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec19"&gt;Clone-level 10-kb resolution copy-number calling&lt;/h3&gt;&lt;p&gt;Once cells were assigned to clones, we also called integer copy number at 10-kb resolution at the clone level. Read counts were computed in 10-kb bins across the genome in every cell and then summed across cells assigned to each clone. Aggregated read counts were then normalized against the read counts from any normal diploid cells sequenced in the same library and then GC corrected using the same modal GC correction described in ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Laks, E. et al. Clonal decomposition and DNA replication states defined by scaled single-cell genome sequencing. Cell 179, 1207–1221 (2019)." href="/articles/s41586-025-09580-0#ref-CR2" id="ref-link-section-d117199423e2275"&gt;2&lt;/a&gt;&lt;/sup&gt;. These normalized GC corrected read counts were then adjusted for ploidy of the clone (inferred from the 500-kb data) and then we applied a HMM to compute integer read counts. The HMM model (code available at &lt;a href="https://github.com/shahcompbio/HMMclone"&gt;https://github.com/shahcompbio/HMMclone&lt;/a&gt;) uses a state space of 0–25 with each state assumed to be a normal distribution with standard deviation 0.2 and mean equal to the integer copy number. The standard deviation was determined empirically from the data. The viterbi algorithm was used to compute the most likely copy-number profile.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec20"&gt;Identifying complex rearrangement processes&lt;/h3&gt;&lt;p&gt;To identify complex structural events, we manually reviewed 10-kb clone-specific copy-number profiles overlayed with SVs for all patients and clones. We then assigned events as follows:&lt;/p&gt;&lt;ol class="u-list-style-none"&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(1)&lt;/span&gt;
                  
                    &lt;p&gt;chromothripsis: high density of rearrangement breakpoints and oscillating copy-number profiles (for example, 004 and 083)&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(2)&lt;/span&gt;
                  
                    &lt;p&gt;breakage-fusion bridge cycles: foldback inversion breakpoints coincident with copy-number changepoints and staircase such as copy-number profiles (for example, 045 and 051)&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(3)&lt;/span&gt;
                  
                    &lt;p&gt;Pyrgo: stacked tandem duplications resulting in tower-like copy-number profiles (for example, 081)&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(4)&lt;/span&gt;
                  
                    &lt;p&gt;complex inter-chromosomal rearrangements: high diversity of copy-number states with translocations between two or more chromosomes (for example, 002)&lt;/p&gt;
                  
                &lt;/li&gt;
                &lt;li&gt;
                  &lt;span class="u-custom-list-number"&gt;(5)&lt;/span&gt;
                  
                    &lt;p&gt;ecDNA: focal high-level amplification with large copy-number diversity between cells (none detected).&lt;/p&gt;
                  
                &lt;/li&gt;
              &lt;/ol&gt;&lt;p&gt;In addition, oncogenic amplifications (whether they were part of an identifiable complex rearrangement process or not) were defined as high-level amplification (more than ten copies), amplifications (more than two times Ploidy). Homozygous deletions were identified by searching for bins with copy-number state = 0 in the 10-kb clone-level copy-number profiles. We therefore may miss homozygous deletion smaller than 10 kb, unless they were identified in MSK-IMPACT targeted sequencing, in which case they were probably truncal alterations.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec21"&gt;Assigning SVs to clones&lt;/h3&gt;&lt;p&gt;Assigning SVs to clones was done using the matrix of read counts per SV per cell, the cell to clone label mapping and the clone-level 10-kb copy-number profiles. First, we summed the SV supporting reads across clones giving an SV by clone matrix. Any SVs with non-zero read counts were assumed to be present in the clone. In addition, when SVs could be mapped to copy-number changepoints identified at 10-kb resolution, we checked whether there existed other clones that had the same copy-number changepoint but lacked read level support for the SV. In these cases, the SV was also assumed to present in that clone. This was to circumvent cases in which the total number of cells was too low to confidently assume the absence of a particular SV. In addition, we manually reviewed all SVs and copy-number profiles to produce a high confidence set of clone-specific SVs. Manual review involved inspecting the location of all SVs relative to copy-number profiles and ensuring absence of SV read support did not coincide with a proximal copy-number change. In some cases, no SVs could be found that were specific to a clone; this was largely due to clones being too small and consequently lacking the cumulative sequencing coverage to detect SVs in pseudobulks. In such cases, we used coarser clone definitions by merging sister clones resulting in clones with enough cells to call clone-specific alterations, typically at least 50 cells was needed.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec22"&gt;Bulk WGS and MSK-IMPACT&lt;/h3&gt;&lt;p&gt;The bulk WGS and MSK-IMPACT targeted sequencing was originally published in ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Vázquez-García, I. et al. Ovarian cancer mutational processes drive site-specific immune evasion. Nature 612, 778–786 (2022)." href="/articles/s41586-025-09580-0#ref-CR3" id="ref-link-section-d117199423e2371"&gt;3&lt;/a&gt;&lt;/sup&gt;. See this publication for data generation, processing and data access.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec23"&gt;Probe design and synthesis&lt;/h3&gt;&lt;p&gt;For most patients we aimed to include 1,000 genomic features encompassing SVs, SNVs and germline single-nucleotide polymorphisms (SNPs). For samples that constituted our pilot (patients 068, 065, 044 and 003) the number of features was lower, between 250 and 400 and included only a limited number of SNVs. Within the SV and SNV groups, these could be classed into truncal (present in every tumour cell) or subclonal (present in a fraction of tumour cells). The number of probes from each class was variable between patients due to differences in the number of SVs and SNVs called in each patient, as well as the clonal structure in each patient. We first required 200 truncal SVs and 200 truncal SNVs. The remaining 600 probes were split between subclonal SVs and SNVs. We ensured we had 200 subclonal SNVs and then the remaining slots were given to subclonal SVs; if there were still slots remaining then we included extra subclonal SNVs. Within the SNV class we included any SNV annotated as ‘High Impact’ in the MSK-IMPACT targeted sequencing. Probes were synthesized by Integrated DNA Technologies using the xGen MRD hybrid probes, from 120-bp sequences provided as FASTA files. We also included a small panel of germline SNPs to verify sample identity throughout the preparation process. No discrepancies were found.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec24"&gt;cfDNA duplex sequencing analysis&lt;/h3&gt;&lt;p&gt;We used the MSK-ACCESS protocol to generate the cfDNA sequencing data; this protocol is described in detail in ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Rose Brannon, A. et al. Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS. Nat. Commun. 12, 3770 (2021)." href="/articles/s41586-025-09580-0#ref-CR13" id="ref-link-section-d117199423e2391"&gt;13&lt;/a&gt;&lt;/sup&gt;. The gene panel used in ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Vázquez-García, I. et al. Ovarian cancer mutational processes drive site-specific immune evasion. Nature 612, 778–786 (2022)." href="/articles/s41586-025-09580-0#ref-CR3" id="ref-link-section-d117199423e2395"&gt;3&lt;/a&gt;&lt;/sup&gt; was replaced with the patient-specific probe sets. Patient probes from at least two patients were pooled together so that for each patient probe set we could estimate background error rates from the counts supporting SVs and SNVs in off-target patients.&lt;/p&gt;&lt;p&gt;To process the cfDNA sequencing we used a suite of tools developed by the Centre for Molecular Oncology informatics team at MSK for use with the MSK-ACCESS assay (&lt;a href="https://github.com/msk-access"&gt;https://github.com/msk-access&lt;/a&gt;). The nucleo pipeline was used to generate bam files from fastq files. The output of this pipeline is double strand error-corrected bam files (duplex), single strand (simplex) and uncorrected bam files that can then be used for downstream applications. Read counts of supporting and reference reads for SNVs and Indels were extracted using &lt;a href="https://github.com/msk-access/GetBaseCountsMultiSample"&gt;https://github.com/msk-access/GetBaseCountsMultiSample&lt;/a&gt;. This takes a MAF file as input and outputs a MAF file with extra columns for the read counts in duplex, simplex or uncorrected bam files. To extract read counts for SVs we used the same version of SVtyper modified for use with DLP+ described above. Discordant reads were only included in read count calculations if the SV size (end − start) was greater than 10&lt;sup&gt;4&lt;/sup&gt; or if it was a translocation. For a split read to be designated as supporting an SV, we required that alignments had evidence of both sides of the breakpoint to be included (option –both_sides). SVs in cfDNA sequencing were also visually inspected using IGV and svviz v.1.5.2 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Spies, N., Zook, J. M., Salit, M. &amp;amp; Sidow, A. Svviz: a read viewer for validating structural variants. Bioinformatics 31, 3994–3996 (2015)." href="/articles/s41586-025-09580-0#ref-CR48" id="ref-link-section-d117199423e2418"&gt;48&lt;/a&gt;&lt;/sup&gt;).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec25"&gt;Computing error rates in cfDNA&lt;/h3&gt;&lt;p&gt;To compute error rates across sequencing types (duplex, simplex, raw uncorrected) and mutation types (SVs and SNVs) we applied the patient-specific probe set to many samples from off-target patients. We then summed the counts of reference supporting reads and variant-supporting reads for off-target variants across all patients, and defined the error rate as variants supporting reads divided by total number of reads.&lt;/p&gt;&lt;p&gt;We could then compare estimated error rates with the theoretical LOD on the basis of the number of mutations and coverage of the assay. We will define the LOD as the smallest tumour fraction that can be reliably detected; this can be defined as when the theoretical LOD (TLOD) is greater than the error rate of the assay. The TLOD is the LOD in the absence of any sequence error and depends on the number of genomic targets and the sequencing coverage. A framework for estimating this value is outlined in ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Zviran, A. et al. Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. Nat. Med. 26, 1114–1124 (2020)." href="/articles/s41586-025-09580-0#ref-CR14" id="ref-link-section-d117199423e2433"&gt;14&lt;/a&gt;&lt;/sup&gt; and given by:&lt;/p&gt;&lt;div id="Equ1" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$M=N(1{-(1-{\rm{TF}})}^{{\rm{cov}}})$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (1)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;where &lt;i&gt;M&lt;/i&gt; is the number of detected mutations, &lt;i&gt;N&lt;/i&gt; is the total number of mutations in the panel, TF is the tumour fraction and cov is the depth of coverage. As in ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Zviran, A. et al. Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. Nat. Med. 26, 1114–1124 (2020)." href="/articles/s41586-025-09580-0#ref-CR14" id="ref-link-section-d117199423e2512"&gt;14&lt;/a&gt;&lt;/sup&gt;, when &lt;i&gt;M&lt;/i&gt; &amp;lt; 1, we interpret it as a detection probability. We show this detection probability as a function of tumour fraction, coverage and the number of mutations in Extended Data Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41586-025-09580-0#Fig11"&gt;5a&lt;/a&gt; (this reproduces Fig. 1e from ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Zviran, A. et al. Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. Nat. Med. 26, 1114–1124 (2020)." href="/articles/s41586-025-09580-0#ref-CR14" id="ref-link-section-d117199423e2523"&gt;14&lt;/a&gt;&lt;/sup&gt;).&lt;/p&gt;&lt;p&gt;We can then define the TLOD as the lowest TF with 99% probability of detection. So TLOD is given by (setting &lt;i&gt;M&lt;/i&gt; = 0.99 and rearranging for TF):&lt;/p&gt;&lt;div id="Equ2" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${\rm{TLOD}}=1-{\left(1-\frac{0.99}{N}\right)}^{\frac{1}{{\rm{cov}}}}$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (2)
                &lt;/p&gt;&lt;/div&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec26"&gt;Estimating clone frequencies&lt;/h3&gt;&lt;p&gt;To estimate clone frequencies, we calculated variant allele frequencies (VAFs) for each clone by summing the total number of variant-supporting reads and dividing them by the total number of reads for all variants assigned to a clone. To mitigate against biases from variant copy number we developed an approach that leverages our ability to calculate accurate cancer cell fractions (CCFs) from our scWGS data. Using our single-cell copy-number phylogenies, we first identify the most-recent common ancestor (MRCA) of cells containing a SV and then calculate the tree-derived CCF, CCF&lt;sub&gt;tree&lt;/sub&gt;, by dividing the number of descendants of the MRCA (&lt;i&gt;n&lt;/i&gt;&lt;sub&gt;MRCA&lt;/sub&gt;) by the total number of cells (&lt;i&gt;n&lt;/i&gt;&lt;sub&gt;total&lt;/sub&gt;).&lt;/p&gt;&lt;div id="Equ3" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${{\rm{CCF}}}_{{\rm{tree}}}=\frac{{n}_{{\rm{MRCA}}}}{{n}_{{\rm{total}}}}$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (3)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;We then calculate the VAF of each SV from the pseudobulk BAM file. These two values give us a way to infer a correction factor, &lt;i&gt;C&lt;/i&gt;, that we use to convert a given VAF measurement to a CCF value.&lt;/p&gt;&lt;div id="Equ4" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$C=\frac{{{\rm{CCF}}}_{{\rm{tree}}}}{{{\rm{VAF}}}_{{\rm{pseudobulk}}}}$$&lt;/span&gt;&lt;/p&gt;&lt;p class="c-article-equation__number"&gt;
                    (4)
                &lt;/p&gt;&lt;/div&gt;&lt;p&gt;This is then applied to VAFs measured from cfDNA. To plot the changes in frequency over time we normalized corrected VAFs so that they summed to 1 at each time point, then applied a spline function to smooth values between time points. When no tumour DNA was detected, we allowed all clones to have VAF = 0. Smoothing was performed using the splinefun function in R with method = ‘monoH.FC’. This resulted in values that were greater than 1 or less than 0 in some cases, we therefore renormalized the data so that frequencies were positive and summed to 1 at each time point. In addition, when there were large periods of time preclinical recurrence without cfDNA samples we assumed tumour DNA was 0 (for example, in patient 107). We did not include clone frequency estimates when plasma tumour fractions were less than 10&lt;sup&gt;−4&lt;/sup&gt; (estimates based on truncal SVs), reasoning that clone frequency estimates at such low tumour fractions would be unreliable and suffer from dropout issues. Given the low error rates, we used the uncorrected raw sequencing for estimating clone frequencies using SVs. For estimating clone frequencies using SNVs we used the same approach but used duplex consensus sequences for read counting due to the higher error rates for SNVs. In patient 139, no SVs were identified in clone B, therefore we used the SNV based clone frequencies for this clone.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec27"&gt;Identifying &lt;i&gt;BRCA&lt;/i&gt; reversion mutations&lt;/h3&gt;&lt;p&gt;For &lt;i&gt;BRCA1/2&lt;/i&gt; mutant cases, we also included probes that captured exonic regions within 200 bp of the mutation, enabling detection of proximal &lt;i&gt;BRCA1/2&lt;/i&gt; reversion mutations&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Weigelt, B. et al. Diverse BRCA1 and BRCA2 reversion mutations in circulating cell-free DNA of therapy-resistant breast or ovarian cancer. Clin. Cancer Res. 23, 6708–6720 (2017)." href="/articles/s41586-025-09580-0#ref-CR49" id="ref-link-section-d117199423e2796"&gt;49&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="Lin, K. K. et al. BRCA reversion mutations in circulating tumor DNA predict primary and acquired resistance to the PARP inhibitor rucaparib in high-grade ovarian carcinoma. Cancer Discov. 9, 210–219 (2019)." href="/articles/s41586-025-09580-0#ref-CR50" id="ref-link-section-d117199423e2799"&gt;50&lt;/a&gt;&lt;/sup&gt;. We used revmut (&lt;a href="https://github.com/inodb/revmut"&gt;https://github.com/inodb/revmut&lt;/a&gt;) to identify putative &lt;i&gt;BRCA&lt;/i&gt; reversion mutations in the first instance. In addition, we inspected alignments in IGV around the &lt;i&gt;BRCA&lt;/i&gt; mutations to look for any extra putative reversion mutations not identified by revmut. This is how we found the reversion mutation present in patient 009. This mutation was a large 1.37 kb deletion that excised the germline mutation, alignments with the same breakpoint sequence, aligning to the same locations were found in 3 postrecurrence samples. This mutation was probably not identified using revmut due to it being unusually large compared with previously reported &lt;i&gt;BRCA&lt;/i&gt; reversion mutations.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec28"&gt;Wright–Fisher modelling and hypothesis testing&lt;/h3&gt;&lt;p&gt;To test for non-neutrality in clone frequencies over time we implemented a modelling and hypothesis testing framework based on a multi-species Wright–Fisher model with varying population size. Population size was assumed to be 10&lt;sup&gt;9&lt;/sup&gt; at the time of surgery (&lt;i&gt;t&lt;/i&gt; = 0) and then varied according to CA-125 concentrations. We set the population size at the time point with the lowest CA-125 level &lt;i&gt;N&lt;/i&gt;&lt;sub&gt;low&lt;/sub&gt; = 10&lt;sup&gt;4&lt;/sup&gt;, assuming this was the period with the smallest tumour cell population. We then set the population size (&lt;i&gt;N&lt;/i&gt;) to vary exponentially according to the following equation:&lt;/p&gt;&lt;div id="Equa" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$$N(t)=A{{\rm{e}}}^{b\times {\rm{CA}}125(t)}$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;where &lt;span class="mathjax-tex"&gt;\(A={N(0)\times {\rm{e}}}^{-b\times {\rm{CA}}125(0)}\)&lt;/span&gt; and &lt;span class="mathjax-tex"&gt;\(b=\frac{\log ({N}_{{\rm{low}}})-N(0)}{{{\rm{CA}}125}_{{\rm{low}}}-{\rm{CA}}125(0)}\)&lt;/span&gt;. We then used the multinomial distribution to simulate clone frequencies over time:&lt;/p&gt;&lt;div id="Equb" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${X}_{1..k}(i+1)={\rm{multinomial}}(N(i),\,{p}_{1..k}(i))$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;where &lt;i&gt;X&lt;/i&gt;&lt;sub&gt;1...&lt;i&gt;k&lt;/i&gt;&lt;/sub&gt;(&lt;i&gt;i&lt;/i&gt; + 1) is the population size of each clone &lt;i&gt;k&lt;/i&gt; in generation &lt;i&gt;i&lt;/i&gt; + 1, &lt;i&gt;N&lt;/i&gt;(&lt;i&gt;i&lt;/i&gt;) is the total population size in generation &lt;i&gt;i&lt;/i&gt; and &lt;i&gt;p&lt;/i&gt;&lt;sub&gt;1...&lt;i&gt;k&lt;/i&gt;&lt;/sub&gt;(&lt;i&gt;i&lt;/i&gt;) are the clone frequencies in generation &lt;i&gt;i&lt;/i&gt; for the &lt;i&gt;k&lt;/i&gt; clones. For generation &lt;i&gt;i&lt;/i&gt; = 1, &lt;i&gt;N&lt;/i&gt;(&lt;i&gt;i&lt;/i&gt; = 1) = 10&lt;sup&gt;9&lt;/sup&gt; and &lt;i&gt;p&lt;/i&gt;&lt;sub&gt;1...&lt;i&gt;k&lt;/i&gt;&lt;/sub&gt;(&lt;i&gt;i&lt;/i&gt; = 1) are given by the clone frequencies estimated from cfDNA at &lt;i&gt;t&lt;/i&gt; = 0. We then forward simulate this process for the clinical time course of each individual patient 1,000 times giving a distribution of clone frequencies at &lt;i&gt;t&lt;/i&gt;&lt;sub&gt;end&lt;/sub&gt;. We assumed a generation time of 4 days&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Dang, C., Gilewski, T. A., Surbone, A. &amp;amp; Norton, L. in Holland-Frei Cancer Medicine 6th edn (eds Kufe, D. W. et al.) Ch. 43 (BC Decker, 2003)." href="/articles/s41586-025-09580-0#ref-CR51" id="ref-link-section-d117199423e3286"&gt;51&lt;/a&gt;&lt;/sup&gt;, and &lt;i&gt;t&lt;/i&gt;&lt;sub&gt;end&lt;/sub&gt; was set to be the final cfDNA time point in each patient. We then calculated a &lt;i&gt;z&lt;/i&gt;-score, comparing the observed clone frequency from data to the mean and standard deviation of the simulated frequencies to calculate a &lt;i&gt;P&lt;/i&gt; value for each clone under the hypothesis of neutral evolution.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec29"&gt;cfDNA WGS&lt;/h3&gt;&lt;p&gt;Whole-genome libraries constructed during the duplex sequencing assay library prep were sequenced to 70× on an illumina NovaSeq using 100 bp reads. Reads were mapped to hg19 using BWA-MEM&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at 
                https://arxiv.org/abs/1303.3997
                
               (2013)." href="/articles/s41586-025-09580-0#ref-CR52" id="ref-link-section-d117199423e3309"&gt;52&lt;/a&gt;&lt;/sup&gt;. Read counts in 0.5-Mb bins across the genome were calculated and GC corrected using QDNAseq&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Scheinin, I. et al. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res. 24, 2022–2032 (2014)." href="/articles/s41586-025-09580-0#ref-CR53" id="ref-link-section-d117199423e3313"&gt;53&lt;/a&gt;&lt;/sup&gt;. To compare this to data from the duplex sequencing targeted assay, we used information from the DLP copy-number profiles and the clone fractions inferred from CloneSeq-SV to predict copy-number profiles measured with cfDNA WGS. Copy-number ratios (&lt;i&gt;R&lt;/i&gt;) in bin &lt;i&gt;i&lt;/i&gt; are given by:&lt;/p&gt;&lt;div id="Equc" class="c-article-equation"&gt;&lt;p class="c-article-equation__content"&gt;&lt;span class="mathjax-tex"&gt;$${R}_{i}=\frac{2n+(1-n){c}_{i}}{2n+(1-n)p}$$&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p&gt;where &lt;i&gt;n&lt;/i&gt; is the normal fraction, &lt;i&gt;c&lt;/i&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt; is the copy number in bin &lt;i&gt;i&lt;/i&gt; and &lt;i&gt;p&lt;/i&gt; is the ploidy of the tumour. We know &lt;i&gt;n&lt;/i&gt; from the TP53 VAF in cfDNA, for &lt;i&gt;c&lt;/i&gt;&lt;sub&gt;&lt;i&gt;i&lt;/i&gt;&lt;/sub&gt; and &lt;i&gt;p&lt;/i&gt; we took the weighted average across clones, with weights given by the estimated clone fractions at each time point.&lt;/p&gt;&lt;p&gt;Heterozygous SNPs identified in the scWGS pipeline were genotyped in the cfDNA WGS. Phasing information from SIGNALS&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Funnell, T. et al. Single-cell genomic variation induced by mutational processes in cancer. Nature 612, 106–115 (2022)." href="/articles/s41586-025-09580-0#ref-CR9" id="ref-link-section-d117199423e3462"&gt;9&lt;/a&gt;&lt;/sup&gt; was used to calculate phased B-allele frequencies (BAFs) in 0.5-Mb bins, resulting in BAF measurements with identical phasing between scWGS and cfDNA WGS. To assess similarity between cfDNA WGS and clone copy-number profiles, we calculated Pearson correlation coefficients between cfDNA WGS and all clones for both read-depth ratios and BAF values, the summed values of these two values were used to identify the most similar clone for each time point.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec30"&gt;scRNAseq data generation and processing&lt;/h3&gt;&lt;p&gt;The scRNAseq data were originally published in ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Vázquez-García, I. et al. Ovarian cancer mutational processes drive site-specific immune evasion. Nature 612, 778–786 (2022)." href="/articles/s41586-025-09580-0#ref-CR3" id="ref-link-section-d117199423e3474"&gt;3&lt;/a&gt;&lt;/sup&gt;; full details of the processing can be found in that study. Pathway scoring was performed with PROGENY&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Schubert, M. et al. Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat. Commun. 9, 20 (2018)." href="/articles/s41586-025-09580-0#ref-CR54" id="ref-link-section-d117199423e3478"&gt;54&lt;/a&gt;&lt;/sup&gt; or the Seurat module scoring function using hallmark pathways.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec31"&gt;TreeAlign&lt;/h3&gt;&lt;p&gt;To match scRNAseq cells to clones identified in DLP we used TreeAlign&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Shi, H. et al. Allele-specific transcriptional effects of subclonal copy number alterations enable genotype-phenotype mapping in cancer cells. Nat. Commun. 15, 2482 (2024)." href="/articles/s41586-025-09580-0#ref-CR33" id="ref-link-section-d117199423e3490"&gt;33&lt;/a&gt;&lt;/sup&gt;. To do this, we genotyped the same set of heterozygous SNPs used to call allele-specific copy number in DLP+ in scRNAseq using cellSNP&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Huang, X. &amp;amp; Huang, Y. Cellsnp-lite: an efficient tool for genotyping single cells. Bioinformatics 
                https://doi.org/10.1093/bioinformatics/btab358
                
               (2021)." href="/articles/s41586-025-09580-0#ref-CR44" id="ref-link-section-d117199423e3494"&gt;44&lt;/a&gt;&lt;/sup&gt;. The per-cell SNP count matrix was then input into TreeAlign along with clone assignments and 10-kb clone copy-number profiles derived from DLP. We used the CloneAlignClone method and used default parameter values apart from min_clone_assign_prob = 0.5. To compare transcriptional heterogeneity for each clone, we took the mean value of the per-cell Seurat-derived module score for all hallmark pathways, then for each patient calculated the maximum value minus the minimum value. These per-patient difference values were then plotted as violin plots ordered by the average difference across the cohort of patients. For patients with longitudinal cfDNA measurements, scRNAseq data were available for patients 107, 014, 045, 009, 002, 026, 083 and 037, however, following application of TreeAlign, in some patients, clones were represented minimally due to differences in data collection from different sites. In patients 107 and 009, all clones were represented with at least 100 cells present from each clone, we therefore focused on these cases when comparing drug-resistant to drug sensitive clones.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec32"&gt;DNA FISH&lt;/h3&gt;&lt;p&gt;DNA FISH was performed using locus-specific probes for &lt;i&gt;CCNE1&lt;/i&gt; (green) and a centromeric probe for chr. 19 (Cen19; orange) as an internal control (Empire Genomics). Representative regions for FISH imaging were selected on the basis of pan-cytokeratin immunofluorescence staining and on haematoxylin and eosin staining performed on adjacent serial sections, to enrich for epithelial tumour areas. Tumour histology annotations of immunofluorescence and haematoxylin and eosin images are described in refs. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Vázquez-García, I. et al. Ovarian cancer mutational processes drive site-specific immune evasion. Nature 612, 778–786 (2022)." href="/articles/s41586-025-09580-0#ref-CR3" id="ref-link-section-d117199423e3509"&gt;3&lt;/a&gt;&lt;/sup&gt; and &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="McPherson, A. et al. Ongoing genome doubling shapes evolvability and immunity in ovarian cancer. Nature 644, 1078–1087 (2025)." href="/articles/s41586-025-09580-0#ref-CR18" id="ref-link-section-d117199423e3513"&gt;18&lt;/a&gt;&lt;/sup&gt;. For quality control, only cells with at least one signal from each probe were retained, ensuring the centromeric signal served as an internal control for ploidy and hybridization efficiency.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec33"&gt;Statistical analysis&lt;/h3&gt;&lt;p&gt;For between-group comparisons, we used two-sided &lt;i&gt;t&lt;/i&gt;-tests. To assess correlations, we used Pearson correlation. All statistical analysis was done using R.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec34"&gt;Data organization&lt;/h3&gt;&lt;p&gt;To facilitate integration of data across several modalities we used the isabl platform&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Medina-Martínez, J. S. et al. Isabl Platform, a digital biobank for processing multimodal patient data. BMC Bioinf. 21, 549 (2020)." href="/articles/s41586-025-09580-0#ref-CR55" id="ref-link-section-d117199423e3537"&gt;55&lt;/a&gt;&lt;/sup&gt;. Isabl is a databasing and data access platform that allows users to straightforwardly link many datasets from the same patient and chain together pipelines across modalities.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec35"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09580-0#MOESM2"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 01 Oct 2025 15:36:28 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE5RTmktNEpDeXlfRVZUaG9XUkRxVUlqY2xsMzNUNEtENkJ1T0F4Q3hNMEthTDBndk1hMnlQRVMzdnFmcDIxR1FUUlM4VExHblJkZjh4SmlPUzQ2Z3Z6ZjQ4</guid></item><item><title>Show HN ：自闭症模拟器-黑客新闻</title><link>https://news.ycombinator.com/item?id=45438346</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="toptext"&gt;&lt;p&gt;Hey all, I built this. It’s not trying to capture every autistic experience (that’d be impossible). It’s based on my own lived experience as well as that of friends on the spectrum.&lt;/p&gt;&lt;p&gt;I'm trying to give people a feel for what masking, decision fatigue, and burnout can look like day-to-day. That’s hard to explain in words, but easier to show through choices and stats. I'm not trying to "define autism".&lt;/p&gt;&lt;p&gt;I’ve gotten good feedback here about resilience, meds, and difficulty tuning. I’ll keep tweaking it. If even a few people walk away thinking, "ah, maybe that’s why my coworker struggles in those situations," then it’s worth it.&lt;/p&gt;&lt;p&gt;Appreciate everyone who’s tried it and shared thoughts.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Hacker News</author><pubDate>Wed, 01 Oct 2025 15:14:30 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiWEFVX3lxTE14Y2JYQVRpa1BoU3J2OV9FMjJIT2o4Skp4TFJyWFY0TEdiNTBRZkoxa2xDVl9WOWZycFdLQ0ZmLWJ1VThVS2V0TjVoVEh2SzRxLU5TUzhNRGw</guid></item><item><title>膳食半胱氨酸通过CD8 + T细胞衍生的IL-22增强肠干性-自然</title><link>https://www.nature.com/articles/s41586-025-09589-5</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;ol class="c-article-references" data-track-component="outbound reference" data-track-context="references section"&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."&gt;&lt;p class="c-article-references__text" id="ref-CR1"&gt;Yilmaz, Ö. H. et al. mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;486&lt;/b&gt;, 490–495 (2012).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature11163" data-track-item_id="10.1038/nature11163" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature11163" aria-label="Article reference 1" data-doi="10.1038/nature11163"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2012Natur.486..490Y" aria-label="ADS reference 1"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XpsVWhsrw%3D" aria-label="CAS reference 1"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22722868" aria-label="PubMed reference 1"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387287" aria-label="PubMed Central reference 1"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=mTORC1%20in%20the%20Paneth%20cell%20niche%20couples%20intestinal%20stem-cell%20function%20to%20calorie%20intake&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fnature11163&amp;amp;volume=486&amp;amp;pages=490-495&amp;amp;publication_year=2012&amp;amp;author=Yilmaz%2C%C3%96H"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."&gt;&lt;p class="c-article-references__text" id="ref-CR2"&gt;Imada, S. et al. Short-term post-fast refeeding enhances intestinal stemness via polyamines. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;633&lt;/b&gt;, 895–904 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-024-07840-z" data-track-item_id="10.1038/s41586-024-07840-z" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-024-07840-z" aria-label="Article reference 2" data-doi="10.1038/s41586-024-07840-z"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2024Natur.633..895I" aria-label="ADS reference 2"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhvVWiu7fL" aria-label="CAS reference 2"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=39169180" aria-label="PubMed reference 2"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12103248" aria-label="PubMed Central reference 2"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Short-term%20post-fast%20refeeding%20enhances%20intestinal%20stemness%20via%20polyamines&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fs41586-024-07840-z&amp;amp;volume=633&amp;amp;pages=895-904&amp;amp;publication_year=2024&amp;amp;author=Imada%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."&gt;&lt;p class="c-article-references__text" id="ref-CR3"&gt;Beyaz, S. et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;531&lt;/b&gt;, 53–58 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature17173" data-track-item_id="10.1038/nature17173" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature17173" aria-label="Article reference 3" data-doi="10.1038/nature17173"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2016Natur.531...53B" aria-label="ADS reference 3"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xjs1emtLY%3D" aria-label="CAS reference 3"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26935695" aria-label="PubMed reference 3"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846772" aria-label="PubMed Central reference 3"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=High-fat%20diet%20enhances%20stemness%20and%20tumorigenicity%20of%20intestinal%20progenitors&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fnature17173&amp;amp;volume=531&amp;amp;pages=53-58&amp;amp;publication_year=2016&amp;amp;author=Beyaz%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."&gt;&lt;p class="c-article-references__text" id="ref-CR4"&gt;Schell, J. C. et al. Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. &lt;i&gt;Nat. Cell Biol.&lt;/i&gt; &lt;b&gt;19&lt;/b&gt;, 1027–1036 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ncb3593" data-track-item_id="10.1038/ncb3593" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fncb3593" aria-label="Article reference 4" data-doi="10.1038/ncb3593"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhtlKjtbrM" aria-label="CAS reference 4"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28812582" aria-label="PubMed reference 4"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137334" aria-label="PubMed Central reference 4"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Control%20of%20intestinal%20stem%20cell%20function%20and%20proliferation%20by%20mitochondrial%20pyruvate%20metabolism&amp;amp;journal=Nat.%20Cell%20Biol.&amp;amp;doi=10.1038%2Fncb3593&amp;amp;volume=19&amp;amp;pages=1027-1036&amp;amp;publication_year=2017&amp;amp;author=Schell%2CJC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."&gt;&lt;p class="c-article-references__text" id="ref-CR5"&gt;Mihaylova, M. M. et al. Fasting activates fatty acid oxidation to enhance intestinal stem cell function during homeostasis and aging. &lt;i&gt;Cell Stem Cell&lt;/i&gt; &lt;b&gt;22&lt;/b&gt;, 769–778 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.stem.2018.04.001" data-track-item_id="10.1016/j.stem.2018.04.001" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.stem.2018.04.001" aria-label="Article reference 5" data-doi="10.1016/j.stem.2018.04.001"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXovFGhs78%3D" aria-label="CAS reference 5"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29727683" aria-label="PubMed reference 5"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940005" aria-label="PubMed Central reference 5"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Fasting%20activates%20fatty%20acid%20oxidation%20to%20enhance%20intestinal%20stem%20cell%20function%20during%20homeostasis%20and%20aging&amp;amp;journal=Cell%20Stem%20Cell&amp;amp;doi=10.1016%2Fj.stem.2018.04.001&amp;amp;volume=22&amp;amp;pages=769-778&amp;amp;publication_year=2018&amp;amp;author=Mihaylova%2CMM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."&gt;&lt;p class="c-article-references__text" id="ref-CR6"&gt;Wang, B. et al. Phospholipid remodeling and cholesterol availability regulate intestinal stemness and tumorigenesis. &lt;i&gt;Cell Stem Cell&lt;/i&gt; &lt;b&gt;22&lt;/b&gt;, 206–220 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.stem.2017.12.017" data-track-item_id="10.1016/j.stem.2017.12.017" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.stem.2017.12.017" aria-label="Article reference 6" data-doi="10.1016/j.stem.2017.12.017"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXisVSit7g%3D" aria-label="CAS reference 6"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29395055" aria-label="PubMed reference 6"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807072" aria-label="PubMed Central reference 6"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Phospholipid%20remodeling%20and%20cholesterol%20availability%20regulate%20intestinal%20stemness%20and%20tumorigenesis&amp;amp;journal=Cell%20Stem%20Cell&amp;amp;doi=10.1016%2Fj.stem.2017.12.017&amp;amp;volume=22&amp;amp;pages=206-220&amp;amp;publication_year=2018&amp;amp;author=Wang%2CB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."&gt;&lt;p class="c-article-references__text" id="ref-CR7"&gt;Cheng, C. W. et al. Ketone body signaling mediates intestinal stem cell homeostasis and adaptation to diet. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;178&lt;/b&gt;, 1115–1131 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2019.07.048" data-track-item_id="10.1016/j.cell.2019.07.048" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2019.07.048" aria-label="Article reference 7" data-doi="10.1016/j.cell.2019.07.048"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhs1GjurzM" aria-label="CAS reference 7"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31442404" aria-label="PubMed reference 7"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732196" aria-label="PubMed Central reference 7"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Ketone%20body%20signaling%20mediates%20intestinal%20stem%20cell%20homeostasis%20and%20adaptation%20to%20diet&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2019.07.048&amp;amp;volume=178&amp;amp;pages=1115-1131&amp;amp;publication_year=2019&amp;amp;author=Cheng%2CCW"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."&gt;&lt;p class="c-article-references__text" id="ref-CR8"&gt;Mana, M. D. et al. High-fat diet-activated fatty acid oxidation mediates intestinal stemness and tumorigenicity. &lt;i&gt;Cell Rep.&lt;/i&gt; &lt;b&gt;35&lt;/b&gt;, 109212 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.celrep.2021.109212" data-track-item_id="10.1016/j.celrep.2021.109212" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.celrep.2021.109212" aria-label="Article reference 8" data-doi="10.1016/j.celrep.2021.109212"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhtlals7nK" aria-label="CAS reference 8"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34107251" aria-label="PubMed reference 8"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258630" aria-label="PubMed Central reference 8"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=High-fat%20diet-activated%20fatty%20acid%20oxidation%20mediates%20intestinal%20stemness%20and%20tumorigenicity&amp;amp;journal=Cell%20Rep.&amp;amp;doi=10.1016%2Fj.celrep.2021.109212&amp;amp;volume=35&amp;amp;publication_year=2021&amp;amp;author=Mana%2CMD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."&gt;&lt;p class="c-article-references__text" id="ref-CR9"&gt;Gehart, H. &amp;amp; Clevers, H. Tales from the crypt: new insights into intestinal stem cells. &lt;i&gt;Nat. Rev. Gastroenterol. Hepatol.&lt;/i&gt; &lt;b&gt;16&lt;/b&gt;, 19–34 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41575-018-0081-y" data-track-item_id="10.1038/s41575-018-0081-y" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41575-018-0081-y" aria-label="Article reference 9" data-doi="10.1038/s41575-018-0081-y"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30429586" aria-label="PubMed reference 9"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Tales%20from%20the%20crypt%3A%20new%20insights%20into%20intestinal%20stem%20cells&amp;amp;journal=Nat.%20Rev.%20Gastroenterol.%20Hepatol.&amp;amp;doi=10.1038%2Fs41575-018-0081-y&amp;amp;volume=16&amp;amp;pages=19-34&amp;amp;publication_year=2019&amp;amp;author=Gehart%2CH&amp;amp;author=Clevers%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."&gt;&lt;p class="c-article-references__text" id="ref-CR10"&gt;Biton, M. et al. T helper cell cytokines modulate intestinal stem cell renewal and differentiation. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;175&lt;/b&gt;, 1307–1320 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2018.10.008" data-track-item_id="10.1016/j.cell.2018.10.008" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2018.10.008" aria-label="Article reference 10" data-doi="10.1016/j.cell.2018.10.008"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXitVOhsrnM" aria-label="CAS reference 10"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30392957" aria-label="PubMed reference 10"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239889" aria-label="PubMed Central reference 10"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=T%20helper%20cell%20cytokines%20modulate%20intestinal%20stem%20cell%20renewal%20and%20differentiation&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2018.10.008&amp;amp;volume=175&amp;amp;pages=1307-1320&amp;amp;publication_year=2018&amp;amp;author=Biton%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."&gt;&lt;p class="c-article-references__text" id="ref-CR11"&gt;Jiang, H. et al. Cytokine/Jak/Stat signaling mediates regeneration and homeostasis in the &lt;i&gt;Drosophila&lt;/i&gt; midgut. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;137&lt;/b&gt;, 1343–1355 (2009).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2009.05.014" data-track-item_id="10.1016/j.cell.2009.05.014" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2009.05.014" aria-label="Article reference 11" data-doi="10.1016/j.cell.2009.05.014"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=19563763" aria-label="PubMed reference 11"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753793" aria-label="PubMed Central reference 11"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cytokine%2FJak%2FStat%20signaling%20mediates%20regeneration%20and%20homeostasis%20in%20the%20Drosophila%20midgut&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2009.05.014&amp;amp;volume=137&amp;amp;pages=1343-1355&amp;amp;publication_year=2009&amp;amp;author=Jiang%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."&gt;&lt;p class="c-article-references__text" id="ref-CR12"&gt;McCarthy, N. et al. Distinct mesenchymal cell populations generate the essential intestinal BMP signaling gradient. &lt;i&gt;Cell Stem Cell&lt;/i&gt; &lt;b&gt;26&lt;/b&gt;, 391–402 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.stem.2020.01.008" data-track-item_id="10.1016/j.stem.2020.01.008" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.stem.2020.01.008" aria-label="Article reference 12" data-doi="10.1016/j.stem.2020.01.008"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXjslyis7w%3D" aria-label="CAS reference 12"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32084389" aria-label="PubMed reference 12"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412576" aria-label="PubMed Central reference 12"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Distinct%20mesenchymal%20cell%20populations%20generate%20the%20essential%20intestinal%20BMP%20signaling%20gradient&amp;amp;journal=Cell%20Stem%20Cell&amp;amp;doi=10.1016%2Fj.stem.2020.01.008&amp;amp;volume=26&amp;amp;pages=391-402&amp;amp;publication_year=2020&amp;amp;author=McCarthy%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."&gt;&lt;p class="c-article-references__text" id="ref-CR13"&gt;Goto, N. et al. Lymphatics and fibroblasts support intestinal stem cells in homeostasis and injury. &lt;i&gt;Cell Stem Cell&lt;/i&gt; &lt;b&gt;29&lt;/b&gt;, 1246–1261 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.stem.2022.06.013" data-track-item_id="10.1016/j.stem.2022.06.013" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.stem.2022.06.013" aria-label="Article reference 13" data-doi="10.1016/j.stem.2022.06.013"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XitVGnsL%2FE" aria-label="CAS reference 13"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35931033" aria-label="PubMed reference 13"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720889" aria-label="PubMed Central reference 13"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Lymphatics%20and%20fibroblasts%20support%20intestinal%20stem%20cells%20in%20homeostasis%20and%20injury&amp;amp;journal=Cell%20Stem%20Cell&amp;amp;doi=10.1016%2Fj.stem.2022.06.013&amp;amp;volume=29&amp;amp;pages=1246-1261&amp;amp;publication_year=2022&amp;amp;author=Goto%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."&gt;&lt;p class="c-article-references__text" id="ref-CR14"&gt;Hou, Q., Huang, J., Ayansola, H., Masatoshi, H. &amp;amp; Zhang, B. Intestinal stem cells and immune cell relationships: potential therapeutic targets for inflammatory bowel diseases. &lt;i&gt;Front. Immunol.&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 623691 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fimmu.2020.623691" data-track-item_id="10.3389/fimmu.2020.623691" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffimmu.2020.623691" aria-label="Article reference 14" data-doi="10.3389/fimmu.2020.623691"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33584726" aria-label="PubMed reference 14"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874163" aria-label="PubMed Central reference 14"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Intestinal%20stem%20cells%20and%20immune%20cell%20relationships%3A%20potential%20therapeutic%20targets%20for%20inflammatory%20bowel%20diseases&amp;amp;journal=Front.%20Immunol.&amp;amp;doi=10.3389%2Ffimmu.2020.623691&amp;amp;volume=11&amp;amp;publication_year=2021&amp;amp;author=Hou%2CQ&amp;amp;author=Huang%2CJ&amp;amp;author=Ayansola%2CH&amp;amp;author=Masatoshi%2CH&amp;amp;author=Zhang%2CB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."&gt;&lt;p class="c-article-references__text" id="ref-CR15"&gt;Valeri, M. &amp;amp; Raffatellu, M. Cytokines IL-17 and IL-22 in the host response to infection. &lt;i&gt;Pathog. Dis.&lt;/i&gt; &lt;b&gt;74&lt;/b&gt;, ftw111 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/femspd/ftw111" data-track-item_id="10.1093/femspd/ftw111" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Ffemspd%2Fftw111" aria-label="Article reference 15" data-doi="10.1093/femspd/ftw111"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27915228" aria-label="PubMed reference 15"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975231" aria-label="PubMed Central reference 15"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cytokines%20IL-17%20and%20IL-22%20in%20the%20host%20response%20to%20infection&amp;amp;journal=Pathog.%20Dis.&amp;amp;doi=10.1093%2Ffemspd%2Fftw111&amp;amp;volume=74&amp;amp;publication_year=2016&amp;amp;author=Valeri%2CM&amp;amp;author=Raffatellu%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."&gt;&lt;p class="c-article-references__text" id="ref-CR16"&gt;Schreurs, R. et al. Intestinal CD8&lt;sup&gt;+&lt;/sup&gt; T cell responses are abundantly induced early in human development but show impaired cytotoxic effector capacities. &lt;i&gt;Mucosal Immunol.&lt;/i&gt; &lt;b&gt;14&lt;/b&gt;, 605–614 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41385-021-00382-x" data-track-item_id="10.1038/s41385-021-00382-x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41385-021-00382-x" aria-label="Article reference 16" data-doi="10.1038/s41385-021-00382-x"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXnsVWjsbY%3D" aria-label="CAS reference 16"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33772147" aria-label="PubMed reference 16"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075922" aria-label="PubMed Central reference 16"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Intestinal%20CD8%2B%20T%20cell%20responses%20are%20abundantly%20induced%20early%20in%20human%20development%20but%20show%20impaired%20cytotoxic%20effector%20capacities&amp;amp;journal=Mucosal%20Immunol.&amp;amp;doi=10.1038%2Fs41385-021-00382-x&amp;amp;volume=14&amp;amp;pages=605-614&amp;amp;publication_year=2021&amp;amp;author=Schreurs%2CR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."&gt;&lt;p class="c-article-references__text" id="ref-CR17"&gt;Lutter, L., Hoytema van Konijnenburg, D. P., Brand, E. C., Oldenburg, B. &amp;amp; van Wijk, F. The elusive case of human intraepithelial T cells in gut homeostasis and inflammation. &lt;i&gt;Nat. Rev. Gastroenterol. Hepatol.&lt;/i&gt; &lt;b&gt;15&lt;/b&gt;, 637–649 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41575-018-0039-0" data-track-item_id="10.1038/s41575-018-0039-0" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41575-018-0039-0" aria-label="Article reference 17" data-doi="10.1038/s41575-018-0039-0"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXht1yktL3L" aria-label="CAS reference 17"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29973676" aria-label="PubMed reference 17"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20elusive%20case%20of%20human%20intraepithelial%20T%20cells%20in%20gut%20homeostasis%20and%20inflammation&amp;amp;journal=Nat.%20Rev.%20Gastroenterol.%20Hepatol.&amp;amp;doi=10.1038%2Fs41575-018-0039-0&amp;amp;volume=15&amp;amp;pages=637-649&amp;amp;publication_year=2018&amp;amp;author=Lutter%2CL&amp;amp;author=Hoytema%20van%20Konijnenburg%2CDP&amp;amp;author=Brand%2CEC&amp;amp;author=Oldenburg%2CB&amp;amp;author=Wijk%2CF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."&gt;&lt;p class="c-article-references__text" id="ref-CR18"&gt;Sullivan, Z. A. et al. γδ T cells regulate the intestinal response to nutrient sensing. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;371&lt;/b&gt;, eaba8310 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.aba8310" data-track-item_id="10.1126/science.aba8310" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.aba8310" aria-label="Article reference 18" data-doi="10.1126/science.aba8310"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXmvF2jsL4%3D" aria-label="CAS reference 18"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33737460" aria-label="PubMed reference 18"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11617329" aria-label="PubMed Central reference 18"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=%CE%B3%CE%B4%20T%20cells%20regulate%20the%20intestinal%20response%20to%20nutrient%20sensing&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.aba8310&amp;amp;volume=371&amp;amp;publication_year=2021&amp;amp;author=Sullivan%2CZA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."&gt;&lt;p class="c-article-references__text" id="ref-CR19"&gt;Hanash, A. M. et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. &lt;i&gt;Immunity&lt;/i&gt; &lt;b&gt;37&lt;/b&gt;, 339–350 (2012).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.immuni.2012.05.028" data-track-item_id="10.1016/j.immuni.2012.05.028" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.immuni.2012.05.028" aria-label="Article reference 19" data-doi="10.1016/j.immuni.2012.05.028"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38Xht1GksbfO" aria-label="CAS reference 19"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22921121" aria-label="PubMed reference 19"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477611" aria-label="PubMed Central reference 19"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Interleukin-22%20protects%20intestinal%20stem%20cells%20from%20immune-mediated%20tissue%20damage%20and%20regulates%20sensitivity%20to%20graft%20versus%20host%20disease&amp;amp;journal=Immunity&amp;amp;doi=10.1016%2Fj.immuni.2012.05.028&amp;amp;volume=37&amp;amp;pages=339-350&amp;amp;publication_year=2012&amp;amp;author=Hanash%2CAM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."&gt;&lt;p class="c-article-references__text" id="ref-CR20"&gt;Lindemans, C. A. et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;528&lt;/b&gt;, 560–564 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature16460" data-track-item_id="10.1038/nature16460" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature16460" aria-label="Article reference 20" data-doi="10.1038/nature16460"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2015Natur.528..560L" aria-label="ADS reference 20"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhvF2mt7vM" aria-label="CAS reference 20"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26649819" aria-label="PubMed reference 20"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720437" aria-label="PubMed Central reference 20"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Interleukin-22%20promotes%20intestinal-stem-cell-mediated%20epithelial%20regeneration&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fnature16460&amp;amp;volume=528&amp;amp;pages=560-564&amp;amp;publication_year=2015&amp;amp;author=Lindemans%2CCA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."&gt;&lt;p class="c-article-references__text" id="ref-CR21"&gt;Gronke, K. et al. Interleukin-22 protects intestinal stem cells against genotoxic stress. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;566&lt;/b&gt;, 249–253 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-019-0899-7" data-track-item_id="10.1038/s41586-019-0899-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-019-0899-7" aria-label="Article reference 21" data-doi="10.1038/s41586-019-0899-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2019Natur.566..249G" aria-label="ADS reference 21"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXmtVylu7w%3D" aria-label="CAS reference 21"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30700914" aria-label="PubMed reference 21"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420091" aria-label="PubMed Central reference 21"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Interleukin-22%20protects%20intestinal%20stem%20cells%20against%20genotoxic%20stress&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fs41586-019-0899-7&amp;amp;volume=566&amp;amp;pages=249-253&amp;amp;publication_year=2019&amp;amp;author=Gronke%2CK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."&gt;&lt;p class="c-article-references__text" id="ref-CR22"&gt;Zenewicz, L. A. et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. &lt;i&gt;Immunity&lt;/i&gt; &lt;b&gt;29&lt;/b&gt;, 947–957 (2008).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.immuni.2008.11.003" data-track-item_id="10.1016/j.immuni.2008.11.003" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.immuni.2008.11.003" aria-label="Article reference 22" data-doi="10.1016/j.immuni.2008.11.003"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXhtlymtQ%3D%3D" aria-label="CAS reference 22"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=19100701" aria-label="PubMed reference 22"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269819" aria-label="PubMed Central reference 22"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Innate%20and%20adaptive%20interleukin-22%20protects%20mice%20from%20inflammatory%20bowel%20disease&amp;amp;journal=Immunity&amp;amp;doi=10.1016%2Fj.immuni.2008.11.003&amp;amp;volume=29&amp;amp;pages=947-957&amp;amp;publication_year=2008&amp;amp;author=Zenewicz%2CLA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."&gt;&lt;p class="c-article-references__text" id="ref-CR23"&gt;Aparicio-Domingo, P. et al. Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage. &lt;i&gt;J. Exp. Med.&lt;/i&gt; &lt;b&gt;212&lt;/b&gt;, 1783–1791 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1084/jem.20150318" data-track-item_id="10.1084/jem.20150318" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1084%2Fjem.20150318" aria-label="Article reference 23" data-doi="10.1084/jem.20150318"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhslKqsrjL" aria-label="CAS reference 23"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26392223" aria-label="PubMed reference 23"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612094" aria-label="PubMed Central reference 23"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Type%203%20innate%20lymphoid%20cells%20maintain%20intestinal%20epithelial%20stem%20cells%20after%20tissue%20damage&amp;amp;journal=J.%20Exp.%20Med.&amp;amp;doi=10.1084%2Fjem.20150318&amp;amp;volume=212&amp;amp;pages=1783-1791&amp;amp;publication_year=2015&amp;amp;author=Aparicio-Domingo%2CP"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."&gt;&lt;p class="c-article-references__text" id="ref-CR24"&gt;Keir, M. E., Yi, T., Lu, T. T. &amp;amp; Ghilardi, N. The role of IL-22 in intestinal health and disease. &lt;i&gt;J. Exp. Med.&lt;/i&gt; &lt;b&gt;217&lt;/b&gt;, e20192195 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1084/jem.20192195" data-track-item_id="10.1084/jem.20192195" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1084%2Fjem.20192195" aria-label="Article reference 24" data-doi="10.1084/jem.20192195"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32997932" aria-label="PubMed reference 24"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062536" aria-label="PubMed Central reference 24"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20role%20of%20IL-22%20in%20intestinal%20health%20and%20disease&amp;amp;journal=J.%20Exp.%20Med.&amp;amp;doi=10.1084%2Fjem.20192195&amp;amp;volume=217&amp;amp;publication_year=2020&amp;amp;author=Keir%2CME&amp;amp;author=Yi%2CT&amp;amp;author=Lu%2CTT&amp;amp;author=Ghilardi%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."&gt;&lt;p class="c-article-references__text" id="ref-CR25"&gt;Muñoz, J. et al. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+ 4’ cell markers. &lt;i&gt;EMBO J.&lt;/i&gt; &lt;b&gt;31&lt;/b&gt;, 3079–3091 (2012).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/emboj.2012.166" data-track-item_id="10.1038/emboj.2012.166" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Femboj.2012.166" aria-label="Article reference 25" data-doi="10.1038/emboj.2012.166"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22692129" aria-label="PubMed reference 25"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400017" aria-label="PubMed Central reference 25"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20Lgr5%20intestinal%20stem%20cell%20signature%3A%20robust%20expression%20of%20proposed%20quiescent%20%E2%80%98%2B%204%E2%80%99%20cell%20markers&amp;amp;journal=EMBO%20J.&amp;amp;doi=10.1038%2Femboj.2012.166&amp;amp;volume=31&amp;amp;pages=3079-3091&amp;amp;publication_year=2012&amp;amp;author=Mu%C3%B1oz%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."&gt;&lt;p class="c-article-references__text" id="ref-CR26"&gt;Haber, A. L. et al. A single-cell survey of the small intestinal epithelium. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;551&lt;/b&gt;, 333–339 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature24489" data-track-item_id="10.1038/nature24489" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature24489" aria-label="Article reference 26" data-doi="10.1038/nature24489"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2017Natur.551..333H" aria-label="ADS reference 26"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhslygtLjK" aria-label="CAS reference 26"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29144463" aria-label="PubMed reference 26"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022292" aria-label="PubMed Central reference 26"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20single-cell%20survey%20of%20the%20small%20intestinal%20epithelium&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fnature24489&amp;amp;volume=551&amp;amp;pages=333-339&amp;amp;publication_year=2017&amp;amp;author=Haber%2CAL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."&gt;&lt;p class="c-article-references__text" id="ref-CR27"&gt;Gebert, N. et al. Region-specific proteome changes of the intestinal epithelium during aging and dietary restriction. &lt;i&gt;Cell Rep.&lt;/i&gt; &lt;b&gt;31&lt;/b&gt;, 107565 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.celrep.2020.107565" data-track-item_id="10.1016/j.celrep.2020.107565" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.celrep.2020.107565" aria-label="Article reference 27" data-doi="10.1016/j.celrep.2020.107565"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXosVOqtb4%3D" aria-label="CAS reference 27"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32348758" aria-label="PubMed reference 27"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446723" aria-label="PubMed Central reference 27"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Region-specific%20proteome%20changes%20of%20the%20intestinal%20epithelium%20during%20aging%20and%20dietary%20restriction&amp;amp;journal=Cell%20Rep.&amp;amp;doi=10.1016%2Fj.celrep.2020.107565&amp;amp;volume=31&amp;amp;publication_year=2020&amp;amp;author=Gebert%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."&gt;&lt;p class="c-article-references__text" id="ref-CR28"&gt;Hou, Q. et al. Exogenous &lt;span class="u-small-caps"&gt;l&lt;/span&gt;-arginine increases intestinal stem cell function through CD90&lt;sup&gt;+&lt;/sup&gt; stromal cells producing mTORC1-induced Wnt2b. &lt;i&gt;Commun. Biol.&lt;/i&gt; &lt;b&gt;3&lt;/b&gt;, 611 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s42003-020-01347-9" data-track-item_id="10.1038/s42003-020-01347-9" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs42003-020-01347-9" aria-label="Article reference 28" data-doi="10.1038/s42003-020-01347-9"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXitF2jt7rO" aria-label="CAS reference 28"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33097830" aria-label="PubMed reference 28"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584578" aria-label="PubMed Central reference 28"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Exogenous%20l-arginine%20increases%20intestinal%20stem%20cell%20function%20through%20CD90%2B%20stromal%20cells%20producing%20mTORC1-induced%20Wnt2b&amp;amp;journal=Commun.%20Biol.&amp;amp;doi=10.1038%2Fs42003-020-01347-9&amp;amp;volume=3&amp;amp;publication_year=2020&amp;amp;author=Hou%2CQ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."&gt;&lt;p class="c-article-references__text" id="ref-CR29"&gt;Bannai, S. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. &lt;i&gt;J. Biol. Chem.&lt;/i&gt; &lt;b&gt;261&lt;/b&gt;, 2256–2263 (1986).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0021-9258(17)35926-4" data-track-item_id="10.1016/S0021-9258(17)35926-4" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0021-9258%2817%2935926-4" aria-label="Article reference 29" data-doi="10.1016/S0021-9258(17)35926-4"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaL28XhtVKqs7s%3D" aria-label="CAS reference 29"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=2868011" aria-label="PubMed reference 29"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Exchange%20of%20cystine%20and%20glutamate%20across%20plasma%20membrane%20of%20human%20fibroblasts&amp;amp;journal=J.%20Biol.%20Chem.&amp;amp;doi=10.1016%2FS0021-9258%2817%2935926-4&amp;amp;volume=261&amp;amp;pages=2256-2263&amp;amp;publication_year=1986&amp;amp;author=Bannai%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."&gt;&lt;p class="c-article-references__text" id="ref-CR30"&gt;Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;449&lt;/b&gt;, 1003–1007 (2007).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature06196" data-track-item_id="10.1038/nature06196" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature06196" aria-label="Article reference 30" data-doi="10.1038/nature06196"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2007Natur.449.1003B" aria-label="ADS reference 30"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXht1Wgtr3E" aria-label="CAS reference 30"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=17934449" aria-label="PubMed reference 30"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Identification%20of%20stem%20cells%20in%20small%20intestine%20and%20colon%20by%20marker%20gene%20Lgr5&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fnature06196&amp;amp;volume=449&amp;amp;pages=1003-1007&amp;amp;publication_year=2007&amp;amp;author=Barker%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."&gt;&lt;p class="c-article-references__text" id="ref-CR31"&gt;Huch, M. et al. In vitro expansion of single Lgr5&lt;sup&gt;+&lt;/sup&gt; liver stem cells induced by Wnt-driven regeneration. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;494&lt;/b&gt;, 247–250 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature11826" data-track-item_id="10.1038/nature11826" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature11826" aria-label="Article reference 31" data-doi="10.1038/nature11826"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2013Natur.494..247H" aria-label="ADS reference 31"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXhsVyqtbY%3D" aria-label="CAS reference 31"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=23354049" aria-label="PubMed reference 31"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634804" aria-label="PubMed Central reference 31"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=In%20vitro%20expansion%20of%20single%20Lgr5%2B%20liver%20stem%20cells%20induced%20by%20Wnt-driven%20regeneration&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fnature11826&amp;amp;volume=494&amp;amp;pages=247-250&amp;amp;publication_year=2013&amp;amp;author=Huch%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."&gt;&lt;p class="c-article-references__text" id="ref-CR32"&gt;Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;564&lt;/b&gt;, 268–272 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-018-0694-x" data-track-item_id="10.1038/s41586-018-0694-x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-018-0694-x" aria-label="Article reference 32" data-doi="10.1038/s41586-018-0694-x"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2018Natur.564..268Z" aria-label="ADS reference 32"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXisVarsr7F" aria-label="CAS reference 32"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30479382" aria-label="PubMed reference 32"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Lineage%20tracking%20reveals%20dynamic%20relationships%20of%20T%20cells%20in%20colorectal%20cancer&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fs41586-018-0694-x&amp;amp;volume=564&amp;amp;pages=268-272&amp;amp;publication_year=2018&amp;amp;author=Zhang%2CL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."&gt;&lt;p class="c-article-references__text" id="ref-CR33"&gt;Oliveira, G. et al. Landscape of helper and regulatory antitumour CD4&lt;sup&gt;+&lt;/sup&gt; T cells in melanoma. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;605&lt;/b&gt;, 532–538 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-022-04682-5" data-track-item_id="10.1038/s41586-022-04682-5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-022-04682-5" aria-label="Article reference 33" data-doi="10.1038/s41586-022-04682-5"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2022Natur.605..532O" aria-label="ADS reference 33"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38Xht1SrsrvO" aria-label="CAS reference 33"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35508657" aria-label="PubMed reference 33"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815755" aria-label="PubMed Central reference 33"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Landscape%20of%20helper%20and%20regulatory%20antitumour%20CD4%2B%20T%20cells%20in%20melanoma&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fs41586-022-04682-5&amp;amp;volume=605&amp;amp;pages=532-538&amp;amp;publication_year=2022&amp;amp;author=Oliveira%2CG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."&gt;&lt;p class="c-article-references__text" id="ref-CR34"&gt;Hao, Z. &amp;amp; Rajewsky, K. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. &lt;i&gt;J. Exp. Med.&lt;/i&gt; &lt;b&gt;194&lt;/b&gt;, 1151–1164 (2001).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1084/jem.194.8.1151" data-track-item_id="10.1084/jem.194.8.1151" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1084%2Fjem.194.8.1151" aria-label="Article reference 34" data-doi="10.1084/jem.194.8.1151"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXnslGisrs%3D" aria-label="CAS reference 34"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=11602643" aria-label="PubMed reference 34"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193512" aria-label="PubMed Central reference 34"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Homeostasis%20of%20peripheral%20B%20cells%20in%20the%20absence%20of%20B%20cell%20influx%20from%20the%20bone%20marrow&amp;amp;journal=J.%20Exp.%20Med.&amp;amp;doi=10.1084%2Fjem.194.8.1151&amp;amp;volume=194&amp;amp;pages=1151-1164&amp;amp;publication_year=2001&amp;amp;author=Hao%2CZ&amp;amp;author=Rajewsky%2CK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."&gt;&lt;p class="c-article-references__text" id="ref-CR35"&gt;Taub, D. D. et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. &lt;i&gt;J. Exp. Med.&lt;/i&gt; &lt;b&gt;177&lt;/b&gt;, 1809–1814 (1993).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1084/jem.177.6.1809" data-track-item_id="10.1084/jem.177.6.1809" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1084%2Fjem.177.6.1809" aria-label="Article reference 35" data-doi="10.1084/jem.177.6.1809"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK3sXitFWisLc%3D" aria-label="CAS reference 35"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=8496693" aria-label="PubMed reference 35"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Recombinant%20human%20interferon-inducible%20protein%2010%20is%20a%20chemoattractant%20for%20human%20monocytes%20and%20T%20lymphocytes%20and%20promotes%20T%20cell%20adhesion%20to%20endothelial%20cells&amp;amp;journal=J.%20Exp.%20Med.&amp;amp;doi=10.1084%2Fjem.177.6.1809&amp;amp;volume=177&amp;amp;pages=1809-1814&amp;amp;publication_year=1993&amp;amp;author=Taub%2CDD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."&gt;&lt;p class="c-article-references__text" id="ref-CR36"&gt;Klein, R. S. et al. Neuronal CXCL10 directs CD8&lt;sup&gt;+&lt;/sup&gt; T-cell recruitment and control of West Nile virus encephalitis. &lt;i&gt;J. Virol.&lt;/i&gt; &lt;b&gt;79&lt;/b&gt;, 11457–11466 (2005).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1128/JVI.79.17.11457-11466.2005" data-track-item_id="10.1128/JVI.79.17.11457-11466.2005" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1128%2FJVI.79.17.11457-11466.2005" aria-label="Article reference 36" data-doi="10.1128/JVI.79.17.11457-11466.2005"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXps1GltLg%3D" aria-label="CAS reference 36"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=16103196" aria-label="PubMed reference 36"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1193600" aria-label="PubMed Central reference 36"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Neuronal%20CXCL10%20directs%20CD8%2B%20T-cell%20recruitment%20and%20control%20of%20West%20Nile%20virus%20encephalitis&amp;amp;journal=J.%20Virol.&amp;amp;doi=10.1128%2FJVI.79.17.11457-11466.2005&amp;amp;volume=79&amp;amp;pages=11457-11466&amp;amp;publication_year=2005&amp;amp;author=Klein%2CRS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."&gt;&lt;p class="c-article-references__text" id="ref-CR37"&gt;Sabat, R., Ouyang, W. &amp;amp; Wolk, K. Therapeutic opportunities of the IL-22–IL-22R1 system. &lt;i&gt;Nat. Rev. Drug Discov.&lt;/i&gt; &lt;b&gt;13&lt;/b&gt;, 21–38 (2014).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nrd4176" data-track-item_id="10.1038/nrd4176" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnrd4176" aria-label="Article reference 37" data-doi="10.1038/nrd4176"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXlslam" aria-label="CAS reference 37"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24378801" aria-label="PubMed reference 37"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Therapeutic%20opportunities%20of%20the%20IL-22%E2%80%93IL-22R1%20system&amp;amp;journal=Nat.%20Rev.%20Drug%20Discov.&amp;amp;doi=10.1038%2Fnrd4176&amp;amp;volume=13&amp;amp;pages=21-38&amp;amp;publication_year=2014&amp;amp;author=Sabat%2CR&amp;amp;author=Ouyang%2CW&amp;amp;author=Wolk%2CK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."&gt;&lt;p class="c-article-references__text" id="ref-CR38"&gt;Rankin, L. C. et al. Complementarity and redundancy of IL-22-producing innate lymphoid cells. &lt;i&gt;Nat. Immunol.&lt;/i&gt; &lt;b&gt;17&lt;/b&gt;, 179–186 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ni.3332" data-track-item_id="10.1038/ni.3332" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fni.3332" aria-label="Article reference 38" data-doi="10.1038/ni.3332"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhvVygur7N" aria-label="CAS reference 38"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26595889" aria-label="PubMed reference 38"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Complementarity%20and%20redundancy%20of%20IL-22-producing%20innate%20lymphoid%20cells&amp;amp;journal=Nat.%20Immunol.&amp;amp;doi=10.1038%2Fni.3332&amp;amp;volume=17&amp;amp;pages=179-186&amp;amp;publication_year=2016&amp;amp;author=Rankin%2CLC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."&gt;&lt;p class="c-article-references__text" id="ref-CR39"&gt;Corrêa, R. O. et al. Inulin diet uncovers complex diet–microbiota–immune cell interactions remodeling the gut epithelium. &lt;i&gt;Microbiome&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 90 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s40168-023-01520-2" data-track-item_id="10.1186/s40168-023-01520-2" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s40168-023-01520-2" aria-label="Article reference 39" data-doi="10.1186/s40168-023-01520-2"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37101209" aria-label="PubMed reference 39"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131329" aria-label="PubMed Central reference 39"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Inulin%20diet%20uncovers%20complex%20diet%E2%80%93microbiota%E2%80%93immune%20cell%20interactions%20remodeling%20the%20gut%20epithelium&amp;amp;journal=Microbiome&amp;amp;doi=10.1186%2Fs40168-023-01520-2&amp;amp;volume=11&amp;amp;publication_year=2023&amp;amp;author=Corr%C3%AAa%2CRO"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."&gt;&lt;p class="c-article-references__text" id="ref-CR40"&gt;Liu, X. et al. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer. &lt;i&gt;Nat. Cell Biol.&lt;/i&gt; &lt;b&gt;22&lt;/b&gt;, 476–486 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41556-020-0496-x" data-track-item_id="10.1038/s41556-020-0496-x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41556-020-0496-x" aria-label="Article reference 40" data-doi="10.1038/s41556-020-0496-x"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXlvFKgtLg%3D" aria-label="CAS reference 40"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32231310" aria-label="PubMed reference 40"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194135" aria-label="PubMed Central reference 40"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cystine%20transporter%20regulation%20of%20pentose%20phosphate%20pathway%20dependency%20and%20disulfide%20stress%20exposes%20a%20targetable%20metabolic%20vulnerability%20in%20cancer&amp;amp;journal=Nat.%20Cell%20Biol.&amp;amp;doi=10.1038%2Fs41556-020-0496-x&amp;amp;volume=22&amp;amp;pages=476-486&amp;amp;publication_year=2020&amp;amp;author=Liu%2CX"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."&gt;&lt;p class="c-article-references__text" id="ref-CR41"&gt;Paul, M. S. et al. Coenzyme A fuels T cell anti-tumor immunity. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;33&lt;/b&gt;, 2415–2427 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2021.11.010" data-track-item_id="10.1016/j.cmet.2021.11.010" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2021.11.010" aria-label="Article reference 41" data-doi="10.1016/j.cmet.2021.11.010"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Coenzyme%20A%20fuels%20T%20cell%20anti-tumor%20immunity&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2021.11.010&amp;amp;volume=33&amp;amp;pages=2415-2427&amp;amp;publication_year=2021&amp;amp;author=Paul%2CMS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."&gt;&lt;p class="c-article-references__text" id="ref-CR42"&gt;Dibble, C. C. et al. PI3K drives the de novo synthesis of coenzyme A from vitamin B5. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;608&lt;/b&gt;, 192–198 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-022-04984-8" data-track-item_id="10.1038/s41586-022-04984-8" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-022-04984-8" aria-label="Article reference 42" data-doi="10.1038/s41586-022-04984-8"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2022Natur.608..192D" aria-label="ADS reference 42"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XhvFGqtLzP" aria-label="CAS reference 42"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35896750" aria-label="PubMed reference 42"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352595" aria-label="PubMed Central reference 42"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=PI3K%20drives%20the%20de%20novo%20synthesis%20of%20coenzyme%20A%20from%20vitamin%20B5&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fs41586-022-04984-8&amp;amp;volume=608&amp;amp;pages=192-198&amp;amp;publication_year=2022&amp;amp;author=Dibble%2CCC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."&gt;&lt;p class="c-article-references__text" id="ref-CR43"&gt;Barritt, S. A., DuBois-Coyne, S. E. &amp;amp; Dibble, C. C. Coenzyme A biosynthesis: mechanisms of regulation, function and disease. &lt;i&gt;Nat. Metab.&lt;/i&gt; &lt;b&gt;6&lt;/b&gt;, 1008–1023 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s42255-024-01059-y" data-track-item_id="10.1038/s42255-024-01059-y" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs42255-024-01059-y" aria-label="Article reference 43" data-doi="10.1038/s42255-024-01059-y"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhsVagur7P" aria-label="CAS reference 43"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38871981" aria-label="PubMed reference 43"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Coenzyme%20A%20biosynthesis%3A%20mechanisms%20of%20regulation%2C%20function%20and%20disease&amp;amp;journal=Nat.%20Metab.&amp;amp;doi=10.1038%2Fs42255-024-01059-y&amp;amp;volume=6&amp;amp;pages=1008-1023&amp;amp;publication_year=2024&amp;amp;author=Barritt%2CSA&amp;amp;author=DuBois-Coyne%2CSE&amp;amp;author=Dibble%2CCC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."&gt;&lt;p class="c-article-references__text" id="ref-CR44"&gt;Sibon, O. C. M. &amp;amp; Strauss, E. Coenzyme A: to make it or uptake it? &lt;i&gt;Nat. Rev. Mol. Cell Biol.&lt;/i&gt; &lt;b&gt;17&lt;/b&gt;, 605–606 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nrm.2016.110" data-track-item_id="10.1038/nrm.2016.110" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnrm.2016.110" aria-label="Article reference 44" data-doi="10.1038/nrm.2016.110"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xhtl2lsrrI" aria-label="CAS reference 44"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27552973" aria-label="PubMed reference 44"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Coenzyme%20A%3A%20to%20make%20it%20or%20uptake%20it%3F&amp;amp;journal=Nat.%20Rev.%20Mol.%20Cell%20Biol.&amp;amp;doi=10.1038%2Fnrm.2016.110&amp;amp;volume=17&amp;amp;pages=605-606&amp;amp;publication_year=2016&amp;amp;author=Sibon%2COCM&amp;amp;author=Strauss%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45."&gt;&lt;p class="c-article-references__text" id="ref-CR45"&gt;Siudeja, K. et al. Impaired coenzyme A metabolism affects histone and tubulin acetylation in &lt;i&gt;Drosophila&lt;/i&gt; and human cell models of pantothenate kinase associated neurodegeneration. &lt;i&gt;EMBO Mol. Med.&lt;/i&gt; &lt;b&gt;3&lt;/b&gt;, 755–766 (2011).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/emmm.201100180" data-track-item_id="10.1002/emmm.201100180" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Femmm.201100180" aria-label="Article reference 45" data-doi="10.1002/emmm.201100180"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXhs1yks7nP" aria-label="CAS reference 45"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=21998097" aria-label="PubMed reference 45"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377114" aria-label="PubMed Central reference 45"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Impaired%20coenzyme%20A%20metabolism%20affects%20histone%20and%20tubulin%20acetylation%20in%20Drosophila%20and%20human%20cell%20models%20of%20pantothenate%20kinase%20associated%20neurodegeneration&amp;amp;journal=EMBO%20Mol.%20Med.&amp;amp;doi=10.1002%2Femmm.201100180&amp;amp;volume=3&amp;amp;pages=755-766&amp;amp;publication_year=2011&amp;amp;author=Siudeja%2CK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="46."&gt;&lt;p class="c-article-references__text" id="ref-CR46"&gt;Srinivasan, B. et al. Extracellular 4′-phosphopantetheine is a source for intracellular coenzyme A synthesis. &lt;i&gt;Nat. Chem. Biol.&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 784–792 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nchembio.1906" data-track-item_id="10.1038/nchembio.1906" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnchembio.1906" aria-label="Article reference 46" data-doi="10.1038/nchembio.1906"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhtlylsrnI" aria-label="CAS reference 46"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26322826" aria-label="PubMed reference 46"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Extracellular%204%E2%80%B2-phosphopantetheine%20is%20a%20source%20for%20intracellular%20coenzyme%20A%20synthesis&amp;amp;journal=Nat.%20Chem.%20Biol.&amp;amp;doi=10.1038%2Fnchembio.1906&amp;amp;volume=11&amp;amp;pages=784-792&amp;amp;publication_year=2015&amp;amp;author=Srinivasan%2CB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="47."&gt;&lt;p class="c-article-references__text" id="ref-CR47"&gt;Tu, W. B., Christofk, H. R. &amp;amp; Plath, K. Nutrient regulation of development and cell fate decisions. &lt;i&gt;Development&lt;/i&gt; &lt;b&gt;150&lt;/b&gt;, dev199961 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1242/dev.199961" data-track-item_id="10.1242/dev.199961" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1242%2Fdev.199961" aria-label="Article reference 47" data-doi="10.1242/dev.199961"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXitFKqtLjM" aria-label="CAS reference 47"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37260407" aria-label="PubMed reference 47"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281554" aria-label="PubMed Central reference 47"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nutrient%20regulation%20of%20development%20and%20cell%20fate%20decisions&amp;amp;journal=Development&amp;amp;doi=10.1242%2Fdev.199961&amp;amp;volume=150&amp;amp;publication_year=2023&amp;amp;author=Tu%2CWB&amp;amp;author=Christofk%2CHR&amp;amp;author=Plath%2CK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="48."&gt;&lt;p class="c-article-references__text" id="ref-CR48"&gt;Wang, J. et al. Dependence of mouse embryonic stem cells on threonine catabolism. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;325&lt;/b&gt;, 435–439 (2009).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.1173288" data-track-item_id="10.1126/science.1173288" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.1173288" aria-label="Article reference 48" data-doi="10.1126/science.1173288"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2009Sci...325..435W" aria-label="ADS reference 48"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXovVCgtLY%3D" aria-label="CAS reference 48"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=19589965" aria-label="PubMed reference 48"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373593" aria-label="PubMed Central reference 48"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Dependence%20of%20mouse%20embryonic%20stem%20cells%20on%20threonine%20catabolism&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.1173288&amp;amp;volume=325&amp;amp;pages=435-439&amp;amp;publication_year=2009&amp;amp;author=Wang%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="49."&gt;&lt;p class="c-article-references__text" id="ref-CR49"&gt;Shyh-Chang, N. et al. Influence of threonine metabolism on &lt;i&gt;S&lt;/i&gt;-adenosylmethionine and histone methylation. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;339&lt;/b&gt;, 222–226 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.1226603" data-track-item_id="10.1126/science.1226603" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.1226603" aria-label="Article reference 49" data-doi="10.1126/science.1226603"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2013Sci...339..222S" aria-label="ADS reference 49"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=23118012" aria-label="PubMed reference 49"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Influence%20of%20threonine%20metabolism%20on%20S-adenosylmethionine%20and%20histone%20methylation&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.1226603&amp;amp;volume=339&amp;amp;pages=222-226&amp;amp;publication_year=2013&amp;amp;author=Shyh-Chang%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="50."&gt;&lt;p class="c-article-references__text" id="ref-CR50"&gt;Shiraki, N. et al. Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells. &lt;i&gt;Cell Metab.&lt;/i&gt; &lt;b&gt;19&lt;/b&gt;, 780–794 (2014).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2014.03.017" data-track-item_id="10.1016/j.cmet.2014.03.017" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2014.03.017" aria-label="Article reference 50" data-doi="10.1016/j.cmet.2014.03.017"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXmsVCjtrY%3D" aria-label="CAS reference 50"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24746804" aria-label="PubMed reference 50"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Methionine%20metabolism%20regulates%20maintenance%20and%20differentiation%20of%20human%20pluripotent%20stem%20cells&amp;amp;journal=Cell%20Metab.&amp;amp;doi=10.1016%2Fj.cmet.2014.03.017&amp;amp;volume=19&amp;amp;pages=780-794&amp;amp;publication_year=2014&amp;amp;author=Shiraki%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="51."&gt;&lt;p class="c-article-references__text" id="ref-CR51"&gt;Taya, Y. et al. Depleting dietary valine permits nonmyeloablative mouse hematopoietic stem cell transplantation. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;354&lt;/b&gt;, 1152–1155 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.aag3145" data-track-item_id="10.1126/science.aag3145" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.aag3145" aria-label="Article reference 51" data-doi="10.1126/science.aag3145"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2016Sci...354.1152T" aria-label="ADS reference 51"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XhvFGrt7bL" aria-label="CAS reference 51"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27934766" aria-label="PubMed reference 51"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 51" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Depleting%20dietary%20valine%20permits%20nonmyeloablative%20mouse%20hematopoietic%20stem%20cell%20transplantation&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.aag3145&amp;amp;volume=354&amp;amp;pages=1152-1155&amp;amp;publication_year=2016&amp;amp;author=Taya%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="52."&gt;&lt;p class="c-article-references__text" id="ref-CR52"&gt;Jones, C. L. et al. Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II. &lt;i&gt;Blood&lt;/i&gt; &lt;b&gt;134&lt;/b&gt;, 389–394 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1182/blood.2019898114" data-track-item_id="10.1182/blood.2019898114" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1182%2Fblood.2019898114" aria-label="Article reference 52" data-doi="10.1182/blood.2019898114"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXhvVOrtLrK" aria-label="CAS reference 52"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31101624" aria-label="PubMed reference 52"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659257" aria-label="PubMed Central reference 52"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 52" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cysteine%20depletion%20targets%20leukemia%20stem%20cells%20through%20inhibition%20of%20electron%20transport%20complex%20II&amp;amp;journal=Blood&amp;amp;doi=10.1182%2Fblood.2019898114&amp;amp;volume=134&amp;amp;pages=389-394&amp;amp;publication_year=2019&amp;amp;author=Jones%2CCL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="53."&gt;&lt;p class="c-article-references__text" id="ref-CR53"&gt;Farrelly, L. A. et al. Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;567&lt;/b&gt;, 535–539 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-019-1024-7" data-track-item_id="10.1038/s41586-019-1024-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-019-1024-7" aria-label="Article reference 53" data-doi="10.1038/s41586-019-1024-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2019Natur.567..535F" aria-label="ADS reference 53"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXmslKhurw%3D" aria-label="CAS reference 53"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30867594" aria-label="PubMed reference 53"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557285" aria-label="PubMed Central reference 53"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Histone%20serotonylation%20is%20a%20permissive%20modification%20that%20enhances%20TFIID%20binding%20to%20H3K4me3&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fs41586-019-1024-7&amp;amp;volume=567&amp;amp;pages=535-539&amp;amp;publication_year=2019&amp;amp;author=Farrelly%2CLA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="54."&gt;&lt;p class="c-article-references__text" id="ref-CR54"&gt;Qi, L. et al. Aspartate availability limits hematopoietic stem cell function during hematopoietic regeneration. &lt;i&gt;Cell Stem Cell&lt;/i&gt; &lt;b&gt;28&lt;/b&gt;, 1982–1999 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.stem.2021.07.011" data-track-item_id="10.1016/j.stem.2021.07.011" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.stem.2021.07.011" aria-label="Article reference 54" data-doi="10.1016/j.stem.2021.07.011"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvFWisbzF" aria-label="CAS reference 54"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34450065" aria-label="PubMed reference 54"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571029" aria-label="PubMed Central reference 54"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 54" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Aspartate%20availability%20limits%20hematopoietic%20stem%20cell%20function%20during%20hematopoietic%20regeneration&amp;amp;journal=Cell%20Stem%20Cell&amp;amp;doi=10.1016%2Fj.stem.2021.07.011&amp;amp;volume=28&amp;amp;pages=1982-1999&amp;amp;publication_year=2021&amp;amp;author=Qi%2CL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="55."&gt;&lt;p class="c-article-references__text" id="ref-CR55"&gt;Bao, L. et al. Amino acid transporter SLC7A5 regulates cell proliferation and secretary cell differentiation and distribution in the mouse intestine. &lt;i&gt;Int. J. Biol. Sci.&lt;/i&gt; &lt;b&gt;20&lt;/b&gt;, 2187–2201 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.7150/ijbs.94297" data-track-item_id="10.7150/ijbs.94297" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.7150%2Fijbs.94297" aria-label="Article reference 55" data-doi="10.7150/ijbs.94297"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhtVaksLbE" aria-label="CAS reference 55"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38617535" aria-label="PubMed reference 55"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11008275" aria-label="PubMed Central reference 55"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 55" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Amino%20acid%20transporter%20SLC7A5%20regulates%20cell%20proliferation%20and%20secretary%20cell%20differentiation%20and%20distribution%20in%20the%20mouse%20intestine&amp;amp;journal=Int.%20J.%20Biol.%20Sci.&amp;amp;doi=10.7150%2Fijbs.94297&amp;amp;volume=20&amp;amp;pages=2187-2201&amp;amp;publication_year=2024&amp;amp;author=Bao%2CL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="56."&gt;&lt;p class="c-article-references__text" id="ref-CR56"&gt;Hughes, C. E. et al. Cysteine toxicity drives age-related mitochondrial decline by altering iron homeostasis. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;180&lt;/b&gt;, 296–310 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2019.12.035" data-track-item_id="10.1016/j.cell.2019.12.035" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2019.12.035" aria-label="Article reference 56" data-doi="10.1016/j.cell.2019.12.035"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXnvFeltLw%3D" aria-label="CAS reference 56"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31978346" aria-label="PubMed reference 56"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164368" aria-label="PubMed Central reference 56"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 56" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cysteine%20toxicity%20drives%20age-related%20mitochondrial%20decline%20by%20altering%20iron%20homeostasis&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2019.12.035&amp;amp;volume=180&amp;amp;pages=296-310&amp;amp;publication_year=2020&amp;amp;author=Hughes%2CCE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="57."&gt;&lt;p class="c-article-references__text" id="ref-CR57"&gt;Jouandin, P. et al. Lysosomal cystine mobilization shapes the response of TORC1 and tissue growth to fasting. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;375&lt;/b&gt;, eabc4203 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.abc4203" data-track-item_id="10.1126/science.abc4203" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.abc4203" aria-label="Article reference 57" data-doi="10.1126/science.abc4203"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XkvFyhurw%3D" aria-label="CAS reference 57"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=35175796" aria-label="PubMed reference 57"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926155" aria-label="PubMed Central reference 57"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 57" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Lysosomal%20cystine%20mobilization%20shapes%20the%20response%20of%20TORC1%20and%20tissue%20growth%20to%20fasting&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.abc4203&amp;amp;volume=375&amp;amp;publication_year=2022&amp;amp;author=Jouandin%2CP"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="58."&gt;&lt;p class="c-article-references__text" id="ref-CR58"&gt;Song, T. et al. Dietary cysteine drives body fat loss via FMRFamide signaling in &lt;i&gt;Drosophila&lt;/i&gt; and mouse. &lt;i&gt;Cell Res.&lt;/i&gt; &lt;b&gt;33&lt;/b&gt;, 434–447 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41422-023-00800-8" data-track-item_id="10.1038/s41422-023-00800-8" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41422-023-00800-8" aria-label="Article reference 58" data-doi="10.1038/s41422-023-00800-8"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXnvFeis78%3D" aria-label="CAS reference 58"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37055592" aria-label="PubMed reference 58"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235132" aria-label="PubMed Central reference 58"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 58" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Dietary%20cysteine%20drives%20body%20fat%20loss%20via%20FMRFamide%20signaling%20in%20Drosophila%20and%20mouse&amp;amp;journal=Cell%20Res.&amp;amp;doi=10.1038%2Fs41422-023-00800-8&amp;amp;volume=33&amp;amp;pages=434-447&amp;amp;publication_year=2023&amp;amp;author=Song%2CT"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="59."&gt;&lt;p class="c-article-references__text" id="ref-CR59"&gt;Ishii, I. et al. Cystathionine γ-lyase-deficient mice require dietary cysteine to protect against acute lethal myopathy and oxidative injury. &lt;i&gt;J. Biol. Chem.&lt;/i&gt; &lt;b&gt;285&lt;/b&gt;, 26358–26368 (2010).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1074/jbc.M110.147439" data-track-item_id="10.1074/jbc.M110.147439" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1074%2Fjbc.M110.147439" aria-label="Article reference 59" data-doi="10.1074/jbc.M110.147439"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtVahtbnK" aria-label="CAS reference 59"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=20566639" aria-label="PubMed reference 59"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924062" aria-label="PubMed Central reference 59"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 59" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cystathionine%20%CE%B3-lyase-deficient%20mice%20require%20dietary%20cysteine%20to%20protect%20against%20acute%20lethal%20myopathy%20and%20oxidative%20injury&amp;amp;journal=J.%20Biol.%20Chem.&amp;amp;doi=10.1074%2Fjbc.M110.147439&amp;amp;volume=285&amp;amp;pages=26358-26368&amp;amp;publication_year=2010&amp;amp;author=Ishii%2CI"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="60."&gt;&lt;p class="c-article-references__text" id="ref-CR60"&gt;Mani, S., Yang, G. &amp;amp; Wang, R. A critical life-supporting role for cystathionine γ-lyase in the absence of dietary cysteine supply. &lt;i&gt;Free Radical Biol. Med.&lt;/i&gt; &lt;b&gt;50&lt;/b&gt;, 1280–1287 (2011).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.freeradbiomed.2011.01.038" data-track-item_id="10.1016/j.freeradbiomed.2011.01.038" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.freeradbiomed.2011.01.038" aria-label="Article reference 60" data-doi="10.1016/j.freeradbiomed.2011.01.038"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXltFykt7k%3D" aria-label="CAS reference 60"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 60" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20critical%20life-supporting%20role%20for%20cystathionine%20%CE%B3-lyase%20in%20the%20absence%20of%20dietary%20cysteine%20supply&amp;amp;journal=Free%20Radical%20Biol.%20Med.&amp;amp;doi=10.1016%2Fj.freeradbiomed.2011.01.038&amp;amp;volume=50&amp;amp;pages=1280-1287&amp;amp;publication_year=2011&amp;amp;author=Mani%2CS&amp;amp;author=Yang%2CG&amp;amp;author=Wang%2CR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="61."&gt;&lt;p class="c-article-references__text" id="ref-CR61"&gt;Varghese, A. et al. Unravelling cysteine-deficiency-associated rapid weight loss. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;643&lt;/b&gt;, 776–784 (2025).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41586-025-08996-y" data-track-item_id="10.1038/s41586-025-08996-y" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41586-025-08996-y" aria-label="Article reference 61" data-doi="10.1038/s41586-025-08996-y"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="ads reference" data-track-action="ads reference" href="http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&amp;amp;bibcode=2025Natur.643..776V" aria-label="ADS reference 61"&gt;ADS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2MXhs1KjsbfP" aria-label="CAS reference 61"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=40399674" aria-label="PubMed reference 61"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12267064" aria-label="PubMed Central reference 61"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 61" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Unravelling%20cysteine-deficiency-associated%20rapid%20weight%20loss&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fs41586-025-08996-y&amp;amp;volume=643&amp;amp;pages=776-784&amp;amp;publication_year=2025&amp;amp;author=Varghese%2CA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="62."&gt;&lt;p class="c-article-references__text" id="ref-CR62"&gt;Lee, A. H. et al. Cysteine depletion triggers adipose tissue thermogenesis and weight loss. &lt;i&gt;Nat. Metab.&lt;/i&gt; &lt;b&gt;7&lt;/b&gt;, 1204–1222 (2025).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s42255-025-01297-8" data-track-item_id="10.1038/s42255-025-01297-8" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs42255-025-01297-8" aria-label="Article reference 62" data-doi="10.1038/s42255-025-01297-8"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2MXhs1yjtL%2FE" aria-label="CAS reference 62"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=40461845" aria-label="PubMed reference 62"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12198010" aria-label="PubMed Central reference 62"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 62" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cysteine%20depletion%20triggers%20adipose%20tissue%20thermogenesis%20and%20weight%20loss&amp;amp;journal=Nat.%20Metab.&amp;amp;doi=10.1038%2Fs42255-025-01297-8&amp;amp;volume=7&amp;amp;pages=1204-1222&amp;amp;publication_year=2025&amp;amp;author=Lee%2CAH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="63."&gt;&lt;p class="c-article-references__text" id="ref-CR63"&gt;Marí, M. et al. Mitochondrial glutathione: recent insights and role in disease. &lt;i&gt;Antioxidants&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, 909 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.3390/antiox9100909" data-track-item_id="10.3390/antiox9100909" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3390%2Fantiox9100909" aria-label="Article reference 63" data-doi="10.3390/antiox9100909"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32987701" aria-label="PubMed reference 63"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598719" aria-label="PubMed Central reference 63"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 63" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Mitochondrial%20glutathione%3A%20recent%20insights%20and%20role%20in%20disease&amp;amp;journal=Antioxidants&amp;amp;doi=10.3390%2Fantiox9100909&amp;amp;volume=9&amp;amp;publication_year=2020&amp;amp;author=Mar%C3%AD%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="64."&gt;&lt;p class="c-article-references__text" id="ref-CR64"&gt;Singh, P. et al. Taurine deficiency as a driver of aging. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;380&lt;/b&gt;, eabn9257 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.abn9257" data-track-item_id="10.1126/science.abn9257" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.abn9257" aria-label="Article reference 64" data-doi="10.1126/science.abn9257"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXht1CgsLbM" aria-label="CAS reference 64"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=37289866" aria-label="PubMed reference 64"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630957" aria-label="PubMed Central reference 64"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 64" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Taurine%20deficiency%20as%20a%20driver%20of%20aging&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.abn9257&amp;amp;volume=380&amp;amp;publication_year=2023&amp;amp;author=Singh%2CP"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="65."&gt;&lt;p class="c-article-references__text" id="ref-CR65"&gt;Chi, F. Summary of project PR002592. &lt;i&gt;Metabolomics Workbench &lt;/i&gt;&lt;a href="https://doi.org/10.21228/M8M54Q" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.21228/M8M54Q"&gt;https://doi.org/10.21228/M8M54Q&lt;/a&gt; (2025).&lt;/p&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 01 Oct 2025 15:11:15 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTFBYTHRpdUpVR3phVlVTSi1VdGRVM0hRbDQyNzVsWENLYnBaWHBfcjJHc0dsenBaT3NYUWhBQ3FTQkxiT0xISHpiR18zSi12RWNoR2x0TTc3YzRFOThNdFhJ</guid></item><item><title>肌萎缩侧索硬化症患者对C9orf72蛋白的自身免疫应答-自然</title><link>https://www.nature.com/articles/s41586-025-09588-6</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec15-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec16"&gt;Study approval&lt;/h3&gt;&lt;p&gt;All participants provided written informed consent for participation in the study. Ethical approval was obtained from the Institutional Review Boards at La Jolla Institute for Immunology (protocol numbers VD-124, VD-118, VD-155 and VD-171), Massachusetts General Hospital (protocol number 2006P000982), Emory University (protocol number CR003-IRB00078771), University of California, Irvine (protocol number 20163191), National Institutes of Health (protocol number 17N0131), University of California, San Diego (protocol number 120295) and Columbia University Irving Medical Center (CUMC; protocol numbers IRB-AAAQ9714 and AAAS1669). Research activities with samples from Sanguine Biosciences (a fee-for-service, contract research organization) are not considered human participants research under Health and Human Services regulations.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec17"&gt;Study participants&lt;/h3&gt;&lt;p&gt;Individuals with ALS (&lt;i&gt;n&lt;/i&gt; = 40) and healthy control individuals (&lt;i&gt;n&lt;/i&gt; = 28) were recruited by Massachusetts General Hospital, Emory University, University of California, Irvine, Sanguine Biosciences and the National Institutes of Health, referred to as the study cohort in the &lt;a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/s41586-025-09588-6#Sec15"&gt;Methods&lt;/a&gt;. An additional 14 participants with ALS were included from the University of California, San Diego and served as a validation cohort. Samples from Massachusetts General Hospital were used to perform preliminary experiments and are not included in the data presented in this study. Inclusion criteria for patients with ALS consisted of: (i) a diagnosis of familial or sporadic ALS according to the El Escorial criteria; (ii) aged 20 years or older at the time of symptom onset; and (iii) the ability to provide informed consent. Exclusion criteria included: (i) other major neurological or medical diseases that could cause progressive weakness or cognitive dysfunction; and (ii) an unstable medical condition that would make participation unsafe. Inclusion criteria for age- and sex-matched control individuals consisted of: (i) age including 53–82 to match the ages of individuals with ALS; (ii) sex matching that of individuals with ALS; and (iii) the ability to provide informed consent. Exclusion criteria for control participants were the same as those for ALS, with the addition of self-reported ALS genetic risk factors (that is, ALS in first-degree blood relatives). ALS diagnosis was based on clinical criteria (symptoms and examination findings). Typically, the diagnosis was associated with clinical findings of upper and lower motor dysfunction, a progressive course and a failure of diagnostic tests such as brain and spinal cord magnetic resonance imaging (MRI), electrophysiological testing and routine laboratory studies to identify an alternative cause. If the clinical presentation deviated from these typical features, a neuromuscular specialist with extensive experience in diagnosing ALS was consulted to adjudicate the diagnosis.&lt;/p&gt;&lt;p&gt;Specific clinical information on the participants with ALS was collected, including age and sex, the time since ALS symptom onset, the time when the individual started experiencing symptoms related to their ALS diagnosis, the time after ALS diagnosis and the time of donation after the initial diagnosis of ALS to understand the duration of the disease (Table &lt;a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41586-025-09588-6#Tab1"&gt;1&lt;/a&gt;). ALSFRS-R data were used to evaluate the functional status of participants with ALS and monitor functional changes in patients over time. ALSFRS-R data were missing for 7 participants with ALS from the study cohort and all 14 patients from the validation cohort; these were excluded from analyses in which the ALSFRS-R was used. Predicted survival time was obtained using the online ENCALS prediction model&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Westeneng, H. J. et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 17, 423–433 (2018)." href="/articles/s41586-025-09588-6#ref-CR31" id="ref-link-section-d136171171e3000"&gt;31&lt;/a&gt;&lt;/sup&gt; (&lt;a href="http://tool.encalssurvivalmodel.org/"&gt;http://tool.encalssurvivalmodel.org/&lt;/a&gt;), a well-established and widely used survival prediction tool for participants with ALS, originally developed using data from more than 10,000 individuals across several ALS centres in Europe. The classification is based on diagnostic delay (months), progression rate (points decrease on ALSFRS-R per month), forced vital capacity (percentage of predicted capacity based on normative values for sex, age and height), definite ALS (according to El Escorial criteria), frontotemporal dementia (yes or no), C9orf72 repeat expansion (yes or no) and site of onset. The prediction model classifies patients into one of five categories on the basis of predicted survival time: very short, short, intermediate, long or very long. Genetic mutations were noted on an individual basis if genetic sequencing was performed. Twenty-four individuals with ALS were HLA-typed at an American Society for Histocompatibility and Immunogenetics (ASHI)–accredited laboratory at Murdoch University in Western Australia. Typing for HLA class II (DQA1, DQB1, DRB1, DRB3, DRB4, DRB5 and DPB1) was performed using locus-specific PCR amplification, sequencing was done using the Illumina MiSeq platform and the alleles were called using an ASHI-accredited HLA allele caller software pipeline, IIID HLA analysis suite (&lt;a href="http://www.iiid.com.au/laboratory-testing/"&gt;http://www.iiid.com.au/laboratory-testing/&lt;/a&gt;). The full HLA typing data for these patients are provided in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09588-6#MOESM1"&gt;2&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Individuals with PD (&lt;i&gt;n&lt;/i&gt; = 15) were recruited by the Movement Disorders Clinic at the Department of Neurology at CUMC. Inclusion criteria for the patients consisted of (i) clinically diagnosed PD with the presence of bradykinesia and either resting tremor or rigidity; (ii) PD diagnosis between the age of 35 and 80; (iii) history establishing the benefit of dopaminergic medication; and (iv) ability to provide informed consent. Exclusion criteria for PD were: (i) atypical parkinsonism or other neurological disorders; (ii) history of cancer within the past three years; (iii) autoimmune disease; and (iv) chronic immune-modulatory therapy. The recruited individuals with PD all met the UK Parkinson’s Disease Society Brain Bank criteria for PD.&lt;/p&gt;&lt;p&gt;Individuals with AD (&lt;i&gt;n&lt;/i&gt; = 15) were recruited from the Alzheimer’s Disease Research Center at CUMC or from PrecisionMed (a fee-for-service, contract research organization). Patients recruited from CUMC were diagnosed by neurologists according to the National Institute of Aging and Alzheimer’s Association criteria&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 263–269 (2011)." href="/articles/s41586-025-09588-6#ref-CR24" id="ref-link-section-d136171171e3033"&gt;24&lt;/a&gt;&lt;/sup&gt;; those recruited from PrecisionMed were diagnosed according to NINCDS-ADRDA criteria&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="McKhann, G. et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34, 939–944 (1984)." href="/articles/s41586-025-09588-6#ref-CR23" id="ref-link-section-d136171171e3037"&gt;23&lt;/a&gt;&lt;/sup&gt;, by a neurologist or internist. The donors with AD and those with PD were selected to be age- and sex-matched to the donors with ALS.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec18"&gt;Isolation of PBMCs&lt;/h3&gt;&lt;p&gt;Venous blood was collected from each participant in either heparin or EDTA-containing blood bags or tubes, as previously reported and described. PBMCs were isolated from whole blood by density-gradient centrifugation using Ficoll Paque Plus (GE). In brief, blood was first spun at 800&lt;i&gt;g&lt;/i&gt; for 15 min with brakes off to remove plasma. Plasma-depleted blood was then diluted with RPMI, and 35 ml of blood was carefully layered on tubes containing 15 ml Ficoll Paque Plus. These tubes were centrifuged at 800&lt;i&gt;g&lt;/i&gt; for 25 min with the brakes off. The interphase cell layer resulting from this spin was collected, washed with RPMI, counted and cryopreserved in 90% v/v fetal bovine serum (FBS) and 10% v/v dimethyl sulfoxide (DMSO), and stored in liquid nitrogen until tested. The detailed protocol for PBMC isolation can be found at protocols.io (&lt;a href="https://doi.org/10.17504/protocols.io.bw2ipgce"&gt;https://doi.org/10.17504/protocols.io.bw2ipgce&lt;/a&gt;).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec19"&gt;Antigen pools&lt;/h3&gt;&lt;p&gt;Sets of overlapping peptides spanning the sequences of TDP-43 (101 peptides; NCBI ABO32290.1), SOD1 (29 peptides; UniProt ID &lt;a href="https://www.uniprot.org/uniprotkb/P00441/entry"&gt;P00441&lt;/a&gt;), and C9orf72 antigens (100 peptides; UniProt ID &lt;a href="https://www.uniprot.org/uniprotkb/Q96LT7/entry"&gt;Q96LT7&lt;/a&gt;). A previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Dan, J. M. et al. A cytokine-independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD4+ T cells in blood. J. Immunol. 197, 983–993 (2016)." href="/articles/s41586-025-09588-6#ref-CR21" id="ref-link-section-d136171171e3084"&gt;21&lt;/a&gt;&lt;/sup&gt; pool encompassing EBV epitopes was used as a control. Peptides were synthesized commercially as crude material on a 1-mg scale by TC Peptide Lab. Lyophilized peptide products were dissolved in 100% DMSO at a concentration of 20 mg ml&lt;sup&gt;−1&lt;/sup&gt;, and their quality was spot-checked by mass spectrometry. These peptides were also combined in ‘megapools’ as described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="da Silva Antunes, R. et al. The MegaPool approach to characterize adaptive CD4+ and CD8+ T cell responses. Curr. Protoc. 3, e934 (2023)." href="/articles/s41586-025-09588-6#ref-CR19" id="ref-link-section-d136171171e3090"&gt;19&lt;/a&gt;&lt;/sup&gt; and used in the antigen screening experiments. C9orf72 peptides were also tested individually, as described in the main text.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec20"&gt;In vitro expansion of antigen-specific cells and FluoroSpot assay&lt;/h3&gt;&lt;p&gt;In vitro expansion and subsequent FluoroSpot assays were performed as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Lindestam Arlehamn, C. S. et al. α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease. Nat. Commun. 11, 1875 (2020)." href="/articles/s41586-025-09588-6#ref-CR20" id="ref-link-section-d136171171e3103"&gt;20&lt;/a&gt;&lt;/sup&gt;. An equal number of ALS and control samples were included per experiment, to reduce the risk of technical biases. The ALS and control donors were randomly assigned to the individual experimental groups. In brief, PBMCs were thawed and then stimulated with neuroantigen or EBV peptide pools (5 μg ml&lt;sup&gt;−1&lt;/sup&gt;) for four days. After four days, cells were supplemented with fresh RPMI and IL-2 (10 U ml&lt;sup&gt;−1&lt;/sup&gt;, ProspecBio), and fed again every three days until day 11. After two weeks of culture, T cell responses to neuroantigen pools were measured by IFNγ, IL-5 and IL-10 FluoroSpot assays. Plates (Mabtech) were coated overnight at 4 °C with an antibody mixture of mouse anti-human IFNγ (clone 1-D1K, Mabtech), mouse anti-human IL-5 (clone TRFK5, Mabtech) and mouse anti-human IL-10 (clone 9D7, Mabtech). A total of 1 × 10&lt;sup&gt;5&lt;/sup&gt; of the collected cells were plated in each well of the coated FluoroSpot plates along with each respective antigen (5 μg ml&lt;sup&gt;−1&lt;/sup&gt;), and incubated at 37 °C in 5% CO&lt;sub&gt;2&lt;/sub&gt; for 22 h. Cells were also stimulated with 10 μg ml&lt;sup&gt;−1&lt;/sup&gt; phytohaemagglutinin (positive control) and DMSO corresponding to the concentration in the peptide pool dilutions (negative control) to assess non-specific cytokine production. All conditions were tested in triplicate. After incubation, cells were removed, and membranes were washed. An antibody cocktail containing IFNγ (7-B6-1-FS-BAM), IL-5 (5A10-WASP) and IL-10 (12G8-biotin) prepared in phosphate-buffered saline (PBS) with 0.1% bovine serum albumin was added and incubated for two hours at room temperature. Membranes were then washed again, and secondary antibodies (anti-BAM-490, anti-WASP-640 and SA-550) were incubated for one hour at room temperature. Then, membranes were washed, incubated with fluorescence enhancer (Mabtech) and air-dried for reading. Spots were read and counted using the Mabtech Apex (v.2.0) software on the Mabtech IRIS system. The dilutions of all antibodies used are provided in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09588-6#MOESM1"&gt;3&lt;/a&gt;. Responses were considered positive if they met all three of the following criteria: (i) DMSO background-subtracted SFCs per 10&lt;sup&gt;6&lt;/sup&gt; PBMCs ≥ 100; (ii) stimulation index ≥ 2 compared with DMSO controls; and (iii) &lt;i&gt;P&lt;/i&gt; ≤ 0.05 by Student’s &lt;i&gt;t&lt;/i&gt;-test or Poisson distribution test. Negative responses were assigned as 100 SFCs per 10&lt;sup&gt;6&lt;/sup&gt; PBMCs, the lower limit of detection of the assay. The total SFCs per donor measurement was obtained by combining the individual IFNγ, IL-5 and IL-10 SFC values for all samples with a positive response. If no positive response was detected for any of the cytokines, the total cytokine response was assigned as 100 SFCs per 10&lt;sup&gt;6&lt;/sup&gt; PBMCs. The average cytokine response was calculated by dividing the individual cytokine SFCs by the total SFCs, and the cytokine ratios were calculated by dividing cytokine SFC values.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec21"&gt;HLA II binding predictions&lt;/h3&gt;&lt;p&gt;The number of predicted binding events of peptides to the 27 most common HLA-DR, HLA-DQ and HLA-DP class II allelic variants was analysed using the MHC-II Binding Prediction Results tool available at the Immune Epitope Database (IEDB)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Greenbaum, J. et al. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 63, 325–335 (2011)." href="/articles/s41586-025-09588-6#ref-CR28" id="ref-link-section-d136171171e3144"&gt;28&lt;/a&gt;&lt;/sup&gt;. As suggested by the IEDB, we used the NetMHCIIpan-4.1 EL prediction method, and set the cut-off for a binding event as a predicted binding percentile score threshold of 20% or less&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Williams, G. P. et al. PINK1 is a target of T cell responses in Parkinson’s disease. J. Clin. Invest. 135, e180478 (2024)." href="/articles/s41586-025-09588-6#ref-CR18" id="ref-link-section-d136171171e3148"&gt;18&lt;/a&gt;&lt;/sup&gt;. Predicted binding strength was obtained using the NetMHCIIpan-4.1 EL prediction method, and is reported as a normalized rank value compared with peptides from 10,000 randomly selected peptides, with a small value indicating high affinity&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Paul, S. et al. Experimental validation of the RATE tool for inferring HLA restrictions of T cell epitopes. BMC Immunol. 18, 20 (2017)." href="/articles/s41586-025-09588-6#ref-CR25" id="ref-link-section-d136171171e3152"&gt;25&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec22"&gt;Inference of HLA restrictions&lt;/h3&gt;&lt;p&gt;HLA restrictions were inferred using RATE, hosted by the IEDB&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Paul, S. et al. Experimental validation of the RATE tool for inferring HLA restrictions of T cell epitopes. BMC Immunol. 18, 20 (2017)." href="/articles/s41586-025-09588-6#ref-CR25" id="ref-link-section-d136171171e3164"&gt;25&lt;/a&gt;&lt;/sup&gt;. In brief, RATE infers HLA restrictions by considering the presence or absence of a response to a given epitope as the biological outcome. It calculates the relative frequency of the individuals responding to a given epitope and expressing a given allele, compared with the general test population, and the associated statistical significance. Because spurious results can be observed for HLA alleles in linkage disequilibrium, peptide–HLA associations were validated using the NetMHCIIpan-4.1 EL method, with a percentile score threshold of 30% or less, to validate that the peptides were predicted to bind to their corresponding HLA allele.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec23"&gt;Flow cytometry&lt;/h3&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec24"&gt;Spectral methods (Cytek Aurora)&lt;/h4&gt;&lt;p&gt;Cells were washed, counted and plated in a 96-well plate at a density of 1 × 10&lt;sup&gt;6&lt;/sup&gt; cells per well. Cells were then stained with a mixture of the following antibodies: fixable viability dye eFluor 506 (Thermo Fisher Scientific), CD4-APC-eF780 (clone: RPA-T4, Thermo Fisher Scientific), CD8-BUV496 (clone: RPA-T8, BD Biosciences), CD20-BV563 (clone: 2H7, BD), CD56-APC (clone: 5.1H11, BioLegend), gdTCR-BV421 (clone: 11F2, BD), CCR4-PE Cy-7 (clone: IG1, BD), CD16-PE Cy5 (clone: 3G8, Thermo Fisher Scientific), CD14-BV480 (clone: M5E2, BD), HLA-DR-AF700 (clone: LN3, Thermo Fisher Scientific), CD161-BV650 (clone: DX12, BD), CXCR3-PE (clone: G025H7, BioLegend), CD19-BV605 (clone: HIB19, BioLegend), CD38-PerCP-Cy5.5 (clone: HIT2, BD), CD3-BUV805 (clone: UCHT1, BD), CCR7-BV785 (clone: G043H7, BioLegend), CCR6-BUV395 (clone: 11A, BD), CD26-FITC (clone: BA5b, BioLegend), CD127-PEFire700 (clone: A019D5, BioLegend), CD45-PE Dazzle594 (clone: HI30, BioLegend), CD25-BV711 (clone: M-A251, BioLegend) and CD45RA-BV570 (clone: HI100, BioLegend), for 20 min at 4 °C in the dark. The dilutions of all antibodies used are provided in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09588-6#MOESM1"&gt;3&lt;/a&gt;. Stained cells were washed twice and resuspended in 100 µl PBS to be run on the Cytek Aurora System (Cytek). FCS files produced from the Cytek Aurora flow cytometer, using the SpectroFlo flow cytometry software (Cytek,v.3.3), were then analysed using FlowJo software (v.10.10.0, Tree Star).&lt;/p&gt;&lt;h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec25"&gt;ICS methods (Fortessa X-20)&lt;/h4&gt;&lt;p&gt;Antigen-specific cells were expanded for two weeks as described above. On day 14, cells were washed, counted, plated in a 96-well plate at a density of 1 × 10&lt;sup&gt;6&lt;/sup&gt; cells per well, and restimulated with the C9orf72 megapool. After a two-hour incubation, cells were treated for an additional 4 h with GolgiPlug (BD) and GolgiStop (BD). Cells were then washed and stained with a mixture of the following antibodies: fixable viability dye eFluor 506 (Thermo Fisher Scientific), CD4-APC-eF780 (clone: RPA-T4, Thermo Fisher Scientific), CD3-AF700 (clone: UCHT1, BD) and CD8-BV650 (clone: RPA-T8, BioLegend). Cells were incubated for 30 min at 4 °C. Cells were then washed and fixed and permeabilized using the Cyto-Fast Fix/Perm buffer (BioLegend) for 20 min at room temperature. After permeabilization, cells were stained with the following mixture: IL-10-APC (clone: JES3-19F1, BioLegend), IL-4-BV421 (clone: MD425D2, BioLegend), IFNγ-FITC (clone: 4S.B2, Thermo Fisher Scientific) and IL-17-BV785 (clone: BL168, BioLegend) for 20 min at room temperature in the dark. The dilutions of all antibodies used are provided in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09588-6#MOESM1"&gt;3&lt;/a&gt;. Stained cells were then washed twice and resuspended in 100 µl PBS to be run on the Fortessa X-20 flow cytometer (BD). FCS files produced from the Fortessa X-20, using FACSDiva (v.9.2), were then analysed using FlowJo software. The average proportion of each cytokine for each donor was determined by dividing the frequency of cells releasing each cytokine by the total number of cells releasing any of the three cytokines for each donor.&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec26"&gt;Statistical analysis&lt;/h3&gt;&lt;p&gt;Statistical analyses were performed and graphs were created using GraphPad Prism’s descriptive statistics, two-tailed Mann–Whitney test, one-way ANOVA with Dunnett’s multiple comparisons test, two-tailed Fisher exact test and Spearman’s r test as applicable (GraphPad Prism, v.10).&lt;/p&gt;&lt;h3 class="c-article__sub-heading c-article__sub-heading--divider" id="Sec27"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41586-025-09588-6#MOESM2"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 01 Oct 2025 15:09:40 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE1NT1dGcmIzNE9ITy1Mcm9WWFpzWXhYc01rLVgzQW9DRGo4RXVMNHpXeW12RjZoOWE5NjVVSEY0MDZuajZVb0MzWW5rMFJ5OTFWUkRKVkR4SzNZZGtYMWN3</guid></item><item><title>阿尔茨海默氏症药物对一些自闭症儿童的益处令人惊讶- ScienceAlert</title><link>https://www.sciencealert.com/alzheimers-drug-shows-surprising-benefits-for-some-kids-with-autism</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content"&gt;
			&lt;p&gt;A drug used to slow  &lt;a href="https://www.sciencealert.com/go/IaO" class="lar_link lar_link_outgoing" data-linkid="73015" data-postid="175989" rel="nofollow" target="_self"&gt;Alzheimer's&lt;/a&gt; disease may help improve social behaviors in some children with  &lt;a href="https://www.sciencealert.com/autism-spectrum-disorder" class="lar_link lar_link_outgoing" data-linkid="73013" data-postid="175989" rel="nofollow" target="_self"&gt;autism spectrum disorder&lt;/a&gt; (&lt;span&gt;ASD&lt;/span&gt;).&lt;/p&gt;&lt;p&gt;The results of a small  &lt;a href="https://www.sciencealert.com/clinical-trials" class="lar_link lar_link_outgoing" data-linkid="73032" data-postid="175989" rel="nofollow" target="_self"&gt;clinical trial&lt;/a&gt; are promising, although not yet conclusive. They suggest that a specific subset of young people with  &lt;a href="https://www.sciencealert.com/autism-spectrum-disorder" class="lar_link lar_link_outgoing" data-linkid="73013" data-postid="175989" rel="nofollow" target="_self"&gt;ASD&lt;/a&gt; may experience positive outcomes from taking memantine, despite previous &lt;a href="https://doi.org/10.1002/14651858.CD013845.pub2"&gt;studies&lt;/a&gt; finding no clear benefits.&lt;/p&gt;&lt;p&gt;&lt;a href="https://en.wikipedia.org/wiki/Memantine"&gt;Memantine&lt;/a&gt; (sometimes sold under the brand name Namenda) is an oral medication that blocks the brain's receptors for &lt;a href="https://en.wikipedia.org/wiki/Glutamate_(neurotransmitter)"&gt;glutamate&lt;/a&gt; – a neurotransmitter that can be toxic in high amounts. Reducing glutamate across the brain can help slow the progression of neurodegenerative conditions.&lt;/p&gt;&lt;p&gt;A brain region particularly rich in glutamate receptors is the &lt;a href="https://en.wikipedia.org/wiki/Anterior_cingulate_cortex#Social_evaluation"&gt;pregenual anterior cingulate cortex&lt;/a&gt; (pgACC), which is involved in social processing and emotional awareness.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Related: &lt;a href="https://www.sciencealert.com/brain-scans-show-neuron-structures-look-different-in-kids-with-autism"&gt;Brain Scans Show Neuron Structures Look Different in Kids With Autism&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Some evidence suggests that glutamate can be imbalanced in the pgACC in individuals with ASD, possibly explaining behaviors and symptoms related to communication and social interactions.&lt;/p&gt;&lt;figure id="attachment_175991" aria-describedby="caption-attachment-175991" class="wp-caption alignnone"&gt;&lt;img decoding="async" src="https://www.sciencealert.com/images/2025/10/Extracted-Cingulate-Cortex-regions-of-interest-Color-coded-regions-of-interest-of-the-642x616.png" alt="Cingulate Cortex" class="size-medium wp-image-175991" srcset="https://www.sciencealert.com/images/2025/10/Extracted-Cingulate-Cortex-regions-of-interest-Color-coded-regions-of-interest-of-the-642x616.png 642w, https://www.sciencealert.com/images/2025/10/Extracted-Cingulate-Cortex-regions-of-interest-Color-coded-regions-of-interest-of-the-432x415.png 432w, https://www.sciencealert.com/images/2025/10/Extracted-Cingulate-Cortex-regions-of-interest-Color-coded-regions-of-interest-of-the-768x737.png 768w, https://www.sciencealert.com/images/2025/10/Extracted-Cingulate-Cortex-regions-of-interest-Color-coded-regions-of-interest-of-the-600x576.png 600w, https://www.sciencealert.com/images/2025/10/Extracted-Cingulate-Cortex-regions-of-interest-Color-coded-regions-of-interest-of-the.png 850w" sizes="(max-width: 642px) 100vw, 642px" loading="lazy"&gt;&lt;figcaption id="caption-attachment-175991" class="wp-caption-text"&gt;Location of the cingulate cortex in the human brain. (Overbye et al., &lt;a href="https://doi.org/10.1016/j.dcn.2019.100665"&gt;&lt;em&gt;Dev. Cog. Neuro.&lt;/em&gt;&lt;/a&gt;, 2019)&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;In 2017, however, a &lt;a href="https://doi.org/10.1089/cap.2015.0146"&gt;clinical trial&lt;/a&gt; found that taking memantine provided no significant benefit to the social responsiveness of &lt;a href="https://www.sciencealert.com/a-hidden-pattern-in-childrens-eyes-can-reveal-if-they-have-autism"&gt;children with ASD&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Now, researchers at Massachusetts General Hospital and Harvard University have led a new clinical trial to follow up on those results, evaluating the drug's effect at higher doses and among a more specific subset of children.&lt;/p&gt;&lt;p&gt;Their randomized trial was completed by 33 young people without intellectual disability, aged 8 to 17, who were predominantly male. Half the group took 20 milligrams of memantine daily for 12 weeks, while the other half took a  &lt;a href="https://www.sciencealert.com/what-is-a-placebo" class="lar_link lar_link_outgoing" data-linkid="102371" data-postid="175989" rel="nofollow" target="_self"&gt;placebo&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;The best responders to memantine were individuals who exhibited abnormally high glutamate levels in the pgACC.&lt;/p&gt;&lt;p&gt;Among these children, adult caregivers reported memantine improving communication, interaction, and engagement with others significantly more than a placebo.&lt;/p&gt;&lt;p&gt;While the results are promising, the authors of the study caution that larger  &lt;a href="https://www.sciencealert.com/clinical-trials" class="lar_link lar_link_outgoing" data-linkid="73032" data-postid="175989" rel="nofollow" target="_self"&gt;clinical trials&lt;/a&gt; are needed before any definitive conclusions can be made.&lt;/p&gt;&lt;p&gt;Even if memantine does turn out to improve the lives of children with ASD, it may only benefit some individuals.&lt;/p&gt;&lt;p&gt;Among all the participants in the recent clinical trial, just over half showed abnormally elevated glutamate levels in the pgACC.&lt;/p&gt;&lt;p&gt;Previous trials, like the one from 2017, may have overlooked this significant result because they did not hone in on subsets of ASD.&lt;/p&gt;&lt;p&gt; &lt;a href="https://www.sciencealert.com/autism-spectrum-disorder" class="lar_link lar_link_outgoing" data-linkid="73013" data-postid="175989" rel="nofollow" target="_self"&gt;Autism&lt;/a&gt; exists on a spectrum, encompassing a &lt;a href="https://www.niehs.nih.gov/health/topics/conditions/autism"&gt;vast range of conditions&lt;/a&gt;, with&lt;a href="https://www.mayoclinic.org/diseases-conditions/autism-spectrum-disorder/symptoms-causes/syc-20352928"&gt; large variations in symptoms and severity&lt;/a&gt;, impacted by the &lt;a href="https://www.sciencealert.com/several-psychiatric-disorders-share-the-same-root-cause-study-finds"&gt;complex interplay&lt;/a&gt; of &lt;a href="https://www.sciencealert.com/artificial-brain-reveals-the-genetic-origins-of-autism-spectrum-disorder"&gt;genetics&lt;/a&gt; and &lt;a href="https://www.sciencealert.com/study-identifies-gut-microbe-imbalances-that-predict-autism-and-adhd"&gt;environmental factors&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;There is very probably &lt;a href="https://www.sciencealert.com/earliest-biological-signals-of-autism-found-in-mini-brains-experiment"&gt;no single cause&lt;/a&gt; &lt;a href="https://www.sciencealert.com/autism-linked-with-dna-our-ancestors-inherited-from-neanderthals"&gt;behind the disorder&lt;/a&gt;, which means that one single treatment is unlikely to be effective &lt;a href="https://www.sciencealert.com/world-autism-awareness-day-an-expert-explains-why-stimming-is-important"&gt;or necessary&lt;/a&gt; for all.&lt;/p&gt;&lt;p&gt;Nevertheless, researchers behind the recent clinical trial &lt;a href="https://doi.org/10.1001/jamanetworkopen.2025.34927"&gt;think&lt;/a&gt; that memantine has the potential to improve outcomes for a "substantial proportion of patients, with minimal unnecessary exposure to those who may not benefit."&lt;/p&gt;&lt;p&gt;The team calls for further research.&lt;/p&gt;&lt;p&gt;The study was published in &lt;a href="https://doi.org/10.1001/jamanetworkopen.2025.34927"&gt;&lt;i&gt;JAMA&lt;/i&gt;&lt;/a&gt;.&lt;/p&gt;
		&lt;/div&gt;
	&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ScienceAlert</author><pubDate>Wed, 01 Oct 2025 15:02:59 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMinAFBVV95cUxPWTl5eWZwT3NSVkdtMFNFOXhGSnh2ZkcwQy0tdmZ2LTNEaGdfdEpUbE5nQUprdHNDMjM1cVRpSEZFMGU4WnRHT1BUM0NWT0VTb0MyQ3BjVVo2dXdlbThnYk9YSXp0cHlwNjlvZW5kajZZMnJ1NXBTbjNRSjN3Yk1SbC0xRGNhRC1UMUlka2dZYjVBT3BFZDZIdjNKRlo</guid></item><item><title>科学家发现，自闭症的遗传根源因诊断年龄而异-英国《金融时报》</title><link>https://www.ft.com/content/77d8f44d-6df0-4785-8ca7-ef8093b49240</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="o-grid-row details-section o3-type-body-base css-pmzbjb"&gt;&lt;p&gt;&lt;span&gt;&lt;span&gt;FT Digital Edition: today’s FT, cover to cover on any device. This subscription does not include access to ft.com or the FT App.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Financial Times</author><pubDate>Wed, 01 Oct 2025 15:00:03 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMicEFVX3lxTE42VXowVXJuQjluU2M5Qk5idDFfZUl1ZmZ5LVNLTGNVMERySC1oRUtiMWNITkVNbEFwa0NRMDEwbW1SbjlUTWY1M0JmRVZ6UkdNcmNCcDNnVGhHUy1GSkpIa1N1bmEwT3ZWR0xUUzlWMVg</guid></item><item><title>基因研究显示，可能存在不同形式的自闭症，不仅严重程度不同- NBC新闻</title><link>https://www.nbcnews.com/health/health-news/autism-spectrum-disorder-genetic-analysis-multiple-forms-age-diagnosis-rcna234741</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article-body__content"&gt;&lt;p id="anchor-6af5df" class="body-graf"&gt;People who learn they have autism after age 6 — the &lt;a href="https://www.epicresearch.org/articles/diagnosis-of-autism-occurring-earlier-in-children-though-still-late-for-many-initial-diagnosis-in-adulthood-increasing-in-women" target="_blank"&gt;current median age at diagnosis&lt;/a&gt; — are often described as having a “milder” form of autism than people diagnosed as toddlers.&lt;/p&gt;&lt;p id="anchor-50b683" class="body-graf"&gt;A new study challenges that assumption.&lt;/p&gt;&lt;p id="taboolaReadMoreBelow"&gt;&lt;/p&gt;&lt;p id="anchor-e0cb3e" class="body-graf"&gt;A genetic analysis finds that people with autism spectrum disorder diagnosed in late childhood or adolescence actually have “a different form of autism,” not a less severe one, said Varun Warrier, senior author of a study &lt;a href="https://dx.doi.org/10.1038/s41586-025-09542-6" target="_blank"&gt;published Wednesday in Nature&lt;/a&gt;.&lt;/p&gt;&lt;p id="anchor-17a13e" class="body-graf"&gt;The “genetic profile” of people with late-diagnosis autism actually looks more like depression, attention-deficit/hyperactivity disorder and post-traumatic stress disorder than early childhood autism, said Warrier, an autism researcher at the University of Cambridge. &lt;/p&gt;&lt;p id="anchor-0b8acf" class="body-graf"&gt;The study illustrates that autism is not a single condition with one root cause, but rather an umbrella term for a cluster of conditions with similar — although not identical — features, said Geraldine Dawson, founding director of the Duke Center for Autism and Brain Development, who wasn’t involved in the new report. &lt;/p&gt;&lt;p id="anchor-3f21dc" class="body-graf"&gt;Alycia Halladay, chief science officer at the Autism Science Foundation, who wasn’t involved in the study, said: “This paper reinforces yet again how complex autism is and &lt;a href="https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2737582" target="_blank"&gt;how much genetics plays a role&lt;/a&gt; not just in a diagnosis but in the features of that diagnosis.  There is no one cause of autism, &lt;a href="https://www.nbcnews.com/health/health-news/trump-acetaminophen-fda-pregnancy-autism-cause-rcna232909" target="_blank"&gt;despite claims against Tylenol&lt;/a&gt;.”&lt;/p&gt;&lt;p id="anchor-2607a5" class="body-graf"&gt;Authors of the new study analyzed long-term social, emotional and behavioral information about children in the United Kingdom and Australia, as well as genetic data about more than 45,000 autistic people in Europe and the United States.&lt;/p&gt;&lt;h2 id="anchor-e049b6" class="body-heading"&gt;Different genetic profiles&lt;/h2&gt;&lt;p id="anchor-aa8745" class="body-graf"&gt;Researchers didn’t focus on a single gene or even a few genes. Instead, they looked at sets of thousands of genetic variants that together influence particular traits. &lt;/p&gt;&lt;p id="anchor-555dba" class="body-graf"&gt;While one genetic profile may lead to difficulties with social interactions during the toddler or preschool years, another set of genes may cause an increase in such problems during late childhood and beyond, Warrier said.&lt;/p&gt;&lt;p id="anchor-81405a" class="body-graf"&gt;The new study suggests that some autistic children “develop differently and may not receive a diagnosis earlier on because their features may not yet have clearly emerged,” Warrier said. “It is important to understand what these features are and ensure that we are assessing autistic people across the lifespan.”&lt;/p&gt;&lt;p id="anchor-4db37c" class="body-graf"&gt;Most autism diagnoses &lt;a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825472" target="_blank"&gt;are made before age 18&lt;/a&gt;, with 22% of diagnoses occurring by age 4, 20% from 5 to 8, 15% from 9 to 12 and 16% from 13 to 17.&lt;/p&gt;&lt;p id="anchor-b8adc9" class="body-graf"&gt;Adult diagnoses are more common in women. Twenty-five percent of women with autism &lt;a href="https://www.epicresearch.org/articles/diagnosis-of-autism-occurring-earlier-in-children-though-still-late-for-many-initial-diagnosis-in-adulthood-increasing-in-women" target="_blank"&gt;were diagnosed at age 19&lt;/a&gt; or older last year, compared with 12% of men, according to Epic Research.&lt;/p&gt;&lt;p id="anchor-2b2046" class="body-graf"&gt;In the study, adolescents diagnosed with autism had more difficulties managing emotional issues and relationships with peers than other kids. &lt;/p&gt;&lt;p id="anchor-e1fd2d" class="body-graf"&gt;That was the struggle for Adeline Lacroix of Toronto. &lt;/p&gt;&lt;p id="anchor-c90ce4" class="body-graf"&gt;Lacroix, now 42, who was raised in France, had trouble making friends as a child. She “wondered why in school we learned things that were to me quite easy, such as mathematics, but we didn’t learn how to make friends, which for me was much more difficult,” she said.&lt;/p&gt;&lt;p id="anchor-af7599" class="body-graf"&gt;Lacroix often didn’t understand when other people were being ironic or making a joke. Although she got good grades, “I felt I was very dumb because I didn’t understand a lot of things.”&lt;/p&gt;&lt;figure class="styles_inlineImage__FvnTh styles_medium__MEKii" id="anchor-6071d6"&gt;&lt;picture class="styles_image__i32F7" data-testid="picture" data-flavor="fit" data-original-height="1667" data-original-width="2500"&gt;&lt;source media="(min-width: 1000px)" srcset="https://media-cldnry.s-nbcnews.com/image/upload/t_fit-560w,f_avif,q_auto:eco,dpr_2/rockcms/2025-09/250930-Autism-Adeline-ew-554p-6d980e.jpg 2x, https://media-cldnry.s-nbcnews.com/image/upload/t_fit-560w,f_auto,q_auto:best/rockcms/2025-09/250930-Autism-Adeline-ew-554p-6d980e.jpg 1x"&gt;&lt;/source&gt;&lt;source media="(min-width: 320px)" srcset="https://media-cldnry.s-nbcnews.com/image/upload/t_fit-760w,f_avif,q_auto:eco,dpr_2/rockcms/2025-09/250930-Autism-Adeline-ew-554p-6d980e.jpg 2x, https://media-cldnry.s-nbcnews.com/image/upload/t_fit-760w,f_auto,q_auto:best/rockcms/2025-09/250930-Autism-Adeline-ew-554p-6d980e.jpg 1x"&gt;&lt;/source&gt;&lt;img loading="lazy" src="https://media-cldnry.s-nbcnews.com/image/upload/t_fit-760w,f_auto,q_auto:best/rockcms/2025-09/250930-Autism-Adeline-ew-554p-6d980e.jpg" alt="Adeline Lacroix's life changed when she was diagnosed with autism at age 30."&gt;&lt;/picture&gt;&lt;figcaption class="caption styles_caption__TCewG" data-testid="caption"&gt;&lt;span class="caption__container" data-testid="caption__container"&gt;Adeline Lacroix's life changed when she was diagnosed with autism at age 30.&lt;/span&gt;&lt;span class="caption__source" data-testid="caption__source"&gt;Courtesy Adeline Lacroix&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p id="anchor-26868d" class="body-graf"&gt;Her frustration led to depression and thoughts of death. “I didn’t really want to die, but at the same time I was so tired,” she said.&lt;/p&gt;&lt;p id="anchor-fe8b4c" class="body-graf"&gt;Her life changed when she was diagnosed with autism at age 30. Suddenly, she realized why understanding conversations was so hard. &lt;/p&gt;&lt;p class="recommended-intersection-ref" data-activity-map="recommended-article-body-recommended" data-testid="recommended-wrapper"&gt;&lt;/p&gt;&lt;p class="recommended-intersection-ref" data-activity-map="recommended-article-body-recommended" data-testid="recommended-wrapper"&gt;&lt;/p&gt;&lt;p id="anchor-69eba9" class="body-graf"&gt;She changed careers, abandoning her old job as a schoolteacher to pursue a doctorate in psychology and neuroscience. Lacroix now has a supportive partner and a job she loves at the Center for Addiction and Mental Health in Toronto, where she researches women and girls with autism. &lt;/p&gt;&lt;p id="anchor-bdbfe3" class="body-graf"&gt;“I’m very happy with my life,” she said.&lt;/p&gt;&lt;p id="anchor-007330" class="body-graf"&gt;Although many young people with autism are still diagnosed relatively late in childhood because of a lack of screening and resources in their communities, increased awareness and wider access to testing have helped lower the age at which children are diagnosed with autism, allowing them to get critical early support. &lt;/p&gt;&lt;p id="anchor-5f7a26" class="body-graf"&gt;Increased acceptance of neurodiversity is also motivating &lt;a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825472" target="_blank"&gt;a growing number&lt;/a&gt; of teens and adults &lt;a href="https://www.epicresearch.org/articles/diagnosis-of-autism-occurring-earlier-in-children-though-still-late-for-many-initial-diagnosis-in-adulthood-increasing-in-women" target="_blank"&gt;to seek out testing for autism, &lt;/a&gt;which can involve difficulties in communication and social interactions, as well as restricted or repetitive behaviors or interests. From 2011 to 2022, autism diagnoses among adults 26 to 34 &lt;a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2825472" target="_blank"&gt;grew by 450%&lt;/a&gt;, the largest relative increase among any age group.&lt;/p&gt;&lt;p id="anchor-c4c810" class="body-graf"&gt;In the Nature study, the first to link a genetic profile to the timing of autism diagnosis, newly diagnosed adolescents had an increased risk of depression.&lt;/p&gt;&lt;p id="anchor-70e3cf" class="body-graf"&gt;The increase in depression could stem from both a genetic predisposition and a lack of support faced by young people whose unique learning needs and social challenges go unaddressed for years, Warrier said.&lt;/p&gt;&lt;p id="anchor-3fa49b" class="body-graf"&gt;“Children who have undiagnosed autism may not receive the support they need,” he said. “They may be bullied, excluded and may be vulnerable socially. It is only when they are struggling that caregivers seek out professional help and they receive an autism diagnosis.”&lt;/p&gt;&lt;p id="anchor-bbe68d" class="body-graf"&gt;In future research, he said, Warrier hopes to study how a person’s social environment — whether supportive or hostile — affects the risk of depression in later-diagnosed people. Although school and community services often focus on youngsters, Warrier said it’s important to support people with autism of all ages.&lt;/p&gt;&lt;h2 id="anchor-f23304" class="body-heading"&gt;&lt;strong&gt;The emotional toll of trying to blend in&lt;/strong&gt;&lt;/h2&gt;&lt;p id="anchor-d7a884" class="body-graf"&gt;Sam Brandsen, who grew up in a small town in Iowa where few people were familiar with autism, didn’t get that critical support. &lt;/p&gt;&lt;p id="anchor-06eab0" class="body-graf"&gt;In the sixth grade, he was bullied for being different. Kids made fun of him for rocking back and forth, a behavior that he found soothing. Boys shoved him into lockers and tied his shoelaces to his desk to make him fall.&lt;/p&gt;&lt;p id="anchor-167eab" class="body-graf"&gt;By force of will, he managed to sit still at his desk. But the mental and emotional effort he expended took a heavy toll, Brandsen said, causing him to suffer panic attacks between classes.&lt;/p&gt;&lt;figure class="styles_inlineImage__FvnTh styles_medium__MEKii styles_portrait__NEQhG" id="anchor-a29e7f"&gt;&lt;picture class="styles_image__i32F7" data-testid="picture" data-flavor="fit" data-original-height="2175" data-original-width="1740"&gt;&lt;source media="(min-width: 1000px)" srcset="https://media-cldnry.s-nbcnews.com/image/upload/t_fit-560w,f_avif,q_auto:eco,dpr_2/rockcms/2025-09/250930-ausitm-sam-ew-554p-f4ccff.jpg 2x, https://media-cldnry.s-nbcnews.com/image/upload/t_fit-560w,f_auto,q_auto:best/rockcms/2025-09/250930-ausitm-sam-ew-554p-f4ccff.jpg 1x"&gt;&lt;/source&gt;&lt;source media="(min-width: 320px)" srcset="https://media-cldnry.s-nbcnews.com/image/upload/t_fit-760w,f_avif,q_auto:eco,dpr_2/rockcms/2025-09/250930-ausitm-sam-ew-554p-f4ccff.jpg 2x, https://media-cldnry.s-nbcnews.com/image/upload/t_fit-760w,f_auto,q_auto:best/rockcms/2025-09/250930-ausitm-sam-ew-554p-f4ccff.jpg 1x"&gt;&lt;/source&gt;&lt;img loading="lazy" src="https://media-cldnry.s-nbcnews.com/image/upload/t_fit-760w,f_auto,q_auto:best/rockcms/2025-09/250930-ausitm-sam-ew-554p-f4ccff.jpg" alt="Sam Brandson was diagnosed with autism at 27 when his son was 18 months old."&gt;&lt;/picture&gt;&lt;figcaption class="caption styles_caption__TCewG" data-testid="caption"&gt;&lt;span class="caption__container" data-testid="caption__container"&gt;“You know that you’re different, but you don’t really have a framework for understanding what that difference is,” said Sam Brandsen who was diagnosed with autism at 27.&lt;/span&gt;&lt;span class="caption__source" data-testid="caption__source"&gt;Sam Brandson&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;p id="anchor-6e7ad6" class="body-graf"&gt;Brandsen, now 31, said he wasn’t diagnosed with autism until four years ago, after his 18-month-old son was diagnosed with it. &lt;/p&gt;&lt;p id="anchor-db6ec2" class="body-graf"&gt;Like Lacroix, Brandsen said he felt relieved to better understand himself. Instead of wasting energy to act like everyone else, he said, “I’d rather use that energy to just be a kinder person.”&lt;/p&gt;&lt;p id="anchor-a648f6" class="body-graf"&gt;Brandsen said he can understand why people with autism who are diagnosed later in life may have a greater risk of mental distress.&lt;/p&gt;&lt;p id="anchor-571296" class="body-graf"&gt;“You know that you’re different, but you don’t really have a framework for understanding what that difference is,” said Brandsen, a part-time postdoctoral researcher at the University of Alberta in Canada and a member of the Autism Society’s Council of Autistic Advisors. “You’re trying to make sense of rules that seem to make sense to everyone else, and you don’t know why it’s not clicking for you.”&lt;/p&gt;&lt;p id="anchor-41c843" class="body-graf"&gt;Although Brandsen said he understands why scientists want to study the causes of autism, he said he hopes they will spend more time researching ways to help people with autism lead full, independent lives. &lt;/p&gt;&lt;p id="anchor-369845" class="body-graf"&gt;His son has a number of disabilities, Brandsen said, but the boy also experiences tremendous joy.&lt;/p&gt;&lt;p id="anchor-09c688" class="body-graf"&gt;“There’s so many ways that he’s changed my life profoundly for the better, even if it’s been kind of a harder path at times,” Brandsen said. “But then he can also take so much joy from just watching a train.”&lt;/p&gt;&lt;p id="anchor-2f6888" class="endmark body-graf"&gt;&lt;em&gt;If you or someone you know is in crisis, call or text 988, or go to &lt;/em&gt;&lt;a href="http://988lifeline.org/" target="_blank"&gt;&lt;em&gt;988lifeline.org&lt;/em&gt;&lt;/a&gt;&lt;em&gt;, to reach the Suicide &amp;amp; Crisis Lifeline. You can also call the network, previously known as the National Suicide Prevention Lifeline, at 800-273-8255, or visit &lt;/em&gt;&lt;a href="http://speakingofsuicide.com/resources" target="_blank"&gt;&lt;em&gt;SpeakingOfSuicide.com/resources&lt;/em&gt;&lt;/a&gt;&lt;em&gt;.&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>NBC News</author><pubDate>Wed, 01 Oct 2025 15:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiwgFBVV95cUxOd3ZTUkxkZlkyTDFLNk9QYWpTREVJOFNxYzJKTW13QUFENzUxcFhkM2szT09KVFM2MExxUTBHdEkwT0VtXzMtcGNDNXQ1czlWOEFNOFlyM3NzNTR4MFRRYVp5eF8wT2FfN0Y0Zk9oZTdhY1ZMYk9lWmNOVVhpc3plbjFwc3ppV0Z0WnJkSjZXREc1MmNPZGhIbS0td0RsOWhfRlFJV2JlX01nclNyU1RYcWRhY0FpYXRNYlhPUmdUcC04d9IBVkFVX3lxTFBaUW5zNEUwamFPRGw4c3kwQ3laUHZEZ0dnUFFUS1hQXzluYlh6ZHVIU2RHZWZqZ3dfY0dwUWlYSTcwSnR3WklhZGJpOVBheU1oSVVuRDFn</guid></item><item><title>ALS突破显示致命疾病是由免疫攻击驱动的-彭博社</title><link>https://www.bloomberg.com/news/articles/2025-10-01/immune-cells-found-to-attack-neurons-in-als-offering-new-treatment-target</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;section class="box main"&gt;
                &lt;h2 class="main__heading"&gt;We've detected unusual activity from your computer network&lt;/h2&gt;
                &lt;p class="continue"&gt;To continue, please click the box below to let us know you're not a robot.&lt;/p&gt;
                &lt;p id="px-captcha"&gt;&lt;/p&gt;
            &lt;/section&gt;
            &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Bloomberg.com</author><pubDate>Wed, 01 Oct 2025 15:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiwgFBVV95cUxPY2w4VldNdDNzTU5YaFpDcmR4dTFLRnN3WUEtQjJoaHp3YTJPSWw4bmNSVmxQYVhqUUhFaXlvZnExX0JWRGszY1BqZHdrelk0c242andET2E2M1UwY0hvdzBNbm9VTVhnVU01d29NbC02a21EMDQ4WTNCcTd2N3dITGpmWTljbEhMSnVVWHJvTFZSaEgtc3RtRE90TUdnWXJwVkVtSWZQVUY0T2E1aXBGOWRsT2lUbHFLMmtydy1RUnJWdw</guid></item><item><title>用舌头诊断流感的一步- EurekAlert ！</title><link>https://www.eurekalert.org/news-releases/1099648</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="entry"&gt;
            
                            &lt;p&gt;Flu season is fast approaching in the northern hemisphere&lt;strong&gt;. &lt;/strong&gt;And a taste-based influenza test&lt;strong&gt; &lt;/strong&gt;could someday&lt;strong&gt; &lt;/strong&gt;have you swapping nasal swabs for chewing gum. A new molecular sensor has been designed to release a thyme flavor when it encounters the influenza virus. Researchers reporting in &lt;em&gt;ACS Central Science &lt;/em&gt;say that they plan to incorporate this type of low-tech sensor into gum or lozenges to increase at-home screenings and potentially prevent pre-symptomatic transmission of the disease.&lt;/p&gt;

&lt;p&gt;Staying home is critical to preventing the spread of infectious diseases like influenza; however, people with the flu are contagious before they develop symptoms. Current flu diagnostics like nasal swab-based PCR tests are accurate, but they are slow and expensive. At-home lateral flow tests, akin to those used to test for COVID-19, are convenient and generally low-cost, but don’t catch pre-symptomatic infections.&lt;/p&gt;

&lt;p&gt;As written in their published study, Lorenz Meinel and colleagues address these flu detection shortcomings “by switching away from complex detectors and machinery and toward a detector that is available for anyone, everywhere and anytime: the tongue.”&lt;/p&gt;

&lt;p&gt;The team developed a molecular sensor that releases a flavor that human tongues can detect — thymol, found in the spice thyme. The sensor is based on a substrate of the influenza virus glycoprotein called neuraminidase (the “N” in H1N1). Influenza viruses use neuraminidase to break certain bonds on the host’s cell to infect it. So, the researchers synthesized a neuraminidase substrate and attached a thymol molecule to it. Thymol registers as a strong herbal taste on the tongue. Theoretically, when the synthesized sensor is in the mouth of someone infected with the flu, the viruses lob off the thymol molecules, and their flavor is detected by the tongue.  &lt;/p&gt;

&lt;p&gt;After developing their molecular sensor, the researchers conducted lab tests with it. In vials with human saliva from people diagnosed with the flu, the sensor released free thymol within 30 minutes. When they tested the sensor on human and mouse cells, it didn’t change the cells’ functioning. Next, Meinel and team hope to start human clinical trials in about two years to confirm the sensor’s thymol taste sensations in people with pre- and post-symptomatic influenza.&lt;/p&gt;

&lt;p&gt;If incorporated into chewing gums or lozenges, “this sensor could be a rapid and accessible first-line screening tool to help protect people in high-risk environments,” says Meinel.&lt;/p&gt;

&lt;p&gt;&lt;em&gt;The authors acknowledge funding from the Federal Ministry of Research and Education (now called the Federal Ministry of Research, Technology and Space) and have registered a patent with the European Patent Office on this technology.&lt;/em&gt;&lt;/p&gt;

&lt;p&gt;The paper’s abstract will be available on Oct. 1 at 8 a.m. Eastern time here: &lt;a href="http://pubs.acs.org/doi/abs/10.1021/acscentsci.5c01179"&gt;http://pubs.acs.org/doi/abs/10.1021/acscentsci.5c01179&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;###&lt;/p&gt;

&lt;p&gt;The American Chemical Society (ACS) is a nonprofit organization founded in 1876 and chartered by the U.S. Congress. ACS is committed to improving all lives through the transforming power of chemistry. Its mission is to advance scientific knowledge, empower a global community and champion scientific integrity, and its vision is a world built on science. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, e-books and weekly news periodical Chemical &amp;amp; Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and&lt;strong&gt; &lt;/strong&gt;analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and&lt;strong&gt; &lt;/strong&gt;Columbus, Ohio.&lt;/p&gt;

&lt;p&gt;Registered journalists can subscribe to the &lt;a href="https://www.eurekalert.org/press/acspress/home"&gt;ACS journalist news portal on EurekAlert!&lt;/a&gt; to access embargoed and public science press releases. For media inquiries, contact &lt;a href="mailto:newsroom@acs.org"&gt;newsroom@acs.org&lt;/a&gt;.&lt;/p&gt;

&lt;p&gt;&lt;em&gt;Note: ACS does not conduct research but publishes and publicizes peer-reviewed scientific studies.&lt;/em&gt;&lt;/p&gt;

&lt;p&gt;Follow us: &lt;a href="https://www.facebook.com/AmericanChemicalSociety/"&gt;Facebook&lt;/a&gt; | &lt;a href="https://www.linkedin.com/company/american-chemical-society/"&gt;LinkedIn&lt;/a&gt; | &lt;a href="https://www.instagram.com/amerchemsociety/"&gt;Instagram&lt;/a&gt;&lt;strong&gt; &lt;/strong&gt;&lt;/p&gt;

            
                        &lt;hr class="hidden-xs hidden-sm"&gt;
            &lt;hr class="major visible-sm"&gt;
            &lt;div class="featured_image"&gt;
                &lt;div class="details"&gt;
										                                            &lt;div class="well"&gt;
                            &lt;h4&gt;Journal&lt;/h4&gt;
                            &lt;p&gt;ACS Central Science&lt;/p&gt;
                        &lt;/div&gt;
                                                                
                                                                                                        &lt;div class="well"&gt;
                            &lt;h4&gt;Article Title&lt;/h4&gt;
                            &lt;p&gt;A Viral Neuraminidase-Specific Sensor for Taste-Based Detection of Influenza&lt;/p&gt;
                        &lt;/div&gt;
                                                                &lt;div class="well"&gt;
                            &lt;h4&gt;Article Publication Date&lt;/h4&gt;
                            &lt;p&gt;1-Oct-2025&lt;/p&gt;
                        &lt;/div&gt;
                                                            					                &lt;/div&gt;
            &lt;/div&gt;
                    &lt;/div&gt;

        

        &lt;div class="well article_disclaimer hidden-search"&gt;
    &lt;p&gt;&lt;strong&gt;Disclaimer:&lt;/strong&gt; AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.&lt;/p&gt;
&lt;/div&gt;

        &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>EurekAlert!</author><pubDate>Wed, 01 Oct 2025 14:47:54 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiXEFVX3lxTE5IcUlKSGRIVnl5U2xlcy1TUjJTbjkwdzNvZk83dEdKcVR4XzhzVVJ1bm5ZeU5aMnZqTU1pSkRwbUViOVhYQUFvenZ2SGVRYWktUFlnNEdVSzI3dXlQ</guid></item><item><title>事故可能会使4岁的Rexburg在婴儿期从瘫痪中恢复多年后瘫痪- KSL.com</title><link>https://www.ksl.com/article/51383728/crash-may-leave-rexburg-4-year-old-paralyzed-years-after-recovering-from-paralysis-as-an-infant</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="articleContainer"&gt;&lt;p&gt;REXBURG, Idaho — Four-year-old Carter Grover has persevered through more than most adults will in their entire lives.&lt;/p&gt;&lt;p&gt;At 7 months old, Carter contracted a virus as a complication from COVID-19, which caused him to become paralyzed from the neck down.&lt;/p&gt;&lt;p&gt;"He had contracted COVID from the day care that he was at, which caused him to get this virus called transverse myelitis," says Katherine Grover, Carter's mom. "We had miraculously made an almost full recovery from that."&lt;/p&gt;&lt;p&gt;According to the Mayo Clinic, transverse myelitis is a neurological disorder that results in inflammation of both sides of one section of the spinal cord. This can cause pain, muscle weakness, sensory problems, bladder and bowel dysfunction, and paralysis.&lt;/p&gt;&lt;p&gt;"We did a lot of physical therapy three times a week, and occupational therapy every week. It's been a wild ride. He just started walking again in April of 2024 last year. He was walking again and quickly learned how to run," Katherine Grover says. "Every three months we would go to Lehi, Utah, down to the new Primary Children's Clinic, which is incredible, to get Botox shots in his joints to keep him from stiffening up."&lt;/p&gt;&lt;p&gt;Even through the rollercoaster of health setbacks, she says Carter is a loving, funny and energetic kid.&lt;/p&gt;&lt;p&gt;"Carter is just so happy to be alive. He's got a little attitude, of course, but who doesn't these days? He loves dancing, he loves music, he loves all animals," she said. "He's just so playful and happy, and he always needs to be right there with me in everything that I do."&lt;/p&gt;&lt;p&gt;On Sept. 22, Carter's grandmother, Laurie Peterson, was driving him to his physical therapy appointment, which he goes to three times a week in Rexburg, when she suffered a medical emergency.&lt;/p&gt;&lt;figure&gt;&lt;figcaption&gt;Laurie Peterson and Carter Grover during Carter’s first appointment at Primary Children’s Hospital. (Photo: Katherine Grover)&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;"She suffered a stroke that led to her being unable to stop properly at the stop sign and was hit by another oncoming vehicle. It did, unfortunately, involve a hay-baler," Grover said. "We do feel like the vehicle rolled, but we aren't sure. They were both wearing seat belts at the time."&lt;/p&gt;&lt;p&gt;Six people were transported to the hospital, including Carter and his grandmother.&lt;/p&gt;&lt;p&gt;Katherine Grover was at Costco when she received the call from law enforcement, learning that her mother and son had been in a serious car crash and were both unconscious at the scene.&lt;/p&gt;&lt;p&gt;"They were rushed to EIRMC in Idaho Falls, and somehow (Peterson) had become coherent enough to give them my name and phone number," Grover said. "Shortly after that, she crashed and had to be intubated."&lt;/p&gt;&lt;p&gt;Shortly after being rushed to Eastern Idaho Regional Medical Center, Carter was flown to Primary Children's Hospital in Salt Lake City.&lt;/p&gt;&lt;p&gt;"The accident caused a spinal cord tear in the C1 and C2 of (Carter's) spine, and his C5 and C6 were also damaged," Katherine Grover explains. "Due to the severity of the spinal cord tear, it has left Carter paralyzed from the neck down, and he is unable to breathe on his own."&lt;/p&gt;&lt;p&gt;According to Grover, doctors have given Carter a difficult prognosis. Still, the family says they are choosing to keep hope alive.&lt;/p&gt;&lt;p&gt;"The chances of him being able to walk again and breathe on his own again are pretty slim," Grover said. "But, he is extremely cognizant of his brain. Activity is excellent, and he is awake, and he is communicating with me and the nurses and doctors with his eyes."&lt;/p&gt;&lt;figure&gt;&lt;figcaption&gt;Carter Grover is shown in this undated photo. (Photo: Katherine Grover)&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;Grover said she has been staying with Carter in Utah, while her sister, Emily Gonzales, has been with their mother, as she is in critical condition in the ICU at Eastern Idaho Regional Medical Center.&lt;/p&gt;&lt;p&gt;Gonzales says Peterson has suffered multiple strokes and is not "out of the woods yet."&lt;/p&gt;&lt;p&gt;"Unfortunately, she did suffer multiple strokes, and those were on the left side of her brain," Gonzales says. "She's got a long road of recovery as well. She has two broken collar bones, a fractured sternum, broken ribs, fractured pelvis, a laceration to her spleen, and two pneumothoraxes, so she's got holes in each lung."&lt;/p&gt;&lt;p&gt;Despite all the challenges, the sisters say that the community's support has been overwhelming, and they have been flooded with help from family and friends.&lt;/p&gt;&lt;p&gt;"I am just so humbled and honored to have such amazing and incredible people in my life," Grover said. "Carter's preschool came, they made him pictures and a big poster that everybody signed and drew on. And they brought a bunch of books, and they brought Carter's favorite stuffed lion."&lt;/p&gt;&lt;p&gt;Gonzales, who owns The Neighborhood Barber in Idaho Falls, says she was recently grateful to learn that her co-workers had planned a fundraiser* for Carter titled "Cuts for Carter."&lt;/p&gt;&lt;figure&gt;&lt;figcaption&gt;The Cut for Carter fundraiser. (Photo: FaceBook)&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;"My team has just been so incredibly amazing, and they want to help and support," Gonzales says. "They started a cut-a-thon that they're hosting at my shop on Oct. 11, and all the proceeds they get from that day are going to be donated towards Carter's recovery and to help my sister out with whatever she needs while she's in Utah."&lt;/p&gt;&lt;p&gt;Gonzales also started a &lt;a href="https://www.gofundme.com/f/help-support-carters-healing-journey" rel="nofollow" target="_blank"&gt;GoFundMe&lt;/a&gt;* to raise money for Carter's medical treatment, recovery and other expenses while the family is in Utah.&lt;/p&gt;&lt;p&gt;"Carter has really surprised so many doctors and has overcome every challenge that he has been faced with," Gonzales said. "As he's grown older, he just keeps proving doctors, and everybody wrong."&lt;/p&gt;&lt;p&gt;Grover says she wants the community to know that her mother is strong and an inspiration to the family, which keeps them believing that she will fully recover.&lt;/p&gt;&lt;p&gt;"She's an amazing woman. She raised three kids by herself, holding down a full-time job," Grover says. "We are fortunate enough to have my mother so active in our lives, and my children are blessed because we have her."&lt;/p&gt;&lt;p&gt;Despite the hardship their family is facing, Grover says a favorite saying of Carter's continues to come to mind and provides her with comfort.&lt;/p&gt;&lt;p&gt;"Carter is so strong-minded, and he's going to get through this, too," Grover says. "One of Carter's sayings that he always says to me every day is, 'You're my favorite heart.'"&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;hr&gt;&lt;p&gt;&lt;em&gt;*KSL.com does not assure that the money deposited to the account will be applied for the benefit of the persons named as beneficiaries. If you are considering a deposit to the account, you should consult your own advisers and otherwise proceed at your own risk.&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="kt_disclaimer"&gt;
                                    The Key Takeaways for this article were generated with the assistance of large language models and reviewed by our editorial team. The article, itself, is solely human-written.
                                &lt;/p&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>KSL.com</author><pubDate>Wed, 01 Oct 2025 14:47:07 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMizAFBVV95cUxPMGVYenA5eHk1QjdVbkw0TzZxRGxEaVhUSmtrTjVYZ0VfV3JPMVFoZDFQTF9DeEgyWnpfV29QNkVRYV9wZF9ycm9BMTRycnppQ3VjVDlFdzA3QkdabFZGV3U3RXBDc2ZiU0ZybkxJeVVQUnp1TzdrUTNBMXotSkRUSTVTa1J1dmNGZUpvZXR6eWtQdzA0c1VYQUtTMTFIS0RjaVhhYnhxcFQ4OFRjaVhtSG1mdDVEdWxuMlhxNVhWWW9HLVZjcUxBWkNVUTE</guid></item><item><title>科学家终于揭示了长COVID脑雾的生物学基础-SciTechDaily</title><link>https://scitechdaily.com/scientists-finally-reveal-biological-basis-of-long-covid-brain-fog/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content cf entry-content content-spacious"&gt;

		
				
		&lt;figure id="attachment_496825" aria-describedby="caption-attachment-496825" class="wp-caption aligncenter"&gt;&lt;a href="https://scitechdaily.com/images/Tired-Woman-Brain-Fog.jpg"&gt;&lt;img fetchpriority="high" decoding="async" class="wp-image-496825 size-large" src="https://scitechdaily.com/images/Tired-Woman-Brain-Fog-777x406.jpg" alt="Tired Woman Brain Fog" srcset="https://scitechdaily.com/images/Tired-Woman-Brain-Fog-777x406.jpg 777w, https://scitechdaily.com/images/Tired-Woman-Brain-Fog-400x209.jpg 400w, https://scitechdaily.com/images/Tired-Woman-Brain-Fog-768x401.jpg 768w, https://scitechdaily.com/images/Tired-Woman-Brain-Fog-1536x803.jpg 1536w, https://scitechdaily.com/images/Tired-Woman-Brain-Fog-150x78.jpg 150w, https://scitechdaily.com/images/Tired-Woman-Brain-Fog-450x235.jpg 450w, https://scitechdaily.com/images/Tired-Woman-Brain-Fog-1200x627.jpg 1200w, https://scitechdaily.com/images/Tired-Woman-Brain-Fog.jpg 2000w" sizes="(max-width: 777px) 100vw, 777px"&gt;&lt;/a&gt;&lt;figcaption id="caption-attachment-496825" class="wp-caption-text"&gt;Scientists have identified a biological explanation for Long COVID brain fog, revealing a potential path toward diagnosis and treatment. Credit: Stock&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p&gt;&lt;strong&gt;Researchers employed a specialized brain imaging technique to identify a potential biomarker and therapeutic target for Long COVID.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;More than four years after the onset of the &lt;span class="glossaryLink" aria-describedby="tt" data-cmtooltip="cmtt_0b676823caf75809ce1fbae5b113f943" data-gt-translate-attributes='[{"attribute":"data-cmtooltip", "format":"html"}]' tabindex="0" role="link"&gt;COVID-19&lt;/span&gt; pandemic, scientists are still working to fully understand the lingering effects of infection with &lt;span class="glossaryLink" aria-describedby="tt" data-cmtooltip="cmtt_4ce189aab1816e0f5a2e19a25e494f2d" data-gt-translate-attributes='[{"attribute":"data-cmtooltip", "format":"html"}]' tabindex="0" role="link"&gt;SARS-CoV-2&lt;/span&gt;. One of the most concerning outcomes is Long COVID, a chronic condition that can emerge after the initial illness and bring a wide range of lasting health problems.&lt;/p&gt;
&lt;p&gt;Among its most common and disruptive symptoms is cognitive impairment, often described as “brain fog.” Studies suggest that over 80% of people living with Long COVID experience this issue, which can make it difficult to work or handle daily responsibilities. With hundreds of millions of cases worldwide, the condition has become both a major public health concern and a growing socioeconomic burden.&lt;/p&gt;
&lt;p&gt;Despite how widespread Long COVID is, its root causes remain unclear. Some imaging studies have revealed changes in brain structure, but these findings have not explained the molecular processes that lead to cognitive symptoms. Because the molecules that regulate communication between neurons are extremely difficult to study directly, researchers currently lack objective biomarkers that could confirm a Long COVID diagnosis or guide the development of effective treatments.&lt;/p&gt;
&lt;h4&gt;A Breakthrough in Brain Imaging&lt;/h4&gt;
&lt;p&gt;To address this challenge, a research team led by Professor Takuya Takahashi from the Graduate School of Medicine at Yokohama City University, Japan, has made a significant breakthrough in understanding the cause of Long COVID brain fog.&lt;/p&gt;
&lt;figure id="attachment_496826" aria-describedby="caption-attachment-496826" class="wp-caption aligncenter"&gt;&lt;a href="https://scitechdaily.com/images/Molecular-Brain-Imaging-as-a-Tool-for-Understanding-Long-COVID.jpg"&gt;&lt;img decoding="async" class="size-large wp-image-496826" src="https://scitechdaily.com/images/Molecular-Brain-Imaging-as-a-Tool-for-Understanding-Long-COVID-777x801.jpg" alt="Molecular Brain Imaging as a Tool for Understanding Long COVID" srcset="https://scitechdaily.com/images/Molecular-Brain-Imaging-as-a-Tool-for-Understanding-Long-COVID-777x801.jpg 777w, https://scitechdaily.com/images/Molecular-Brain-Imaging-as-a-Tool-for-Understanding-Long-COVID-400x413.jpg 400w, https://scitechdaily.com/images/Molecular-Brain-Imaging-as-a-Tool-for-Understanding-Long-COVID-768x792.jpg 768w, https://scitechdaily.com/images/Molecular-Brain-Imaging-as-a-Tool-for-Understanding-Long-COVID-150x155.jpg 150w, https://scitechdaily.com/images/Molecular-Brain-Imaging-as-a-Tool-for-Understanding-Long-COVID-450x464.jpg 450w, https://scitechdaily.com/images/Molecular-Brain-Imaging-as-a-Tool-for-Understanding-Long-COVID-1200x1238.jpg 1200w, https://scitechdaily.com/images/Molecular-Brain-Imaging-as-a-Tool-for-Understanding-Long-COVID.jpg 1367w" sizes="(max-width: 777px) 100vw, 777px"&gt;&lt;/a&gt;&lt;figcaption id="caption-attachment-496826" class="wp-caption-text"&gt;These brain images show how increased levels of AMPA receptors correlate with both cognitive dysfunctions and inflammatory biomarkers. Credit: Professor Takuya Takahashi from Yokohama City University&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p&gt;As explained in their paper, published in &lt;em&gt;Brain Communications&lt;/em&gt; on October 1, 2025, the team hypothesized that patients with brain fog might exhibit disrupted expression of AMPA receptors (AMPARs)—key molecules for memory and learning—based on prior research into psychiatric and neurological disorders such as depression, bipolar disorder, schizophrenia, and dementia. Thus, they used a novel method called [&lt;sup&gt;11&lt;/sup&gt;C]K-2 AMPAR PET imaging to directly visualize and quantify the density of AMPARs in the living human brain.&lt;/p&gt;
&lt;p&gt;By comparing imaging data from 30 patients with Long COVID to 80 healthy individuals, the researchers found a notable and widespread increase in the density of AMPARs across the brains of patients. This elevated receptor density was directly correlated with the severity of their cognitive impairment, suggesting a clear link between these molecular changes and the symptoms. Additionally, the concentrations of various inflammatory markers were also correlated with AMPAR levels, indicating a possible interaction between inflammation and receptor expression.&lt;/p&gt;
&lt;h4&gt;Toward New Diagnostic and Treatment Strategies&lt;/h4&gt;
&lt;p&gt;Taken together, the study’s findings represent a crucial step forward in addressing many unresolved issues regarding Long COVID. The systemic increase in AMPARs provides a direct biological explanation for the cognitive symptoms, highlighting a target for potential treatments. For example, drugs that suppress AMPAR activity could be a viable approach to mitigate brain fog. Interestingly, the team’s analysis also demonstrated that imaging data can be used to distinguish patients from healthy controls with 100% sensitivity and 91% specificity.&lt;/p&gt;
&lt;p&gt;“By applying our newly developed AMPA receptor PET imaging technology, we aim to provide a novel perspective and innovative solutions to the pressing medical challenge that is Long COVID,” remarks Prof. Takahashi.&lt;/p&gt;
&lt;p&gt;While further efforts will be needed to find a definitive solution for Long COVID, this work is a promising step in the right direction. “Our findings clearly demonstrate that Long COVID brain fog should be recognized as a legitimate clinical condition. This could encourage the healthcare industry to accelerate the development of diagnostic and therapeutic approaches for this disorder,” concludes Prof. Takahashi.&lt;/p&gt;
&lt;p&gt;In summary, the team’s findings resolve key uncertainties about the biological basis of Long COVID brain fog and may pave the way for novel diagnostic tools and effective therapies for patients suffering from this condition.&lt;/p&gt;
&lt;p&gt;Reference: “Systemic increase of AMPA receptors associated with cognitive impairment of long COVID” by Yu Fujimoto, Hiroki Abe, Tsuyoshi Eiro, Sakiko Tsugawa, Meiro Tanaka, Mai Hatano, Waki Nakajima, Sadamitsu Ichijo, Tetsu Arisawa, Yuuki Takada, Kimito Kimura, Akane Sano, Koichi Hirahata, Nobuyuki Sasaki, Yuichi Kimura and Takuya Takahashi, 1 October 2025, &lt;i&gt;Brain Communications&lt;/i&gt;.&lt;br&gt;
&lt;a href="https://doi.org/10.1093/braincomms/fcaf337" data-google-interstitial="false"&gt;DOI: 10.1093/braincomms/fcaf337&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;This clinical trial project was supported by donations from the READYFOR crowdfunding platform (https://readyfor.jp/). This project was partially supported by Takeda Science Foundation (T.T.), the Japan Agency for Medical Research and Development (AMED) under grant numbers JP24wm0625304 (T.T.), and JST through the Establishment of University Fellowships Towards the Creation of Science Technology Innovation program, under grant JPMJFS2140 (Y.F.).&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Never miss a breakthrough: &lt;a href="https://scitechdaily.com/newsletter/"&gt;Join the SciTechDaily newsletter.&lt;/a&gt;&lt;/b&gt;&lt;br&gt;&lt;b&gt;Follow us on &lt;a href="https://www.google.com/preferences/source?q=scitechdaily.com"&gt;Google&lt;/a&gt;, &lt;a href="https://profile.google.com/cp/CgsvbS8wMTF2bTJuZA"&gt;Discover&lt;/a&gt;, and &lt;a href="https://news.google.com/publications/CAAqLAgKIiZDQklTRmdnTWFoSUtFSE5qYVhSbFkyaGtZV2xzZVM1amIyMG9BQVAB?hl=en-US&amp;amp;gl=US&amp;amp;ceid=US%3Aen"&gt;News&lt;/a&gt;.&lt;/b&gt;&lt;/p&gt;
				
		
		
		
	&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>SciTechDaily</author><pubDate>Wed, 01 Oct 2025 14:19:42 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMilwFBVV95cUxQLW9jcl9JVXQ0bndzNEhpTW9IZVlTVW9YSVlZUjhwVi1fN3pDbzF4NHRzb01Ha1M5a283Rk5Ub0ZQbm5nTzgyVVJCMjhKQ2I4bTdwQWVfa1RiS2w0SXdYVE8xaTVfalZkQ3I0TTF3aDNOakZfUzZZUkROU2Y2WkZ0UC1GVkszeC1EVlFlRjRCX0JCcmFnanVJ</guid></item><item><title>2025年乳腺癌宣传月-世界卫生组织（ WHO ）</title><link>https://www.who.int/news-room/events/detail/2025/10/01/default-calendar/breast-cancer-awareness-month-2025</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div&gt;&lt;p&gt;&lt;strong&gt;October is Breast Cancer Awareness Month&lt;/strong&gt;, a time to create awareness, honour the millions of lives affected by breast cancer and reaffirm our global commitment to equitable access to care and improved survival for all. This year, we highlight the theme: &lt;strong&gt;Every Story is Unique, Every Journey Matters.&lt;/strong&gt;&lt;/p&gt;&lt;h2&gt;&lt;strong&gt;Why this theme?&lt;/strong&gt;&lt;/h2&gt;&lt;p&gt;Every breast cancer diagnosis is personal. Behind every diagnosis is a story — of courage, resilience, and hope. This theme reminds us that breast cancer touches the lives of women and their families around the world differently, and that every journey deserves compassion, dignity, and support. This year’s theme recognizes the diversity of experiences and reinforces the need for compassionate, timely and quality care for all—regardless of geography, income or background.&lt;/p&gt;&lt;h2&gt;&lt;strong&gt;The global challenge&lt;/strong&gt;&lt;/h2&gt;&lt;p&gt;Breast cancer is the most commonly diagnosed cancer among women worldwide. In 2022, approximately 2.3 million women were diagnosed and another 670,000 died from the disease. These are not just numbers but mothers, sisters, daughters and friends that deserve hope and dignity. While the 5-year survival rates in high-income countries exceeds 90%, the figures drop to 66% in India and 40% in South Africa. These disparities are driven by unequal access to early detection, timely diagnosis and effective treatment. If the current trend continues, the incidence and mortality are projected to rise by 40% by 2050 hence the need for urgent and coordinated action. Indeed, where a woman lives should not determine whether she survives. &lt;/p&gt;&lt;p&gt;Established in 2021, the WHO Global Breast Cancer Initiative together with partners is working with countries to reduce breast cancer mortality by strengthening health systems &lt;/p&gt;&lt;h2&gt;&lt;strong&gt;The GBCI’s strategic approach: The 60–60–80 targets&lt;/strong&gt;&lt;/h2&gt;&lt;p&gt;We have the tools to prevent, diagnose and treat breast cancer. The GBCI advises countries to implement evidence-based strategies across three pillars:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;Pillar One: Health promotion and early detection&lt;/strong&gt; Empower individuals and communities to recognize symptoms and seek care early. &lt;em&gt;Target: 60% of invasive breast cancers are diagnosed at stage I or II.&lt;/em&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Pillar Two: Timely diagnosis&lt;/strong&gt; Ensure diagnostic services are accessible and efficient. &lt;em&gt;Target: patients receiving a diagnosis within 60 days of initial presentation.&lt;/em&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Comprehensive treatment&lt;/strong&gt; Deliver equitable, uninterrupted comprehensive care for all patients. &lt;em&gt;Target: 80% of patients complete their recommended treatment.&lt;/em&gt;&lt;/li&gt;&lt;/ul&gt;&lt;h2&gt;&lt;strong&gt;The goal of Breast Cancer Awareness Month 2025&lt;/strong&gt;&lt;/h2&gt;&lt;p&gt;The overarching goals are to increase awareness and promote behaviour change for early detection of breast cancer, advocate for improved access to care and honour persons with lived experience. &lt;/p&gt;&lt;h2&gt;&lt;strong&gt;Objectives&lt;/strong&gt;&lt;/h2&gt;&lt;ol&gt;&lt;li&gt;To highlight the importance of health promotion, early detection and timely diagnosis linked to comprehensive treatment.&lt;/li&gt;&lt;li&gt;To foster multisectoral partnerships by engaging stakeholders to co-create and amplify impact.&lt;/li&gt;&lt;li&gt;To promote equitable access to quality care through adoption and implementation of the GBCI targets.&lt;/li&gt;&lt;/ol&gt;&lt;h2&gt;&lt;strong&gt;October 2025 highlights&lt;/strong&gt;&lt;/h2&gt;&lt;ul&gt;&lt;li&gt;&lt;strong&gt;Global storytelling campaign:&lt;/strong&gt; Whether you are a policymaker, health worker, partner, survivor or advocate, we invite you to &lt;a href="https://docs.google.com/forms/d/e/1FAIpQLSfwCNegBlwZjfsGsBZuQXHkm1rv_H-NkDXLJ5AbGeLiPnHuwg/viewform" target="_blank" data-sf-ec-immutable=""&gt;submit short videos, posts or podcasts&lt;/a&gt; showcasing your experience and how you are commemorating Breast Cancer Awareness Month.&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Advocacy toolkit&lt;/strong&gt;: Find us on social media and share your journey using &lt;strong&gt;#EveryStoryIsUnique&lt;/strong&gt; to amplify our message.&lt;strong&gt;&lt;em&gt;&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;The Third Global Breast Cancer Initiative Informal Partners Meeting:&lt;/strong&gt;&lt;strong&gt;&lt;em&gt; &lt;/em&gt;&lt;/strong&gt;on 8 October, we will convene a partners´ meeting to deliberate on key priority areas and launch a training manual intended to build foundational knowledge, skills and capacity for GBCI implementation. If your country or institution is interested in using this manual, &lt;a href="https://forms.cloud.microsoft/Pages/ResponsePage.aspx?id=t8AQ9iS9OUuBCz3CgK-1kNC6-b-fpGRBl_ixdA24S4lUMEYzVEU5R1RSMFI1MTdOQUY1QktTRkFUMy4u" target="_blank" data-sf-ec-immutable=""&gt;fill in this form&lt;/a&gt; and we will provide you with further details.&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Local and regional events:&lt;/strong&gt; Screenings, outreach, webinars, shows, advocacy activities and more will take place throughout the month.&lt;/li&gt;&lt;/ul&gt;&lt;h2&gt;&lt;strong&gt;&lt;/strong&gt;&lt;strong&gt;How to get involved&lt;/strong&gt;&lt;/h2&gt;&lt;p&gt;&lt;strong&gt;Be a champion for breast cancer awareness and equity in access to care:&lt;/strong&gt;&lt;br&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;share your story or amplify others’ to inspire and inform;&lt;/li&gt;&lt;li&gt;organize awareness events in your community or workplace;&lt;/li&gt;&lt;li&gt;advocate for policies that improve access to breast cancer services; or&lt;/li&gt;&lt;li&gt;support your local organization through donations or volunteering.&lt;strong&gt;&lt;/strong&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Join us this October in amplifying voices, sharing stories and driving change. Together, we can build a world where &lt;strong&gt;e&lt;/strong&gt;&lt;strong&gt;very life touched by breast cancer is empowered and supported to receive the care they need everywhere.&lt;/strong&gt;&lt;/p&gt;&lt;p&gt; &lt;/p&gt;&lt;/div&gt;
    &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>World Health Organization (WHO)</author><pubDate>Wed, 01 Oct 2025 14:04:48 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiqgFBVV95cUxPMm8yYm9oWFEzaDdpWEZFZmdBV25oeUpSNDBfeUN2QWo0OUhVWVhzSjMtbzZZSUo1LXFfWjZldVRCRXI5SkY2OHRyaTRSa1prc2tFbzYyOVFIUnFBVlhvaXdZclBIeFdsOWl6NXBSWW0xLWw5Q1BVZU80UFBULXJKcW82dVFQU0tGSVdHX210ck9qbFRYNkhiRmdYQXVJa1Ftd0JfRUdkMHlRZw</guid></item><item><title>即使在戒烟后，长时间饮酒也会阻止肝脏愈合–现在我们知道原因了- IFLScience</title><link>https://www.iflscience.com/too-much-alcohol-for-too-long-can-stop-liver-healing-even-after-quitting-now-we-know-why-81009</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;p id="isPasted"&gt;The liver is one of the human body’s most impressive organs, able to regenerate itself even after it’s damaged or a bit of it is lopped off – but its abilities can only be pushed so far. Long term, excessive alcohol use can stop it from being able to heal itself even after someone &lt;a href="https://www.iflscience.com/this-is-how-long-it-takes-the-brain-to-recover-following-alcohol-use-disorder-cessation-71490" target="_blank"&gt;stops drinking&lt;/a&gt;, and in a new study, researchers have now determined why, down to the molecular level.&lt;/p&gt;&lt;span class="piano-gate" id="piano-gate"&gt;&lt;p&gt;“We knew that the liver stops functioning and stops regenerating in patients with alcohol-related hepatitis and cirrhosis, even when a patient has discontinued consuming alcohol, but we didn’t know why,” said University of Illinois biochemistry professor Auinash Kalsotra in a &lt;a href="https://news.illinois.edu/long-term-alcohol-use-suspends-liver-cells-in-limbo-preventing-regeneration/" target="_blank"&gt;statement&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;“The only real life-saving treatment option once a patient reaches the liver failure stage in those diseases is transplantation. But if we understood why these livers were failing, maybe we could intervene.”&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;To find out what was going on, a team co-led by Kalsotra and Duke University hepatologist Professor Anna Mae Diehl examined and compared samples taken from healthy livers with those affected by alcohol-associated hepatitis (inflammation of the liver) or &lt;a href="https://www.iflscience.com/horrifying-video-shows-what-heavy-drinking-does-to-your-liver-47597" target="_blank"&gt;cirrhosis&lt;/a&gt; (scarring of the liver).&lt;/p&gt;&lt;p&gt;What they discovered was that, in the diseased livers, damaged cells were stuck in a kind of limbo between being damaged and entering a regenerative state.&lt;/p&gt;&lt;p id="trendmd-suggestions" data-pid-resource="RRUGNY3"&gt;&lt;/p&gt;&lt;p&gt;In healthy livers, cells that need to regenerate revert to fetal-like progenitor cells, which then multiply before reverting to functional “adult” cells once again. The alcohol-associated diseased cells were trapped at the beginning of this process.&lt;/p&gt;&lt;p class="piano-inline"&gt;&lt;/p&gt;&lt;p&gt;“They are neither functional adult cells nor proliferative progenitor cells. Since they are not functioning, more pressure builds on the remaining cells. So they try to regenerate, and they’re all ending up in this unproductive quasi-progenitor state, and that’s what is causing liver failure,” said graduate students Ullas Chembazhi and Sushant Bangru, co-first authors of the study.&lt;/p&gt;&lt;p&gt;But what was causing this to happen? The team zoomed in further, investigating the differences between healthy and diseased samples on a molecular scale – that meant looking at RNA and proteins, as it’s a change in the pattern of gene expression that controls the shift to the &lt;a href="https://www.iflscience.com/newly-identified-cell-may-have-the-power-to-regenerate-the-liver-53216" target="_blank"&gt;regenerative&lt;/a&gt; state and back again.&lt;/p&gt;&lt;p&gt;When genes are expressed, DNA is transcribed into molecules called &lt;a href="https://www.iflscience.com/mrna-cant-change-the-dna-in-our-cells-heres-why-71734" target="_blank"&gt;messenger RNAs&lt;/a&gt; (mRNAs), which are responsible for carrying the instructions to make a protein to the ribosomes (the cell’s protein-building machines). Before protein production happens, parts of the newly made mRNAs are cut out, known as splicing.&lt;/p&gt;&lt;p&gt;Kalsotra and Diehl’s team discovered that in diseased cells, the splicing process goes awry, causing the protein the mRNA encodes to end up in the completely wrong place, affecting the shift to regeneration.&lt;/p&gt;&lt;p&gt;“Proteins function at a very specific place in the cell, and that is directed by sequences within the protein that take the protein to that particular spot. We found that, in many cases, the sequence that dictates where the protein localizes within a cell was misspliced. That’s why it was important that we did the multiple analyses we did,” Kalsotra explained.&lt;/p&gt;&lt;p&gt;“There was the same amount of RNA and protein, but the protein was not at the right place to function. Due to missplicing, key proteins that are required for productive liver regeneration were getting stuck in the cytoplasm, when they needed to be in the nucleus.”&lt;/p&gt;&lt;p&gt;The team found that the splicing-gone-wrong appears to be driven by a deficiency in a protein that binds to mRNA to splice it, its production and activity dampened down as result of the inflammation triggered in alcohol-associated liver diseases. The good news is that with this new molecular understanding, we might also be on the way to new treatments.&lt;/p&gt;&lt;p&gt;“I’m hopeful these findings will become a launching pad for future clinical studies. We can use these misspliced RNAs as diagnostic markers or develop treatments that can curb the inflammation. And if we can correct the splicing defects, then maybe we can improve recovery and restore damaged livers,” Kalsotra concluded.&lt;/p&gt;&lt;p&gt;The study is published in &lt;a href="https://rdcu.be/eI1Mz" target="_blank"&gt;Nature Communications&lt;/a&gt;.&lt;/p&gt;&lt;/span&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>IFLScience</author><pubDate>Wed, 01 Oct 2025 13:54:01 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMivgFBVV95cUxNcUZZYkxkVFMta2pxd042Mkd2Z0p2cVVUWklLRlhvTDRkclBmV05BczZFbnpyLVEzUkRackxybUFBUWU2c1U1b0tfcmJjdUd3b3pZNVBuY0FPdzhoa0d3MnhlS2tDc0NRTWZ1YXp1MEcyR3FDaXNoOEtib2Ztbzl4OGN1bl9wa1ZOWmhkYnpubFRqSVlNamw2ejJMTzJxd01sWkFXdGQ5UjhILWVPdGh1Y0FUajJycTRkV180RGJn</guid></item><item><title>脑细胞中的脂肪堆积可以为阿尔茨海默氏症的治疗提供新的靶点- ScienceAlert</title><link>https://www.sciencealert.com/fat-buildup-in-brain-cells-could-provide-new-target-for-alzheimers-treatment</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="post-content"&gt;
			&lt;p&gt;A new study suggests fat deposits in the brain may play a larger role in  &lt;a href="https://www.sciencealert.com/go/IaO" class="lar_link lar_link_outgoing" data-linkid="73015" data-postid="175770" rel="nofollow" target="_self"&gt;Alzheimer's&lt;/a&gt; disease than previously thought. This could open a new avenue for potential treatment.&lt;/p&gt;&lt;p&gt;Research has &lt;a href="https://www.sciencealert.com/newly-identified-proteins-may-explain-devastating-effects-of-alzheimers"&gt;long focused on proteins&lt;/a&gt; found abnormally clumping in brains with neurodegeneration, but targeting these clumps has so far &lt;a href="https://www.nature.com/articles/d41586-018-05719-4"&gt;produced mixed results&lt;/a&gt;. So some researchers continue to search for missing components in our Alzheimer's disease model.&lt;/p&gt;&lt;p&gt;"In our view, directly targeting plaques or tangles will not solve the problem; we need to restore function of immune cells in the brain," &lt;a href="https://www.purdue.edu/newsroom/2025/Q3/purdue-led-study-shows-how-fat-disables-the-brains-immune-shield-in-alzheimers-disease/"&gt;explains&lt;/a&gt; Purdue University chemist Gaurav Chopra.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Related: &lt;a href="https://www.sciencealert.com/the-cause-of-alzheimers-could-be-coming-from-within-your-mouth"&gt;The Cause of Alzheimer's Could Be Coming From Within Your Mouth&lt;/a&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This is based on &lt;a href="https://doi.org/10.1038/s41586-021-03960-y"&gt;recent research&lt;/a&gt; revealing that immune cells, such as &lt;a href="https://en.wikipedia.org/wiki/Astrocyte"&gt;astrocytes&lt;/a&gt; and &lt;a href="https://en.wikipedia.org/wiki/Microglia"&gt;microglia&lt;/a&gt;, are being disrupted by associated fat molecules. The amyloid beta protein clumps may themselves be a symptom of the same issue, not a direct cause.&lt;/p&gt;&lt;figure id="attachment_175773" aria-describedby="caption-attachment-175773" class="wp-caption alignnone"&gt;&lt;img decoding="async" src="https://www.sciencealert.com/images/2025/09/GreenAstrocytesSitWithingNeuronsRedAndOtherCellsBlue-e1759137918373.jpg" alt="Green astrocytes, red nucleated neurons and blue nucleated other cell types" class="wp-image-175773 size-full" loading="lazy"&gt;&lt;figcaption id="caption-attachment-175773" class="wp-caption-text"&gt;Micrograph of mammalian brain tissue, showing the diversity of brain cells, including astrocytes (green), nuclei of neurons (red), and the nuclei of other cells (blue). (jmimages/iStock/Getty Images Plus)&lt;/figcaption&gt;&lt;/figure&gt;&lt;p&gt;So in their new study, neuroscientist Priya Prakash and colleagues investigated what's happening with the fats in these cells using images of brain tissue from Alzheimer's patients.&lt;/p&gt;&lt;p&gt;They found that when these support cells are near amyloid beta plaques – within 10 micrometers – they accumulate so many lipids that their plaque-clearing rate drops by 40 percent compared to healthy microglia.&lt;/p&gt;&lt;p&gt;"We showed that amyloid beta is directly responsible for the fat that forms inside microglia," &lt;a href="https://www.purdue.edu/newsroom/2025/Q3/purdue-led-study-shows-how-fat-disables-the-brains-immune-shield-in-alzheimers-disease/"&gt;says&lt;/a&gt; Chopra. "Because of these fatty deposits, microglial cells become dysfunctional – they stop clearing amyloid beta and stop doing their job."&lt;/p&gt;&lt;p&gt;The researchers then identified the enzyme causing this excessive fat storage: DGAT2. And this could provide a new potential target for treatment.&lt;/p&gt;&lt;p&gt;"What we've seen is that when we target the fat-making enzyme and either remove or degrade it, we restore the microglia's ability to fight disease and maintain balance in the brain – which is what they're meant to do," &lt;a href="https://www.purdue.edu/newsroom/2025/Q3/purdue-led-study-shows-how-fat-disables-the-brains-immune-shield-in-alzheimers-disease/"&gt;explains&lt;/a&gt; Chopra.&lt;/p&gt;&lt;p&gt;An increasing number of people face cognitive decline, either personally or in loved ones, with almost &lt;a href="https://www.who.int/news-room/fact-sheets/detail/dementia"&gt;10 million new cases of dementia&lt;/a&gt; globally each year. Despite decades of research, treatment outcomes &lt;a href="https://www.sciencealert.com/new-discovery-could-explain-why-weve-been-misled-over-the-cause-of-alzheimers"&gt;remain unclear&lt;/a&gt;, so exploring new tactics like this is essential to improving lives, but there's still a long way to go.&lt;/p&gt;&lt;p&gt;"By pinpointing this lipid burden and the DGAT2 switch that drives it, we reveal a completely new therapeutic angle," &lt;a href="https://www.purdue.edu/newsroom/2025/Q3/purdue-led-study-shows-how-fat-disables-the-brains-immune-shield-in-alzheimers-disease/"&gt;says&lt;/a&gt; Purdue University neuroimmunologist Palak Manchanda.&lt;/p&gt;&lt;p&gt;"Restore microglial metabolism and you may restore the brain's own defense against disease."&lt;/p&gt;&lt;p&gt;This research was published in &lt;em&gt;&lt;a href="https://doi.org/10.1016/j.immuni.2025.04.029"&gt;Immunity&lt;/a&gt;&lt;/em&gt;.&lt;/p&gt;
		&lt;/div&gt;
	&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ScienceAlert</author><pubDate>Wed, 01 Oct 2025 13:02:54 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiqAFBVV95cUxPbHR6aHJkYWM5V1F5YTBLS1Nka1NRRE0ycmNDZ3UyUTcxV0pOTVlIYUlGd0RmSlJ0cDZtZHgyeklDbHR1OGlfQzBkMGFoaVJ5b1lKSlRpdHhNS3ExR1JaYk81N0F2MkU2X3NUYndfTEpFRVdNbHotWDlGU29nTXJtUmNRa2VrT055U3NfdGhDd3FRYnJMcWMxeFk2YWMyNGRaM3BheW5kcU4</guid></item><item><title>具有异常症状的新型冠状病毒变异体席卷美国，令人不寒而栗的警告是，即使是非常轻微的病例现在也会面临“持久影响” -每日邮报</title><link>https://www.dailymail.co.uk/health/article-15152407/Covid-variants-Nimbus-Stratus-unusual-symptoms.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div itemprop="articleBody"&gt;&lt;p class="mol-para-with-font"&gt;A croaky voice and a sharp, 'razor blade' sore throat are emerging as tell-tale signs of the latest Covid variants now sweeping the US. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The strains, XFB, dubbed Stratus, and NB.1.8.1, known as Nimbus, are fueling a surge in infections, with cases spiking specifically in the northeast in the last several weeks. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;In the US, nationwide Covid wastewater levels, used to measure the community spread of a virus, are 'moderate,' according to the &lt;a target="_self" href="/news/centers-for-disease-control-and-prevention-cdc/index.html" id="mol-7420e6d0-9ec3-11f0-93b5-310f19149515"&gt;CDC&lt;/a&gt;, but four states are recording 'very high' levels and levels in the northeast region are on the rise. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Dr Aaron Glatt, an infectious disease expert from Mount Sinai hospital in New York, told Today.com that patients were complaining of 'severe pain, as if their throat is covered with razor blades'.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;He added: 'While not specific to &lt;a target="_self" href="/news/coronavirus/index.html" id="mol-6e719040-9eb9-11f0-892a-5b328e744882" class=""&gt;Covid-19&lt;/a&gt;, this expression has been used to describe sore throat symptoms in some patients with the most recent Covid-19 variant.'&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;While many experts urge Covid vaccination to prevent infection, they warn that confusion over who is eligible for the Covid vaccine could lead to declining vaccination rates and an increase in Covid cases. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Officials placed more restrictions on Covid vaccines, with a CDC vaccine panel voting against recommending the shots in favor of 'individual decision-making.'&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Dr Tyler Evans, an infectious diseases expert who was New York City's chief medical officer during the pandemic's first wave, told Daily Mail: 'Covid activity is clearly on the rise again. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'While we’re in a much better place than in 2020, rising transmission still poses a risk to those with underlying conditions or limited access to care. Concern should lead to preparedness, but not panic.'&lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;Some have reported a sharp, razor-like sore throat is a distinct sign you're infected with one of the new Covid variants, amid a rise in cases&lt;/p&gt;&lt;/div&gt;&lt;p class="mol-para-with-font"&gt;Dr Evans added: 'The dominant strain in the US right now is an Omicron subvariant called Nimbus (NB.1.8.1). It spreads quickly but is not more severe than earlier forms. It can still be dangerous for older adults, people with chronic conditions, and those with weakened immune systems.'&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The new strains can also cause more familiar Covid complaints such as headaches, coughing, fatigue and a runny or blocked nose.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Experts stress they are no more dangerous than earlier versions, but genetic mutations mean they spread more easily.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;However, Dr Laura Malone, director of the Pediatric Post-Covid-19 Rehabilitation Clinic at Kennedy Krieger Institute in Baltimore, told The New York Times just because an infection is mild or you recover well, doesn't mean that lasting effects can't happen, including long Covid. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;'Just because you got through your first infection and didn’t develop long Covid, it’s not that you are completely out of the woods,' she said. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The CDC says that it receives little data on Covid variants from the states every year, leading it to have 'low confidence' in the estimates, but it warns that the variant is likely causing an increasing proportion of infections.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The agency's wastewater estimates are based on reports from hundreds of sites across the US that analyze the water for signs of Covid.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;An increase or decrease indicates more or fewer people, respectively, are shedding the virus, suggesting infections are rising or falling.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Nationally, Covid wastewater levels began rising at the end of August and peaked through mid September. They've been on the decline since the week of September 13, but regionally, other parts of the US are seeing an increase.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Nevada, Utah, Delaware and Connecticut are all recording 'very high' levels.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;XFG was first detected in January in Southeast Asia and was found in the US two months later.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;In May, it accounted for just three percent of Covid infections in the US. But as of September 9, it made up 80 percent of US Covid cases.&lt;/p&gt;&lt;div class="artSplitter mol-img-group"&gt;  &lt;p class="imageCaption"&gt;The above map shows Covid wastewater levels in the US&lt;/p&gt;&lt;/div&gt;&lt;p class="mol-para-with-font"&gt;In the UK, the Health Security Agency (UKHSA) said positivity had risen from 7.6 to 8.4 percent in just a week, while Covid hospital admissions increased from two to 2.73 per 100,000. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The UKHSA advises anyone with symptoms to stay at home if possible and avoid contact with vulnerable people. Those who must go out are urged to wear a face covering.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;It advised: 'If you have symptoms of a respiratory infection, such as Covid-19, and you have a high temperature or do not feel well enough to go to work or carry out normal activities, you should avoid contact with vulnerable people and stay at home if possible.'&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;People over 75, those with weakened immune systems and care home residents are eligible for the winter Covid booster, available on the NHS app, online, or at walk-in centers.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;In the UK, health officials have launched a winter vaccination drive, urging millions to come forward for Covid and &lt;a target="_self" href="/health/flu/index.html" id="mol-b24d9790-9ec9-11f0-b39d-974608fca751"&gt;flu&lt;/a&gt; vaccines as hospitalizations creep up.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Pregnant women and children are also invited for vaccination, and toddlers can this year get a flu spray at community pharmacies. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;The rise in cases comes just days after a controversial South Korean study claimed Covid vaccines 'might raise the risk of cancer'. &lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Published in Biomarker Research, it failed to explain how the jabs could trigger the disease.&lt;/p&gt;&lt;p class="mol-para-with-font"&gt;Experts dismissed the findings as 'superficially alarming', warning the conclusions were hugely overblown. Scientists have repeatedly said there is no credible evidence that Covid vaccines interfere with tumor suppressors or fuel cancer growth.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Daily Mail</author><pubDate>Wed, 01 Oct 2025 13:02:54 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMipgFBVV95cUxNbTZmNlRzZjBCY3FxM0JNMnYyczBEcHNrNE1ONHE1Rlo1dmYwTXBVTzhfSzlNMkhXd2lZb0VpaGpsZjZTMGxORWZvd1lLZU8zQjg3SElmYkJGbGxzWXFmRlhnVDBKVkNILVFJRW5RS1phLTI2V1pNTWRVbjQ0UzduMC1hSl9xRTRSSW15WUhiQ2tES3Bfc1dHOHd3S3F5eXVYcldGNE130gGrAUFVX3lxTFBHN08zcnhSekJCcEJsR1c5dGtFakdhXzFoUXY3SVUxNXlERWdRSWJCTmdiX2JqLWRXekc0dXRYMWpOa0E3c3JmazVtVnRuYlJRQk45Y2xjeWNNTUdoSFNXc3h6TWZNc1ljbkV4QkVTUUhabFdZeGtCRWxKMGpCR1BGaHAzVk5mNmtqenZ0Rl9uM1VMbDBHREJwd0ZDUFZ0dWlYRnFSUVRibjE4dw</guid></item><item><title>她想让人们发笑-所以她写了自己的讣告，引起了病毒式的轰动-哥伦比亚广播公司新闻</title><link>https://www.cbsnews.com/boston/news/linda-murphy-wrote-own-obituary-als/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;section class="content__body"&gt;
    &lt;p&gt;A Massachusetts woman who battled ALS is going out in her own words. Linda Murphy has become a posthumous viral sensation for a tongue-in-cheek self-obituary that has been published locally and nationally.&lt;/p&gt;&lt;p&gt;Murphy, who was raised in Framingham and lived in Boylston, not only wrote her own obituary, but she also picked out her own casket, chose the music at her funeral, and planned a dance party in her own honor.&lt;/p&gt;&lt;h2&gt;The "life of the party"&lt;/h2&gt;&lt;p&gt;"She was the life of the party. She was the party," said her daughter, Justine Hastings, with a laugh. "One of my favorite comments was, 'I just read this, and I just wish I could have had a glass of wine with her."&lt;/p&gt;&lt;p&gt;Murphy passed away following a battle with Bulbar ALS. She had been unable to speak for about a year. When she first felt symptoms such as slurred speech and trouble swallowing, she went to the doctors at Massachusetts General Hospital with a request.&lt;/p&gt;&lt;p&gt;"(She) said, 'I have ALS. Prove me wrong.' And they did every single test, and she diagnosed herself," said Hastings, "That is the most 'my mom' thing she has ever done."&lt;/p&gt;

    
&lt;p id="mpu-plus-outstream-middle" data-ad="mpu-plus-outstream-middle" class="ad-mpu-plus-outstream-middle ad-wrapper " data-ad-unit='"mpu-plus-outstream-middle"'&gt;
&lt;/p&gt;
&lt;h2&gt;An obituary that went viral&lt;/h2&gt;&lt;p&gt;Murphy was also diagnosed with breast cancer in 2012 and survived. The journey not only pushed her daughter to become a nurse, but it also prompted Linda to write a book about her battle. The tongue-in-cheek book, titled "F-Off Cancer," was written to show that people can still have a fun life while battling cancer. Her obituary carries some of that same humor.&lt;/p&gt;&lt;p&gt;"She starts the obituary, 'Well, if you are reading this, then it looks like I am dead. Wow. It actually happened. I died of FOMO due to complications of ALS," Hastings read from the start of her mom's obituary before skipping down to this part: "I lived my life with two superpowers. My first of which everyone was jealous of, was that I could drink as much as I wanted and never seemed to get hungover. The real wonder is why I didn't die of liver failure."&lt;/p&gt;&lt;p&gt;As friends, family and strangers alike read her self-tribute, they began to connect with a woman trapped in her own body, looking to go out on her own terms. Murphy wrote the obituary about six months ago when she could still type with her hands. By the end, she could only sign a few hand signals. She wrote about that trapped feeling in her obituary.&lt;/p&gt;&lt;p&gt;"My stupid Bulbar ALS got me to the sad point of not being able to talk. Never speaking means never being able to say, 'I love you!' It means not being able to call my Mr. BoJangles over for a snack, and it means not being able to order at the Dunkin' drive through," she wrote. "As far as eating, it totally stinks to sit at the table while people around you are eating juicy burgers hot off the grill, heaping piles of Chinese food, a healthy portion of pasta Alfredo, or Chipotle — and I just have to smile and act like I'm enjoying my bowl of puréed baby mush!"&lt;/p&gt;

    
    
&lt;p id="mpu-flex-inc3" data-ad="mpu-flex-inc" class="ad-mpu-flex-inc ad-wrapper " data-ad-unit='["mpu-flex-inc",3]'&gt;
&lt;/p&gt;
&lt;p&gt;Though she handled it with humor, Hastings said that feeling of being trapped was a real struggle for her mom.&lt;/p&gt;&lt;p&gt;"The hardest thing up until the end is that people would say she looks so amazing. 'Oh, you look great! You're smiling! You're not sick! You're okay! But behind closed doors, the struggle was so real," Hastings said.&lt;/p&gt;&lt;h2&gt;Buy scratch tickets, not flowers&lt;/h2&gt;&lt;p&gt;In her obituary, Murphy told people to be kind - and not to buy her flowers.&lt;/p&gt;&lt;p&gt;"Please be kind to everyone: the telemarketer, the grocery clerk, the Dunkin's staff, the tailgater, your family, your friends. Speak nicely and positively. Is there really ever a reason to be negative? I don't think so…"&lt;/p&gt;&lt;p&gt;"PLEASE PLEASE PLEASE don't waste money on flowers," she wrote. "Buy a bunch of scratch tickets and give them out to strangers along your way. Make people happy, that is the best way that you can honor my memory."&lt;/p&gt;&lt;p&gt;It is something she used to do while she was alive and a tradition her family says they will continue in her honor.&lt;/p&gt;&lt;p&gt;Murphy had her brain and spinal cord donated for ALS research. &lt;a href="https://mccarthyfh.com/tribute/linda-murphy-21-476/" target="_blank" rel="nofollow noopener"&gt;You can read her full obituary here&lt;/a&gt;. &lt;/p&gt;

      

                    
        
      
                  
    
    



    
      
    
  

          
  
        
      &lt;div class="content-author"&gt;
      &lt;a href="https://www.cbsnews.com/team/Mike-Sullivan/" class="content-author__name" data-invalid-url-rewritten-http=""&gt;Mike  Sullivan&lt;/a&gt;

      &lt;div class="content-author__bio"&gt;
        &lt;div class="content-author__full-information"&gt;
          &lt;p class="content-author__text"&gt;Mike Sullivan is a multimedia journalist for WBZ-TV.&lt;/p&gt;
        &lt;/div&gt;
      &lt;/div&gt;
    &lt;/div&gt;
        &lt;/section&gt;

  
  

        &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>CBS News</author><pubDate>Wed, 01 Oct 2025 12:44:47 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMifEFVX3lxTE9KOXlVcFlISWRhRnB5UEd5UWdPQWtzLWZ3R0xEU3R6bWEyVE9GVUctNE1FR0hqcWQtWUFvek43R1RSRndGSTdsQ2E2QW1COXVfT250VWZrNlkxSTlHTGpvSGI2Y0FTc2dwUlNIaDVMZWJSOVRMVy1TM2Z3Y2s</guid></item><item><title>结肠癌在年轻人中呈上升趋势–研究指出了一个主要罪魁祸首| Devi Sridhar -《卫报》</title><link>https://www.theguardian.com/commentisfree/2025/oct/01/colon-cancer-young-people-smoking-ultra-processed-foods</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="article-body-commercial-selector article-body-viewer-selector dcr-11jq3zt"&gt;&lt;p class="dcr-130mj7b"&gt;&lt;span class="dcr-15rw6c2"&gt;C&lt;/span&gt;ancer used to be seen as part of ageing: something that mainly afflicted people over the age of 60 or 70. But although it is still true that the &lt;a href="https://commonslibrary.parliament.uk/research-briefings/sn06887/" data-link-name="in body link"&gt;majority of new cancer diagnoses&lt;/a&gt; affect the over-70s, the pattern is changing in subtle ways. Some cancers are increasingly found in younger people.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Take colorectal (bowel) cancer: while rates have declined in those over 60, data shows a &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7994182/" data-link-name="in body link"&gt;sharp increase in many developed countries&lt;/a&gt; among people under 50, in what’s called early-onset disease.&lt;/p&gt;&lt;p id="sign-in-gate"&gt;&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;This isn’t just due to wider screening or better diagnosis, and it isn’t only found in one particular country or community. The increase is &lt;a href="https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00600-4/fulltext" data-link-name="in body link"&gt;real and global&lt;/a&gt;, rising from approximately 94,700 cases &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9323588/" data-link-name="in body link"&gt;in 1990 to 225,736 in 2019&lt;/a&gt;. A study across Europe found that &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6839794/" data-link-name="in body link"&gt;for those aged 20-29&lt;/a&gt;, incidence rose 7.9% per year between 2004 and 2016, with the rates increasing by 4.9% in those aged 30–39, and 1.6% in the 40-49 group in roughly the same period. Not only is colon cancer increasing in every age cohort under 50, the growth rate is highest in the youngest group. &lt;a href="https://www.iarc.who.int/news-events/increase-of-early-onset-colorectal-cancer-a-cohort-effect/#:~:text=The%20research%20team%20estimates%20that,%2Da%2Dcohort%2Deffect/" data-link-name="in body link"&gt;Modelling suggests&lt;/a&gt; that early-onset colorectal cancer could double every 15 years in Australia, Canada, the UK and the US.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;In England, the NHS bowel cancer screening programme covers people aged 50-74 by &lt;a href="https://www.gov.uk/guidance/bowel-cancer-screening-programme-overview#:~:text=population%20screening%20programmes.-,Target%20population,on%200800%20707%2060%2060." data-link-name="in body link"&gt;inviting them for a free screening&lt;/a&gt; every two years. However, this age range excludes younger people, who are usually only diagnosed at a late stage when the cancer has spread and they are symptomatic.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;What’s causing the rise in young people? We can rule out genetics: &lt;a href="https://www.cancer.gov/types/colorectal/hp/colorectal-genetics-pdq#:~:text=About%2075%25%20of%20patients%20with,overall.%5B3%2C4%5D" data-link-name="in body link"&gt;it’s estimated&lt;/a&gt; that 75% of cases are in people with no previous family history or known genetic predisposition. Scientists have started to look at environmental factors tied to the increase in colon cancer since the 1960s, with each generation &lt;a href="https://www.theguardian.com/commentisfree/2023/jul/25/cancer-striking-earlier-ultra-processed-foods" data-link-name="in body link"&gt;more likely to get cancer&lt;/a&gt; than the previous one.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;One factor keeps emerging as a major culprit: &lt;a href="https://www.theguardian.com/society/2025/apr/28/ultra-processed-food-increases-risk-of-early-death-international-study-finds" data-link-name="in body link"&gt;ultra-processed foods&lt;/a&gt;, with a &lt;a href="https://www.nature.com/articles/s41574-025-01159-z" data-link-name="in body link"&gt;2025 review&lt;/a&gt; in Nature Reviews Endocrinology&lt;em&gt; &lt;/em&gt;highlighting the links. These foods, roughly defined as factory-packaged snacks, ready meals, sugary cereals, soft drinks, processed meats and many fast foods, &lt;a href="https://www.theguardian.com/society/2024/feb/28/ultra-processed-food-32-harmful-effects-health-review" data-link-name="in body link"&gt;now make up more than half the average diet&lt;/a&gt; in countries such as the UK and US.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;The evidence is growing: a major study published in the &lt;a href="https://www.bmj.com/content/378/bmj-2021-068921#:~:text=What%20this%20study%20adds%20*%20High%20consumption,for%20better%20health%20outcomes%20in%20the%20population." data-link-name="in body link"&gt;British Medical Journal&lt;/a&gt; looked at three large US cohorts to examine the association of ultra-processed foods with the risk of colorectal cancer. One of these cohorts involved more than 46,000 men, tracked over 24 to 28 years. Compared with the group that consumed ultra-processed food the least, the risk of those who consumed the most of developing colorectal cancer – even accounting for nutrition and weight – was 29% higher. The authors conclude that further studies are needed to understand the physiological mechanisms of how exactly ultra-processed foods contribute to cancer development.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;What’s interesting is while much of the research has linked ultra-processed foods to the rise in obesity, which is then a major risk factor for numerous cancers, the study above points to the growth in colorectal cancer in those &lt;em&gt;of normal weight&lt;/em&gt;. Could it be that ultra-processed foods may be carcinogenic regardless of someone’s body mass index (BMI)? In other words, are those foods bad for your health even if you have an active lifestyle and are in a healthy weight range?&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;Diets high in ultra-processed foods &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11901572/" data-link-name="in body link"&gt;have been linked&lt;/a&gt; to disruptions in insulin signalling, chronic low-grade inflammation and alterations in the gut microbiome, all of which are mechanisms implicated in cancer development. What we eat affects how our cells grow, how our immune systems function and how our gut bacteria – which help regulate inflammation and immunity – behave. &lt;a href="https://aacrjournals.org/cancerres/article/77/1/27/616090/Dietary-Emulsifier-Induced-Low-Grade-Inflammation" data-link-name="in body link"&gt;Emulsifiers&lt;/a&gt;, &lt;a href="https://www.sciencedirect.com/science/article/abs/pii/S0378111920302596" data-link-name="in body link"&gt;additives&lt;/a&gt; and &lt;a href="https://ehp.niehs.nih.gov/doi/full/10.1289/ehp.10271" data-link-name="in body link"&gt;artificial sweeteners&lt;/a&gt; commonly found in ultra-processed foods have been shown in animal studies to promote intestinal inflammation and tumour growth. Meanwhile, the lack of fibre and protective phytochemicals (health-promoting compounds found in plants) in these foods &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9455721/" data-link-name="in body link"&gt;can alter the gut microbiome&lt;/a&gt; needed for the body to function optimally.&lt;/p&gt;&lt;figure data-spacefinder-role="inline" data-spacefinder-type="model.dotcomrendering.pageElements.NewsletterSignupBlockElement" class="dcr-173mewl"&gt;&lt;a data-ignore="global-link-styling" href="#EmailSignup-skip-link-9" class="dcr-jzxpee"&gt;skip past newsletter promotion&lt;/a&gt;&lt;aside aria-label="newsletter promotion" class="dcr-av5vqf"&gt;&lt;div class="dcr-10et71f"&gt;&lt;p class="dcr-1sbse14"&gt;Sign up to &lt;span&gt;Matters of Opinion&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="dcr-1xjndtj"&gt;Guardian columnists and writers on what they’ve been debating, thinking about, reading, and more&lt;/p&gt;&lt;gu-island name="SecureSignup" priority="feature" deferuntil="visible" props='{"newsletterId":"matters-of-opinion","successDescription":"Guardian columnists and writers on what they’ve been debating, thinking about, reading, and more"}'&gt;&lt;/gu-island&gt;&lt;span class="dcr-1eusqlu"&gt;&lt;strong&gt;Privacy Notice: &lt;/strong&gt;Newsletters may contain information about charities, online ads, and content funded by outside parties. If you do not have an account, we will create a guest account for you on &lt;a data-ignore="global-link-styling" href="https://www.theguardian.com" rel="noreferrer" class="dcr-1rjy2q9"&gt;theguardian.com&lt;/a&gt; to send you this newsletter. You can complete full registration at any time. For more information about how we use your data see our &lt;a data-ignore="global-link-styling" href="https://www.theguardian.com/help/privacy-policy" rel="noreferrer" class="dcr-1rjy2q9"&gt;Privacy Policy&lt;/a&gt;. We use Google reCaptcha to protect our website and the Google &lt;a data-ignore="global-link-styling" href="https://policies.google.com/privacy" rel="noreferrer" class="dcr-1rjy2q9"&gt;Privacy Policy&lt;/a&gt; and &lt;a data-ignore="global-link-styling" href="https://policies.google.com/terms" rel="noreferrer" class="dcr-1rjy2q9"&gt;Terms of Service&lt;/a&gt; apply.&lt;/span&gt;&lt;/aside&gt;&lt;p id="EmailSignup-skip-link-9" tabindex="0" aria-label="after newsletter promotion" role="note" class="dcr-jzxpee"&gt;after newsletter promotion&lt;/p&gt;&lt;/figure&gt;&lt;figure id="5409c343-d07f-4445-b5bb-00a406875811" data-spacefinder-role="richLink" data-spacefinder-type="model.dotcomrendering.pageElements.RichLinkBlockElement" class="dcr-47fhrn"&gt;&lt;gu-island name="RichLinkComponent" priority="feature" deferuntil="idle" props='{"richLinkIndex":10,"element":{"_type":"model.dotcomrendering.pageElements.RichLinkBlockElement","prefix":"Related: ","text":"Ultra-processed foods: the 19 things everyone needs to know","elementId":"5409c343-d07f-4445-b5bb-00a406875811","role":"richLink","url":"https://www.theguardian.com/food/2023/sep/06/ultra-processed-foods-the-19-things-everyone-needs-to-know"},"ajaxUrl":"https://api.nextgen.guardianapps.co.uk","format":{"design":8,"display":0,"theme":1}}'&gt;&lt;/gu-island&gt;&lt;/figure&gt;&lt;p class="dcr-130mj7b"&gt;It took decades but we now accept that tobacco causes lung cancer, and that alcohol raises the risk of breast and liver cancer. The next decade may see the inclusion of ultra-processed foods as a key risk factor for colorectal cancer, particularly in young adults. I’m not writing this to scare you. It’s rather to reflect on recent research from rigorous and long-term studies. What we eat matters more than you might think.&lt;/p&gt;&lt;p class="dcr-130mj7b"&gt;If smoking was the cancer villain of the 20th century, eating ultra-processed food may be its 21st-century counterpart. The science isn’t yet settled, but it’s building rapidly. It’s been often said that food is medicine. And as we’re increasingly learning, food is prevention. On that note, a &lt;a href="https://hsph.harvard.edu/news/regular-yogurt-consumption-may-reduce-colon-cancer-risk/" data-link-name="in body link"&gt;2025 study&lt;/a&gt; found that regularly eating yoghurt may reduce the risk of developing colon cancer, a subset of colorectal cancer. So if there’s one takeaway from reading this: eat more yoghurt, and fewer ultra-processed foods.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Guardian</author><pubDate>Wed, 01 Oct 2025 12:27:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMirgFBVV95cUxOQ2pkWnZYRmxtTEs1WWt4c2pNbDg0VDFyRmhEYmNDLXI1STlsT2tsZlFvaUczSm9TcEVVQlhFX3JHZ2l4VElVZnNYZXExQjlVQXdodUxRaldwb3pwRVNTOHpUZ2NDanFuR0pPZmszYm5obTBhdjBVRHQtVDdfVmlteERxUEhRdmh4TzFsdFlnWjE4QUZTOVg0SU42Q09ZdzJrMEcwemZkYWJCVFg3amc</guid></item><item><title>我是一名传染病医生。以下是我在飞机上坐在怀疑接种疫苗的人旁边时发生的事情。- HuffPost</title><link>https://www.huffpost.com/entry/infectious-disease-doctor-anti-vaccine-airplane_n_68d2e961e4b03fb4d93463e7</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;section class="entry__content-list js-entry-content js-cet-subunit"&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;It’s hard to believe that infectious diseases have become a political litmus test, but they are now very much part of the “with us or against us” mental sorting more and more people seem to be doing these days. And the topic seems to be everywhere. Do you think the U.S. should continue &lt;/span&gt;&lt;a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01186-9/fulltext" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="funding aid programs for diseases such as AIDS, TB and malaria" data-vars-item-type="text" data-vars-unit-name="68d2e961e4b03fb4d93463e7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01186-9/fulltext" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="0"&gt;&lt;span&gt;funding aid programs for diseases such as AIDS, TB and malaria&lt;/span&gt;&lt;/a&gt;&lt;span&gt;? Are you pleased or horrified about &lt;/span&gt;&lt;a href="https://www.nytimes.com/2025/09/03/us/florida-vaccine-mandates.html" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Florida’s plans to undo school vaccine mandates" data-vars-item-type="text" data-vars-unit-name="68d2e961e4b03fb4d93463e7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.nytimes.com/2025/09/03/us/florida-vaccine-mandates.html" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="1"&gt;&lt;span&gt;Florida’s plans to undo school vaccine mandates&lt;/span&gt;&lt;/a&gt;&lt;span&gt;? Do you seek out or steer clear of the annual flu vaccine?&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;As someone who recently completed 15 years of post-college training to become an infectious diseases physician-scientist, I can’t avoid these conversations. I just wish I knew the magic words to reach people willing to jettison decades of evidence and research for something they read online. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;I am proud of my work and committed to my profession. Yet in a country polarized by everything from the &lt;/span&gt;&lt;a href="https://www.nytimes.com/2025/09/16/us/politics/trump-kirk-free-speech-hate-speech-left.html" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="response to the abhorrent assassination of Charlie Kirk" data-vars-item-type="text" data-vars-unit-name="68d2e961e4b03fb4d93463e7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.nytimes.com/2025/09/16/us/politics/trump-kirk-free-speech-hate-speech-left.html" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="2"&gt;&lt;span&gt;response to the abhorrent assassination of Charlie Kirk&lt;/span&gt;&lt;/a&gt;&lt;span&gt; to &lt;/span&gt;&lt;a href="https://www.nytimes.com/2025/09/15/health/rfk-jr-hhs-vaccine-committee-members.html" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="RFK Jr.’s abrupt reconfiguration of the nation’s vaccine advisory committee" data-vars-item-type="text" data-vars-unit-name="68d2e961e4b03fb4d93463e7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.nytimes.com/2025/09/15/health/rfk-jr-hhs-vaccine-committee-members.html" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="3"&gt;&lt;span&gt;RFK Jr.’s abrupt reconfiguration of the nation’s vaccine advisory committee&lt;/span&gt;&lt;/a&gt;&lt;span&gt;, I hesitated to share my occupation with the talkative young man I was recently seated next to on a flight.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;When the inevitable career question came up, he jumped right in. Despite the early hour and lack of sleep, with no viable exit option, I decided to face the challenge, though I braced for the worst.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Lyme disease was first on the list. We were flying out of Connecticut, after all. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“You’ve never heard that Lyme disease was created as a bioterrorism weapon?” I had not (because &lt;/span&gt;&lt;a href="https://www.jci.org/articles/view/21681" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="it wasn’t" data-vars-item-type="text" data-vars-unit-name="68d2e961e4b03fb4d93463e7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.jci.org/articles/view/21681" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="4"&gt;&lt;span&gt;it wasn’t&lt;/span&gt;&lt;/a&gt;&lt;span&gt;). Somehow, in between the hours caring for patients, researching disease pathogenesis and staying up to date on the literature in my field, I had missed this infectious disease conspiracy du jour.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“It’s called Lyme because that’s where they released it.” &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;No. Old Lyme, Connecticut, is where epidemiologists realized that patients’ symptoms coincided with recent tick bites and then confirmed that local ticks carried the disease-causing bacteria.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“You can’t cure it; it was made to weaponize.” Actually, we have very &lt;/span&gt;&lt;a href="https://www.cdc.gov/lyme/hcp/clinical-care/index.html" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="effective antibiotics" data-vars-item-type="text" data-vars-unit-name="68d2e961e4b03fb4d93463e7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.cdc.gov/lyme/hcp/clinical-care/index.html" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="5"&gt;&lt;span&gt;effective antibiotics&lt;/span&gt;&lt;/a&gt;&lt;span&gt; to kill the bacteria (though some people can develop a &lt;/span&gt;&lt;a href="https://www.cdc.gov/lyme/signs-symptoms/chronic-symptoms-and-lyme-disease.html" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="complex post-treatment Lyme disease syndrome" data-vars-item-type="text" data-vars-unit-name="68d2e961e4b03fb4d93463e7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.cdc.gov/lyme/signs-symptoms/chronic-symptoms-and-lyme-disease.html" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="6"&gt;&lt;span&gt;complex post-treatment Lyme disease syndrome&lt;/span&gt;&lt;/a&gt;&lt;span&gt;). I’m not a military strategist, but I can’t imagine that indiscriminately infecting outdoor enthusiasts with a non-deadly, treatable disease that requires transmission via a slow-feeding arthropod would be an ideal bioterrorism plan.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“But why is it spreading so fast now?” &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Climate change, expanding tick habitats and food sources, and a lack of winters that kill them.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;He laughed. “So in your ‘profesh’ opinion, Lyme disease as a bioterrorism weapon is a bunch of horseshit?” &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Yes. That I do agree with.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;We moved on to the next obvious infectious disease topic: COVID-19. I gave him space. He wasn’t sparring with a lack of respect, nor was I. We opened up about experiencing the pandemic in completely different ways. He described how hard it was being forced to get vaccinated, feeling coerced to keep his job but fearing the vaccine’s purported harms.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;I shared my experience working in the hospital. I told him how I had witnessed numerous people die alone, and how the vaccine was a true savior. He believed it was only old people who had died. I told him I had seen enough young, healthy people become debilitated that I would never make that bet, not in that pandemic or the next one. In fact, by September 2023, &lt;/span&gt;&lt;a href="https://data.cdc.gov/National-Center-for-Health-Statistics/Provisional-COVID-19-Deaths-by-Sex-and-Age/9bhg-hcku/data_preview" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="more than 25,000 18-39-year-olds had died from COVID in the U.S." data-vars-item-type="text" data-vars-unit-name="68d2e961e4b03fb4d93463e7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://data.cdc.gov/National-Center-for-Health-Statistics/Provisional-COVID-19-Deaths-by-Sex-and-Age/9bhg-hcku/data_preview" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="7"&gt;&lt;span&gt;more than 25,000 18-39-year-olds had died from COVID in the U.S.&lt;/span&gt;&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;blockquote class="cli cli-pullquote"&gt;&lt;p class="cli-pullquote__placeholder"&gt;&lt;/p&gt;&lt;div class="cli-pullquote__content"&gt;&lt;p class="cli-pullquote__quote accent-cli"&gt;“He wasn’t sparring with a lack of respect, nor was I. We opened up about experiencing the pandemic in completely different ways.”&lt;/p&gt;&lt;/div&gt;&lt;/blockquote&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;I tried to hear his concerns. I admitted that my passion for science and what I had experienced as a physician may have made me unfairly dismissive of people whose primary concerns were being stuck at home unable to pay rent or educate their children. I acknowledged that there’s always a small chance that some people might experience an adverse reaction to any medical intervention, be it a vaccine or over-the-counter drug, and I can understand why that makes some people hesitate.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;But I also reiterated the rigor of the scientific process involved in developing treatments, reviewing safety data, and ultimately making clinical recommendations. I told him that mRNA vaccines are neither new — &lt;a href="https://www.niaid.nih.gov/diseases-conditions/decades-making-mrna-covid-19-vaccines" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="they’ve been in development for decades" data-vars-item-type="text" data-vars-unit-name="68d2e961e4b03fb4d93463e7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.niaid.nih.gov/diseases-conditions/decades-making-mrna-covid-19-vaccines" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="8"&gt;they’ve been in development for decades&lt;/a&gt; — nor a government-led conspiracy to genetically manipulate the population. The reference to “genetic material” may lead to misconceptions, but mRNA does not enter the cell nucleus, where our DNA resides. Our cells do not even possess the molecular machinery capable of turning mRNA into DNA. That’s &lt;a href="https://www.cdc.gov/covid/vaccines/how-they-work.html#:~:text=How%20mRNA%20COVID%2D19%20vaccines%20work" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="fact" data-vars-item-type="text" data-vars-unit-name="68d2e961e4b03fb4d93463e7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.cdc.gov/covid/vaccines/how-they-work.html#:~:text=How%20mRNA%20COVID%2D19%20vaccines%20work" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="9"&gt;fact&lt;/a&gt;, not just my “profesh” opinion.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;It felt real, the effort to hear and speak to each other. And I learned things from him, too. In response to my insistence that his infection-related conspiracy theories were nothing but that, he admitted, “Yeah, you’re probably right.” Then he added, with a smile on his face, “But conspiracies are a lot more fun.”&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;em&gt;&lt;span&gt;Conspiracies are a lot more fun&lt;/span&gt;&lt;/em&gt;&lt;span&gt;. Maybe vaccine or disease origin conspiracies are fun — if you’re young and healthy, if you’re bored, if you’re motivated to access a community that promises you “inside information.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;By the time our flight was over, our conversation had covered a wide geographic and political space. The experience left me with genuine hope that we could maintain trust in each other and reminded me that scientists and physicians cannot give up on having these conversations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“With COVID, vaccines, Lyme disease, any of it — I’m not your enemy,” I told my seatmate as we were getting ready to disembark. “And I know you’re not the enemy, either.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“True,” he agreed. “But they always want to make someone your enemy.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="support-huffpost-entry-support-huffpost-mid-article" class="cli support-huffpost-mid-article primary-cli cli cli-text cli-support-huffpost hidden"&gt;&lt;div class="cli-support-huffpost__content-wrapper"&gt;&lt;p class="cli-support-huffpost__title default-title"&gt;&lt;span class="cli-support-huffpost__title--first"&gt;20 Years Of&lt;/span&gt;&lt;span class="cli-support-huffpost__title--second"&gt;Free&lt;/span&gt;&lt;span class="cli-support-huffpost__title--third"&gt;Journalism&lt;/span&gt;&lt;/p&gt;&lt;div class="contributor-once-variation"&gt;&lt;p class="cli-support-huffpost__title"&gt;&lt;span class="cli-support-huffpost__title--first"&gt;Your Support&lt;/span&gt;&lt;span class="cli-support-huffpost__title--second"&gt;Fuels&lt;/span&gt;&lt;span class="cli-support-huffpost__title--third"&gt;Our Mission&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="contributor-canceled-variation"&gt;&lt;p class="cli-support-huffpost__title"&gt;&lt;span class="cli-support-huffpost__title--first"&gt;Your Support&lt;/span&gt;&lt;span class="cli-support-huffpost__title--second"&gt;Fuels&lt;/span&gt;&lt;span class="cli-support-huffpost__title--third"&gt;Our Mission&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="cli-support-huffpost__container"&gt;&lt;div class="cli-support-huffpost__message-container"&gt;&lt;div class="cli-support-huffpost__message support-huffpost__message--main"&gt;&lt;p class="cli-support-huffpost__sub-headline"&gt;&lt;/p&gt;&lt;p&gt;For two decades, HuffPost has been fearless, unflinching, and relentless in pursuit of the truth. Support our mission to keep us around for the next 20 — we can't do this without you.&lt;/p&gt;&lt;/div&gt;&lt;div class="cli-support-huffpost__message variation contributor-once-variation"&gt;&lt;p&gt;We remain committed to providing you with the unflinching, fact-based journalism everyone deserves.&lt;/p&gt;&lt;p&gt;Thank you again for your support along the way. We’re truly grateful for readers like you! Your initial support helped get us here and bolstered our newsroom, which kept us strong during uncertain times. Now as we continue, we need your help more than ever. &lt;a href="https://www.huffpost.com/support" class="cli-support-huffpost__message__link js-entry-link" data-vars-item-name="we're offering an ad-free experience" data-vars-item-type="text" data-vars-unit-name="main" data-vars-unit-type="buzz_body" data-vars-target-content-id="/support" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component" data-vars-position-in-subunit="15"&gt;We hope you will join us once again&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;div class="cli-support-huffpost__message variation contributor-canceled-variation"&gt;&lt;p&gt;We remain committed to providing you with the unflinching, fact-based journalism everyone deserves.&lt;/p&gt;&lt;p&gt;Thank you again for your support along the way. We’re truly grateful for readers like you! Your initial support helped get us here and bolstered our newsroom, which kept us strong during uncertain times. Now as we continue, we need your help more than ever. &lt;a href="https://www.huffpost.com/support" class="cli-support-huffpost__message__link js-entry-link" data-vars-item-name="we're offering an ad-free experience" data-vars-item-type="text" data-vars-unit-name="main" data-vars-unit-type="buzz_body" data-vars-target-content-id="/support" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component" data-vars-position-in-subunit="15"&gt;We hope you will join us once again&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;a class="cli-support-huffpost__support-button accent-button" href="https://www.huffpost.com/support?utm_campaign=mid-article-web" data-vars-item-name-overwritable="support-huffpost" data-vars-item-name="Support HuffPost" data-vars-item-type="button" data-vars-unit-name="main" data-vars-unit-type="buzz_body" data-vars-target-content-id="/support" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component" data-vars-position-in-subunit="14"&gt;Support HuffPost&lt;/a&gt;&lt;p class="support-huffpost-login"&gt;Already contributed? &lt;a class="js-entry-link-no-impression" href="https://login.huffpost.com/login?dest=https%3A%2F%2Fwww.huffpost.com%2Fentry%2Finfectious-disease-doctor-anti-vaccine-airplane_n_68d2e961e4b03fb4d93463e7%3Fhp_auth_done%3D1" data-vars-item-name="Log in to hide these messages" data-vars-item-type="text" data-vars-unit-name="68d2e961e4b03fb4d93463e7" data-vars-unit-type="buzz_body" data-vars-target-content-id="/login" data-vars-target-content-type="utility" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component"&gt;Log in to hide these messages.&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;em&gt;&lt;span&gt;Exactly&lt;/span&gt;&lt;/em&gt;&lt;span&gt;. That is what conspiracy theories require. That is why we have to talk to each other. See me as a person. And I will do the same.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;I am not your enemy. Neither is science.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;em&gt;&lt;span&gt;Morgan Goheen, M.D., Ph.D., works at Yale School of Medicine as a research scientist and board-certified infectious diseases physician, and she is a Public Voices Fellow of The OpEd Project in Partnership with Yale University.&lt;/span&gt;&lt;/em&gt;&lt;/p&gt;&lt;/div&gt;&lt;/section&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>HuffPost</author><pubDate>Wed, 01 Oct 2025 12:09:09 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiqAFBVV95cUxOV05DY3IwVVNOZy1PcHhCeXVYbEFZOGRXamV4SkI5WDRUSEZWX2t0SFRmQ245ZEFqSzZ5M2VBSnUxZW5Sa2p0N0VWSmVZR0VtanNwd0JBRGpQTzVJb1FoQmpFMzlrWVRCeDVwSTI2Y1ZOUkpRZUdMcnNRbk1wT25oaTBDUXRHd2YxMUdPb2FkUTJaYWFOa0ZkMEJiR0k0aGI0WmVIUzdzdFXSAa4BQVVfeXFMTkFuM21DRDlJTWxuQkJKb2gwV2xHekxFY3dBSU1vT0NyVE1lM2tMRVlzQnNhc3BpSjJnQ1UzNi01eE9zTDBVOU5BLTlNSERQcnRDTmI5UlV2LURzLXhwZmZSTThLWE9KMFBtd0xUZXFycmRtM0p5MDFfemhhdWtjcWw5LXdqNGYxcUZyd0phT2U0TEFmaWFkeU1jWVg2bUhqRGFjVlBNVlBjeG5SX0JR</guid></item><item><title>他们迫切需要一个婴儿。他们转向尖端机器人。-《华盛顿邮报》</title><link>https://www.washingtonpost.com/technology/2025/10/01/ivf-babies-ai-robots-fertility/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="wpds-c-PJLV article-body type-text grid-center grid-body" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="N75ZJC737RHRBEPO4EBS3PK43A" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;MEXICO CITY — When she walked into an IVF clinic in June, Alin Quintana knew it would be the last time she would try to conceive a child. She had prepared herself spiritually and mentally&lt;b&gt; &lt;/b&gt;for the visit: She had traveled to a nearby state to leave prayer ribbons at a shrine dedicated to Mary Undoer of Knots, a manifestation beloved in Latin America. She had received a blessing from her priest. That morning, as Quintana and her husband wound their way for hours from the unpaved outskirts of the Mexican capital toward the swanky clinic in one of its richest neighborhoods, her mind was alert, as if she were making a recording. She was focusing on the moment, she said, to drown out the weight of painful memories — a lost pregnancy, a burst fallopian tube, emergency surgery, 96 monthly cycles of hope and crushing disappointment.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Washington Post</author><pubDate>Wed, 01 Oct 2025 12:02:23 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijAFBVV95cUxOZ0w1Tk5kU2RlX0lrMEYzZHE2R2hFZEx1cElqRVp3U2NXN214SUMxbGs2dlNFN1oxd2JpTXRVbHlucWxuVlRJNHJqclhxMHVZTlkxX1ZjR0JhbE1WMWIwV2d5c2w4MXBNa1FwdWVPRFdVb0NQRjZJdjBzNEwyOVRJQnBDU2VZU1h2VzlIMA</guid></item><item><title>骑自行车掩盖了我对糖的痴迷–这就是为什么这种习惯如此难以戒除以及科学如何提供帮助- BikeRadar</title><link>https://www.bikeradar.com/advice/health/cycling-sugar-obsession</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div _ngcontent-purplestorefront-c2920483845 class="purple-inner-container purple-content-body-inner"&gt;&lt;p&gt;I don’t know about you, but I’m a lot more disciplined with my diet and exercise in the colder months than the warmer ones.&lt;/p&gt;
&lt;p&gt;Longer days and better weather might mean I’m more active on the bike in the summer, but winter instils more structure.&lt;/p&gt;
&lt;p&gt;Lengthier evenings offer more time for structured workouts on my Wattbike, but crucially, I travel less – for work and leisure.&lt;/p&gt;
&lt;p&gt;In my world, travel means flux and the first casualty of being on the road, whether on a work assignment or away with family, is always my diet. I’m sure I’m not alone in this. Multi-course meals in restaurants, monster hotel breakfasts… on summer holidays, a daily gelato is a family ritual.&lt;/p&gt;
&lt;p&gt;It's got me thinking a lot about sugar and my relationship with it: whether I have too much in my diet; if so, how I could reduce it; the relationship between sugar and exercise, and whether sugar addiction – an idea that gets bandied about – is a real concern.&lt;/p&gt;
&lt;p&gt;I certainly crave sugar, that’s not up for debate. In a similar way to alcohol – which is definitely addictive – when I get into a run of days consuming a lot of sugar, such as on holiday or when I’m away from home, my intake can snowball.&lt;/p&gt;
&lt;p&gt;In my more disciplined winter periods, my habits improve and it’s not something I think about constantly. But is that enough to make sugar addictive? What is the definition, exactly, of an addictive substance? More on that later.&lt;/p&gt;

&lt;p purpleid="9bd32034-9489-4d1e-963b-578c03afac70"&gt;&lt;/p&gt;
&lt;h2 class="wp-block-heading"&gt;Off the leash&lt;/h2&gt;
&lt;figure class="wp-block-image size-large"&gt;&lt;img loading="lazy" decoding="async" src="https://c02.purpledshub.com/uploads/sites/39/2025/10/JohnWhitneySugar.jpg?webp=1&amp;amp;w=1200" alt="John Whitney" class="wp-image-941858"&gt;&lt;figcaption class="wp-element-caption"&gt;We crave sugar so much that some scientists argue it’s an addictive substance. &lt;span&gt;&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p&gt;For now, we’ll look at the amount of sugar that should be in our diets.&lt;/p&gt;
&lt;p&gt;In the UK, when the National Health Service talks about the sugar we should be cutting back on, it’s talking about ‘free sugars’ and natural sugars.&lt;/p&gt;
&lt;p&gt;Free sugars are those that are added to foods and drinks such as fizzy drinks and breakfast cereals, which may have been refined and processed.&lt;/p&gt;

&lt;p&gt;It’s not necessarily only refined sugars that we should be limiting, but natural ones, found in smoothies and honey, too.&lt;/p&gt;
&lt;p&gt;‘Free’, in this definition, means sugar that’s no longer in the cells of the food, such as an orange. The fibre within the orange, which contributes to maintaining a healthy gut, is removed and stops us from feeling full. &lt;/p&gt;
&lt;p&gt;If you end up drinking half a carton of fresh orange juice, you might be consuming the juice of 10 oranges, but a lot of the good stuff is left on the table.&lt;/p&gt;
&lt;p&gt;While sugar found naturally in milk, fruit and vegetables is of less concern, it’s still included in the daily recommended limit of sugar found on food labels.&lt;/p&gt;
&lt;p&gt;Worked your way through a punnet of strawberries at lunch? That natural sugar is still going to tot up and end up in belly fat if you’re consuming too many calories.&lt;/p&gt;

&lt;p&gt;The NHS says adults shouldn’t be eating more than 30g of free sugar a day – that’s seven sugar cubes, which isn’t much when you think a can of full-fat cola can contain nine.&lt;/p&gt;
&lt;p&gt;In the USA, 50g is the recommended limit in a daily 2,000-calorie diet. &lt;/p&gt;
&lt;p&gt;In reality, these aren’t limits we should be rubbing up against – this type of sugar has no nutritional value, we can live without any of it and excessive consumption can lead to the development of type 2 diabetes. So, maybe that’s the only reason you’d ever need to cut it out entirely.&lt;/p&gt;
&lt;p&gt;I’ve certainly met people, cyclists like me, who’ve tried this. It’s no mean feat, though. Western food culture, with free sugar finding its way into all manner of packaged foods, makes it hard to escape.&lt;/p&gt;
&lt;p&gt;But that’s forgetting there are many things in this life that we want but don’t need, such as the substances at the heart of defined addictions – &lt;a href="https://www.bikeradar.com/advice/fitness-and-training/how-alcohol-can-affect-your-riding"&gt;alcohol&lt;/a&gt; and drugs, for example.&lt;/p&gt;
&lt;p&gt;Can sugar, then, go beyond being something we crave, something that makes us feel good momentarily and lights up the dopamine centres in our brains, to become a full-blown addiction?&lt;/p&gt;
&lt;figure class="wp-block-image size-large"&gt;&lt;img loading="lazy" decoding="async" src="https://c02.purpledshub.com/uploads/sites/39/2025/09/GettyImages-1292400571.jpg?webp=1&amp;amp;w=1200" alt class="wp-image-941193"&gt;&lt;figcaption class="wp-element-caption"&gt;We've evolved to hunt sugar, but evolution hadn't reckoned on how abundant it'd be in 2025. &lt;span&gt;Getty Images&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p&gt;“The term addiction can be quite triggering and evoke a lot of emotion in people,” says Dr Sam Impey, former lead nutritionist at British Cycling and current scientific advisor for Puresport, the supplement and hydration firm.&lt;/p&gt;
&lt;p&gt;“It’s probably the substance that the human body is most evolutionary designed to hunt and gather because it’s the most efficient source of energy for our bodies. &lt;/p&gt;
&lt;p&gt;"You have sugar sensors in the lining of your mouth, which tell your brain to expect carbohydrates when you eat them. Our bodies are incredibly sensitive to the amounts of carbohydrate in our diet.&lt;/p&gt;
&lt;p&gt;“I don't think that sugar per se is addictive, but we have a good internal reward system from having an appropriate amount of carbohydrates and sugars in our diet.”&lt;/p&gt;

&lt;p&gt;Many scientists agree with Dr Impey, but that hasn’t stopped the debate over sugar.&lt;/p&gt;
&lt;p&gt;A 2007 French study, famously, found that rats preferred sugar-sweetened water to cocaine. &lt;/p&gt;
&lt;p&gt;In 2016, however, a paper published in the &lt;em&gt;European Journal of Nutrition&lt;/em&gt;, which reviewed the research on the idea of sugar addiction, argued there was little evidence to support it in humans. &lt;/p&gt;
&lt;p&gt;It found addiction-like behaviours in animals, such as bingeing, only occur in the context of intermittent access to the sweet things, rather than on the neuro-chemical level.&lt;/p&gt;
&lt;p&gt;If we put the possibility of addiction to one side and treat our hunger for sugar as cravings, how might we control our urges and reduce our sugar intake?&lt;/p&gt;
&lt;p&gt;A 2025 study from Columbia University in New York put our ‘sweet tooth’ under the spotlight by mapping, for the first time, the 3D structure of the human tongue’s sweet taste receptor. &lt;/p&gt;
&lt;p&gt;This, the researchers say, could lead to the discovery of new regulators of the receptor that would alter our appetite for sugar.&lt;/p&gt;
&lt;p&gt;Humans’ sweet receptors, unlike those for bitter and sour, haven’t evolved to be particularly sophisticated, says the study. &lt;/p&gt;
&lt;p&gt;This helps us focus on finding and detecting sugar-rich foods for energy, but evolution hadn’t reckoned on the bountiful supply of sugar in the Western diet in 2025.&lt;/p&gt;
&lt;p&gt;"The leading role that sugar plays in obesity cannot be overlooked," says the study’s co-author Juen Zhang.&lt;/p&gt;
&lt;p&gt;“The artificial sweeteners that we use today to replace sugar just don’t meaningfully change our desire for sugar. Now that we know what the receptor looks like, we might be able to design something better.”&lt;/p&gt;
&lt;h2 class="wp-block-heading"&gt;Fuel in the tank&lt;/h2&gt;
&lt;figure class="wp-block-image size-full"&gt;&lt;img loading="lazy" decoding="async" src="https://c02.purpledshub.com/uploads/sites/39/2025/09/GettyImages-2219385707.jpg?webp=1&amp;amp;w=1200" alt class="wp-image-941192"&gt;&lt;figcaption class="wp-element-caption"&gt;Cyclists shouldn't be afraid to fuel their efforts with sugar. &lt;span&gt; Getty Images&lt;/span&gt;&lt;/figcaption&gt;&lt;/figure&gt;
&lt;p&gt;If evolution has shaped us to seek out sweet things, and some of us have hard-to-control cravings for sugar-filled foods, it puts someone like me – who frequently cycles long distances at high intensities and relies on far more than 30g of free sugar a day to power workouts – in something of a bind.&lt;/p&gt;
&lt;p&gt;My own weight tends to yo-yo somewhat, depending on how much I’m cycling. &lt;/p&gt;
&lt;p&gt;The problem is I don’t tend to adjust my off-bike diet when I’m doing less cycling: like many cyclists, I enjoy a cake stop on a ride, but I also just enjoy a cake stop. &lt;/p&gt;
&lt;p&gt;Does the bag of gummies I devour on a bike ride give me the cravings to do the same in front of the TV?&lt;/p&gt;
&lt;p&gt;&lt;a href="https://www.bikeradar.com/news/how-many-calories-do-riders-consume-on-the-biggest-mountain-days"&gt;Cyclists at the Tour de France&lt;/a&gt;, for example, consume up to 6,000 calories a day during the toughest stages, and more than 100g of sugar an hour when on the bike. The higher the number, the better, in fact – it all powers forward motion.&lt;/p&gt;
&lt;p&gt;In these situations, free sugars – simple sugar &lt;a href="https://www.bikeradar.com/advice/nutrition/best-energy-gels-for-cycling"&gt;energy gels&lt;/a&gt; and gummies, for instance – are not just fine, but encouraged. They’re broken down and used fast by the body and don’t lead to a spike in blood sugar, which is not the case when you’re at rest.&lt;/p&gt;
&lt;p&gt;When at rest, the muscles – once at capacity – don’t need the sugar and, with no place for the excess to go, blood sugar spikes. &lt;/p&gt;
&lt;p&gt;In the general population, over time, this causes problems: type 2 diabetes can develop, where the body can’t create enough insulin – the hormone that regulates blood glucose and is deadly without controls.&lt;/p&gt;
&lt;p&gt;The solution for me seems to be in reshaping off-bike habits associated with sugar, perhaps by being more aware of how the food industry stacks the odds against me in terms of my sugar cravings.&lt;/p&gt;
&lt;p&gt;Dr. Impey continues: “The challenge comes in the development of modern food sources – things have become hyper-palatable with the addition of sweeteners and emulsifiers that change the mouth feel.&lt;/p&gt;
&lt;p&gt;“You have to look at what sugar is packaged in, especially in modern, processed food sources. The issues come not necessarily directly from sugar, but from some of the other stuff around it.”&lt;/p&gt;
&lt;p&gt;In terms of exercise, Dr. Impey says, we shouldn’t be afraid of fuelling it with sugar. &lt;/p&gt;
&lt;p&gt;“This is something that's really changed in the last few years – this move to fuelling effectively during training. &lt;/p&gt;
&lt;p&gt;"Not just to improve training quality and outcomes – you'll definitely get better adaptations and performance – but also the additional benefits around being in a slightly better total energy balance.”&lt;/p&gt;
&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>BikeRadar</author><pubDate>Wed, 01 Oct 2025 12:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMicEFVX3lxTE93eFhCX2dPZDJrX0ZtN3JkZVU0YzJFRTlJcEY0ODJVaUdFTW5SNDc2LXlmNi1kT2ZBclV5cWN5NDB5dEtSanlJSEd1Nklkb3dfbUE5bGxwbUE1ZXg4eXZPZ28zTG0tZk1weWdUR0J1VWM</guid></item><item><title>我是一名胃肠病学家。这八个技巧将改善您的肠道健康-《每日电讯报》</title><link>https://www.telegraph.co.uk/health-fitness/diet/gut-health/gastroenterologist-gut-health-tips/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="component article-body-text    " data-test="article-body-text"&gt;
  
  

	

	
	

	
	



  
  
    &lt;p&gt;Another way we consume them is through our diet. Antibiotics are misused in the production of the foods that we eat, especially through meat as they can be used as a growth product. If you give an animal lots of antibiotics, they get fatter and reach market weight faster. There are UK and EU rules preventing that, but it still happens.&lt;/p&gt;&lt;p&gt;The reason this is so important is that so much of the harm that is done to our gut is by the destruction of microbes. Antibiotics are the number one driver of that – they create an internal climate crisis, a catastrophic loss of microbes that define so much of our health.&lt;/p&gt;&lt;p&gt;If you are taking a one-off course of penicillin, it will have very little impact on your gut. The problem comes if you’re having broad-spectrum antibiotics repeatedly in life, the &lt;a class="ck-custom-link" href="https://www.telegraph.co.uk/health-fitness/wellbeing/mental-health/fluoroquinolone-antibiotic-side-effects/"&gt;consequences can be long-lasting and very profound&lt;/a&gt;. If this occurs in childhood, it increases the risk of obesity, type 2 diabetes and asthma, and even the risk of bowel cancer. It also has a big impact on our immune system and gut function.&lt;/p&gt;&lt;p&gt;If you have had to take antibiotics, I recommend eating plenty of plant-based foods like vegetables, fruit and legumes; tucking into food that is naturally high in prebiotic fibres, like chicory and bananas; and having some fermented foods. Additionally, having a multi-strain, high-dose probiotic supplement for eight weeks, as it can prevent some of the complications from antibiotics, like diarrhoea, and encourage “good” bacteria to grow in the gut.&lt;/p&gt;&lt;p&gt;To limit antibiotics in your diet, I recommend avoiding meat from big supermarkets and asking your butcher if antibiotics were used in the rearing of the meat products you’re buying. Some animal products will state “antibiotic-free” on the label, which is always the better choice.&lt;/p&gt;&lt;h2 class="u-heading-size-medium u-heading-style-normal"&gt;Give meditation a go&lt;/h2&gt;&lt;p&gt;We’re beginning to understand how the gut and brain are hardwired and how they signal to each other. Research has linked meditation, which has benefits for mental health, with better gut health, in particular a more diverse microbiome and more “good” gut bacteria.&lt;/p&gt;&lt;p&gt;Mindfulness is not a panacea and it’s not going to magically make everything better. But it may well reduce your stress hormones which are ruinous for gut microbes. So if you are living a very busy, frantic life, taking a little bit of time out of your day and having &lt;a class="ck-custom-link" href="https://www.telegraph.co.uk/health-fitness/wellbeing/stress/what-is-mindfulness-how-to-do-meditation-reduce-stress/"&gt;a bit of calm and focus&lt;/a&gt; really will support your gut and many other aspects of your health. When it comes to gut health, it’s a science of marginal gains – form small habits that have important benefits.&lt;/p&gt;&lt;p&gt;In practice, meditation is about giving yourself some time in the day and prioritising it and yourself. I often take 15 to 20 minutes and focus on my mental processes and thoughts and escape a little bit from the pressures that we all face.&lt;/p&gt;&lt;h2 class="u-heading-size-medium u-heading-style-normal"&gt;Breastfeed your children&lt;/h2&gt;&lt;p&gt;If you’re an adult, this ship has sailed but for new mothers, the most important thing that you can do is set up your child’s gut in early life. The very best evidenced way of doing that is &lt;a class="ck-custom-link" href="https://www.telegraph.co.uk/health-fitness/parenting/children/forget-the-politics-health-benefits-breastfeeding/"&gt;breastfeeding&lt;/a&gt;. It will protect both your maternal microbiome and the infant’s gut. This is due to the living bacteria in the breast milk, which are transferred to breastfed babies, and the oligosaccharides in milk, which are complex sugars that are broken down in the developing gut, supporting the growth of friendly microbes in their digestive system.&lt;/p&gt;&lt;p&gt;Formula-fed infants have very different strains of bacteria in their gut that are more inflammatory and we know are associated with worse health outcomes. Some women can’t breastfeed so don’t have this choice but, if you can, the evidence is overwhelming that you should.&lt;/p&gt;&lt;p&gt;&lt;em&gt;As told to Emily Craig&lt;/em&gt;&lt;/p&gt;
  
&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Telegraph</author><pubDate>Wed, 01 Oct 2025 11:34:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMimgFBVV95cUxQZFBuLVRrX0ZUcEkzb2tDSUtxLUFXaUhCbTRRZUdzRk85c21kdnlLb1c4dHh6c1FkT1Zsb0pVaDJRektjZU8xLTFUMjdDU3RtTVAxS3MwWTJ3dzlBM2xCWEd2OEhwX0YtRWhPakFwMkR0V3lNczMwYXpFOG9qSmtzNVd0ZDJFUXZLS08zMGI2anZUbVVaNTFTaFd3</guid></item><item><title>帕金森病脑组织中α-突触核蛋白低聚物的大规模可视化-自然</title><link>https://www.nature.com/articles/s41551-025-01496-4</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;ol class="c-article-references" data-track-component="outbound reference" data-track-context="references section"&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."&gt;&lt;p class="c-article-references__text" id="ref-CR1"&gt;Sveinbjornsdottir, S. The clinical symptoms of Parkinson’s disease. &lt;i&gt;J. Neurochem.&lt;/i&gt; &lt;b&gt;139&lt;/b&gt;, 318–324 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/jnc.13691" data-track-item_id="10.1111/jnc.13691" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fjnc.13691" aria-label="Article reference 1" data-doi="10.1111/jnc.13691"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XhtFCrt7rI" aria-label="CAS reference 1"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27401947" aria-label="PubMed reference 1"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20clinical%20symptoms%20of%20Parkinson%E2%80%99s%20disease&amp;amp;journal=J.%20Neurochem.&amp;amp;doi=10.1111%2Fjnc.13691&amp;amp;volume=139&amp;amp;pages=318-324&amp;amp;publication_year=2016&amp;amp;author=Sveinbjornsdottir%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."&gt;&lt;p class="c-article-references__text" id="ref-CR2"&gt;Chaudhuri, K. R., Healy, D. G. &amp;amp; Schapira, A. H. Non-motor symptoms of Parkinson’s disease: diagnosis and management. &lt;i&gt;Lancet Neurol.&lt;/i&gt; &lt;b&gt;5&lt;/b&gt;, 235–245 (2006).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S1474-4422(06)70373-8" data-track-item_id="10.1016/S1474-4422(06)70373-8" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS1474-4422%2806%2970373-8" aria-label="Article reference 2" data-doi="10.1016/S1474-4422(06)70373-8"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=16488379" aria-label="PubMed reference 2"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Non-motor%20symptoms%20of%20Parkinson%E2%80%99s%20disease%3A%20diagnosis%20and%20management&amp;amp;journal=Lancet%20Neurol.&amp;amp;doi=10.1016%2FS1474-4422%2806%2970373-8&amp;amp;volume=5&amp;amp;pages=235-245&amp;amp;publication_year=2006&amp;amp;author=Chaudhuri%2CKR&amp;amp;author=Healy%2CDG&amp;amp;author=Schapira%2CAH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."&gt;&lt;p class="c-article-references__text" id="ref-CR3"&gt;Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. &amp;amp; Goedert, M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;95&lt;/b&gt;, 6469–6473 (1998).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.95.11.6469" data-track-item_id="10.1073/pnas.95.11.6469" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.95.11.6469" aria-label="Article reference 3" data-doi="10.1073/pnas.95.11.6469"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK1cXjtlKgtLo%3D" aria-label="CAS reference 3"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=9600990" aria-label="PubMed reference 3"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC27806" aria-label="PubMed Central reference 3"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=%CE%B1-Synuclein%20in%20filamentous%20inclusions%20of%20Lewy%20bodies%20from%20Parkinson%E2%80%99s%20disease%20and%20dementia%20with%20Lewy%20bodies&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.95.11.6469&amp;amp;volume=95&amp;amp;pages=6469-6473&amp;amp;publication_year=1998&amp;amp;author=Spillantini%2CMG&amp;amp;author=Crowther%2CRA&amp;amp;author=Jakes%2CR&amp;amp;author=Hasegawa%2CM&amp;amp;author=Goedert%2CM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."&gt;&lt;p class="c-article-references__text" id="ref-CR4"&gt;Braak, H. et al. Staging of brain pathology related to sporadic Parkinson’s disease. &lt;i&gt;Neurobiol. Aging&lt;/i&gt; &lt;b&gt;24&lt;/b&gt;, 197–211 (2003).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0197-4580(02)00065-9" data-track-item_id="10.1016/S0197-4580(02)00065-9" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0197-4580%2802%2900065-9" aria-label="Article reference 4" data-doi="10.1016/S0197-4580(02)00065-9"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=12498954" aria-label="PubMed reference 4"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Staging%20of%20brain%20pathology%20related%20to%20sporadic%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Neurobiol.%20Aging&amp;amp;doi=10.1016%2FS0197-4580%2802%2900065-9&amp;amp;volume=24&amp;amp;pages=197-211&amp;amp;publication_year=2003&amp;amp;author=Braak%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."&gt;&lt;p class="c-article-references__text" id="ref-CR5"&gt;Attems, J. et al. Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. &lt;i&gt;Acta Neuropathol.&lt;/i&gt; &lt;b&gt;141&lt;/b&gt;, 159–172 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s00401-020-02255-2" data-track-item_id="10.1007/s00401-020-02255-2" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00401-020-02255-2" aria-label="Article reference 5" data-doi="10.1007/s00401-020-02255-2"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXjvVKqu7k%3D" aria-label="CAS reference 5"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33399945" aria-label="PubMed reference 5"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847437" aria-label="PubMed Central reference 5"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Neuropathological%20consensus%20criteria%20for%20the%20evaluation%20of%20Lewy%20pathology%20in%20post-mortem%20brains%3A%20a%20multi-centre%20study&amp;amp;journal=Acta%20Neuropathol.&amp;amp;doi=10.1007%2Fs00401-020-02255-2&amp;amp;volume=141&amp;amp;pages=159-172&amp;amp;publication_year=2021&amp;amp;author=Attems%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."&gt;&lt;p class="c-article-references__text" id="ref-CR6"&gt;Konno, T., Ross, O. A., Puschmann, A., Dickson, D. W. &amp;amp; Wszolek, Z. K. Autosomal dominant Parkinson’s disease caused by SNCA duplications. &lt;i&gt;Parkinsonism Relat. Disord.&lt;/i&gt; &lt;b&gt;22&lt;/b&gt;, S1–S6 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.parkreldis.2015.09.007" data-track-item_id="10.1016/j.parkreldis.2015.09.007" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.parkreldis.2015.09.007" aria-label="Article reference 6" data-doi="10.1016/j.parkreldis.2015.09.007"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26350119" aria-label="PubMed reference 6"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Autosomal%20dominant%20Parkinson%E2%80%99s%20disease%20caused%20by%20SNCA%20duplications&amp;amp;journal=Parkinsonism%20Relat.%20Disord.&amp;amp;doi=10.1016%2Fj.parkreldis.2015.09.007&amp;amp;volume=22&amp;amp;pages=S1-S6&amp;amp;publication_year=2016&amp;amp;author=Konno%2CT&amp;amp;author=Ross%2COA&amp;amp;author=Puschmann%2CA&amp;amp;author=Dickson%2CDW&amp;amp;author=Wszolek%2CZK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."&gt;&lt;p class="c-article-references__text" id="ref-CR7"&gt;Singleton, A. B. et al. α-Synuclein locus triplication causes Parkinson’s disease. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;302&lt;/b&gt;, 841 (2003).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.1090278" data-track-item_id="10.1126/science.1090278" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.1090278" aria-label="Article reference 7" data-doi="10.1126/science.1090278"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXoslehsbc%3D" aria-label="CAS reference 7"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=14593171" aria-label="PubMed reference 7"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=%CE%B1-Synuclein%20locus%20triplication%20causes%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.1090278&amp;amp;volume=302&amp;amp;publication_year=2003&amp;amp;author=Singleton%2CAB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."&gt;&lt;p class="c-article-references__text" id="ref-CR8"&gt;Krüger, R. et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson’s disease. &lt;i&gt;Nat. Genet&lt;/i&gt; &lt;b&gt;18&lt;/b&gt;, 106–108 (1998).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ng0298-106" data-track-item_id="10.1038/ng0298-106" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fng0298-106" aria-label="Article reference 8" data-doi="10.1038/ng0298-106"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=9462735" aria-label="PubMed reference 8"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=AlaSOPro%20mutation%20in%20the%20gene%20encoding%20%CE%B1-synuclein%20in%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Nat.%20Genet&amp;amp;doi=10.1038%2Fng0298-106&amp;amp;volume=18&amp;amp;pages=106-108&amp;amp;publication_year=1998&amp;amp;author=Kr%C3%BCger%2CR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."&gt;&lt;p class="c-article-references__text" id="ref-CR9"&gt;Zarranz, J. J. et al. The new mutation, E46K, of α-synuclein causes parkinson and Lewy body dementia. &lt;i&gt;Ann. Neurol.&lt;/i&gt; &lt;b&gt;55&lt;/b&gt;, 164–173 (2004).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/ana.10795" data-track-item_id="10.1002/ana.10795" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fana.10795" aria-label="Article reference 9" data-doi="10.1002/ana.10795"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXhs1Sgtb0%3D" aria-label="CAS reference 9"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=14755719" aria-label="PubMed reference 9"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20new%20mutation%2C%20E46K%2C%20of%20%CE%B1-synuclein%20causes%20parkinson%20and%20Lewy%20body%20dementia&amp;amp;journal=Ann.%20Neurol.&amp;amp;doi=10.1002%2Fana.10795&amp;amp;volume=55&amp;amp;pages=164-173&amp;amp;publication_year=2004&amp;amp;author=Zarranz%2CJJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."&gt;&lt;p class="c-article-references__text" id="ref-CR10"&gt;Appel-Cresswell, S. et al. Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson’s disease. &lt;i&gt;Mov. Disord.&lt;/i&gt; &lt;b&gt;28&lt;/b&gt;, 811–813 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/mds.25421" data-track-item_id="10.1002/mds.25421" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fmds.25421" aria-label="Article reference 10" data-doi="10.1002/mds.25421"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXht1amu7jP" aria-label="CAS reference 10"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=23457019" aria-label="PubMed reference 10"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Alpha-synuclein%20p.H50Q%2C%20a%20novel%20pathogenic%20mutation%20for%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Mov.%20Disord.&amp;amp;doi=10.1002%2Fmds.25421&amp;amp;volume=28&amp;amp;pages=811-813&amp;amp;publication_year=2013&amp;amp;author=Appel-Cresswell%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."&gt;&lt;p class="c-article-references__text" id="ref-CR11"&gt;Lesage, S. et al. G51D α-synuclein mutation causes a novel Parkinsonian–pyramidal syndrome. &lt;i&gt;Ann. Neurol.&lt;/i&gt; &lt;b&gt;73&lt;/b&gt;, 459–471 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/ana.23894" data-track-item_id="10.1002/ana.23894" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fana.23894" aria-label="Article reference 11" data-doi="10.1002/ana.23894"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXosFKit7o%3D" aria-label="CAS reference 11"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=23526723" aria-label="PubMed reference 11"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=G51D%20%CE%B1-synuclein%20mutation%20causes%20a%20novel%20Parkinsonian%E2%80%93pyramidal%20syndrome&amp;amp;journal=Ann.%20Neurol.&amp;amp;doi=10.1002%2Fana.23894&amp;amp;volume=73&amp;amp;pages=459-471&amp;amp;publication_year=2013&amp;amp;author=Lesage%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."&gt;&lt;p class="c-article-references__text" id="ref-CR12"&gt;Polymeropoulos, M. H. et al. Mutation in the α-synuclein gene identified in families with Parkinson’s disease. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;276&lt;/b&gt;, 2045–2047 (1997).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.276.5321.2045" data-track-item_id="10.1126/science.276.5321.2045" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.276.5321.2045" aria-label="Article reference 12" data-doi="10.1126/science.276.5321.2045"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK2sXkt1altr4%3D" aria-label="CAS reference 12"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=9197268" aria-label="PubMed reference 12"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Mutation%20in%20the%20%CE%B1-synuclein%20gene%20identified%20in%20families%20with%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.276.5321.2045&amp;amp;volume=276&amp;amp;pages=2045-2047&amp;amp;publication_year=1997&amp;amp;author=Polymeropoulos%2CMH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."&gt;&lt;p class="c-article-references__text" id="ref-CR13"&gt;Guo, Y. et al. Genetic analysis and literature review of SNCA variants in Parkinson’s disease. &lt;i&gt;Front. Aging Neurosci.&lt;/i&gt; &lt;b&gt;13&lt;/b&gt;, 648151 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fnagi.2021.648151" data-track-item_id="10.3389/fnagi.2021.648151" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffnagi.2021.648151" aria-label="Article reference 13" data-doi="10.3389/fnagi.2021.648151"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38Xit1Gitbc%3D" aria-label="CAS reference 13"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34456707" aria-label="PubMed reference 13"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397385" aria-label="PubMed Central reference 13"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Genetic%20analysis%20and%20literature%20review%20of%20SNCA%20variants%20in%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Front.%20Aging%20Neurosci.&amp;amp;doi=10.3389%2Ffnagi.2021.648151&amp;amp;volume=13&amp;amp;publication_year=2021&amp;amp;author=Guo%2CY"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."&gt;&lt;p class="c-article-references__text" id="ref-CR14"&gt;Bisi, N. et al. α-Synuclein: an all-inclusive trip around its structure, influencing factors and applied techniques. &lt;i&gt;Front. Chem.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, 666585 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fchem.2021.666585" data-track-item_id="10.3389/fchem.2021.666585" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffchem.2021.666585" aria-label="Article reference 14" data-doi="10.3389/fchem.2021.666585"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhvVGku7fE" aria-label="CAS reference 14"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34307295" aria-label="PubMed reference 14"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292672" aria-label="PubMed Central reference 14"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=%CE%B1-Synuclein%3A%20an%20all-inclusive%20trip%20around%20its%20structure%2C%20influencing%20factors%20and%20applied%20techniques&amp;amp;journal=Front.%20Chem.&amp;amp;doi=10.3389%2Ffchem.2021.666585&amp;amp;volume=9&amp;amp;publication_year=2021&amp;amp;author=Bisi%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."&gt;&lt;p class="c-article-references__text" id="ref-CR15"&gt;Choi, M. L. et al. Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity. &lt;i&gt;Nat. Neurosci.&lt;/i&gt; &lt;b&gt;25&lt;/b&gt;, 1134–1148 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41593-022-01140-3" data-track-item_id="10.1038/s41593-022-01140-3" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41593-022-01140-3" aria-label="Article reference 15" data-doi="10.1038/s41593-022-01140-3"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38Xit1yhtr%2FE" aria-label="CAS reference 15"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36042314" aria-label="PubMed reference 15"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448679" aria-label="PubMed Central reference 15"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Pathological%20structural%20conversion%20of%20%CE%B1-synuclein%20at%20the%20mitochondria%20induces%20neuronal%20toxicity&amp;amp;journal=Nat.%20Neurosci.&amp;amp;doi=10.1038%2Fs41593-022-01140-3&amp;amp;volume=25&amp;amp;pages=1134-1148&amp;amp;publication_year=2022&amp;amp;author=Choi%2CML"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."&gt;&lt;p class="c-article-references__text" id="ref-CR16"&gt;Roberts, R. F., Wade-Martins, R. &amp;amp; Alegre-Abarrategui, J. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain. &lt;i&gt;Brain&lt;/i&gt; &lt;b&gt;138&lt;/b&gt;, 1642–1657 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/brain/awv040" data-track-item_id="10.1093/brain/awv040" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fbrain%2Fawv040" aria-label="Article reference 16" data-doi="10.1093/brain/awv040"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=25732184" aria-label="PubMed reference 16"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614141" aria-label="PubMed Central reference 16"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Direct%20visualization%20of%20alpha-synuclein%20oligomers%20reveals%20previously%20undetected%20pathology%20in%20Parkinson%E2%80%99s%20disease%20brain&amp;amp;journal=Brain&amp;amp;doi=10.1093%2Fbrain%2Fawv040&amp;amp;volume=138&amp;amp;pages=1642-1657&amp;amp;publication_year=2015&amp;amp;author=Roberts%2CRF&amp;amp;author=Wade-Martins%2CR&amp;amp;author=Alegre-Abarrategui%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."&gt;&lt;p class="c-article-references__text" id="ref-CR17"&gt;Fusco, G. et al. Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers. &lt;i&gt;Science&lt;/i&gt; &lt;b&gt;358&lt;/b&gt;, 1440–1443 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/science.aan6160" data-track-item_id="10.1126/science.aan6160" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscience.aan6160" aria-label="Article reference 17" data-doi="10.1126/science.aan6160"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhvFGmtrzN" aria-label="CAS reference 17"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=29242346" aria-label="PubMed reference 17"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Structural%20basis%20of%20membrane%20disruption%20and%20cellular%20toxicity%20by%20%CE%B1-synuclein%20oligomers&amp;amp;journal=Science&amp;amp;doi=10.1126%2Fscience.aan6160&amp;amp;volume=358&amp;amp;pages=1440-1443&amp;amp;publication_year=2017&amp;amp;author=Fusco%2CG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."&gt;&lt;p class="c-article-references__text" id="ref-CR18"&gt;Winner, B. et al. In vivo demonstration that α-synuclein oligomers are toxic. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;108&lt;/b&gt;, 4194–4199 (2011).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.1100976108" data-track-item_id="10.1073/pnas.1100976108" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.1100976108" aria-label="Article reference 18" data-doi="10.1073/pnas.1100976108"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXjsF2nu78%3D" aria-label="CAS reference 18"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=21325059" aria-label="PubMed reference 18"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053976" aria-label="PubMed Central reference 18"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=In%20vivo%20demonstration%20that%20%CE%B1-synuclein%20oligomers%20are%20toxic&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.1100976108&amp;amp;volume=108&amp;amp;pages=4194-4199&amp;amp;publication_year=2011&amp;amp;author=Winner%2CB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."&gt;&lt;p class="c-article-references__text" id="ref-CR19"&gt;Cremades, N. et al. Direct observation of the interconversion of normal and toxic forms of α-synuclein. &lt;i&gt;Cell&lt;/i&gt; &lt;b&gt;149&lt;/b&gt;, 1048–1059 (2012).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cell.2012.03.037" data-track-item_id="10.1016/j.cell.2012.03.037" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cell.2012.03.037" aria-label="Article reference 19" data-doi="10.1016/j.cell.2012.03.037"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XnslSgtLk%3D" aria-label="CAS reference 19"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22632969" aria-label="PubMed reference 19"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383996" aria-label="PubMed Central reference 19"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Direct%20observation%20of%20the%20interconversion%20of%20normal%20and%20toxic%20forms%20of%20%CE%B1-synuclein&amp;amp;journal=Cell&amp;amp;doi=10.1016%2Fj.cell.2012.03.037&amp;amp;volume=149&amp;amp;pages=1048-1059&amp;amp;publication_year=2012&amp;amp;author=Cremades%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."&gt;&lt;p class="c-article-references__text" id="ref-CR20"&gt;Villar-Piqué, A., Lopes da Fonseca, T. &amp;amp; Outeiro, T. F. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies. &lt;i&gt;J. Neurochem.&lt;/i&gt; &lt;b&gt;139&lt;/b&gt;, 240–255 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/jnc.13249" data-track-item_id="10.1111/jnc.13249" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fjnc.13249" aria-label="Article reference 20" data-doi="10.1111/jnc.13249"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26190401" aria-label="PubMed reference 20"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Structure%2C%20function%20and%20toxicity%20of%20alpha-synuclein%3A%20the%20Bermuda%20triangle%20in%20synucleinopathies&amp;amp;journal=J.%20Neurochem.&amp;amp;doi=10.1111%2Fjnc.13249&amp;amp;volume=139&amp;amp;pages=240-255&amp;amp;publication_year=2016&amp;amp;author=Villar-Piqu%C3%A9%2CA&amp;amp;author=Lopes%20da%20Fonseca%2CT&amp;amp;author=Outeiro%2CTF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."&gt;&lt;p class="c-article-references__text" id="ref-CR21"&gt;Du, X., Xie, X. &amp;amp; Liu, R. The role of α-synuclein oligomers in Parkinson’s disease. &lt;i&gt;Int. J. Mol. Sci.&lt;/i&gt; &lt;b&gt;21&lt;/b&gt;, 8645 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.3390/ijms21228645" data-track-item_id="10.3390/ijms21228645" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3390%2Fijms21228645" aria-label="Article reference 21" data-doi="10.3390/ijms21228645"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXisFyhurjL" aria-label="CAS reference 21"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33212758" aria-label="PubMed reference 21"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697105" aria-label="PubMed Central reference 21"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20role%20of%20%CE%B1-synuclein%20oligomers%20in%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Int.%20J.%20Mol.%20Sci.&amp;amp;doi=10.3390%2Fijms21228645&amp;amp;volume=21&amp;amp;publication_year=2020&amp;amp;author=Du%2CX&amp;amp;author=Xie%2CX&amp;amp;author=Liu%2CR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."&gt;&lt;p class="c-article-references__text" id="ref-CR22"&gt;Stöckl, M. T., Zijlstra, N. &amp;amp; Subramaniam, V. α-Synuclein oligomers: an amyloid pore? &lt;i&gt;Mol. Neurobiol.&lt;/i&gt; &lt;b&gt;47&lt;/b&gt;, 613–621 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s12035-012-8331-4" data-track-item_id="10.1007/s12035-012-8331-4" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s12035-012-8331-4" aria-label="Article reference 22" data-doi="10.1007/s12035-012-8331-4"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22956232" aria-label="PubMed reference 22"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=%CE%B1-Synuclein%20oligomers%3A%20an%20amyloid%20pore%3F&amp;amp;journal=Mol.%20Neurobiol.&amp;amp;doi=10.1007%2Fs12035-012-8331-4&amp;amp;volume=47&amp;amp;pages=613-621&amp;amp;publication_year=2013&amp;amp;author=St%C3%B6ckl%2CMT&amp;amp;author=Zijlstra%2CN&amp;amp;author=Subramaniam%2CV"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."&gt;&lt;p class="c-article-references__text" id="ref-CR23"&gt;Danzer, K. M. et al. Different species of α-synuclein oligomers induce calcium influx and seeding. &lt;i&gt;J. Neurosci.&lt;/i&gt; &lt;b&gt;27&lt;/b&gt;, 9220–9232 (2007).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1523/JNEUROSCI.2617-07.2007" data-track-item_id="10.1523/JNEUROSCI.2617-07.2007" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1523%2FJNEUROSCI.2617-07.2007" aria-label="Article reference 23" data-doi="10.1523/JNEUROSCI.2617-07.2007"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtVSnsLfM" aria-label="CAS reference 23"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=17715357" aria-label="PubMed reference 23"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6672196" aria-label="PubMed Central reference 23"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Different%20species%20of%20%CE%B1-synuclein%20oligomers%20induce%20calcium%20influx%20and%20seeding&amp;amp;journal=J.%20Neurosci.&amp;amp;doi=10.1523%2FJNEUROSCI.2617-07.2007&amp;amp;volume=27&amp;amp;pages=9220-9232&amp;amp;publication_year=2007&amp;amp;author=Danzer%2CKM"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."&gt;&lt;p class="c-article-references__text" id="ref-CR24"&gt;Tetzlaff, J. E. et al. CHIP targets toxic α-synuclein oligomers for degradation. &lt;i&gt;J. Biol. Chem.&lt;/i&gt; &lt;b&gt;283&lt;/b&gt;, 17962–17968 (2008).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1074/jbc.M802283200" data-track-item_id="10.1074/jbc.M802283200" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1074%2Fjbc.M802283200" aria-label="Article reference 24" data-doi="10.1074/jbc.M802283200"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXnsVCgtrg%3D" aria-label="CAS reference 24"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=18436529" aria-label="PubMed reference 24"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=CHIP%20targets%20toxic%20%CE%B1-synuclein%20oligomers%20for%20degradation&amp;amp;journal=J.%20Biol.%20Chem.&amp;amp;doi=10.1074%2Fjbc.M802283200&amp;amp;volume=283&amp;amp;pages=17962-17968&amp;amp;publication_year=2008&amp;amp;author=Tetzlaff%2CJE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."&gt;&lt;p class="c-article-references__text" id="ref-CR25"&gt;Näsström, T. et al. The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties. &lt;i&gt;Free Radic. Biol. Med.&lt;/i&gt; &lt;b&gt;50&lt;/b&gt;, 428–437 (2011).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.freeradbiomed.2010.11.027" data-track-item_id="10.1016/j.freeradbiomed.2010.11.027" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.freeradbiomed.2010.11.027" aria-label="Article reference 25" data-doi="10.1016/j.freeradbiomed.2010.11.027"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=21130160" aria-label="PubMed reference 25"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20lipid%20peroxidation%20products%204-oxo-2-nonenal%20and%204-hydroxy-2-nonenal%20promote%20the%20formation%20of%20%CE%B1-synuclein%20oligomers%20with%20distinct%20biochemical%2C%20morphological%2C%20and%20functional%20properties&amp;amp;journal=Free%20Radic.%20Biol.%20Med.&amp;amp;doi=10.1016%2Fj.freeradbiomed.2010.11.027&amp;amp;volume=50&amp;amp;pages=428-437&amp;amp;publication_year=2011&amp;amp;author=N%C3%A4sstr%C3%B6m%2CT"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."&gt;&lt;p class="c-article-references__text" id="ref-CR26"&gt;Rockenstein, E. et al. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo. &lt;i&gt;Brain&lt;/i&gt; &lt;b&gt;137&lt;/b&gt;, 1496–1513 (2014).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/brain/awu057" data-track-item_id="10.1093/brain/awu057" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fbrain%2Fawu057" aria-label="Article reference 26" data-doi="10.1093/brain/awu057"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24662516" aria-label="PubMed reference 26"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999721" aria-label="PubMed Central reference 26"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Accumulation%20of%20oligomer-prone%20%CE%B1-synuclein%20exacerbates%20synaptic%20and%20neuronal%20degeneration%20in%20vivo&amp;amp;journal=Brain&amp;amp;doi=10.1093%2Fbrain%2Fawu057&amp;amp;volume=137&amp;amp;pages=1496-1513&amp;amp;publication_year=2014&amp;amp;author=Rockenstein%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."&gt;&lt;p class="c-article-references__text" id="ref-CR27"&gt;Luth, E. S., Stavrovskaya, I. G., Bartels, T., Kristal, B. S. &amp;amp; Selkoe, D. J. Soluble, prefibrillar α-synuclein oligomers promote complex I-dependent, Ca&lt;sup&gt;2+&lt;/sup&gt;-induced mitochondrial dysfunction. &lt;i&gt;J. Biol. Chem.&lt;/i&gt; &lt;b&gt;289&lt;/b&gt;, 21490–21507 (2014).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1074/jbc.M113.545749" data-track-item_id="10.1074/jbc.M113.545749" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1074%2Fjbc.M113.545749" aria-label="Article reference 27" data-doi="10.1074/jbc.M113.545749"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24942732" aria-label="PubMed reference 27"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118111" aria-label="PubMed Central reference 27"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Soluble%2C%20prefibrillar%20%CE%B1-synuclein%20oligomers%20promote%20complex%20I-dependent%2C%20Ca2%2B-induced%20mitochondrial%20dysfunction&amp;amp;journal=J.%20Biol.%20Chem.&amp;amp;doi=10.1074%2Fjbc.M113.545749&amp;amp;volume=289&amp;amp;pages=21490-21507&amp;amp;publication_year=2014&amp;amp;author=Luth%2CES&amp;amp;author=Stavrovskaya%2CIG&amp;amp;author=Bartels%2CT&amp;amp;author=Kristal%2CBS&amp;amp;author=Selkoe%2CDJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."&gt;&lt;p class="c-article-references__text" id="ref-CR28"&gt;Chen, S. W. et al. Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;112&lt;/b&gt;, E1994–E2003 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXmtVaqsrw%3D" aria-label="CAS reference 28"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=25855634" aria-label="PubMed reference 28"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413268" aria-label="PubMed Central reference 28"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Structural%20characterization%20of%20toxic%20oligomers%20that%20are%20kinetically%20trapped%20during%20%CE%B1-synuclein%20fibril%20formation&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;volume=112&amp;amp;pages=E1994-E2003&amp;amp;publication_year=2015&amp;amp;author=Chen%2CSW"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."&gt;&lt;p class="c-article-references__text" id="ref-CR29"&gt;Bengoa-Vergniory, N., Roberts, R. F., Wade-Martins, R. &amp;amp; Alegre-Abarrategui, J. Alpha-synuclein oligomers: a new hope. &lt;i&gt;Acta Neuropathol.&lt;/i&gt; &lt;b&gt;134&lt;/b&gt;, 819–838 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s00401-017-1755-1" data-track-item_id="10.1007/s00401-017-1755-1" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00401-017-1755-1" aria-label="Article reference 29" data-doi="10.1007/s00401-017-1755-1"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhtlarsLrO" aria-label="CAS reference 29"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=28803412" aria-label="PubMed reference 29"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663814" aria-label="PubMed Central reference 29"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Alpha-synuclein%20oligomers%3A%20a%20new%20hope&amp;amp;journal=Acta%20Neuropathol.&amp;amp;doi=10.1007%2Fs00401-017-1755-1&amp;amp;volume=134&amp;amp;pages=819-838&amp;amp;publication_year=2017&amp;amp;author=Bengoa-Vergniory%2CN&amp;amp;author=Roberts%2CRF&amp;amp;author=Wade-Martins%2CR&amp;amp;author=Alegre-Abarrategui%2CJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."&gt;&lt;p class="c-article-references__text" id="ref-CR30"&gt;Hughes, C. D. et al. Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis. &lt;i&gt;Acta Neuropathol.&lt;/i&gt; &lt;b&gt;137&lt;/b&gt;, 103–120 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s00401-018-1907-y" data-track-item_id="10.1007/s00401-018-1907-y" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00401-018-1907-y" aria-label="Article reference 30" data-doi="10.1007/s00401-018-1907-y"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXhslCjtrjJ" aria-label="CAS reference 30"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30225556" aria-label="PubMed reference 30"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Picomolar%20concentrations%20of%20oligomeric%20alpha-synuclein%20sensitizes%20TLR4%20to%20play%20an%20initiating%20role%20in%20Parkinson%E2%80%99s%20disease%20pathogenesis&amp;amp;journal=Acta%20Neuropathol.&amp;amp;doi=10.1007%2Fs00401-018-1907-y&amp;amp;volume=137&amp;amp;pages=103-120&amp;amp;publication_year=2019&amp;amp;author=Hughes%2CCD"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."&gt;&lt;p class="c-article-references__text" id="ref-CR31"&gt;Dimant, H. et al. Direct detection of alpha synuclein oligomers in vivo. &lt;i&gt;Acta Neuropathol. Commun.&lt;/i&gt; &lt;b&gt;1&lt;/b&gt;, 6 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/2051-5960-1-6" data-track-item_id="10.1186/2051-5960-1-6" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/2051-5960-1-6" aria-label="Article reference 31" data-doi="10.1186/2051-5960-1-6"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24252244" aria-label="PubMed reference 31"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776213" aria-label="PubMed Central reference 31"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Direct%20detection%20of%20alpha%20synuclein%20oligomers%20in%20vivo&amp;amp;journal=Acta%20Neuropathol.%20Commun.&amp;amp;doi=10.1186%2F2051-5960-1-6&amp;amp;volume=1&amp;amp;publication_year=2013&amp;amp;author=Dimant%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."&gt;&lt;p class="c-article-references__text" id="ref-CR32"&gt;Outeiro, T. F. Alpha-synuclein antibody characterization: why semantics matters. &lt;i&gt;Mol. Neurobiol.&lt;/i&gt; &lt;b&gt;58&lt;/b&gt;, 2202–2203 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s12035-020-02269-7" data-track-item_id="10.1007/s12035-020-02269-7" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s12035-020-02269-7" aria-label="Article reference 32" data-doi="10.1007/s12035-020-02269-7"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXosVKrtg%3D%3D" aria-label="CAS reference 32"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33411246" aria-label="PubMed reference 32"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018929" aria-label="PubMed Central reference 32"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Alpha-synuclein%20antibody%20characterization%3A%20why%20semantics%20matters&amp;amp;journal=Mol.%20Neurobiol.&amp;amp;doi=10.1007%2Fs12035-020-02269-7&amp;amp;volume=58&amp;amp;pages=2202-2203&amp;amp;publication_year=2021&amp;amp;author=Outeiro%2CTF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."&gt;&lt;p class="c-article-references__text" id="ref-CR33"&gt;Kumar, S. T. et al. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology. &lt;i&gt;Neurobiol. Dis.&lt;/i&gt; &lt;b&gt;146&lt;/b&gt;, 105086 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.nbd.2020.105086" data-track-item_id="10.1016/j.nbd.2020.105086" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.nbd.2020.105086" aria-label="Article reference 33" data-doi="10.1016/j.nbd.2020.105086"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXitFeqs7%2FL" aria-label="CAS reference 33"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32971232" aria-label="PubMed reference 33"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=How%20specific%20are%20the%20conformation-specific%20%CE%B1-synuclein%20antibodies%3F%20Characterization%20and%20validation%20of%2016%20%CE%B1-synuclein%20conformation-specific%20antibodies%20using%20well-characterized%20preparations%20of%20%CE%B1-synuclein%20monomers%2C%20fibrils%20and%20oligomers%20with%20distinct%20structures%20and%20morphology&amp;amp;journal=Neurobiol.%20Dis.&amp;amp;doi=10.1016%2Fj.nbd.2020.105086&amp;amp;volume=146&amp;amp;publication_year=2020&amp;amp;author=Kumar%2CST"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."&gt;&lt;p class="c-article-references__text" id="ref-CR34"&gt;Sekiya, H. et al. Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation. &lt;i&gt;Acta Neuropathol.&lt;/i&gt; &lt;b&gt;137&lt;/b&gt;, 455–466 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s00401-019-01961-w" data-track-item_id="10.1007/s00401-019-01961-w" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00401-019-01961-w" aria-label="Article reference 34" data-doi="10.1007/s00401-019-01961-w"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXmslGrtbo%3D" aria-label="CAS reference 34"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30721406" aria-label="PubMed reference 34"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Wide%20distribution%20of%20alpha-synuclein%20oligomers%20in%20multiple%20system%20atrophy%20brain%20detected%20by%20proximity%20ligation&amp;amp;journal=Acta%20Neuropathol.&amp;amp;doi=10.1007%2Fs00401-019-01961-w&amp;amp;volume=137&amp;amp;pages=455-466&amp;amp;publication_year=2019&amp;amp;author=Sekiya%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."&gt;&lt;p class="c-article-references__text" id="ref-CR35"&gt;Andrews, R. et al. Direct visualisation of alpha-synuclein oligomers in human brain tissue—raw data. &lt;i&gt;Aligning Science Across Parkinsons&lt;/i&gt; &lt;a href="https://doi.org/10.5281/ZENODO.10610924" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.5281/ZENODO.10610924"&gt;https://doi.org/10.5281/ZENODO.10610924&lt;/a&gt; (2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."&gt;&lt;p class="c-article-references__text" id="ref-CR36"&gt;Andrews, R., Fu, B., Toomey, C. E., Breiter, J. C. &amp;amp; Lee, S. F. Direct visualisation of alpha-synuclein oligomers in human brain tissue—processed data. &lt;i&gt;Aligning Science Across Parkinsons&lt;/i&gt; &lt;a href="https://doi.org/10.5281/ZENODO.10610657" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.5281/ZENODO.10610657"&gt;https://doi.org/10.5281/ZENODO.10610657&lt;/a&gt; (2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."&gt;&lt;p class="c-article-references__text" id="ref-CR37"&gt;Goedert, M., Spillantini, M. G., Del Tredici, K. &amp;amp; Braak, H. 100 years of Lewy pathology. &lt;i&gt;Nat. Rev. Neurol.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, 13–24 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nrneurol.2012.242" data-track-item_id="10.1038/nrneurol.2012.242" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnrneurol.2012.242" aria-label="Article reference 37" data-doi="10.1038/nrneurol.2012.242"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXntlWr" aria-label="CAS reference 37"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=23183883" aria-label="PubMed reference 37"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=100%20years%20of%20Lewy%20pathology&amp;amp;journal=Nat.%20Rev.%20Neurol.&amp;amp;doi=10.1038%2Fnrneurol.2012.242&amp;amp;volume=9&amp;amp;pages=13-24&amp;amp;publication_year=2013&amp;amp;author=Goedert%2CM&amp;amp;author=Spillantini%2CMG&amp;amp;author=Tredici%2CK&amp;amp;author=Braak%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."&gt;&lt;p class="c-article-references__text" id="ref-CR38"&gt;Lee, J.-E. et al. Mapping surface hydrophobicity of α-synuclein oligomers at the nanoscale. &lt;i&gt;Nano Lett.&lt;/i&gt; &lt;b&gt;18&lt;/b&gt;, 7494–7501 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/acs.nanolett.8b02916" data-track-item_id="10.1021/acs.nanolett.8b02916" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Facs.nanolett.8b02916" aria-label="Article reference 38" data-doi="10.1021/acs.nanolett.8b02916"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXitVKiu73M" aria-label="CAS reference 38"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30380895" aria-label="PubMed reference 38"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295917" aria-label="PubMed Central reference 38"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Mapping%20surface%20hydrophobicity%20of%20%CE%B1-synuclein%20oligomers%20at%20the%20nanoscale&amp;amp;journal=Nano%20Lett.&amp;amp;doi=10.1021%2Facs.nanolett.8b02916&amp;amp;volume=18&amp;amp;pages=7494-7501&amp;amp;publication_year=2018&amp;amp;author=Lee%2CJ-E"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."&gt;&lt;p class="c-article-references__text" id="ref-CR39"&gt;Whiten, D. R. et al. Nanoscopic characterisation of individual endogenous protein aggregates in human neuronal cells. &lt;i&gt;ChemBioChem&lt;/i&gt; &lt;b&gt;19&lt;/b&gt;, 2033–2038 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/cbic.201800209" data-track-item_id="10.1002/cbic.201800209" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fcbic.201800209" aria-label="Article reference 39" data-doi="10.1002/cbic.201800209"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXhs1Ort7zK" aria-label="CAS reference 39"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30051958" aria-label="PubMed reference 39"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220870" aria-label="PubMed Central reference 39"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Nanoscopic%20characterisation%20of%20individual%20endogenous%20protein%20aggregates%20in%20human%20neuronal%20cells&amp;amp;journal=ChemBioChem&amp;amp;doi=10.1002%2Fcbic.201800209&amp;amp;volume=19&amp;amp;pages=2033-2038&amp;amp;publication_year=2018&amp;amp;author=Whiten%2CDR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."&gt;&lt;p class="c-article-references__text" id="ref-CR40"&gt;Sahl, S. J. et al. Delayed emergence of subdiffraction-sized mutant huntingtin fibrils following inclusion body formation. &lt;i&gt;Q. Rev. Biophys.&lt;/i&gt; &lt;b&gt;49&lt;/b&gt;, e2 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1017/S0033583515000219" data-track-item_id="10.1017/S0033583515000219" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1017%2FS0033583515000219" aria-label="Article reference 40" data-doi="10.1017/S0033583515000219"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26350150" aria-label="PubMed reference 40"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Delayed%20emergence%20of%20subdiffraction-sized%20mutant%20huntingtin%20fibrils%20following%20inclusion%20body%20formation&amp;amp;journal=Q.%20Rev.%20Biophys.&amp;amp;doi=10.1017%2FS0033583515000219&amp;amp;volume=49&amp;amp;publication_year=2016&amp;amp;author=Sahl%2CSJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."&gt;&lt;p class="c-article-references__text" id="ref-CR41"&gt;Oliveira, V. C. et al. Sudan Black B treatment reduces autofluorescence and improves resolution of in situ hybridization specific fluorescent signals of brain sections. &lt;i&gt;Histol. Histopathol.&lt;/i&gt; &lt;b&gt;25&lt;/b&gt;, 1017–1024 (2010).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DC%2BC3crgsl2nsg%3D%3D" aria-label="CAS reference 41"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=20552552" aria-label="PubMed reference 41"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Sudan%20Black%20B%20treatment%20reduces%20autofluorescence%20and%20improves%20resolution%20of%20in%20situ%20hybridization%20specific%20fluorescent%20signals%20of%20brain%20sections&amp;amp;journal=Histol.%20Histopathol.&amp;amp;volume=25&amp;amp;pages=1017-1024&amp;amp;publication_year=2010&amp;amp;author=Oliveira%2CVC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."&gt;&lt;p class="c-article-references__text" id="ref-CR42"&gt;Luk, K. C. et al. Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;106&lt;/b&gt;, 20051–20056 (2009).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.0908005106" data-track-item_id="10.1073/pnas.0908005106" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.0908005106" aria-label="Article reference 42" data-doi="10.1073/pnas.0908005106"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXhsFGjtLvL" aria-label="CAS reference 42"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=19892735" aria-label="PubMed reference 42"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785290" aria-label="PubMed Central reference 42"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Exogenous%20%CE%B1-synuclein%20fibrils%20seed%20the%20formation%20of%20Lewy%20body-like%20intracellular%20inclusions%20in%20cultured%20cells&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.0908005106&amp;amp;volume=106&amp;amp;pages=20051-20056&amp;amp;publication_year=2009&amp;amp;author=Luk%2CKC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."&gt;&lt;p class="c-article-references__text" id="ref-CR43"&gt;Chen, L. &amp;amp; Feany, M. B. α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a &lt;i&gt;Drosophila&lt;/i&gt; model of Parkinson disease. &lt;i&gt;Nat. Neurosci.&lt;/i&gt; &lt;b&gt;8&lt;/b&gt;, 657–663 (2005).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nn1443" data-track-item_id="10.1038/nn1443" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnn1443" aria-label="Article reference 43" data-doi="10.1038/nn1443"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXjsFyktL0%3D" aria-label="CAS reference 43"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=15834418" aria-label="PubMed reference 43"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=%CE%B1-Synuclein%20phosphorylation%20controls%20neurotoxicity%20and%20inclusion%20formation%20in%20a%20Drosophila%20model%20of%20Parkinson%20disease&amp;amp;journal=Nat.%20Neurosci.&amp;amp;doi=10.1038%2Fnn1443&amp;amp;volume=8&amp;amp;pages=657-663&amp;amp;publication_year=2005&amp;amp;author=Chen%2CL&amp;amp;author=Feany%2CMB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."&gt;&lt;p class="c-article-references__text" id="ref-CR44"&gt;Kahle, P. J. et al. Hyperphosphorylation and insolubility of α‐synuclein in transgenic mouse oligodendrocytes. &lt;i&gt;EMBO Rep.&lt;/i&gt; &lt;b&gt;3&lt;/b&gt;, 583–588 (2002).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/embo-reports/kvf109" data-track-item_id="10.1093/embo-reports/kvf109" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fembo-reports%2Fkvf109" aria-label="Article reference 44" data-doi="10.1093/embo-reports/kvf109"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD38XltVykt74%3D" aria-label="CAS reference 44"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=12034752" aria-label="PubMed reference 44"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1084143" aria-label="PubMed Central reference 44"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Hyperphosphorylation%20and%20insolubility%20of%20%CE%B1%E2%80%90synuclein%20in%20transgenic%20mouse%20oligodendrocytes&amp;amp;journal=EMBO%20Rep.&amp;amp;doi=10.1093%2Fembo-reports%2Fkvf109&amp;amp;volume=3&amp;amp;pages=583-588&amp;amp;publication_year=2002&amp;amp;author=Kahle%2CPJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45."&gt;&lt;p class="c-article-references__text" id="ref-CR45"&gt;Gorbatyuk, O. S. et al. The phosphorylation state of Ser-129 in human α-synuclein determines neurodegeneration in a rat model of Parkinson disease. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;105&lt;/b&gt;, 763–768 (2008).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.0711053105" data-track-item_id="10.1073/pnas.0711053105" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.0711053105" aria-label="Article reference 45" data-doi="10.1073/pnas.0711053105"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXpvFOqtA%3D%3D" aria-label="CAS reference 45"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=18178617" aria-label="PubMed reference 45"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206610" aria-label="PubMed Central reference 45"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20phosphorylation%20state%20of%20Ser-129%20in%20human%20%CE%B1-synuclein%20determines%20neurodegeneration%20in%20a%20rat%20model%20of%20Parkinson%20disease&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.0711053105&amp;amp;volume=105&amp;amp;pages=763-768&amp;amp;publication_year=2008&amp;amp;author=Gorbatyuk%2COS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="46."&gt;&lt;p class="c-article-references__text" id="ref-CR46"&gt;Fujiwara, H. et al. α-Synuclein is phosphorylated in synucleinopathy lesions. &lt;i&gt;Nat. Cell Biol.&lt;/i&gt; &lt;b&gt;4&lt;/b&gt;, 160–164 (2002).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ncb748" data-track-item_id="10.1038/ncb748" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fncb748" aria-label="Article reference 46" data-doi="10.1038/ncb748"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD38XhsVKnur4%3D" aria-label="CAS reference 46"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=11813001" aria-label="PubMed reference 46"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=%CE%B1-Synuclein%20is%20phosphorylated%20in%20synucleinopathy%20lesions&amp;amp;journal=Nat.%20Cell%20Biol.&amp;amp;doi=10.1038%2Fncb748&amp;amp;volume=4&amp;amp;pages=160-164&amp;amp;publication_year=2002&amp;amp;author=Fujiwara%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="47."&gt;&lt;p class="c-article-references__text" id="ref-CR47"&gt;Janezic, S. et al. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;110&lt;/b&gt;, E4016–E4025 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.1309143110" data-track-item_id="10.1073/pnas.1309143110" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.1309143110" aria-label="Article reference 47" data-doi="10.1073/pnas.1309143110"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXhslejtr7L" aria-label="CAS reference 47"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24082145" aria-label="PubMed reference 47"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3801069" aria-label="PubMed Central reference 47"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Deficits%20in%20dopaminergic%20transmission%20precede%20neuron%20loss%20and%20dysfunction%20in%20a%20new%20Parkinson%20model&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.1309143110&amp;amp;volume=110&amp;amp;pages=E4016-E4025&amp;amp;publication_year=2013&amp;amp;author=Janezic%2CS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="48."&gt;&lt;p class="c-article-references__text" id="ref-CR48"&gt;Needham, L.-M. et al. ThX—a next-generation probe for the early detection of amyloid aggregates. &lt;i&gt;Chem. Sci.&lt;/i&gt; &lt;b&gt;11&lt;/b&gt;, 4578–4583 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1039/C9SC04730A" data-track-item_id="10.1039/C9SC04730A" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1039%2FC9SC04730A" aria-label="Article reference 48" data-doi="10.1039/C9SC04730A"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXjsVOqu7g%3D" aria-label="CAS reference 48"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=34122915" aria-label="PubMed reference 48"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159457" aria-label="PubMed Central reference 48"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=ThX%E2%80%94a%20next-generation%20probe%20for%20the%20early%20detection%20of%20amyloid%20aggregates&amp;amp;journal=Chem.%20Sci.&amp;amp;doi=10.1039%2FC9SC04730A&amp;amp;volume=11&amp;amp;pages=4578-4583&amp;amp;publication_year=2020&amp;amp;author=Needham%2CL-M"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="49."&gt;&lt;p class="c-article-references__text" id="ref-CR49"&gt;Born, M. &amp;amp; Wolf, E. &lt;i&gt;Principles of Optics: Electromagnetic Theory of Propagation, Interference and Diffraction of Light.&lt;/i&gt; (Cambridge Univ. Press, 1999).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1017/CBO9781139644181" data-track-item_id="10.1017/CBO9781139644181" data-track-value="book reference" data-track-action="book reference" href="https://doi.org/10.1017%2FCBO9781139644181" aria-label="Book reference 49" data-doi="10.1017/CBO9781139644181"&gt;Book&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Principles%20of%20Optics%3A%20Electromagnetic%20Theory%20of%20Propagation%2C%20Interference%20and%20Diffraction%20of%20Light.&amp;amp;doi=10.1017%2FCBO9781139644181&amp;amp;publication_year=1999&amp;amp;author=Born%2CM&amp;amp;author=Wolf%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="50."&gt;&lt;p class="c-article-references__text" id="ref-CR50"&gt;Abbe Ernst. beiträge zur theorie des mikroskops und der mikroskopischen wahrnehmung. &lt;i&gt;Arch. mikrosk. Anat.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, 413–468 (1873).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/BF02956173" data-track-item_id="10.1007/BF02956173" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/BF02956173" aria-label="Article reference 50" data-doi="10.1007/BF02956173"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Ernst.%20beitr%C3%A4ge%20zur%20theorie%20des%20mikroskops%20und%20der%20mikroskopischen%20wahrnehmung&amp;amp;journal=Arch.%20mikrosk.%20Anat.&amp;amp;doi=10.1007%2FBF02956173&amp;amp;volume=9&amp;amp;pages=413-468&amp;amp;publication_year=1873&amp;amp;author=Abbe%2C"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="51."&gt;&lt;p class="c-article-references__text" id="ref-CR51"&gt;&lt;i&gt;Single-Molecule Techniques: a Laboratory Manual&lt;/i&gt; (Cold Spring Harbor Laboratory Press, 2008).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="52."&gt;&lt;p class="c-article-references__text" id="ref-CR52"&gt;Hanna, M. G. et al. Whole slide imaging equivalency and efficiency study: experience at a large academic center. &lt;i&gt;Mod. Pathol.&lt;/i&gt; &lt;b&gt;32&lt;/b&gt;, 916–928 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41379-019-0205-0" data-track-item_id="10.1038/s41379-019-0205-0" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41379-019-0205-0" aria-label="Article reference 52" data-doi="10.1038/s41379-019-0205-0"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30778169" aria-label="PubMed reference 52"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 52" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Whole%20slide%20imaging%20equivalency%20and%20efficiency%20study%3A%20experience%20at%20a%20large%20academic%20center&amp;amp;journal=Mod.%20Pathol.&amp;amp;doi=10.1038%2Fs41379-019-0205-0&amp;amp;volume=32&amp;amp;pages=916-928&amp;amp;publication_year=2019&amp;amp;author=Hanna%2CMG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="53."&gt;&lt;p class="c-article-references__text" id="ref-CR53"&gt;Fu, B. et al. RASP: optimal single puncta detection in complex cellular backgrounds. &lt;i&gt;J. Phys. Chem. B&lt;/i&gt; &lt;b&gt;128&lt;/b&gt;, 3585–3597 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/acs.jpcb.4c00174" data-track-item_id="10.1021/acs.jpcb.4c00174" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Facs.jpcb.4c00174" aria-label="Article reference 53" data-doi="10.1021/acs.jpcb.4c00174"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXns12rt7s%3D" aria-label="CAS reference 53"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38593280" aria-label="PubMed reference 53"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11033865" aria-label="PubMed Central reference 53"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=RASP%3A%20optimal%20single%20puncta%20detection%20in%20complex%20cellular%20backgrounds&amp;amp;journal=J.%20Phys.%20Chem.%20B&amp;amp;doi=10.1021%2Facs.jpcb.4c00174&amp;amp;volume=128&amp;amp;pages=3585-3597&amp;amp;publication_year=2024&amp;amp;author=Fu%2CB"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="54."&gt;&lt;p class="c-article-references__text" id="ref-CR54"&gt;Hosken, J. W. J. Ricker wavelets in their various guises. &lt;i&gt;First Break&lt;/i&gt; &lt;b&gt;6&lt;/b&gt;, (1988).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="55."&gt;&lt;p class="c-article-references__text" id="ref-CR55"&gt;Spillantini, M. G. et al. α-Synuclein in Lewy bodies. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;388&lt;/b&gt;, 839–840 (1997).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/42166" data-track-item_id="10.1038/42166" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2F42166" aria-label="Article reference 55" data-doi="10.1038/42166"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK2sXlslWru7o%3D" aria-label="CAS reference 55"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=9278044" aria-label="PubMed reference 55"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 55" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=%CE%B1-Synuclein%20in%20Lewy%20bodies&amp;amp;journal=Nature&amp;amp;doi=10.1038%2F42166&amp;amp;volume=388&amp;amp;pages=839-840&amp;amp;publication_year=1997&amp;amp;author=Spillantini%2CMG"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="56."&gt;&lt;p class="c-article-references__text" id="ref-CR56"&gt;Jellinger, K. A. A critical reappraisal of current staging of Lewy-related pathology in human brain. &lt;i&gt;Acta Neuropathol.&lt;/i&gt; &lt;b&gt;116&lt;/b&gt;, 1–16 (2008).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s00401-008-0406-y" data-track-item_id="10.1007/s00401-008-0406-y" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00401-008-0406-y" aria-label="Article reference 56" data-doi="10.1007/s00401-008-0406-y"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXosVOjtbw%3D" aria-label="CAS reference 56"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=18592254" aria-label="PubMed reference 56"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 56" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=A%20critical%20reappraisal%20of%20current%20staging%20of%20Lewy-related%20pathology%20in%20human%20brain&amp;amp;journal=Acta%20Neuropathol.&amp;amp;doi=10.1007%2Fs00401-008-0406-y&amp;amp;volume=116&amp;amp;pages=1-16&amp;amp;publication_year=2008&amp;amp;author=Jellinger%2CKA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="57."&gt;&lt;p class="c-article-references__text" id="ref-CR57"&gt;Jellinger, K. A. α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study. &lt;i&gt;Acta Neuropathol.&lt;/i&gt; &lt;b&gt;106&lt;/b&gt;, 191–202 (2003).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1007/s00401-003-0725-y" data-track-item_id="10.1007/s00401-003-0725-y" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00401-003-0725-y" aria-label="Article reference 57" data-doi="10.1007/s00401-003-0725-y"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=12845452" aria-label="PubMed reference 57"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 57" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=%CE%B1-Synuclein%20pathology%20in%20Parkinson%E2%80%99s%20and%20Alzheimer%E2%80%99s%20disease%20brain%3A%20incidence%20and%20topographic%20distribution%E2%80%94a%20pilot%20study&amp;amp;journal=Acta%20Neuropathol.&amp;amp;doi=10.1007%2Fs00401-003-0725-y&amp;amp;volume=106&amp;amp;pages=191-202&amp;amp;publication_year=2003&amp;amp;author=Jellinger%2CKA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="58."&gt;&lt;p class="c-article-references__text" id="ref-CR58"&gt;Sharon, R. et al. The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson’s disease. &lt;i&gt;Neuron&lt;/i&gt; &lt;b&gt;37&lt;/b&gt;, 583–595 (2003).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0896-6273(03)00024-2" data-track-item_id="10.1016/S0896-6273(03)00024-2" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0896-6273%2803%2900024-2" aria-label="Article reference 58" data-doi="10.1016/S0896-6273(03)00024-2"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXhvFelt7o%3D" aria-label="CAS reference 58"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=12597857" aria-label="PubMed reference 58"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 58" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20formation%20of%20highly%20soluble%20oligomers%20of%20%CE%B1-synuclein%20is%20regulated%20by%20fatty%20acids%20and%20enhanced%20in%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Neuron&amp;amp;doi=10.1016%2FS0896-6273%2803%2900024-2&amp;amp;volume=37&amp;amp;pages=583-595&amp;amp;publication_year=2003&amp;amp;author=Sharon%2CR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="59."&gt;&lt;p class="c-article-references__text" id="ref-CR59"&gt;Kramer, M. L. &amp;amp; Schulz-Schaeffer, W. J. Presynaptic α-synuclein aggregates, not lewy bodies, cause neurodegeneration in dementia with lewy bodies. &lt;i&gt;J. Neurosci.&lt;/i&gt; &lt;b&gt;27&lt;/b&gt;, 1405–1410 (2007).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1523/JNEUROSCI.4564-06.2007" data-track-item_id="10.1523/JNEUROSCI.4564-06.2007" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1523%2FJNEUROSCI.4564-06.2007" aria-label="Article reference 59" data-doi="10.1523/JNEUROSCI.4564-06.2007"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXhvFCrurg%3D" aria-label="CAS reference 59"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=17287515" aria-label="PubMed reference 59"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6673583" aria-label="PubMed Central reference 59"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 59" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Presynaptic%20%CE%B1-synuclein%20aggregates%2C%20not%20lewy%20bodies%2C%20cause%20neurodegeneration%20in%20dementia%20with%20lewy%20bodies&amp;amp;journal=J.%20Neurosci.&amp;amp;doi=10.1523%2FJNEUROSCI.4564-06.2007&amp;amp;volume=27&amp;amp;pages=1405-1410&amp;amp;publication_year=2007&amp;amp;author=Kramer%2CML&amp;amp;author=Schulz-Schaeffer%2CWJ"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="60."&gt;&lt;p class="c-article-references__text" id="ref-CR60"&gt;Paleologou, K. E. et al. Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. &lt;i&gt;Brain&lt;/i&gt; &lt;b&gt;132&lt;/b&gt;, 1093–1101 (2008).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/brain/awn349" data-track-item_id="10.1093/brain/awn349" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fbrain%2Fawn349" aria-label="Article reference 60" data-doi="10.1093/brain/awn349"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 60" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Detection%20of%20elevated%20levels%20of%20soluble%20-synuclein%20oligomers%20in%20post-mortem%20brain%20extracts%20from%20patients%20with%20dementia%20with%20Lewy%20bodies&amp;amp;journal=Brain&amp;amp;doi=10.1093%2Fbrain%2Fawn349&amp;amp;volume=132&amp;amp;pages=1093-1101&amp;amp;publication_year=2008&amp;amp;author=Paleologou%2CKE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="61."&gt;&lt;p class="c-article-references__text" id="ref-CR61"&gt;Tokuda, T. et al. Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease. &lt;i&gt;Biochem. Biophys. Res. Commun.&lt;/i&gt; &lt;b&gt;349&lt;/b&gt;, 162–166 (2006).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.bbrc.2006.08.024" data-track-item_id="10.1016/j.bbrc.2006.08.024" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.bbrc.2006.08.024" aria-label="Article reference 61" data-doi="10.1016/j.bbrc.2006.08.024"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD28XpsVKrsb8%3D" aria-label="CAS reference 61"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=16930553" aria-label="PubMed reference 61"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 61" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Decreased%20%CE%B1-synuclein%20in%20cerebrospinal%20fluid%20of%20aged%20individuals%20and%20subjects%20with%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Biochem.%20Biophys.%20Res.%20Commun.&amp;amp;doi=10.1016%2Fj.bbrc.2006.08.024&amp;amp;volume=349&amp;amp;pages=162-166&amp;amp;publication_year=2006&amp;amp;author=Tokuda%2CT"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="62."&gt;&lt;p class="c-article-references__text" id="ref-CR62"&gt;Park, M. J., Cheon, S.-M., Bae, H.-R., Kim, S.-H. &amp;amp; Kim, J. W. Elevated levels of α-synuclein oligomer in the cerebrospinal fluid of drug-naïve patients with parkinson’s disease. &lt;i&gt;J. Clin. Neurol.&lt;/i&gt; &lt;b&gt;7&lt;/b&gt;, 215 (2011).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.3988/jcn.2011.7.4.215" data-track-item_id="10.3988/jcn.2011.7.4.215" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3988%2Fjcn.2011.7.4.215" aria-label="Article reference 62" data-doi="10.3988/jcn.2011.7.4.215"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22259618" aria-label="PubMed reference 62"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259496" aria-label="PubMed Central reference 62"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 62" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Elevated%20levels%20of%20%CE%B1-synuclein%20oligomer%20in%20the%20cerebrospinal%20fluid%20of%20drug-na%C3%AFve%20patients%20with%20parkinson%E2%80%99s%20disease&amp;amp;journal=J.%20Clin.%20Neurol.&amp;amp;doi=10.3988%2Fjcn.2011.7.4.215&amp;amp;volume=7&amp;amp;publication_year=2011&amp;amp;author=Park%2CMJ&amp;amp;author=Cheon%2CS-M&amp;amp;author=Bae%2CH-R&amp;amp;author=Kim%2CS-H&amp;amp;author=Kim%2CJW"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="63."&gt;&lt;p class="c-article-references__text" id="ref-CR63"&gt;Aasly, J. O. et al. Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic &lt;i&gt;LRRK2&lt;/i&gt; mutation carriers. &lt;i&gt;Front. Aging Neurosci.&lt;/i&gt; &lt;b&gt;6&lt;/b&gt;, 248 (2014).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fnagi.2014.00248" data-track-item_id="10.3389/fnagi.2014.00248" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffnagi.2014.00248" aria-label="Article reference 63" data-doi="10.3389/fnagi.2014.00248"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=25309429" aria-label="PubMed reference 63"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174885" aria-label="PubMed Central reference 63"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 63" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Elevated%20levels%20of%20cerebrospinal%20fluid%20%CE%B1-synuclein%20oligomers%20in%20healthy%20asymptomatic%20LRRK2%20mutation%20carriers&amp;amp;journal=Front.%20Aging%20Neurosci.&amp;amp;doi=10.3389%2Ffnagi.2014.00248&amp;amp;volume=6&amp;amp;publication_year=2014&amp;amp;author=Aasly%2CJO"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="64."&gt;&lt;p class="c-article-references__text" id="ref-CR64"&gt;Parnetti, L. et al. Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson’s disease. &lt;i&gt;Mov. Disord.&lt;/i&gt; &lt;b&gt;29&lt;/b&gt;, 1019–1027 (2014).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/mds.25772" data-track-item_id="10.1002/mds.25772" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fmds.25772" aria-label="Article reference 64" data-doi="10.1002/mds.25772"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXhtFyksr3M" aria-label="CAS reference 64"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=24436092" aria-label="PubMed reference 64"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 64" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cerebrospinal%20fluid%20lysosomal%20enzymes%20and%20alpha%E2%80%90synuclein%20in%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Mov.%20Disord.&amp;amp;doi=10.1002%2Fmds.25772&amp;amp;volume=29&amp;amp;pages=1019-1027&amp;amp;publication_year=2014&amp;amp;author=Parnetti%2CL"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="65."&gt;&lt;p class="c-article-references__text" id="ref-CR65"&gt;Majbour, N. K. et al. Cerebrospinal α-synuclein oligomers reflect disease motor severity in DeNoPa longitudinal cohort. &lt;i&gt;Mov. Disord.&lt;/i&gt; &lt;b&gt;36&lt;/b&gt;, 2048–2056 (2021).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/mds.28611" data-track-item_id="10.1002/mds.28611" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fmds.28611" aria-label="Article reference 65" data-doi="10.1002/mds.28611"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXhs1CmsbzM" aria-label="CAS reference 65"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=33978256" aria-label="PubMed reference 65"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 65" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Cerebrospinal%20%CE%B1-synuclein%20oligomers%20reflect%20disease%20motor%20severity%20in%20DeNoPa%20longitudinal%20cohort&amp;amp;journal=Mov.%20Disord.&amp;amp;doi=10.1002%2Fmds.28611&amp;amp;volume=36&amp;amp;pages=2048-2056&amp;amp;publication_year=2021&amp;amp;author=Majbour%2CNK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="66."&gt;&lt;p class="c-article-references__text" id="ref-CR66"&gt;Sekiya, H. et al. Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson’s disease. &lt;i&gt;Acta Neuropathol. Commun.&lt;/i&gt; &lt;b&gt;10&lt;/b&gt;, 133 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s40478-022-01440-6" data-track-item_id="10.1186/s40478-022-01440-6" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s40478-022-01440-6" aria-label="Article reference 66" data-doi="10.1186/s40478-022-01440-6"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XisVentLzO" aria-label="CAS reference 66"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36068646" aria-label="PubMed reference 66"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450240" aria-label="PubMed Central reference 66"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 66" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Discrepancy%20between%20distribution%20of%20alpha-synuclein%20oligomers%20and%20Lewy-related%20pathology%20in%20Parkinson%E2%80%99s%20disease&amp;amp;journal=Acta%20Neuropathol.%20Commun.&amp;amp;doi=10.1186%2Fs40478-022-01440-6&amp;amp;volume=10&amp;amp;publication_year=2022&amp;amp;author=Sekiya%2CH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="67."&gt;&lt;p class="c-article-references__text" id="ref-CR67"&gt;Dettmer, U. et al. Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;6&lt;/b&gt;, 7314 (2015).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ncomms8314" data-track-item_id="10.1038/ncomms8314" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fncomms8314" aria-label="Article reference 67" data-doi="10.1038/ncomms8314"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26076669" aria-label="PubMed reference 67"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 67" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Parkinson-causing%20%CE%B1-synuclein%20missense%20mutations%20shift%20native%20tetramers%20to%20monomers%20as%20a%20mechanism%20for%20disease%20initiation&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fncomms8314&amp;amp;volume=6&amp;amp;publication_year=2015&amp;amp;author=Dettmer%2CU"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="68."&gt;&lt;p class="c-article-references__text" id="ref-CR68"&gt;Ramalingam, N. et al. Dynamic physiological α-synuclein S129 phosphorylation is driven by neuronal activity. &lt;i&gt;npj Parkinsons Dis.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, 4 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41531-023-00444-w" data-track-item_id="10.1038/s41531-023-00444-w" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41531-023-00444-w" aria-label="Article reference 68" data-doi="10.1038/s41531-023-00444-w"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXitFSlurg%3D" aria-label="CAS reference 68"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36646701" aria-label="PubMed reference 68"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842642" aria-label="PubMed Central reference 68"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 68" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Dynamic%20physiological%20%CE%B1-synuclein%20S129%20phosphorylation%20is%20driven%20by%20neuronal%20activity&amp;amp;journal=npj%20Parkinsons%20Dis.&amp;amp;doi=10.1038%2Fs41531-023-00444-w&amp;amp;volume=9&amp;amp;publication_year=2023&amp;amp;author=Ramalingam%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="69."&gt;&lt;p class="c-article-references__text" id="ref-CR69"&gt;Parra-Rivas, L. A. et al. Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function. &lt;i&gt;Neuron&lt;/i&gt; &lt;b&gt;111&lt;/b&gt;, 4006–4023.e10 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.neuron.2023.11.020" data-track-item_id="10.1016/j.neuron.2023.11.020" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.neuron.2023.11.020" aria-label="Article reference 69" data-doi="10.1016/j.neuron.2023.11.020"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXis1OqurrK" aria-label="CAS reference 69"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38128479" aria-label="PubMed reference 69"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10766085" aria-label="PubMed Central reference 69"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 69" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Serine-129%20phosphorylation%20of%20%CE%B1-synuclein%20is%20an%20activity-dependent%20trigger%20for%20physiologic%20protein-protein%20interactions%20and%20synaptic%20function&amp;amp;journal=Neuron&amp;amp;doi=10.1016%2Fj.neuron.2023.11.020&amp;amp;volume=111&amp;amp;pages=4006-4023.e10&amp;amp;publication_year=2023&amp;amp;author=Parra-Rivas%2CLA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="70."&gt;&lt;p class="c-article-references__text" id="ref-CR70"&gt;Horrocks, M. H. et al. Single-molecule imaging of individual amyloid protein aggregates in human biofluids. &lt;i&gt;ACS Chem. Neurosci.&lt;/i&gt; &lt;b&gt;7&lt;/b&gt;, 399–406 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/acschemneuro.5b00324" data-track-item_id="10.1021/acschemneuro.5b00324" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Facschemneuro.5b00324" aria-label="Article reference 70" data-doi="10.1021/acschemneuro.5b00324"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xht1Kgsr4%3D" aria-label="CAS reference 70"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=26800462" aria-label="PubMed reference 70"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 70" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Single-molecule%20imaging%20of%20individual%20amyloid%20protein%20aggregates%20in%20human%20biofluids&amp;amp;journal=ACS%20Chem.%20Neurosci.&amp;amp;doi=10.1021%2Facschemneuro.5b00324&amp;amp;volume=7&amp;amp;pages=399-406&amp;amp;publication_year=2016&amp;amp;author=Horrocks%2CMH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="71."&gt;&lt;p class="c-article-references__text" id="ref-CR71"&gt;Bongiovanni, M. N. et al. Multi-dimensional super-resolution imaging enables surface hydrophobicity mapping. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;7&lt;/b&gt;, 13544 (2016).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/ncomms13544" data-track-item_id="10.1038/ncomms13544" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fncomms13544" aria-label="Article reference 71" data-doi="10.1038/ncomms13544"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XitFamsb%2FF" aria-label="CAS reference 71"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=27929085" aria-label="PubMed reference 71"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155161" aria-label="PubMed Central reference 71"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 71" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Multi-dimensional%20super-resolution%20imaging%20enables%20surface%20hydrophobicity%20mapping&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fncomms13544&amp;amp;volume=7&amp;amp;publication_year=2016&amp;amp;author=Bongiovanni%2CMN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="72."&gt;&lt;p class="c-article-references__text" id="ref-CR72"&gt;Shaib, A. H. et al. One-step nanoscale expansion microscopy reveals individual protein shapes. &lt;i&gt;Nat. Biotechnol.&lt;/i&gt; &lt;a href="https://doi.org/10.1038/s41587-024-02431-9" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1038/s41587-024-02431-9"&gt;https://doi.org/10.1038/s41587-024-02431-9&lt;/a&gt; (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41587-024-02431-9" data-track-item_id="10.1038/s41587-024-02431-9" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41587-024-02431-9" aria-label="Article reference 72" data-doi="10.1038/s41587-024-02431-9"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=39385007" aria-label="PubMed reference 72"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7616833" aria-label="PubMed Central reference 72"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 72" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=One-step%20nanoscale%20expansion%20microscopy%20reveals%20individual%20protein%20shapes&amp;amp;journal=Nat.%20Biotechnol.&amp;amp;doi=10.1038%2Fs41587-024-02431-9&amp;amp;publication_year=2024&amp;amp;author=Shaib%2CAH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="73."&gt;&lt;p class="c-article-references__text" id="ref-CR73"&gt;Angelova, P. R. et al. Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation. &lt;i&gt;Cell Death Differ.&lt;/i&gt; &lt;b&gt;27&lt;/b&gt;, 2781–2796 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41418-020-0542-z" data-track-item_id="10.1038/s41418-020-0542-z" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41418-020-0542-z" aria-label="Article reference 73" data-doi="10.1038/s41418-020-0542-z"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXot1ajurY%3D" aria-label="CAS reference 73"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32341450" aria-label="PubMed reference 73"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492459" aria-label="PubMed Central reference 73"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 73" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Alpha%20synuclein%20aggregation%20drives%20ferroptosis%3A%20an%20interplay%20of%20iron%2C%20calcium%20and%20lipid%20peroxidation&amp;amp;journal=Cell%20Death%20Differ.&amp;amp;doi=10.1038%2Fs41418-020-0542-z&amp;amp;volume=27&amp;amp;pages=2781-2796&amp;amp;publication_year=2020&amp;amp;author=Angelova%2CPR"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="74."&gt;&lt;p class="c-article-references__text" id="ref-CR74"&gt;Celej, M. S. et al. Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure. &lt;i&gt;Biochem. J.&lt;/i&gt; &lt;b&gt;443&lt;/b&gt;, 719–726 (2012).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1042/BJ20111924" data-track-item_id="10.1042/BJ20111924" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1042%2FBJ20111924" aria-label="Article reference 74" data-doi="10.1042/BJ20111924"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38Xls1Shtr4%3D" aria-label="CAS reference 74"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=22316405" aria-label="PubMed reference 74"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 74" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Toxic%20prefibrillar%20%CE%B1-synuclein%20amyloid%20oligomers%20adopt%20a%20distinctive%20antiparallel%20%CE%B2-sheet%20structure&amp;amp;journal=Biochem.%20J.&amp;amp;doi=10.1042%2FBJ20111924&amp;amp;volume=443&amp;amp;pages=719-726&amp;amp;publication_year=2012&amp;amp;author=Celej%2CMS"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="75."&gt;&lt;p class="c-article-references__text" id="ref-CR75"&gt;Varela, J. A. et al. Optical structural analysis of individual α‐synuclein oligomers. &lt;i&gt;Angew. Chem. Int. Ed.&lt;/i&gt; &lt;b&gt;57&lt;/b&gt;, 4886–4890 (2018).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/anie.201710779" data-track-item_id="10.1002/anie.201710779" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fanie.201710779" aria-label="Article reference 75" data-doi="10.1002/anie.201710779"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXlslSiurg%3D" aria-label="CAS reference 75"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 75" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Optical%20structural%20analysis%20of%20individual%20%CE%B1%E2%80%90synuclein%20oligomers&amp;amp;journal=Angew.%20Chem.%20Int.%20Ed.&amp;amp;doi=10.1002%2Fanie.201710779&amp;amp;volume=57&amp;amp;pages=4886-4890&amp;amp;publication_year=2018&amp;amp;author=Varela%2CJA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="76."&gt;&lt;p class="c-article-references__text" id="ref-CR76"&gt;Shahmoradian, S. H. et al. Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. &lt;i&gt;Nat. Neurosci.&lt;/i&gt; &lt;b&gt;22&lt;/b&gt;, 1099–1109 (2019).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41593-019-0423-2" data-track-item_id="10.1038/s41593-019-0423-2" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41593-019-0423-2" aria-label="Article reference 76" data-doi="10.1038/s41593-019-0423-2"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXht1ersrrJ" aria-label="CAS reference 76"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=31235907" aria-label="PubMed reference 76"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 76" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Lewy%20pathology%20in%20Parkinson%E2%80%99s%20disease%20consists%20of%20crowded%20organelles%20and%20lipid%20membranes&amp;amp;journal=Nat.%20Neurosci.&amp;amp;doi=10.1038%2Fs41593-019-0423-2&amp;amp;volume=22&amp;amp;pages=1099-1109&amp;amp;publication_year=2019&amp;amp;author=Shahmoradian%2CSH"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="77."&gt;&lt;p class="c-article-references__text" id="ref-CR77"&gt;Mahul-Mellier, A.-L. et al. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration. &lt;i&gt;Proc. Natl Acad. Sci. USA&lt;/i&gt; &lt;b&gt;117&lt;/b&gt;, 4971–4982 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1073/pnas.1913904117" data-track-item_id="10.1073/pnas.1913904117" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1073%2Fpnas.1913904117" aria-label="Article reference 77" data-doi="10.1073/pnas.1913904117"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXksVSrtLo%3D" aria-label="CAS reference 77"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=32075919" aria-label="PubMed reference 77"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060668" aria-label="PubMed Central reference 77"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 77" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=The%20process%20of%20Lewy%20body%20formation%2C%20rather%20than%20simply%20%CE%B1-synuclein%20fibrillization%2C%20is%20one%20of%20the%20major%20drivers%20of%20neurodegeneration&amp;amp;journal=Proc.%20Natl%20Acad.%20Sci.%20USA&amp;amp;doi=10.1073%2Fpnas.1913904117&amp;amp;volume=117&amp;amp;pages=4971-4982&amp;amp;publication_year=2020&amp;amp;author=Mahul-Mellier%2CA-L"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="78."&gt;&lt;p class="c-article-references__text" id="ref-CR78"&gt;Wiseman, J. A. et al. Aggregate-prone brain regions in Parkinson’s disease are rich in unique N-terminus α-synuclein conformers with high proteolysis susceptibility. &lt;i&gt;NPJ Parkinsons Dis.&lt;/i&gt; &lt;b&gt;10&lt;/b&gt;, 1 (2024).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41531-023-00614-w" data-track-item_id="10.1038/s41531-023-00614-w" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41531-023-00614-w" aria-label="Article reference 78" data-doi="10.1038/s41531-023-00614-w"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXpsVOiuw%3D%3D" aria-label="CAS reference 78"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=38167744" aria-label="PubMed reference 78"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10762179" aria-label="PubMed Central reference 78"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 78" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Aggregate-prone%20brain%20regions%20in%20Parkinson%E2%80%99s%20disease%20are%20rich%20in%20unique%20N-terminus%20%CE%B1-synuclein%20conformers%20with%20high%20proteolysis%20susceptibility&amp;amp;journal=NPJ%20Parkinsons%20Dis.&amp;amp;doi=10.1038%2Fs41531-023-00614-w&amp;amp;volume=10&amp;amp;publication_year=2024&amp;amp;author=Wiseman%2CJA"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="79."&gt;&lt;p class="c-article-references__text" id="ref-CR79"&gt;Altay, M. F. et al. Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases. &lt;i&gt;npj Parkinson’s Dis.&lt;/i&gt; &lt;b&gt;9&lt;/b&gt;, 161 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41531-023-00604-y" data-track-item_id="10.1038/s41531-023-00604-y" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41531-023-00604-y" aria-label="Article reference 79" data-doi="10.1038/s41531-023-00604-y"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXisFOgtL7F" aria-label="CAS reference 79"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 79" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Development%20and%20validation%20of%20an%20expanded%20antibody%20toolset%20that%20captures%20alpha-synuclein%20pathological%20diversity%20in%20Lewy%20body%20diseases&amp;amp;journal=npj%20Parkinson%E2%80%99s%20Dis.&amp;amp;doi=10.1038%2Fs41531-023-00604-y&amp;amp;volume=9&amp;amp;publication_year=2023&amp;amp;author=Altay%2CMF"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="80."&gt;&lt;p class="c-article-references__text" id="ref-CR80"&gt;Chung, K. et al. Structural and molecular interrogation of intact biological systems. &lt;i&gt;Nature&lt;/i&gt; &lt;b&gt;497&lt;/b&gt;, 332–337 (2013).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature12107" data-track-item_id="10.1038/nature12107" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature12107" aria-label="Article reference 80" data-doi="10.1038/nature12107"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXlslSkurg%3D" aria-label="CAS reference 80"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=23575631" aria-label="PubMed reference 80"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092167" aria-label="PubMed Central reference 80"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 80" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Structural%20and%20molecular%20interrogation%20of%20intact%20biological%20systems&amp;amp;journal=Nature&amp;amp;doi=10.1038%2Fnature12107&amp;amp;volume=497&amp;amp;pages=332-337&amp;amp;publication_year=2013&amp;amp;author=Chung%2CK"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="81."&gt;&lt;p class="c-article-references__text" id="ref-CR81"&gt;Andrews, R. Single-molecule antibody slides for fluorescence microscopy V1. &lt;i&gt;Protocols.io&lt;/i&gt; &lt;a href="https://doi.org/10.17504/protocols.io.ewov1qbbygr2/v1" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.17504/protocols.io.ewov1qbbygr2/v1"&gt;https://doi.org/10.17504/protocols.io.ewov1qbbygr2/v1&lt;/a&gt; (University of Cambridge, 2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="82."&gt;&lt;p class="c-article-references__text" id="ref-CR82"&gt;Breiter, J. Free-floating mouse brain immunohistochemistry V1. &lt;i&gt;Protocols.io&lt;/i&gt; &lt;a href="https://doi.org/10.17504/protocols.io.261ged3j7v47/v1" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.17504/protocols.io.261ged3j7v47/v1"&gt;https://doi.org/10.17504/protocols.io.261ged3j7v47/v1&lt;/a&gt; (University of Cambridge, 2023).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="83."&gt;&lt;p class="c-article-references__text" id="ref-CR83"&gt;Andrews, R. &amp;amp; Lachica, J. Single-molecule immunofluorescence tissue staining protocol for oligomer imaging V2. &lt;i&gt;Protocols.io&lt;/i&gt; &lt;a href="https://doi.org/10.17504/protocols.io.5qpvorp6bv4o/v2" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.17504/protocols.io.5qpvorp6bv4o/v2"&gt;https://doi.org/10.17504/protocols.io.5qpvorp6bv4o/v2&lt;/a&gt; (University of Cambridge and University College London, 2023).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="84."&gt;&lt;p class="c-article-references__text" id="ref-CR84"&gt;Fu, B. Direct visualisation of alpha-synuclein oligomers in human brain. &lt;i&gt;Zenodo&lt;/i&gt; &lt;a href="https://doi.org/10.5281/ZENODO.8319436" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.5281/ZENODO.8319436"&gt;https://doi.org/10.5281/ZENODO.8319436&lt;/a&gt; (2024).&lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="85."&gt;&lt;p class="c-article-references__text" id="ref-CR85"&gt;Tang, X., Ibanez, F. &amp;amp; Tamborindeguy, C. Quenching autofluorescence in the alimentary canal tissues of &lt;i&gt;Bactericera cockerelli&lt;/i&gt; (Hemiptera: Triozidae) for immunofluorescence labeling. &lt;i&gt;Insect Sci.&lt;/i&gt; &lt;b&gt;27&lt;/b&gt;, 475–486 (2020).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/1744-7917.12660" data-track-item_id="10.1111/1744-7917.12660" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2F1744-7917.12660" aria-label="Article reference 85" data-doi="10.1111/1744-7917.12660"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXnvVOhu7s%3D" aria-label="CAS reference 85"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=30663253" aria-label="PubMed reference 85"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 85" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Quenching%20autofluorescence%20in%20the%20alimentary%20canal%20tissues%20of%20Bactericera%20cockerelli%20%28Hemiptera%3A%20Triozidae%29%20for%20immunofluorescence%20labeling&amp;amp;journal=Insect%20Sci.&amp;amp;doi=10.1111%2F1744-7917.12660&amp;amp;volume=27&amp;amp;pages=475-486&amp;amp;publication_year=2020&amp;amp;author=Tang%2CX&amp;amp;author=Ibanez%2CF&amp;amp;author=Tamborindeguy%2CC"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="86."&gt;&lt;p class="c-article-references__text" id="ref-CR86"&gt;Koga, R., Tsuchida, T. &amp;amp; Fukatsu, T. Quenching autofluorescence of insect tissues for in situ detection of endosymbionts. &lt;i&gt;Appl. Entomol. Zool.&lt;/i&gt; &lt;b&gt;44&lt;/b&gt;, 281–291 (2009).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1303/aez.2009.281" data-track-item_id="10.1303/aez.2009.281" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1303%2Faez.2009.281" aria-label="Article reference 86" data-doi="10.1303/aez.2009.281"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXnslWgsr8%3D" aria-label="CAS reference 86"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 86" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Quenching%20autofluorescence%20of%20insect%20tissues%20for%20in%20situ%20detection%20of%20endosymbionts&amp;amp;journal=Appl.%20Entomol.%20Zool.&amp;amp;doi=10.1303%2Faez.2009.281&amp;amp;volume=44&amp;amp;pages=281-291&amp;amp;publication_year=2009&amp;amp;author=Koga%2CR&amp;amp;author=Tsuchida%2CT&amp;amp;author=Fukatsu%2CT"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="87."&gt;&lt;p class="c-article-references__text" id="ref-CR87"&gt;Toomey, C. E. et al. Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s. &lt;i&gt;Acta Neuropathol. Commun.&lt;/i&gt; &lt;b&gt;10&lt;/b&gt;, 134 (2022).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s40478-022-01424-6" data-track-item_id="10.1186/s40478-022-01424-6" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s40478-022-01424-6" aria-label="Article reference 87" data-doi="10.1186/s40478-022-01424-6"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XisVentLvN" aria-label="CAS reference 87"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36076304" aria-label="PubMed reference 87"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461181" aria-label="PubMed Central reference 87"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 87" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Mitochondrial%20dysfunction%20is%20a%20key%20pathological%20driver%20of%20early%20stage%20Parkinson%E2%80%99s&amp;amp;journal=Acta%20Neuropathol.%20Commun.&amp;amp;doi=10.1186%2Fs40478-022-01424-6&amp;amp;volume=10&amp;amp;publication_year=2022&amp;amp;author=Toomey%2CCE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="88."&gt;&lt;p class="c-article-references__text" id="ref-CR88"&gt;Jenkins, E. et al. Antigen discrimination by T cells relies on size-constrained microvillar contact. &lt;i&gt;Nat. Commun.&lt;/i&gt; &lt;b&gt;14&lt;/b&gt;, 1611 (2023).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41467-023-36855-9" data-track-item_id="10.1038/s41467-023-36855-9" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41467-023-36855-9" aria-label="Article reference 88" data-doi="10.1038/s41467-023-36855-9"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXmsV2lt7c%3D" aria-label="CAS reference 88"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=36959206" aria-label="PubMed reference 88"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036606" aria-label="PubMed Central reference 88"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 88" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Antigen%20discrimination%20by%20T%20cells%20relies%20on%20size-constrained%20microvillar%20contact&amp;amp;journal=Nat.%20Commun.&amp;amp;doi=10.1038%2Fs41467-023-36855-9&amp;amp;volume=14&amp;amp;publication_year=2023&amp;amp;author=Jenkins%2CE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="89."&gt;&lt;p class="c-article-references__text" id="ref-CR89"&gt;Rueden, C. T. et al. ImageJ2: ImageJ for the next generation of scientific image data. &lt;i&gt;BMC Bioinforma.&lt;/i&gt; &lt;b&gt;18&lt;/b&gt;, 529 (2017).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="noopener" data-track-label="10.1186/s12859-017-1934-z" data-track-item_id="10.1186/s12859-017-1934-z" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s12859-017-1934-z" aria-label="Article reference 89" data-doi="10.1186/s12859-017-1934-z"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 89" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=ImageJ2%3A%20ImageJ%20for%20the%20next%20generation%20of%20scientific%20image%20data&amp;amp;journal=BMC%20Bioinforma.&amp;amp;doi=10.1186%2Fs12859-017-1934-z&amp;amp;volume=18&amp;amp;publication_year=2017&amp;amp;author=Rueden%2CCT"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="90."&gt;&lt;p class="c-article-references__text" id="ref-CR90"&gt;Edelstein, A., Amodaj, N., Hoover, K., Vale, R. &amp;amp; Stuurman, N. Computer control of microscopes using µManager. &lt;i&gt;Comput. Mol. Biol.&lt;/i&gt; &lt;b&gt;92&lt;/b&gt;, 7.10.1–A.6.19 (2010).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 90" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Computer%20control%20of%20microscopes%20using%20%C2%B5Manager&amp;amp;journal=Comput.%20Mol.%20Biol.&amp;amp;volume=92&amp;amp;pages=7.10.1-A.6.19&amp;amp;publication_year=2010&amp;amp;author=Edelstein%2CA&amp;amp;author=Amodaj%2CN&amp;amp;author=Hoover%2CK&amp;amp;author=Vale%2CR&amp;amp;author=Stuurman%2CN"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;li class="c-article-references__item js-c-reading-companion-references-item" data-counter="91."&gt;&lt;p class="c-article-references__text" id="ref-CR91"&gt;Thompson, M. A., Lew, M. D., Badieirostami, M. &amp;amp; Moerner, W. E. Localizing and tracking single nanoscale emitters in three dimensions with high spatiotemporal resolution using a double-helix point spread function. &lt;i&gt;Nano Lett.&lt;/i&gt; &lt;b&gt;10&lt;/b&gt;, 211–218 (2010).&lt;/p&gt;&lt;p class="c-article-references__links u-hide-print"&gt;&lt;a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/nl903295p" data-track-item_id="10.1021/nl903295p" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Fnl903295p" aria-label="Article reference 91" data-doi="10.1021/nl903295p"&gt;Article&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXhsFGku77F" aria-label="CAS reference 91"&gt;CAS&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;dopt=Abstract&amp;amp;list_uids=20000821" aria-label="PubMed reference 91"&gt;PubMed&lt;/a&gt; 
    &lt;a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806512" aria-label="PubMed Central reference 91"&gt;PubMed Central&lt;/a&gt; 
    &lt;a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 91" href="http://scholar.google.com/scholar_lookup?&amp;amp;title=Localizing%20and%20tracking%20single%20nanoscale%20emitters%20in%20three%20dimensions%20with%20high%20spatiotemporal%20resolution%20using%20a%20double-helix%20point%20spread%20function&amp;amp;journal=Nano%20Lett.&amp;amp;doi=10.1021%2Fnl903295p&amp;amp;volume=10&amp;amp;pages=211-218&amp;amp;publication_year=2010&amp;amp;author=Thompson%2CMA&amp;amp;author=Lew%2CMD&amp;amp;author=Badieirostami%2CM&amp;amp;author=Moerner%2CWE"&gt;
                    Google Scholar&lt;/a&gt; 
                &lt;/p&gt;&lt;/li&gt;&lt;/ol&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 01 Oct 2025 11:29:22 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE5SQUVVdGlYakF3VWtmbVVfZk8xV2ZUTGY3V0tEb2ljYmp3WG5YVFZ0VUdrVDVyalhYSmNwUm1BU3FKSjBmLUV4Zmc4RzhTbHFLVFVrUXFCc0tZU0NEWmtF</guid></item><item><title>60岁以上？是的，您可以锻炼肌肉-方法如下-良好的客房清洁服务</title><link>https://www.goodhousekeeping.com/uk/health/a68113689/over-60-weights/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div data-journey-body="standard-article" class="article-body-content article-body standard-body-content css-1co9szl et2g3wt7"&gt;&lt;p data-node-id="0" class="body_content_break_0"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="1" class="css-15wnvw5 emevuu60"&gt;To live a long, healthy life, you need plenty of muscle... the trouble is, we can start losing muscle mass in our 30s. So what can we do to build it up and sustain it when our own bodies are working against us? The good news is that hitting your 60s doesn’t mean you can’t increase your bulk; it just takes a little more intention when it comes to your training, diet and even the way you prioritise your sleep.&lt;/p&gt;&lt;p data-node-id="2" class="piano-inline-newsletter"&gt;&lt;/p&gt;&lt;p data-node-id="3" class="body_content_break_1"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="4" class="css-15wnvw5 emevuu60"&gt;‘As we age, the body naturally loses muscle mass and strength – a process called sarcopenia, which typically begins in your 30s but accelerates after 60,’ explains Rowan Clift, trainer specialist at &lt;a href="https://go.redirectingat.com?id=127X1143637&amp;amp;url=http%3A%2F%2Fwww.freeletics.com" data-vars-ga-outbound-link="http://www.freeletics.com" data-vars-ga-ux-element="Hyperlink" data-vars-ga-call-to-action="Freeletics" data-vars-ga-product-id="6c6b4413-d6a7-42dc-96d2-4f730322c3b0" rel="nofollow" data-node-id="4.1" data-href="http://www.freeletics.com" data-product-url="http://www.freeletics.com" data-affiliate="true" data-affiliate-url="https://go.redirectingat.com?id=127X1143637&amp;amp;url=http%3A%2F%2Fwww.freeletics.com" data-affiliate-network='{"afflink_redirect":"/_p/afflink/yG9p/freeletics-intensive-workouts-individual-training","site_id":"576e18cc-e59d-42ae-9efb-29fb01df5a48","network":{"name":"Skimlinks"}}' data-vars-ga-product-price="$0.00" data-vars-ga-product-retailer-id="a4eb753a-9125-4353-8e5a-8ab3d1335907" data-vars-ga-link-treatment="(not set) | (not set)" class="body-link product-links css-h40fkh e1aq0z090"&gt;&lt;u data-node-id="4.1.0"&gt;Freeletics&lt;/u&gt;&lt;/a&gt;. &lt;/p&gt;&lt;p data-node-id="5" class="body_content_break_2"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="6" class="css-15wnvw5 emevuu60"&gt;He adds that, for women, hormonal changes after menopause, particularly the decline in oestrogen, make it more difficult for muscles to repair and grow. ‘In addition, oestrogen has a protective effect on muscle and bone, so a reduction means slower recovery, reduced strength gains and an increased risk of injury when training.’&lt;/p&gt;&lt;p id="piano-paywall-container" data-node-id="8" class="piano-container"&gt;&lt;/p&gt;&lt;p data-node-id="10" class="body_content_break_3"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="11" class="css-15wnvw5 emevuu60"&gt;But good muscle definition is entirely possible if you approach it the right way. And it’s never too late to start. ‘As we age, strength training becomes ever more important; not only does it help us build muscle, but helps to protect our bones, elevates our mood and even boosts our metabolism,’ says Rowan.&lt;/p&gt;&lt;h2 data-node-id="12" class="body-h3 css-kh2ktv emevuu60"&gt;Here’s how to do it:&lt;br data-node-id="12.1"&gt;&lt;/h2&gt;&lt;p data-node-id="13" class="body_content_break_4"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="14" class="body-text css-15wnvw5 emevuu60"&gt;&lt;strong data-node-id="14.0"&gt;Stay consistent &lt;/strong&gt;&lt;/p&gt;&lt;ol data-node-id="15" class="css-kw9lqy emevuu60"&gt;&lt;/ol&gt;&lt;p data-node-id="16" class="body_content_break_5"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="17" class="body-text css-15wnvw5 emevuu60"&gt;Nobody’s suggesting you strength train every day, says Rowan. In fact, two to three strength sessions a week are enough. ‘This strikes the right balance between providing enough stimulus for muscles to adapt and grow and allowing sufficient recovery time,’ he adds. Be careful not to overtrain, as this could increase ‘the risk of overuse injuries, especially in older joints and connective tissues.’ And you don’t have to work out in a gym – a floor mat with light dumbbells and resistance bands is all you need to get going. &lt;br data-node-id="17.1"&gt;&lt;br data-node-id="17.2"&gt;&lt;strong data-node-id="17.3"&gt;Prioritise compound movements&lt;/strong&gt;&lt;/p&gt;&lt;ol data-node-id="18" class="css-kw9lqy emevuu60"&gt;&lt;/ol&gt;&lt;p data-node-id="19" class="body_content_break_6"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="20" class="css-15wnvw5 emevuu60"&gt;A compound movement is an exercise which engages ‘multiple muscle groups at once, performed with resistance heavy enough that you reach fatigue,’ according to Rowan. The great benefit of these exercises is that they mimic movements we make in everyday life, making it easier to climb stairs, lift shopping and get up from the floor.&lt;/p&gt;&lt;p data-node-id="21" class="body_content_break_7"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="22" class="css-15wnvw5 emevuu60"&gt;If you’ve never picked up a dumbbell or a barbell in your life, start with a small 2kg weight, or even a can of beans from your cupboard – and progress upwards. So, what would a typical compound workout look like? Think squats, lunges and push-ups for a well-rounded strength training workout, says Rowan. &lt;/p&gt;&lt;p data-node-id="23" class="body_content_break_8"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="24" class="css-15wnvw5 emevuu60"&gt;If you’re a beginner, start with 10 reps of each exercise, holding the weights on your shoulders for squats and lunges. Work through the movements, then repeat the workout three times.&lt;/p&gt;&lt;p data-node-id="25" class="body_content_break_9"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="26" class="css-15wnvw5 emevuu60"&gt;If you prefer an instructor to guide you through a workout, download an app, such as Freeletics or &lt;a href="https://www.onepeloton.com/en-GB/classes/strength" data-vars-ga-outbound-link="https://www.onepeloton.com/en-GB/classes/strength" data-vars-ga-ux-element="Hyperlink" data-vars-ga-call-to-action="Peloton" data-vars-ga-product-id="be3dcbf3-5038-4490-a70f-8a90bac26182" rel="nofollow" data-node-id="26.1" data-href="https://www.onepeloton.com/en-GB/classes/strength" data-product-url="https://www.onepeloton.com/en-GB/classes/strength" data-affiliate="false" data-affiliate-network data-vars-ga-product-price="$0.00" data-vars-ga-product-retailer-id="cb4685d9-9261-4335-9543-2ad2f44fd14e" data-vars-ga-link-treatment="(not set) | (not set)" class="body-link product-links css-h40fkh e1aq0z090"&gt;Peloton&lt;/a&gt;, which have structured strength workouts for all abilities. After a couple of months of doing regular workouts, you’ll start to feel stronger in your day-to-day life, too. &lt;/p&gt;&lt;p data-node-id="27" class="body_content_break_10"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="28" class="css-15wnvw5 emevuu60"&gt;&lt;strong data-node-id="28.0"&gt;No weights? No problem! &lt;/strong&gt;&lt;/p&gt;&lt;p data-node-id="29" class="body_content_break_11"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="30" class="css-15wnvw5 emevuu60"&gt;Rowan recommends resistance band training, pilates with added resistance, water-based resistance training (such as aqua aerobics) or controlled bodyweight exercises. ‘The key is creating sufficient muscle tension, regardless of whether the movement is high or low impact,’ he says. &lt;/p&gt;&lt;p data-node-id="31" class="body_content_break_12"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="32" class="css-15wnvw5 emevuu60"&gt;Resistance band training can be very versatile, as bands come in different tensions, so they’re great for beginners, while also being gentle on joints. The &lt;a href="https://www.onepeloton.com/en-GB/classes/strength/resistance-bands" data-vars-ga-outbound-link="https://www.onepeloton.com/en-GB/classes/strength/resistance-bands" data-vars-ga-ux-element="Hyperlink" data-vars-ga-call-to-action="Peloton app has various resistance band classes" data-vars-ga-product-id="2450a9d0-4548-42cf-aacb-848f5614a92c" rel="nofollow" data-node-id="32.1" data-href="https://www.onepeloton.com/en-GB/classes/strength/resistance-bands" data-product-url="https://www.onepeloton.com/en-GB/classes/strength/resistance-bands" data-affiliate="false" data-affiliate-network data-vars-ga-product-price="$0.00" data-vars-ga-product-retailer-id="6d0fa43b-4389-4807-b994-1dc102cb7b3a" data-vars-ga-link-treatment="(not set) | (not set)" class="body-link product-links css-h40fkh e1aq0z090"&gt;Peloton app has various resistance band classes&lt;/a&gt;, while YouTube also has various &lt;a href="https://www.youtube.com/results?search_query=beginner+resistance+band+workout" data-vars-ga-outbound-link="https://www.youtube.com/results?search_query=beginner+resistance+band+workout" data-vars-ga-ux-element="Hyperlink" data-vars-ga-call-to-action="beginner classes." data-node-id="32.3" class="body-link css-h40fkh emevuu60"&gt;beginner classes.&lt;/a&gt; &lt;/p&gt;&lt;p data-node-id="33" class="body_content_break_13"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="34" class="css-15wnvw5 emevuu60"&gt; Body weight exercises, which use the weight of your body to create resistance and build strength, include push-ups, squats and the plank. For guidance or to follow a specific body weight workout plan, try &lt;a href="https://www.youtube.com/results?search_query=bodyweight+workout+beginner" data-vars-ga-outbound-link="https://www.youtube.com/results?search_query=bodyweight+workout+beginner" data-vars-ga-ux-element="Hyperlink" data-vars-ga-call-to-action="beginner workouts" data-node-id="34.1" class="body-link css-h40fkh emevuu60"&gt;beginner workouts&lt;/a&gt; on Youtube.&lt;/p&gt;&lt;p data-node-id="35" class="body_content_break_14"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="36" class="css-15wnvw5 emevuu60"&gt;&lt;strong data-node-id="36.0"&gt;A well-balanced diet &lt;/strong&gt;&lt;/p&gt;&lt;p data-node-id="37" class="body_content_break_15"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="38" class="css-15wnvw5 emevuu60"&gt;Protein-rich foods like chicken, eggs or tofu should be at the top of your shopping list, Rowan explains, especially when you aim to build muscle, as it ‘provides the amino acids needed to repair and build muscle.’&lt;/p&gt;&lt;p data-node-id="39" class="body_content_break_16"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="40" class="css-15wnvw5 emevuu60"&gt;How much protein is enough? The average daily amount that women should be eating is 45g, but he adds that ‘older adults often need more protein than younger people to stimulate muscle growth effectively. Aim to include a source of high-quality, lean protein with every meal.’ &lt;a href="https://pubmed.ncbi.nlm.nih.gov/32059533/" data-vars-ga-outbound-link="https://pubmed.ncbi.nlm.nih.gov/32059533/" data-vars-ga-ux-element="Hyperlink" data-vars-ga-call-to-action="Research shows that those over 60" data-node-id="40.1" class="body-link css-h40fkh emevuu60"&gt;Research shows that those over 60&lt;/a&gt; should be eating around 1 to 1.2g of protein per kg of body weight; for someone weighing 70kg, this means protein intake should be 70-84g a day. &lt;br data-node-id="40.3"&gt;&lt;br data-node-id="40.4"&gt;You also may need to hit pause on any diets, especially those that restrict calories, as your body needs plenty of energy and nutrients to build muscles. ‘This usually means being in a slight calorie surplus, i.e. eating a little more than you burn, so that your body has the resources to build new muscle tissue. If you’re consistently in a calorie deficit, your body won’t prioritise muscle growth,’ adds Rowan. &lt;/p&gt;&lt;p data-node-id="41" class="body_content_break_17"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="42" class="css-15wnvw5 emevuu60"&gt;&lt;strong data-node-id="42.0"&gt;Getting enough sleep&lt;/strong&gt;&lt;/p&gt;&lt;p data-node-id="43" class="body_content_break_18"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="44" class="css-15wnvw5 emevuu60"&gt;You may not have factored in the importance of sleep when it comes to building muscles, but &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5749041/" data-vars-ga-outbound-link="https://pmc.ncbi.nlm.nih.gov/articles/PMC5749041/" data-vars-ga-ux-element="Hyperlink" data-vars-ga-call-to-action="studies show that poor sleep quality" data-node-id="44.1" class="body-link css-h40fkh emevuu60"&gt;&lt;u data-node-id="44.1.0"&gt;studies show that poor sleep quality&lt;/u&gt;&lt;/a&gt; and duration of sleep can negatively impact how muscles grow, even when you’ve been hitting the gym enough. &lt;/p&gt;&lt;p data-node-id="45" class="body_content_break_19"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="46" class="css-15wnvw5 emevuu60"&gt;Rowan explains this is because ‘during deep sleep, growth hormone is released, which plays a central role in building muscle and repairing tissues. Poor or insufficient sleep wrecks this process, slowing down recovery and leaving you feeling fatigued and less motivated to train.’&lt;/p&gt;&lt;p data-node-id="47" class="body_content_break_20"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="48" class="css-15wnvw5 emevuu60"&gt;So, how much sleep should we be getting? Rowan says for anyone looking to build muscle, prioritising ‘seven to nine hours of quality sleep per night is just as important as training and nutrition.’&lt;/p&gt;&lt;p data-node-id="51" class="css-15wnvw5 emevuu60"&gt;&lt;/p&gt;&lt;p data-node-id="52" class="body_content_break_21"&gt;&lt;/p&gt;&lt;p data-journey-content="true" data-node-id="53" class="css-15wnvw5 emevuu60"&gt;&lt;br data-node-id="53.0"&gt;&lt;br data-node-id="53.1"&gt;&lt;br data-node-id="53.2"&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Good Housekeeping</author><pubDate>Wed, 01 Oct 2025 11:06:39 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMieEFVX3lxTE1uTGhyUW5Ld2tNQUhqX2tDNllWSEVjYlljMDNiYmhOSjl0X3hDTHI3cVVMWnV2MHZLdk1iSnU1bi1pTkZjbG5ucEcwS2RiYkt5Rlg4QVMyRVllYWFMRkRsdUg3alhNY251UG1FWFJCUGZEbnJacExpTA</guid></item><item><title>对人类来说，变老并不是什么新鲜事。那么，为什么我们现在如此糟糕呢？ - Gizmodo</title><link>https://gizmodo.com/growing-old-is-nothing-new-for-humans-so-why-are-we-so-bad-at-it-now-2000664208</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="entry-content prose dark:prose-invert lg:prose-xl "&gt;
        &lt;p&gt;Aging is inevitable, but it hasn’t always looked the same throughout the long history of humankind. That’s one of the core premises behind Michael Gurven’s just-released new book, &lt;em&gt;Seven Decades: How We Evolved to Live Longer.&lt;/em&gt;&lt;/p&gt;&lt;p class="not-prose my-8 -mx-5 xs:max-w-xs xs:mx-auto"&gt;&lt;/p&gt; &lt;p&gt;Gurven is an anthropologist at the University of California, Santa Barbara, who has spent much of his career studying and living alongside communities like the Tsimané of South America, indigenous groups who largely subsist off a combination of farming small crops, hunting, and gathering. Though these people have &lt;a href="https://gizmodo.com/an-indigenous-group-famous-for-its-heart-health-started-1838184949"&gt;increasingly started to come&lt;/a&gt; into contact with the modern world, they still provide a glimpse into humanity’s past prior to widespread industrialization.&lt;/p&gt;  &lt;p class="not-prose"&gt;&lt;/p&gt; &lt;p&gt;Building off his and others’ work with today’s subsistence communities, Gurven makes the compelling case that while the typical lifespan of the average person today has greatly expanded and our health has generally improved, there’s nothing particularly new about human longevity itself. Older people have always existed, even in past eras when survival was much more perilous than it is today. Moreover, he adds, there’s plenty we can learn about how best to grow older in our modern times by studying how our ancestors did it so many eons ago.&lt;/p&gt;

 &lt;p&gt;Gizmodo spoke to Gurven about his decision to not address longevity drugs, the most common misconceptions about aging, and how groups like the Tsimané might better help us better appreciate our elders. The following conversation has been lightly edited for grammar and clarity.&lt;/p&gt;

 &lt;p&gt;&lt;strong&gt;Ed Cara, Gizmodo:&lt;/strong&gt; I think many people who pick up a book about aging would expect to read about the breakthroughs around the corner that will supposedly and significantly prolong our lives. What made you want to focus more on the evolution of human aging?&lt;/p&gt;

 &lt;p&gt;&lt;strong&gt;Michael Gurven: &lt;/strong&gt;Thanks for asking that, because I always worry that the first question I’m gonna get is exactly that: “What are the secrets? What are the hidden gems?”&lt;/p&gt; &lt;p&gt;Everything’s about the potential of where we can end up—the power of regenerative medicine and technology. But &lt;span id="161.82" class="wordsOnlyNodes" tabindex="430"&gt;I wanted to actually kind of look back in order to look forward. &lt;/span&gt;One of the premises of the book is that longevity is not something that is so incredibly recent, but that it’s built into our DNA. It’s built into our biology. We’ve already accomplished the potential for longevity.&lt;/p&gt;

  &lt;p class="not-prose"&gt;&lt;/p&gt; &lt;p&gt;And because of that, I see a different type of optimism. There’s this scare over the &lt;a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4933329/"&gt;silver tsunami&lt;/a&gt; and everything that goes along with the global population aging. I wanted to point out that this is not a new type of problem. It’s not that there were never old people and now all of a sudden there are tons of old people. So I wanted to give a history of understanding that we have already lived with older people as part of our population.&lt;/p&gt;

 &lt;p&gt;And I wanted to argue that rather than longevity being a consequence of our success as a species, the causal arrows may actually be in the opposite direction. That we’ve been a very successful species because of our potential for longevity.&lt;/p&gt; &lt;p&gt;We’ve solved problems before, and we can solve this one moving forward, but it’s not going to be a problem that’s going to be solved just with new technology and improvements in molecular medicine. There are lessons to be learned here by appreciating our natural history.&lt;/p&gt;

 &lt;p&gt;&lt;b&gt;Gizmodo: &lt;/b&gt;Your book covers many different aspects and attitudes about how people today age now compared to the past. What would you say are some of the biggest misconceptions about human longevity and aging?&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Gurven: &lt;/strong&gt;The biggest one is just a misunderstanding of what life expectancy is in general.&lt;/p&gt;

 &lt;p&gt;When people say that life expectancy was much shorter in the past and maybe even as low as the 30s, that doesn’t mean everyone lived to age 30 and then died. Even with shorter life expectancies, you can have people who are much longer-lived than that, because it’s an average. And because we used to have lots of deaths early in life, that basically lowers that average.&lt;/p&gt;

 &lt;p&gt;&lt;strong&gt;Gizmodo:&lt;/strong&gt; Conversely, are there ways that people can romanticize the past and how we lived and died back prior to industrialization?&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Gurven: &lt;/strong&gt;Everyone looks to hunter-gatherers, and they see what they want to see. Either they see the hellish landscape of “all against all” and how life was really awful, or some people see a very romantic scenario, where everyone was vegetarian and hugging trees and in tune with nature, that kind of thing.&lt;/p&gt;

 &lt;p&gt;So actually paying attention to how hunter-gatherers live is an important kind of lesson that I’m trying to convey, with firsthand experience having worked and lived with these kinds of groups. Which of those myths are somewhat off base, and which ones might actually be true?&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Gizmodo:&lt;/strong&gt; Getting to that, what are some of the things that we’ve learned from studying longevity and elder members in communities like the Tsimané?&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Gurven: &lt;/strong&gt;One thing, which maybe goes along with the thinking that no one really lived that long, is just the idea that so many diseases of aging we take for granted are just going to befall us no matter what, because it’s hard to think of aging without thinking about heart disease and dementia and those kinds of things. But the very fact is that in these fairly high mortality populations [like the Tsimané], you don’t see those kinds of diseases, and it’s not because no one is living to those ages when those diseases typically manifest. Even when we follow people from age 40 onwards, we can see that people are not developing heart disease, Alzheimer’s disease, or diabetes.&lt;/p&gt;

 &lt;p&gt;So that’s like a really important kind of lesson because that tells us there’s so much to learn about these diseases, which are our major sources of mortality in the industrialized world.&lt;/p&gt;  &lt;p class="not-prose"&gt;&lt;/p&gt; &lt;p&gt;We already know that if you don’t smoke, are physically active, maintain a reasonable weight, and eat well, you can live a healthier life. But when you can see that at a whole population level, where almost an entire population can live without heart disease, diabetes, and Alzheimer’s, that’s pretty amazing. And so it does demonstrate that these big risk factors—the smoking, physical inactivity, excess weight, etcetera—account for the vast majority of deaths from noncommunicable diseases, which is over half the deaths, basically, that we experience today; it demonstrates that those deaths are actually preventable with things that whole populations are already doing.&lt;/p&gt;

 &lt;p&gt;I also think there are just broader lessons about what older people are doing and their expectations. There’s no formal retirement at age 65 or at any age in hunter-gatherers. There’s no expectation that you now have a life of leisure; you know, pick your cruise. And so, I certainly like the idea that, with this kind of growth mindset, learning is a lifelong process, right? And aging is not just the reverse of growth. It’s not just decline; there’s continued growth.&lt;/p&gt; &lt;p&gt;It doesn’t mean that everyone just keeps doing the exact same thing until they die. In fact, there are great shifts in what men and women tend to do in these societies. But the important point, kind of zooming out, is that they stay relevant, they stay engaged, and they stay involved.&lt;/p&gt;

 &lt;p&gt;&lt;strong&gt;Gizmodo:&lt;/strong&gt; What do you hope people most take away from this book—those reaching their elder years as well as those who have grandparents or other older people in their lives?&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Gurven: &lt;/strong&gt;I hope to inspire, kind of a new type of optimism. Not an optimism that’s just based on maximizing our lives, our longevity, or even our health span. I mean, those things are critical, and I’m glad that there are other books and other people working on that. But what I’m trying to get is people thinking at a deeper level about where we’re at now and where we’re headed in the next couple decades.&lt;/p&gt;

  &lt;p class="not-prose"&gt;&lt;/p&gt; &lt;p&gt;There are no medical solutions that are going to make 85-year-olds biologically like 35-year-olds, right? And so realistically, in the next couple decades, I’m hoping that people get newly inspired about how to rethink elderhood and respectfully think about our older adults as elders, realizing that we have something to learn from them, that there’s a place for them, and that it’s not just a service to those elders, but that we all benefit from having them in our lives.&lt;/p&gt; &lt;p&gt;Part of the looking back in this book is to show all the different ways that we’ve already done this throughout our evolutionary history.&lt;/p&gt;

 &lt;p&gt;&lt;em&gt;Seven Decades: How We Evolved to Live Longer&lt;/em&gt; is being &lt;a href="https://press.princeton.edu/books/hardcover/9780691231990/seven-decades"&gt;published&lt;/a&gt; by Princeton University Press and is available online or in hardcover.&lt;/p&gt;      &lt;/div&gt;
    &lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Gizmodo</author><pubDate>Wed, 01 Oct 2025 11:00:27 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMioAFBVV95cUxQT2hXQk5zcDY1clBPMHRQZkM3TDlqMHJ2VnhHbTJkb2wwWnB1YmJFYkUzUlNsaVNZNGhOclkxcnd5NXlGZW4yRzZhMUl6MDJPRWx3TFFMWWRsVzk4LVNuREEtSnBtbjBNTUliMjdxRlRIN3FYVUxia3ZfTWJnQXpMbXN2bXpMdzFsMWpVbXNvNHJmWVdibmtDV1MxZklzSVhW</guid></item><item><title>急诊室医生警告说，女性的心脏病发作症状是不同的—而且经常被忽视- HuffPost</title><link>https://www.huffpost.com/entry/heart-attack-women-symptoms_l_68d59797e4b0b2f96b455eac</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;section class="entry__content-list js-entry-content js-cet-subunit"&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;At one time, heart disease &lt;a href="https://www.cdc.gov/womens-health/lcod/females.html" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="was believed to largely only happen to men" data-vars-item-type="text" data-vars-unit-name="68d59797e4b0b2f96b455eac" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.cdc.gov/womens-health/lcod/females.html" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="0"&gt;was believed to largely only happen to men&lt;/a&gt;, which meant women weren’t included in health studies on the topic.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;While this has changed ―&lt;a href="https://www.cdc.gov/womens-health/lcod/index.html" role="link" class=" js-entry-link cet-external-link" data-vars-item-name=" and it’s now known that heart disease" data-vars-item-type="text" data-vars-unit-name="68d59797e4b0b2f96b455eac" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.cdc.gov/womens-health/lcod/index.html" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="1"&gt; and it’s now known that heart disease&lt;/a&gt; is the leading cause of death for women (and men) in the United States ― research is still catching up. This means &lt;a href="https://jheor.org/post/2779-women-are-at-a-higher-risk-of-dying-from-heart-disease-in-part-because-doctors-don-t-take-major-sex-and-gender-differences-into-accoun" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="heart health outcomes are worse" data-vars-item-type="text" data-vars-unit-name="68d59797e4b0b2f96b455eac" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://jheor.org/post/2779-women-are-at-a-higher-risk-of-dying-from-heart-disease-in-part-because-doctors-don-t-take-major-sex-and-gender-differences-into-accoun" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="2"&gt;heart health outcomes are worse&lt;/a&gt; for women than they are for men.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Heart disease is an umbrella term for many cardiovascular conditions, including coronary artery disease, which can lead to emergent episodes like &lt;a href="https://www.huffpost.com/life/topic/heart-attack" role="link" class=" js-entry-link cet-internal-link" data-vars-item-name="heart attacks" data-vars-item-type="text" data-vars-unit-name="68d59797e4b0b2f96b455eac" data-vars-unit-type="buzz_body" data-vars-target-content-id="/life/topic/heart-attack" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="3"&gt;heart attacks&lt;/a&gt; ― which are also understudied in women.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“In medical school, when we learn about heart attacks, we learn about something called typical chest pain, and that is ... right behind the center of your chest, and it’s crushing chest pain that usually goes down your left arm and it goes up to your jaw,” said &lt;a href="https://wexnermedical.osu.edu/find-a-doctor/jennah-morgan-md-122929" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Dr. Jennah Morgan" data-vars-item-type="text" data-vars-unit-name="68d59797e4b0b2f96b455eac" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://wexnermedical.osu.edu/find-a-doctor/jennah-morgan-md-122929" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="4"&gt;Dr. Jennah Morgan&lt;/a&gt;, an emergency medicine physician at the Ohio State University’s Wexner Medical Center.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Generally, someone experiencing this type of pain walks into a hospital while gripping their chest and sweating, Morgan added. However, heart attacks don’t present this way in everyone — especially women.&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;Chest pain is still a common heart attack sign for women, but it could feel more like achiness or tightness.&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“Between both men and women, chest pain is still the most common sign,” said &lt;a href="https://www.uchicagomedicine.org/find-a-physician/physician/bernice-fokum" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Dr. Bernice Fokum" data-vars-item-type="text" data-vars-unit-name="68d59797e4b0b2f96b455eac" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.uchicagomedicine.org/find-a-physician/physician/bernice-fokum" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="5"&gt;Dr. Bernice Fokum&lt;/a&gt;, an emergency medicine physician at the University of Chicago Medicine.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;However, chest pain can feel different for men and women, according to Morgan. “In men, it usually is the ‘elephant on my chest,’ this deep, intense pressure pain,” Morgan said. “For women, it might be achiness, it might be a little discomfort, it might be a little squeeze, a little tightness, but it may not be the crushing chest pain that we’ve been taught to look for.”&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;Other common symptoms include shortness of breath, fatigue, acid reflux and nausea.&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;It is also customary for women to have vague symptoms, Fokum said, “which is a bit overwhelming as clinicians because it might be something that you want to write off as, ‘oh, that’s just somebody having some acid reflux’ or, ‘that’s just somebody who slept weird and they’re having some shoulder pain.’”&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Clinicians aren’t the only people who may write the vague symptoms off — women may, too, which may delay care and lead to serious health consequences. &lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Both Fokum and Morgan said the atypical signs of a heart attack in women include shortness of breath, nausea, indigestion, acid reflux, discomfort right below the rib cage, unexplained fatigue, neck pain and back pain.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;These vague symptoms could be signs of many issues other than heart attacks, however, including the flu, a bad night’s sleep and food poisoning, which is both good and bad news.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;While you don’t need to panic the next time you have nausea or have unexplained tiredness, you should also take symptoms seriously if they feel off.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“People know their body,” Fokum said. If you routinely get indigestion after eating spicy food or know your neck pain is from a certain pillow, you likely don’t need to worry much about those symptoms. &lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;If you’re having a “gnawing, really uncomfortable sensation not precipitated by things that normally” occur, perhaps accompanied by shortness of breath, you may want to speak with your primary care doctor, Fokum said. &lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“Or if it is persistent and you are really concerned ... it really might make sense for you to either call the paramedics or go to the emergency department.” &lt;/p&gt;&lt;/div&gt;&lt;figure class="cli cli-image js-no-inject"&gt;&lt;p class="cli-image__spacer"&gt;&lt;/p&gt;&lt;div class="cli-image__source-wrapper"&gt;&lt;div class="cli-image__credit" aria-label="Image Credit: andreswd via Getty Images"&gt;&lt;p class="credit-container"&gt;&lt;span class="credit"&gt;andreswd via Getty Images&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;figcaption class="cli-image__caption caption-cli"&gt;Neck pain, back pain and chest pain can all be signs of a heart attack in women.&lt;/figcaption&gt;&lt;/div&gt;&lt;/figure&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;People with heart attack risk factors should never ignore these symptoms. &lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Women with heart attack risk factors or a family history of heart disease should pay close attention if they have any of the vague symptoms mentioned above, both doctors told HuffPost.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“Think big picture,” Morgan said. “If you have a family history of heart conditions, if you already have predisposing factors” — for example, high blood pressure, diabetes, high cholesterol, kidney disease or a combination of several conditions — it may make it more likely that “something concerning is happening,” she said.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“I would say have a low threshold if you don’t feel well” and also have those risk factors, Morgan said.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;If you have a personal history of heart disease or heart attacks, you should also take all signs seriously, according to Fokum. The same is true if you’re in your 50s, 60s or 70s, when heart attacks are more common.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;But that doesn’t mean younger people should ignore these symptoms. Heart attacks are happening in younger women more often, &lt;a href="https://www.hopkinsmedicine.org/health/conditions-and-diseases/heart-attack/heart-attacks-striking-younger-women" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="research shows" data-vars-item-type="text" data-vars-unit-name="68d59797e4b0b2f96b455eac" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.hopkinsmedicine.org/health/conditions-and-diseases/heart-attack/heart-attacks-striking-younger-women" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="6"&gt;research shows&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;If you have any heart attack symptoms, it’s crucial to advocate for yourself.&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Just as many women are unaware of some of the vague signs of a heart attack, the same knowledge gap exists for some medical professionals. Meaning, your nausea (that’s actually a heart attack) or back pain (that’s actually a heart attack) could be dismissed at the hospital. &lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Only you know what is normal for your body and what’s not, Fokum said. If you notice that you’re very fatigued or feeling unexplained pain, respectfully let your medical care team know at the hospital.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“That may increase the number of tests I do or increase the interventions that I recommend,” Fokum said.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;You could even tell your care team that you suspect you’re having a heart attack. There can be “a lot of bias whenever we, as clinicians, talk to women and assess women’s symptoms and determine what kind of intervention [is needed],” she added. “For a multitude of reasons, there are less lifesaving cardiac interventions that are done for women than men across the board. It is the reality of the situation.”&lt;/p&gt;&lt;/div&gt;&lt;blockquote class="cli cli-pullquote"&gt;&lt;p class="cli-pullquote__placeholder"&gt;&lt;/p&gt;&lt;div class="cli-pullquote__content"&gt;&lt;p class="cli-pullquote__quote accent-cli"&gt;“Heart attack symptoms in women aren’t taken as seriously as those in men, which leads to fewer medical interventions and deadly outcomes.”&lt;/p&gt;&lt;/div&gt;&lt;/blockquote&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;a href="https://www.ahajournals.org/doi/full/10.1161/JAHA.119.014742" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Research shows" data-vars-item-type="text" data-vars-unit-name="68d59797e4b0b2f96b455eac" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.ahajournals.org/doi/full/10.1161/JAHA.119.014742" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="7"&gt;Research shows&lt;/a&gt; that women with symptoms of a heart attack are less likely than men to receive aspirin, which can be protective during a heart attack, and less likely to receive other medical interventions, too, according to Fokum.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“So, somebody being an advocate for themselves in these settings is going to be really paramount in pushing them towards having a higher likelihood of getting the interventions that they need,” she said.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;If your doctor runs tests and it turns out you aren’t having a heart attack, that’s OK. “We certainly have a lot of people who come in and it ends up not being a heart attack. Sometimes it is just simply acid reflux,” Fokum said.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;There is no reason to be embarrassed if you go in for testing because of a serious concern and it turns out you’re not experiencing what you think.&lt;/p&gt;&lt;/div&gt;&lt;figure class="cli cli-image js-no-inject"&gt;&lt;p class="cli-image__spacer"&gt;&lt;/p&gt;&lt;div class="cli-image__source-wrapper"&gt;&lt;div class="cli-image__credit" aria-label="Image Credit: J Studios via Getty Images"&gt;&lt;p class="credit-container"&gt;&lt;span class="credit"&gt;J Studios via Getty Images&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;figcaption class="cli-image__caption caption-cli"&gt;While chest pain is a common sign of heart attack in women, so are vague symptoms such as nausea, fatigue, back pain and acid reflux.&lt;/figcaption&gt;&lt;/div&gt;&lt;/figure&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;If you aren’t sure if you need to go to the emergency department, call for advice.&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Not everyone can afford to just go to the emergency department when a concerning symptom like unexplained fatigue or nausea occurs. &lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;If you suspect you are having a heart attack, it’s crucial that you go to the hospital, but “if you have a question, you have hesitation, I think it’s OK to call [your local emergency department] because if something is really concerning, the person on the other end will say, ‘get here now’ ... I think that message will be clear,” Morgan said.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“If you are concerned and you’re worried about costs, I would say it’s still always better [to go to the hospital]. You can worry about costs later and save your life,” Morgan said. “But if you’re more inclined to say, ‘no, I’m not coming,’ I would at the very least call an emergency department and speak to a healthcare provider, and they can at least give you some support.”&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;There are lifestyle habits that can help lower your heart attack risk.&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;With heart disease being the leading cause of death in the U.S. for women, and increased &lt;a href="https://health.mil/News/Dvids-Articles/2024/03/27/news467058" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="heart attacks" data-vars-item-type="text" data-vars-unit-name="68d59797e4b0b2f96b455eac" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://health.mil/News/Dvids-Articles/2024/03/27/news467058" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="8"&gt;heart attacks&lt;/a&gt; in younger women, it’s important to do what you can to lower your risk.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Exercising is one way to do this, Morgan said. It’s &lt;a href="https://www.heart.org/en/healthy-living/fitness/fitness-basics/aha-recs-for-physical-activity-in-adults" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="recommended that adults get" data-vars-item-type="text" data-vars-unit-name="68d59797e4b0b2f96b455eac" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.heart.org/en/healthy-living/fitness/fitness-basics/aha-recs-for-physical-activity-in-adults" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="9"&gt;recommended that adults get&lt;/a&gt; at least 150 minutes of moderate exercise (such as walking, gardening or dancing) each week, or 75 minutes of vigorous exercise (such as running, singles tennis or swimming).&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;“Then also just eating a high-fiber diet, a diet that is high in vegetables and fruits. But of course, with fruits, you have to make sure that if you have diabetes, that you’re looking at sugar control as well,” Morgan said. “If you already have a diagnosis and you’re already prescribed medication, do your best to stick to your medication regimen,” especially if it’s medication for high cholesterol, high blood pressure, diabetes and more.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;a href="https://www.heart.org/en/health-topics/diabetes/prevention--treatment-of-diabetes/know-your-health-numbers" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="It’s also important to know your numbers " data-vars-item-type="text" data-vars-unit-name="68d59797e4b0b2f96b455eac" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.heart.org/en/health-topics/diabetes/prevention--treatment-of-diabetes/know-your-health-numbers" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="10"&gt;It’s also important to know your numbers &lt;/a&gt;for blood pressure, cholesterol and blood sugar, which can all be gathered through a routine blood test.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Controlling stress is also important for your health. “Stress is horrible for your body. It raises your cortisol levels. It raises your blood pressure. It just really puts everything out of whack,” Fokum said.&lt;/p&gt;&lt;/div&gt;&lt;div id="support-huffpost-entry-support-huffpost-mid-article" class="cli support-huffpost-mid-article primary-cli cli cli-text cli-support-huffpost hidden"&gt;&lt;div class="cli-support-huffpost__content-wrapper"&gt;&lt;p class="cli-support-huffpost__title default-title"&gt;&lt;span class="cli-support-huffpost__title--first"&gt;20 Years Of&lt;/span&gt;&lt;span class="cli-support-huffpost__title--second"&gt;Free&lt;/span&gt;&lt;span class="cli-support-huffpost__title--third"&gt;Journalism&lt;/span&gt;&lt;/p&gt;&lt;div class="contributor-once-variation"&gt;&lt;p class="cli-support-huffpost__title"&gt;&lt;span class="cli-support-huffpost__title--first"&gt;Your Support&lt;/span&gt;&lt;span class="cli-support-huffpost__title--second"&gt;Fuels&lt;/span&gt;&lt;span class="cli-support-huffpost__title--third"&gt;Our Mission&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="contributor-canceled-variation"&gt;&lt;p class="cli-support-huffpost__title"&gt;&lt;span class="cli-support-huffpost__title--first"&gt;Your Support&lt;/span&gt;&lt;span class="cli-support-huffpost__title--second"&gt;Fuels&lt;/span&gt;&lt;span class="cli-support-huffpost__title--third"&gt;Our Mission&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="cli-support-huffpost__container"&gt;&lt;div class="cli-support-huffpost__message-container"&gt;&lt;div class="cli-support-huffpost__message support-huffpost__message--main"&gt;&lt;p class="cli-support-huffpost__sub-headline"&gt;&lt;/p&gt;&lt;p&gt;For two decades, HuffPost has been fearless, unflinching, and relentless in pursuit of the truth. Support our mission to keep us around for the next 20 — we can't do this without you.&lt;/p&gt;&lt;/div&gt;&lt;div class="cli-support-huffpost__message variation contributor-once-variation"&gt;&lt;p&gt;We remain committed to providing you with the unflinching, fact-based journalism everyone deserves.&lt;/p&gt;&lt;p&gt;Thank you again for your support along the way. We’re truly grateful for readers like you! Your initial support helped get us here and bolstered our newsroom, which kept us strong during uncertain times. Now as we continue, we need your help more than ever. &lt;a href="https://www.huffpost.com/support" class="cli-support-huffpost__message__link js-entry-link" data-vars-item-name="we're offering an ad-free experience" data-vars-item-type="text" data-vars-unit-name="main" data-vars-unit-type="buzz_body" data-vars-target-content-id="/support" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component" data-vars-position-in-subunit="12"&gt;We hope you will join us once again&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;div class="cli-support-huffpost__message variation contributor-canceled-variation"&gt;&lt;p&gt;We remain committed to providing you with the unflinching, fact-based journalism everyone deserves.&lt;/p&gt;&lt;p&gt;Thank you again for your support along the way. We’re truly grateful for readers like you! Your initial support helped get us here and bolstered our newsroom, which kept us strong during uncertain times. Now as we continue, we need your help more than ever. &lt;a href="https://www.huffpost.com/support" class="cli-support-huffpost__message__link js-entry-link" data-vars-item-name="we're offering an ad-free experience" data-vars-item-type="text" data-vars-unit-name="main" data-vars-unit-type="buzz_body" data-vars-target-content-id="/support" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component" data-vars-position-in-subunit="12"&gt;We hope you will join us once again&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;a class="cli-support-huffpost__support-button accent-button" href="https://www.huffpost.com/support?utm_campaign=mid-article-web" data-vars-item-name-overwritable="support-huffpost" data-vars-item-name="Support HuffPost" data-vars-item-type="button" data-vars-unit-name="main" data-vars-unit-type="buzz_body" data-vars-target-content-id="/support" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component" data-vars-position-in-subunit="11"&gt;Support HuffPost&lt;/a&gt;&lt;p class="support-huffpost-login"&gt;Already contributed? &lt;a class="js-entry-link-no-impression" href="https://login.huffpost.com/login?dest=https%3A%2F%2Fwww.huffpost.com%2Fentry%2Fheart-attack-women-symptoms_l_68d59797e4b0b2f96b455eac%3Fhp_auth_done%3D1" data-vars-item-name="Log in to hide these messages" data-vars-item-type="text" data-vars-unit-name="68d59797e4b0b2f96b455eac" data-vars-unit-type="buzz_body" data-vars-target-content-id="/login" data-vars-target-content-type="utility" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component"&gt;Log in to hide these messages.&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;While it’s not easy to stay stress-free during busy days and tough economic times, it is important to try. Meditation, socialization, church, therapy and time in nature can all help lower stress. Find a method that works for you.&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;Heart attack symptoms in women aren’t taken as seriously as those in men, which leads to fewer medical interventions and deadly outcomes. If you notice any concerning health symptoms in yourself or in a loved one, go to a doctor immediately and do what you can to get the treatment you deserve. &lt;/p&gt;&lt;/div&gt;&lt;/section&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>HuffPost</author><pubDate>Wed, 01 Oct 2025 11:00:17 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijgFBVV95cUxNcG45ZTQtSTUzVFlBWC0tWUhDUU1fdlB1RTVibHpjTnRhb1ExbXJ2LW5tdk5fSHliQWVYZ1VjSmo3amt1NWo5Uk9Uempvc3BPZm43R0puR3NwdkVvWFBXM0p5ZEhlbE5DZFM5aTB0d2E3OEdEZUZ1MnUzNkt3NlkyWFNWeFI5MDN4OWdIMFln0gGTAUFVX3lxTE5fYUNWVlN2NDV3a2F0d2x0OUZvSDZUWXE3clJ2Ylo0c1A5RjNFXzlVYVB4NUlFSzdNdHdXb2pVN0RDRWRXM1BKcS1IVmxMdUZNRkJHaVQ3Yk9FVDNhUlZqSXh4cWE4bWVTVExpTl90UmRPV1JYdXBLSnZ1V1NBUFY1NzZBRUVNaGY0WmtGVmZpdW9sTQ</guid></item><item><title>自闭症儿童的父母说，这些常见短语不仅粗鲁，而且有害- HuffPost</title><link>https://www.huffpost.com/entry/rudest-things-said-to-parents-autistic-kids_l_68dbfea1e4b0b11989ef8db7</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;section class="entry__content-list js-entry-content js-cet-subunit"&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;As the mother of a child with a neurodivergent condition, I’ve navigated my fair share of uncomfortable comments over the years.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Everyone from fellow parents and family members to my son’s karate class teacher has made inconsiderate or simply ill-informed remarks about my parenting skills or my child’s perceived deficiencies. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;In my son’s case, the &lt;a href="https://www.huffpost.com/entry/how-to-talk-to-kids-with-adhd_l_67dad3d7e4b0fc4b0bd8c5c9" target="_blank" role="link" class=" js-entry-link cet-internal-link" data-vars-item-name="neurodivergent condition is ADHD" data-vars-item-type="text" data-vars-unit-name="68dbfea1e4b0b11989ef8db7" data-vars-unit-type="buzz_body" data-vars-target-content-id="67dad3d7e4b0fc4b0bd8c5c9" data-vars-target-content-type="buzz" data-vars-type="web_internal_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="0"&gt;neurodivergent condition is ADHD&lt;/a&gt;, but another community of parents and children is subject to just as many (if not far more) comments from observers: families with children who are autistic.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;figure class="cli cli-image js-no-inject"&gt;&lt;p class="cli-image__spacer"&gt;&lt;/p&gt;&lt;div class="cli-image__source-wrapper"&gt;&lt;div class="cli-image__credit" aria-label="Image Credit: Tetiana Melnyk via Getty Images"&gt;&lt;p class="credit-container"&gt;&lt;span class="credit"&gt;Tetiana Melnyk via Getty Images&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;figcaption class="cli-image__caption caption-cli"&gt;Parents of autistic kids warn that some of the emerging attitudes on autism aren't just off-putting, but dangerous.&lt;/figcaption&gt;&lt;/div&gt;&lt;/figure&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Recent headlines about Tylenol use during pregnancy potentially &lt;/span&gt;&lt;a href="https://www.huffpost.com/entry/trump-tylenol-medical-experts_n_68d1d274e4b03c190c21ce0b" target="_blank" role="link" class=" js-entry-link cet-internal-link" data-vars-item-name="increasing the risk of neurological conditions such as autism" data-vars-item-type="text" data-vars-unit-name="68dbfea1e4b0b11989ef8db7" data-vars-unit-type="buzz_body" data-vars-target-content-id="68d1d274e4b03c190c21ce0b" data-vars-target-content-type="buzz" data-vars-type="web_internal_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="1"&gt;&lt;span&gt;increasing the risk of neurological conditions such as autism&lt;/span&gt;&lt;/a&gt; (albeit with &lt;a href="https://www.huffpost.com/entry/trump-tylenol-medical-experts_l_68d2acf1e4b03fb4d9341baa" target="_blank" role="link" class=" js-entry-link cet-internal-link" data-vars-item-name="ample pushback from medical professionals)" data-vars-item-type="text" data-vars-unit-name="68dbfea1e4b0b11989ef8db7" data-vars-unit-type="buzz_body" data-vars-target-content-id="68d2acf1e4b03fb4d9341baa" data-vars-target-content-type="buzz" data-vars-type="web_internal_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="2"&gt;ample pushback from medical professionals)&lt;/a&gt;&lt;span&gt; have put this community in the spotlight. But national news developments aside, the comments from outside observers, whether well-meaning or just toxic, are all too common for families who have an autistic child.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“There are a whole host of misconceptions out there about what autism is and how it impacts someone’s life,” &lt;/span&gt;&lt;a href="https://www.bluebirdpsychology.ca/" target="_blank" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Amy Dykstra" data-vars-item-type="text" data-vars-unit-name="68dbfea1e4b0b11989ef8db7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://www.bluebirdpsychology.ca/" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="3"&gt;&lt;span&gt;Amy Dykstra&lt;/span&gt;&lt;/a&gt;&lt;span&gt;, registered psychologist and owner of Bluebird Psychology, told HuffPost. “Autism is a spectrum, but it is common for people to create a mental image of someone who is maybe nonverbal or less able to function independently.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Here are some of the most common insensitive or misinformed comments that parents of children with autism receive and why they can be so harmful (and hurtful).&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;1. ‘She doesn’t look autistic.’&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;This is an all too common comment heard by Whitney Casares, MD, a pediatrician, author of &lt;/span&gt;&lt;a href="https://r.bttn.io?btn_ref=org-677cb81987ed72f9&amp;amp;btn_url=https://www.amazon.com/My-One-Kind-Body-Ultimate/dp/1610028031?tag=thehuffingtop-20%26ascsubtag%3D68dbfea1e4b0b11989ef8db7%252C-1%252C-1%252Cd%252C0%252C0%252Chp-fil-am%253D0%252C0%253A0%252C0%252C0%252C0" role="link" data-amazon-link="true" data-aps-asin="1610028031" data-aps-asc-tag="thehuffingtop-20" data-aps-asc-subtag="68dbfea1e4b0b11989ef8db7,-1,-1,d,0,0,hp-fil-am=0,0:0,0,0,0" class=" js-entry-link cet-external-link" data-vars-item-name="“My One-of-a-Kind Body,”" data-vars-item-type="text" data-vars-unit-name="68dbfea1e4b0b11989ef8db7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://r.bttn.io?btn_ref=org-677cb81987ed72f9&amp;amp;btn_url=https://www.amazon.com/My-One-Kind-Body-Ultimate/dp/1610028031?tag=thehuffingtop-20%26ascsubtag%3D68dbfea1e4b0b11989ef8db7%252C-1%252C-1%252Cd%252C0%252C0%252Chp-fil-am%253D0%252C0%253A0%252C0%252C0%252C0" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="4"&gt;&lt;span&gt;“My One-of-a-Kind Body,”&lt;/span&gt;&lt;/a&gt;&lt;span&gt; and a parent to a 12-year-old daughter who has autism.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“My daughter is a Level 1 autistic child, so she doesn’t have a different look per se, but it’s so important to remember autism is not a look,” said Casares. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“This type of comment invalidates the diagnoses for the family. And it makes families and moms like me feel they have to prove their child’s needs,” Casares explained. “It can be hurtful because they make parents feel like others don’t believe them when they say their child is autistic. It insinuates that parents are making up an excuse for their child’s needs or behaviors.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;2. “I know my kid doesn’t have issues like yours…”&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Often delivered with a heavy dose of pity, this comment makes the parent on the receiving end feel very “othered” and sad, said Allison Hamilton-Rohe, of Silver Spring, Maryland, who has an autistic daughter. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“You would think this comment would be validating, but it just made me feel even more alone,” explained Hamilton-Rohe. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“I’ve had to jettison friends, distance myself from family, and seek out those who are truly understanding, supportive and loving for both myself and my child,” Hamilton-Rohe said. “I’ve had so many awful things said to me, but I don’t hold onto them because I have had to let them go for my mental health.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;3. ‘Your child is high functioning, you’re lucky.’&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;The implication behind this particular remark is that “things could be far worse” for a child who has autism. It shows a lack of understanding of the full spectrum of autism.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“People have a perception that autism falls into two categories: ‘high functioning’ or ‘low functioning,’” explained &lt;/span&gt;&lt;a href="https://playtolearnconsulting.com/meet-polina/" target="_blank" role="link" class=" js-entry-link cet-external-link" data-vars-item-name="Polina Shkadron" data-vars-item-type="text" data-vars-unit-name="68dbfea1e4b0b11989ef8db7" data-vars-unit-type="buzz_body" data-vars-target-content-id="https://playtolearnconsulting.com/meet-polina/" data-vars-target-content-type="url" data-vars-type="web_external_link" data-vars-subunit-name="article_body" data-vars-subunit-type="component" data-vars-position-in-subunit="5"&gt;&lt;span&gt;Polina Shkadron&lt;/span&gt;&lt;/a&gt;&lt;span&gt;, MA, CCC-SLP, MSNE, CTP, ADHD-RSP, a New York City-based neurodivergent specialist and family therapist.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“These terms, unfortunately, have been used in the past and have been habituated as part of a linguistic repertoire that attempts to summarize autism,” added Shkadron. “What the terms actually do is minimize struggles and hone in on challenges, rather than deeply understanding what it takes to live as an autistic individual in a neurotypical world.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;4. ‘Can’t you just discipline him better?’&lt;/strong&gt;&lt;strong&gt;&lt;br&gt;&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Shenequa Brantley, a South Carolina mom whose 6-year-old son is autistic, has received this comment on more than a few occasions. “A lot of people are judgmental,” said Brantley. “They think discipline will change him, but they just don’t understand.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;To help others realize what her son, Marion, is capable of, Brantley started recording videos of his therapy sessions. She often shares those videos at her workplace, where colleagues regularly talk about their children. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;The reaction is often amazement, followed by questions like: “He knows your phone number? He knows your name?’” added Brantley. “Showing the videos helps me share proof of his progress and success.”&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p class="primary-cli cli cli-text "&gt;&lt;h2&gt;&lt;strong&gt;5. ‘Have you tried this or that detox diet?’&lt;/strong&gt;&lt;/h2&gt;&lt;/p&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;This comment, along with many other very similar types of remarks like “Did you vaccinate your child?” or “Have you tried the gluten-free diet?” or “Have you tried to remove sugars from your child’s diet” are all commonly heard by parents of children with autism, and they all imply the same thing: that the parent must have done something wrong or must be to blame, said Kemi Babagbemi, MD, a resident in Manhattan, New York, and mother of a 14-year-old autistic son.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div id="support-huffpost-entry-support-huffpost-mid-article" class="cli support-huffpost-mid-article primary-cli cli cli-text cli-support-huffpost hidden"&gt;&lt;div class="cli-support-huffpost__content-wrapper"&gt;&lt;p class="cli-support-huffpost__title default-title"&gt;&lt;span class="cli-support-huffpost__title--first"&gt;20 Years Of&lt;/span&gt;&lt;span class="cli-support-huffpost__title--second"&gt;Free&lt;/span&gt;&lt;span class="cli-support-huffpost__title--third"&gt;Journalism&lt;/span&gt;&lt;/p&gt;&lt;div class="contributor-once-variation"&gt;&lt;p class="cli-support-huffpost__title"&gt;&lt;span class="cli-support-huffpost__title--first"&gt;Your Support&lt;/span&gt;&lt;span class="cli-support-huffpost__title--second"&gt;Fuels&lt;/span&gt;&lt;span class="cli-support-huffpost__title--third"&gt;Our Mission&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="contributor-canceled-variation"&gt;&lt;p class="cli-support-huffpost__title"&gt;&lt;span class="cli-support-huffpost__title--first"&gt;Your Support&lt;/span&gt;&lt;span class="cli-support-huffpost__title--second"&gt;Fuels&lt;/span&gt;&lt;span class="cli-support-huffpost__title--third"&gt;Our Mission&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="cli-support-huffpost__container"&gt;&lt;div class="cli-support-huffpost__message-container"&gt;&lt;div class="cli-support-huffpost__message support-huffpost__message--main"&gt;&lt;p class="cli-support-huffpost__sub-headline"&gt;&lt;/p&gt;&lt;p&gt;For two decades, HuffPost has been fearless, unflinching, and relentless in pursuit of the truth. Support our mission to keep us around for the next 20 — we can't do this without you.&lt;/p&gt;&lt;/div&gt;&lt;div class="cli-support-huffpost__message variation contributor-once-variation"&gt;&lt;p&gt;We remain committed to providing you with the unflinching, fact-based journalism everyone deserves.&lt;/p&gt;&lt;p&gt;Thank you again for your support along the way. We’re truly grateful for readers like you! Your initial support helped get us here and bolstered our newsroom, which kept us strong during uncertain times. Now as we continue, we need your help more than ever. &lt;a href="https://www.huffpost.com/support" class="cli-support-huffpost__message__link js-entry-link" data-vars-item-name="we're offering an ad-free experience" data-vars-item-type="text" data-vars-unit-name="main" data-vars-unit-type="buzz_body" data-vars-target-content-id="/support" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component" data-vars-position-in-subunit="7"&gt;We hope you will join us once again&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;div class="cli-support-huffpost__message variation contributor-canceled-variation"&gt;&lt;p&gt;We remain committed to providing you with the unflinching, fact-based journalism everyone deserves.&lt;/p&gt;&lt;p&gt;Thank you again for your support along the way. We’re truly grateful for readers like you! Your initial support helped get us here and bolstered our newsroom, which kept us strong during uncertain times. Now as we continue, we need your help more than ever. &lt;a href="https://www.huffpost.com/support" class="cli-support-huffpost__message__link js-entry-link" data-vars-item-name="we're offering an ad-free experience" data-vars-item-type="text" data-vars-unit-name="main" data-vars-unit-type="buzz_body" data-vars-target-content-id="/support" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component" data-vars-position-in-subunit="7"&gt;We hope you will join us once again&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;a class="cli-support-huffpost__support-button accent-button" href="https://www.huffpost.com/support?utm_campaign=mid-article-web" data-vars-item-name-overwritable="support-huffpost" data-vars-item-name="Support HuffPost" data-vars-item-type="button" data-vars-unit-name="main" data-vars-unit-type="buzz_body" data-vars-target-content-id="/support" data-vars-target-content-type="feed" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component" data-vars-position-in-subunit="6"&gt;Support HuffPost&lt;/a&gt;&lt;p class="support-huffpost-login"&gt;Already contributed? &lt;a class="js-entry-link-no-impression" href="https://login.huffpost.com/login?dest=https%3A%2F%2Fwww.huffpost.com%2Fentry%2Frudest-things-said-to-parents-autistic-kids_l_68dbfea1e4b0b11989ef8db7%3Fhp_auth_done%3D1" data-vars-item-name="Log in to hide these messages" data-vars-item-type="text" data-vars-unit-name="68dbfea1e4b0b11989ef8db7" data-vars-unit-type="buzz_body" data-vars-target-content-id="/login" data-vars-target-content-type="utility" data-vars-type="web_internal_link" data-vars-subunit-name="support-huffpost-mid-article" data-vars-subunit-type="component"&gt;Log in to hide these messages.&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“These are the kinds of rude questions and comments that attribute autism to something the parent has done or not done, has not tried enough to do, but ultimately implies parental blame for the autism,” explained Babagbemi, who has heard such remarks from friends, colleagues and even people that work with autistic children in various professional capacities. &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;Before making any type of remark, outside observers should remember that there are human beings on the receiving end of such comments, said Babagbemi, who added that the onus is on the “the general population to get better educated about autism because it’s part of human neurodiversity.”&lt;/span&gt;&lt;span&gt;&lt;br&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div class="primary-cli cli cli-text "&gt;&lt;p&gt;&lt;span&gt;“Recently there seems to be disproportionate negative attention to autism as a disease or something that needs to be cured or something that needs to be eliminated,” added Babagbemi, “which I believe is a dangerous and inhumane way to view autism.” &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/section&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>HuffPost</author><pubDate>Wed, 01 Oct 2025 11:00:17 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiowFBVV95cUxOREVZWkc5RWtjQmxfdWgxa1RHNFZxUENaWjFrTVQ2dUpWNUhaamhJZnRYQU1xOGJFNGEtVzJXY1lIdDhUdWRuVGRHcDJ1NTZFUkVxajAxUGU2VW55N0p0dHlCS2NNck9LVzFXSURNcGc0dHpmTzlzZUM1X3pWUTU3Z3pla1hWMDM1T2RKWjF4T1I5LVlZZ0FQYXpkR2NuTHRWQ0pv0gGoAUFVX3lxTE0wOUh5eEpWUzJZTUlHc0hQN2dxN1RZeG5kWldFYnhfRlhwZlZIMVZwMEF3em1ZRkVTaEJsWGh6TTJkRVp0N1V3T2VGaWdLNTNELTVDUHc4QmJiMmRMUS1HRGlUSXgtV2ZCMk16S1N0VzBJci1lR1o0R0J4bVptZTkySEZTYWdSYVgzYjBMMzA2aXBKc19SUWFnX2ljTzlZWlFkMzNmZEsyTA</guid></item><item><title>随着“Stratus”菌株在全球范围内传播，新型冠状病毒变体XFG.3的症状- LADbible</title><link>https://www.ladbible.com/news/health/symptoms-new-covid-stratus-xfg-604948-20250930</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div&gt;&lt;p class="text_text__nEn66"&gt;More than five years after the World Health Organisation declared coronavirus a global pandemic, a new strain of the disease has swept over Britain.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;The new strain is called 'Stratus' and has two variants, known as XFG and XFG.3, and is making up for a large proportion of new &lt;a class="anchor_link__6t7IO" href="https://www.ladbible.com/coronavirus"&gt;Covid&lt;/a&gt; cases in England.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;The UK &lt;a class="anchor_link__6t7IO" href="https://www.ladbible.com/health"&gt;Health&lt;/a&gt; Security Agency (UKHSA) noted a 7.6 percent increase in coronavirus cases in &lt;a class="anchor_link__6t7IO" href="https://www.ladbible.com/uk-news"&gt;England&lt;/a&gt; by 10 September, compared with the previous week, though it's unclear whether that figure has continued to climb.&lt;/p&gt;&lt;p class="floating-video-player_container__u4D9_"&gt;&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;Despite an increasing number of people contracting the new strain of the virus, experts have expressed they are not concerned about the spread.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;According to Dr Alex Allen, consultant epidemiologist of the UKHSA, it is 'normal for viruses to mutate and change over time', while all strains of Covid are continuously monitored in the UK.&lt;/p&gt;&lt;div class="article-image_articleImage__eyzAn"&gt;&lt;cite class="image-credit_imageCredit__YMlqS"&gt;'Stratus' is causing a hoarse voice, according to experts (Getty Stock Images)&lt;/cite&gt;&lt;/div&gt;&lt;h2&gt;&lt;strong&gt;Symptoms of new Covid strain 'Stratus'&lt;/strong&gt;&lt;/h2&gt;&lt;p class="text_text__nEn66"&gt;While the majority of Stratus symptoms are the same as all the other previous strains of coronavirus, experts have claimed one commonly occurring symptom of this particular strain appears to be a hoarse voice.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;Fortunately, experts have not noticed any increase in the severity of symptoms, meaning the new strain isn't likely to make you feel any more unwell than you would catching the older strains of the virus.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;The Covid vaccines are also believed to work as effectively against Stratus XFG and XFG.3 as previous strains.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;"Based on the available information so far, there is no evidence to suggest that the XFG and XFG.3 variants cause more severe disease than previous variants, or that the vaccines in current use will be less effective against them," Dr Allen explained.&lt;/p&gt;&lt;div class="article-image_articleImage__eyzAn"&gt;&lt;cite class="image-credit_imageCredit__YMlqS"&gt;Gov guidance on the new strain is the same (Getty Stock Images)&lt;/cite&gt;&lt;/div&gt;&lt;h2&gt;&lt;strong&gt;Government guidance on testing positive for Covid&lt;/strong&gt;&lt;/h2&gt;&lt;p class="text_text__nEn66"&gt;Regardless of whether you believe you have the new strain or not, if you test positive for Covid, &lt;a class="anchor_link__6t7IO" target="_blank" rel="noopener" href="https://www.gov.uk/coronavirus"&gt;government guidance&lt;/a&gt; remains unchanged.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;There are no restrictions on coronavirus patients, but you should try and stay at home where possible.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;The UKHSA &lt;a class="anchor_link__6t7IO" target="_blank" rel="noopener" href="https://educationhub.blog.gov.uk/2023/10/what-are-the-latest-rules-around-covid-19-in-schools-colleges-nurseries-and-other-education-settings/"&gt;says&lt;/a&gt; that anyone with symptoms of a respiratory infection, Covid-19 or otherwise, should 'avoid contact' with vulnerable individuals and stay home where possible.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;Meanwhile, there are no restrictions on sending children with coronavirus into schools and nurseries, however, the government guidance is that they should stay home if they are unwell and have a high temperature.&lt;/p&gt;&lt;p class="text_text__nEn66"&gt;The UKHSA doesn't advise Covid testing on children and young people unless advised to do so by a health professional.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>LADbible</author><pubDate>Wed, 01 Oct 2025 10:49:58 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiiwFBVV95cUxQVndIZ3pySlMwUkJ2bkdrLUluRGtDOVM1cUE4alJ0MllVNFRLSUplVldBV2EyQ1dtLTlwTDVZaUZsS21XRGhnS3RVcVpCS2ZpX2JUNE4tbm16amxKczZKeW9QU2hvb01Ld0ZpclVlVWh2WHl0aGtZaHoyYmhHRnNjQ2gyc3NZdTdhZUQ4</guid></item><item><title>这位科学家研究超加工食品。这是他一天吃的东西。-《华盛顿邮报》</title><link>https://www.washingtonpost.com/wellness/2025/10/01/kevin-hall-ultra-processed-foods/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="wpds-c-PJLV article-body type-text" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="GF2PPNQ4WBBNRNHSDPLLGNUS2A" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;A decade ago, most people had never heard of ultra-processed foods.&lt;/p&gt;&lt;/div&gt;&lt;div class="wpds-c-PJLV article-body type-text subtype-from-the-source" data-qa="article-body"&gt;&lt;p data-apitype="text" data-contentid="JZ6UWGAX4BGOLOP7AFGQMVHLUM" data-el="text" class="wpds-c-heFNVF wpds-c-heFNVF-iPJLV-css overrideStyles font-copy" dir="null"&gt;But that changed in 2019, when Kevin Hall, then a scientist at the National Institutes of Health, published a &lt;a href="https://pubmed.ncbi.nlm.nih.gov/31105044/" target="_blank"&gt;study&lt;/a&gt; that shocked the nutrition world.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The Washington Post</author><pubDate>Wed, 01 Oct 2025 10:32:22 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijAFBVV95cUxOaXR5aTdFYUVHZmk1VGV2MURqdXZIcHVobER3cFUxcnNmWlBlSHR4TEJaWjhjc3F3cDdZa3hHbUlSa3M5cXRmNmlaaThNazlfckUxcGFoeWE4RkZqN3hTbzc1SFExZkd1cUFNWE1kbEt5dG94SmxuTkVUb1B2bnJhUldjXy1zVktMcW9mSQ</guid></item><item><title>这位海地出生的医生建立了60亿美元的业务，开发治疗抑郁症和阿尔茨海默氏症的药物-福布斯</title><link>https://www.forbes.com/sites/amyfeldman/2025/10/01/this-haiti-born-doctor-built-a-6-billion-business-developing-drugs-for-depression-and-alzheimers/</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="fs-article fs-premium fs-responsive-text current-article font-body color-body bg-base font-accent article-body premium-container"&gt;&lt;h2 class="subhead-embed color-accent bg-base font-accent font-size text-align"&gt;Axsome Therapeutics has three drugs on the market and five in the pipeline, with the potential to help some 150 million Americans suffering from brain disorders.&lt;/h2&gt;&lt;hr class="embed-base rule-embed color-accent border-solid weight-light"&gt;
&lt;p&gt;&lt;strong&gt;&lt;abbr class="drop-cap color-accent font-accent"&gt;W&lt;/abbr&gt;hen Herriot Tabuteau &lt;/strong&gt;started a drug development company in 2012, he decided to do so differently. First, he’d focus on brain disorders, treatments for which are notoriously difficult to develop and whose efficacy can be hard to prove. And he’d be both CEO and the scientific founder, bringing to bear his dec­ades of experience investing in biotech startups and his medical training. But he’d take no venture capital, self-funding with help from friends and family.&lt;/p&gt;
&lt;p class="halfway_hardwall_1"&gt;&lt;/p&gt;
&lt;p&gt;“If you do things exactly the same way as everybody else, you’re going to have the same outcomes as everybody else. And we wanted to have outcomes that stand apart,” Tabuteau, 57, says, during his first-ever interview with a reporter about his company, Axsome Therapeutics.&lt;/p&gt;
&lt;p class="halfway_hardwall_2"&gt;&lt;/p&gt;&lt;figure class="embed-base image-embed embed-117" role="presentation"&gt;&lt;/figure&gt;&lt;hr class="embed-base rule-embed color-accent border-solid weight-light"&gt;
&lt;p&gt;Named for two parts of a nerve cell, the “axon” and the “soma,” Axsome has come a long way from its beginnings in a windowless three-desk office in New York’s Rockefeller Center, affectionately remembered as “the broom closet.” Today, it has three drugs on the market and five in the pipeline, with the potential to help the estimated 150 million Americans suffering from conditions like depression, ADHD or Alzheimer’s disease. Revenue for the 12 months ended in June reached $495 million, up 70% from the same period in 2024. Axsome is not yet profitable, booking a net loss of $247 million in that time.&lt;/p&gt;
&lt;p class="halfway_hardwall_3"&gt;&lt;/p&gt;
&lt;p&gt;The company trades on the Nasdaq with a market cap of $6.1 billion; Tabuteau is a billionaire thanks to his 15% stake in it, plus options. He figures Axsome could hit $16.5 billion in peak sales from its current drug portfolio, which would put it among the top 25 drug companies by revenue today. That’s assuming all goes to plan, most particularly getting five new drugs through the FDA between now and 2028. It’s a big ask: Only about 25% of drugs do well enough in Phase III trials to move forward in the FDA process.&lt;/p&gt;
&lt;p class="halfway_hardwall_4"&gt;&lt;/p&gt;
&lt;p&gt;Tabuteau was born in Haiti, where his birth mother struggled to raise him and his sister. He recalls experiencing neglect of all kinds—“physical, nutritional, emotional”—but “it taught me resili­ence,” he says now. At age 9, he moved with his dad and adoptive mom to Manhattan’s Upper East Side. Degrees in molecular biology and biochemistry from Wesleyan led him to Yale’s School of Medicine, where he planned to become a neurosurgeon. But he was so unsettled by the transparent unhappiness of his physician professors that he opted against a neurosurgery residency in favor of a job at Goldman Sachs’ health care investment banking group. That was the start of a nearly two-decade career in finance that included stints at Bank of America Securities and hedge fund Healthco/S.A.C. Capital, as well as managing his own funds.&lt;/p&gt;
&lt;p class="article_paragraph_7"&gt;&lt;/p&gt;&lt;figure class="embed-base image-embed embed-114" role="presentation"&gt;&lt;div&gt;&lt;div class="bMqrj"&gt;&lt;p class="Jp--BF7-"&gt;&lt;span class="Ccg9Ib-7 _8XF2kHYM"&gt;A World Apart: After leaving Haiti at age 9, Tabuteau grew up blocks from some of New York City’s preeiminent medical institutions, including Sloan Kettering, Rockefeller University and Weill Cornell. “I was just surrounded by science,” he says.&lt;/span&gt;&lt;/p&gt;&lt;small class="pGGCM2aD"&gt;Jamel Toppin for Forbes&lt;/small&gt;&lt;/div&gt;&lt;/div&gt;&lt;/figure&gt;
&lt;p&gt;&lt;span&gt;From his perch on Wall Street, he watched thousands of early-stage biotechs succeed and fail, and began to develop his own theories about what worked and why. While most biotechs focus on just one drug, he realized that building a portfolio would cut the risk of a flop. To keep costs low, he shunned the industry’s practice of outsourcing clinical trials, betting he could do it cheaper and with greater chance of success in-house. A Phase III trial could easily cost $50 million; Tabuteau could do it for 30% to 50% less. “We got a lot of pushback,” he says, as investors didn’t believe he could run so many trials on such a low budget. Working on multiple drugs helped: When one trial ended his researchers would immediately begin work on the next. &lt;/span&gt;&lt;/p&gt;
&lt;p&gt;Hedging his bets was wise. After going public in 2015, Axsome struggled—not unusual for an early-stage biotech, as drugs can take ten years to get from idea to market, and while Axsome’s trials were cheaper, they were not cheap. The company’s stock puttered along under $10 for years, its market cap dipping below $100 million after an early drug for pain flunked its clinical trial. “Nobody believed in Axsome years ago, and I think there’s still a lot of unbelievers,” says Axsome chief financial officer Nick Pizzie. “It’s a show-me story.”&lt;/p&gt;
&lt;p&gt;Axsome’s prospects skyrocketed with its first big drug, Auvelity. When the treatment for major depressive disorder gained FDA approval in August 2022, shares popped 65% in a week, valuing the company at $3 billion. The drug combines two existing medications for a treatment that can begin to work in just one week, compared to six or eight weeks for serotonin-based anti­depressants, a huge advantage.&lt;/p&gt;
&lt;p&gt;To launch it, Axsome started with 165 sales reps, less than half of what is typical. But it paired those reps with software that could identify which docs were likely to be receptive to its products and to determine whether they’d prefer email, a phone call or a face-to-face meeting. Auvelity is now on track to do $500 million in sales this year, and analysts figure the drug should become a blockbuster, industry parlance for a medication with more than $1 billion in revenue. Earlier this year, the company resolved patent litigation that will keep copycats off the market until at least 2038, a big win.&lt;/p&gt;
&lt;p&gt;Tabuteau’s finance expertise also paid off. In 2022, Axsome acquired a drug called Sunosi, which treats excessive daytime sleepiness in people with narcolepsy or sleep apnea. After pulling together a deal to buy it for $53 million (plus single-digit royalties) in just two weeks over Christmas in 2021, Axsome was able to more than recoup its money when Tabuteau sold the European, Middle Eastern and North African rights to the drug for $66 million (plus milestones and royalties) less than a year later. Sunosi’s revenue is now over $100 million annually. “It was a very shrewd financial transaction,” says Mizuho analyst Graig Suvannavejh.&lt;/p&gt;
&lt;p&gt;Shares have kept climbing, shooting up 35% over the past year to a recent $122, outperforming the Nasdaq Biotech Index, which is up just 1% over the same period. The next treatment to watch: a drug to treat the agitation that often accompanies Alzheimer’s disease. Antipsychotic medications, currently the only treatment available, have serious risks, including death. Axsome’s drug avoids these side effects but has reported mixed results in Phase III clinical trials. Axsome plans to file for approval before the end of September.&lt;/p&gt;
&lt;p&gt;It’s possible the FDA may not greenlight it, but analysts expect the need for an alternative to antipsychotics makes approval likely. It’s core to Tabuteau’s plans to get to $16.5 billion: He projects $1 billion to $3 billion in sales for Auvelity and $1.5 billion to $3 billion from the Alzheimer’s agitation drug annually at their peak. “There is so much ahead of us right now in terms of the pipeline and the number of patients we’re able to address,” he says. “We might be a small company in terms of size, but we’re not a small company in terms of fundamentals or in terms of ambition.”&lt;/p&gt;&lt;hr class="embed-base rule-embed color-accent border-solid weight-light"&gt;
&lt;h3 class="subhead3-embed color-body bg-base font-accent font-size text-align"&gt;&lt;strong&gt;How To Play It&lt;/strong&gt;&lt;/h3&gt;
&lt;h4 class="subhead4-embed color-body bg-base font-accent font-size text-align"&gt;By Jon D. Markman&lt;/h4&gt;&lt;figure class="embed-base image-embed embed-86 alignright" role="presentation"&gt;&lt;div&gt;&lt;p class="bMqrj"&gt;&lt;small class="pGGCM2aD"&gt;Illustration by Patrick Welsh for Forbes &lt;/small&gt;&lt;/p&gt;&lt;/div&gt;&lt;/figure&gt;
&lt;h4 class="subhead4-embed color-body bg-base font-accent font-size text-align"&gt;With medicine entering a brave new world, aggressive biotech firms are exploi­ting untapped markets through innovation. &lt;strong&gt;Vertex Pharmaceuticals&lt;/strong&gt; is leading the charge. Best known for its cystic fibrosis drugs that can treat 95% of all people living with the illness, Vertex is working on cutting-edge therapies, including mRNA treatments developed with Moderna. Second-quarter 2025 sales reached $2.96 billion, up 12% year-over-year, with full-year guidance raised to a high end of $12 billion. Building on its profitable core and breakthrough partnerships, Vertex is positioned to capture future demand. Shares could climb to $520 within 18 months, a gain of more than 30% gain from current levels.&lt;/h4&gt;
&lt;h4 class="subhead4-embed color-body bg-base font-accent font-size text-align"&gt;&lt;em&gt;Jon D. Markman is president of Markman Capital Insight and editor of Digital Creators &amp;amp; Consumers. &lt;/em&gt;&lt;/h4&gt;
&lt;h4 class="subhead4-embed color-body bg-base font-accent font-size text-align"&gt;&lt;br&gt;&lt;/h4&gt;&lt;hr class="embed-base rule-embed color-accent border-solid weight-light"&gt;
&lt;p&gt;&lt;em&gt;The Vault&lt;/em&gt;&lt;/p&gt;
&lt;h2 class="subhead-embed color-accent bg-base font-accent font-size text-align"&gt;&lt;strong&gt;Individual Innovation&lt;/strong&gt;&lt;/h2&gt;&lt;figure class="embed-base image-embed embed-61 alignright" role="presentation"&gt;&lt;/figure&gt;
&lt;h3 class="subhead3-embed color-body bg-base font-accent font-size text-align"&gt;Axsome Therapeutics founder Herriot Tabuteau has more than 400 patents, including for Auvelity, a depression drug that his own company licensed from him (for about $9 million last year). But inventive businessmen are not a new thing. Back in 1979, &lt;em&gt;Forbes&lt;/em&gt; visited the chaotic Midtown Manhattan office of Robert Lester, an “independent inventor” who had big ideas for everything from hidden windshield wipers to an imaging typewriter to an “ultrasonic locating system,” something like an early Apple AirTag. Lester did quite well for himself but, unlike Tabuteau, never really struck it big.&lt;/h3&gt;
&lt;h4 class="subhead4-embed color-body bg-base font-accent font-size text-align"&gt;It’s not easy being a full-time independent inventor in this age of technology. The days of lucrative tinkering in the garage Henry Ford–style are all but over. Lester figures there can’t be more than 100 men like him left in the country. But Lester, who holds “around 50” U.S. patents and has a few more pending, isn’t complaining. He makes a comfortable living. “I have my bad years and my good years, but I live out with all the millionaires in Manhasset. I manage never to earn less than $50,000 a year [$210,000 today].” . . .&lt;/h4&gt;
&lt;h4 class="subhead4-embed color-body bg-base font-accent font-size text-align"&gt;“To be very honest with you, manufacturing never really interested me. When I finish an invention, even before I finish writing the patent application, I’m not interested in it anymore. I’m interested in new things.”&lt;/h4&gt;
&lt;h4 class="subhead4-embed color-body bg-base font-accent font-size text-align"&gt;&lt;strong&gt;—&lt;em&gt;Forbes,&lt;/em&gt; December 10, 1979 &lt;/strong&gt;&lt;/h4&gt;
&lt;h4 class="subhead4-embed color-body bg-base font-accent font-size text-align"&gt;&lt;br&gt;&lt;/h4&gt;&lt;hr class="embed-base rule-embed color-accent border-solid weight-light"&gt;
&lt;h4 class="subhead4-embed color-body bg-base font-accent font-size text-align"&gt;&lt;br&gt;&lt;/h4&gt;
&lt;h3 class="subhead3-embed color-body bg-base font-accent font-size text-align"&gt;&lt;strong&gt;More from Forbes&lt;/strong&gt;&lt;/h3&gt;&lt;a class="embed-base color-body color-body-border link-embed embed-88" href="https://www.forbes.com/sites/amyfeldman/2025/05/26/meet-the-self-made-billionaire-who-made-a-fortune-on-copycat-drugs/" target="_blank" aria-label="Meet India’s Self-Made Biologics Brewmaster Billionaire" data-ga-track="forbesEmbedly:https://www.forbes.com/sites/amyfeldman/2025/05/26/meet-the-self-made-billionaire-who-made-a-fortune-on-copycat-drugs/"&gt;&lt;span class="link-embed__info"&gt;&lt;span class="link-embed__provider"&gt;Forbes&lt;/span&gt;&lt;span class="link-embed__title"&gt;Meet India’s Self-Made Biologics Brewmaster Billionaire&lt;/span&gt;&lt;small class="link-embed__byline"&gt;By &lt;span class="link-embed__author"&gt;Amy Feldman&lt;/span&gt;&lt;/small&gt;&lt;/span&gt;&lt;span class="link-embed__thumbnail-wrapper"&gt;&lt;span class="link-embed__thumbnail allow-inline-style"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;a class="embed-base color-body color-body-border link-embed embed-91" href="https://www.forbes.com/sites/amyfeldman/2025/08/11/longer-leash-on-life-inside-the-dog-longevity-startup-loyal/" target="_blank" aria-label="Longer Leash On Life: Inside The Dog Longevity Startup" data-ga-track="forbesEmbedly:https://www.forbes.com/sites/amyfeldman/2025/08/11/longer-leash-on-life-inside-the-dog-longevity-startup-loyal/"&gt;&lt;span class="link-embed__info"&gt;&lt;span class="link-embed__provider"&gt;Forbes&lt;/span&gt;&lt;span class="link-embed__title"&gt;Longer Leash On Life: Inside The Dog Longevity Startup&lt;/span&gt;&lt;small class="link-embed__byline"&gt;By &lt;span class="link-embed__author"&gt;Amy Feldman&lt;/span&gt;&lt;/small&gt;&lt;/span&gt;&lt;span class="link-embed__thumbnail-wrapper"&gt;&lt;span class="link-embed__thumbnail allow-inline-style"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;a class="embed-base color-body color-body-border link-embed embed-94 link-embed--long-title" href="https://www.forbes.com/sites/amyfeldman/2025/08/07/mit-spinout-strand-therapeutics-raises-153-million-to-make-cancerous-tumors-light-up/" target="_blank" aria-label="MIT Spinout Strand Therapeutics Raises $153 Million To Make Cancerous Tumors Light Up" data-ga-track="forbesEmbedly:https://www.forbes.com/sites/amyfeldman/2025/08/07/mit-spinout-strand-therapeutics-raises-153-million-to-make-cancerous-tumors-light-up/"&gt;&lt;span class="link-embed__info"&gt;&lt;span class="link-embed__provider"&gt;Forbes&lt;/span&gt;&lt;span class="link-embed__title"&gt;MIT Spinout Strand Therapeutics Raises $153 Million To Make Cancerous Tumors Light Up&lt;/span&gt;&lt;small class="link-embed__byline"&gt;By &lt;span class="link-embed__author"&gt;Amy Feldman&lt;/span&gt;&lt;/small&gt;&lt;/span&gt;&lt;span class="link-embed__thumbnail-wrapper"&gt;&lt;span class="link-embed__thumbnail allow-inline-style"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;a class="embed-base color-body color-body-border link-embed embed-97 link-embed--long-title" href="https://www.forbes.com/sites/amyfeldman/2025/09/23/this-startup-hit-a-325-billion-valuation-building-software-to-fix-drug-pricing/" target="_blank" aria-label="This Startup Hit A $3.25 Billion Valuation Building Software To Fix Drug Pricing" data-ga-track="forbesEmbedly:https://www.forbes.com/sites/amyfeldman/2025/09/23/this-startup-hit-a-325-billion-valuation-building-software-to-fix-drug-pricing/"&gt;&lt;span class="link-embed__info"&gt;&lt;span class="link-embed__provider"&gt;Forbes&lt;/span&gt;&lt;span class="link-embed__title"&gt;This Startup Hit A $3.25 Billion Valuation Building Software To Fix Drug Pricing&lt;/span&gt;&lt;small class="link-embed__byline"&gt;By &lt;span class="link-embed__author"&gt;Amy Feldman&lt;/span&gt;&lt;/small&gt;&lt;/span&gt;&lt;span class="link-embed__thumbnail-wrapper"&gt;&lt;span class="link-embed__thumbnail allow-inline-style"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;
&lt;p class="newsletter_signup_article"&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Forbes</author><pubDate>Wed, 01 Oct 2025 10:30:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMi4gFBVV95cUxQSGswakJVd1QzbVp5bjNPLWljOTk4ZDBBUWY5c0RSUEREdWVDWjhmQUhkWUJxSEpyeUNZNDN1c3lrXzhfS2U4T2xZeWpDR2xldGE1dXFaV09nR2N0Slo2ZHFWNVIyOXdHTkdwd002b3p4M19HLW9RUUtKbGhsUUpTdldLa2owTkFhNktYQWJKdGVDMHJZZWVLR3RDNEo2NFZtSm1McGZ6RE9JQUNDZHlLLWlxUmdvNzF3OVRKTmE1STZPRWxIOGJ5MXhwYW1pOUE4UVgyV2R1Qk5hSTRWM3RIa1lB</guid></item><item><title>为什么乳房密度对乳腺癌的检测和预防很重要- ABC新闻-突发新闻、最新新闻和视频</title><link>https://abcnews.go.com/US/dense-breasts-matter-breast-cancer-detection-prevention/story?id=126043209</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="xvlfx ZRifP TKoO eaKKC EcdEg bOdfO qXhdi NFNeu UyHES " data-testid="prism-article-body"&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao MvWXB TjIXL aGjvy ebVHC "&gt;Breast cancer awareness campaigns often focus on mammograms and self-exams. But there's another critical piece of the puzzle that has gotten far less attention until recently: breast density.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;A year after the FDA began requiring mammogram reports to tell women whether their breasts are dense, experts say it's important to explain what that means and why it matters.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"About 40% of women are being diagnosed with dense breasts," Dr. Alpa Patel, senior vice president of population science at the American Cancer Society told ABC News. "You actually find out about your breast density from your first mammogram, and that will actually potentially change over time."&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Breast tissue is made up of fibrous tissue, which holds everything in place, glandular tissue, which produces and carries milk, and fatty tissue, which shapes the breast, according to the Centers for Disease Control and Prevention. Breast density has nothing to do with breast size. Instead, it reflects how much fibrous and glandular tissue there is compared to fat on a mammogram.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;According to the American Cancer Society, women are more likely to have dense breasts if they are younger, pregnant or breastfeeding, taking hormone replacement therapy, or have a lower body weight. Experts say women who are unsure should talk with their health care provider about their individual breast cancer risk and the potential benefits and drawbacks of different screening methods.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;When dense tissue appears white on a mammogram it's the same color as potential tumors, making it harder to detect abnormalities. Some experts liken it to trying to spot a snowball in a snowstorm.&lt;/p&gt;&lt;div class="oLzSq QrHMO fnRUo pvsTF EhJPu vPlOC zNYgW OsTsW RMeqy daRVX ISNQ sKyCY eRftA acPPc MENS nFwaT MCnQE mEeeY SmBjI xegrY rPLsU iulOd NIuqO zzscu lzDCc aHUBM IEgzD OjMNy eQqcx SVqKB GQmdz jaoD VWDdR ONJdw vrZxD OnRTz gbbfF roDbV GPGwb oMlSS gfNzt oJhud eXZcf zhVlX "&gt;&lt;div&gt;&lt;div class="InlineImage GpQCA lZur asrEW " data-testid="prism-inline-image"&gt;&lt;figure class="kzIjN GNmeK pYrtp dSqFO " data-testid="prism-figure"&gt;&lt;figcaption&gt;&lt;div class="nMMea bNYiy Mjgpa dGwha DDmxa jgKNG RGHCC aBIU PriDW lZur " data-testid="prism-caption"&gt;&lt;p class="HXPPJ barbu yKsXL IzgMt VcHIt uhSzI YGNMU cRAsZ xqMcl QtRul "&gt;&lt;span class="hsDdd OOSI GpQCA lZur VlFaz " data-testid="prism-truncate"&gt;&lt;span&gt;&lt;span class="gtOSm FbbUW tUtYa vOCwz EQwFq yCufu eEak Qmvg nyTIa SRXVc vzLa jgBfc WXDas CiUCW kqbG zrdEG txGfn ygKVe BbezD UOtxr CVfpq xijV soGRS XgdC sEIlf daWqJ "&gt;Close up of a doctor using ultrasound scanner performing examination of breast for her patient.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p class="qinlA IpWvx oqZz tylGM lyWxS nWcVF UhTug PPcLh YxlyB "&gt;&lt;span class="gtOSm FbbUW tUtYa vOCwz EQwFq yCufu eEak Qmvg nyTIa SRXVc vzLa jgBfc WXDas CiUCW kqbG zrdEG txGfn ygKVe BbezD UOtxr CVfpq xijV soGRS XgdC sEIlf daWqJ YNujN JGtjI aZFDu rkKLh "&gt;STOCK PHOTO/Getty Images&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/figcaption&gt;&lt;/figure&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Breast density isn't just a screening challenge either. It's also a risk factor, according to the American College of Radiology, which notes that women with dense breasts are 2 to 3 times more likely to develop breast cancer, though they are not more likely to die from it.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Since September 2024, a new federal law requires mammogram reports to state whether breast tissue is dense, and to mention the possibility of additional imaging. For women with dense breasts, several options exist beyond standard mammography.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;3D mammography (also called tomosynthesis) can catch cancers not seen on traditional mammograms but may not be available everywhere. Breast ultrasound uses sound waves to look at the breast and magnetic resonance imaging (MRI) uses radio waves and magnets to make detailed images, often used for high-risk patients. Depending on specific risk factors, providers may recommend one or more of these tests.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;The ACR recommends most women have yearly mammograms starting at age 40. If a woman has additional risk factors or dense breasts, she should discuss this with her doctor to determine the benefit of adding supplemental screening tests in addition to mammogram.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"Breast density confers a slightly increased risk of breast cancer, but there are other factors that can confer a greater risk for breast cancer, such as family history or certain types of gene mutations," Dr. Kimberly Feigin, chief of breast imaging at Memorial Sloan Kettering, told ABC News. "We recommend that primary care physicians do some sort of risk assessment of patients when they are young, so they can determine at what age it's appropriate to start screening."&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;And while not all risk factors are controllable, some are.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;"We estimate about one in five breast cancers is actually preventable through things we have control over," Patel said, pointing out that lifestyle choices can also lower risk.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;She said that limiting alcohol, staying physically active with at least 30 minutes of brisk walking a day, eating a diet rich in fruits and vegetables while cutting back on red and processed meats, and maintaining a healthy weight are steps every woman can take to diminish their chances of breast cancer.&lt;/p&gt;&lt;p class="EkqkG IGXmU nlgHS yuUao lqtkC TjIXL aGjvy "&gt;Dr. Megha Gupta is a Neurology Resident Physician at Barnes-Jewish Hospital/Washington University in St. Louis and a member of the ABC News Medical Unit.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>ABC News - Breaking News, Latest News and Videos</author><pubDate>Wed, 01 Oct 2025 09:31:39 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiogFBVV95cUxQR0JTWWYyV3VuN3NFdmlkOHZZcWM3N3E3OGdVdjl2eXZPSnZ6bVZodU14WHRhMDRyS3RVaXQxdjBtR05HQ0Vrem81SktVaTZCci1KRUNFM0tIdHZfaVlKcFl2cEI4UGhwSm0yS1ppNU1FdlpBS2FzY3YtVTVhOTh4ZGpFdm1mbDVBX0drTzNtWHBLTTdyanczUzdiZTVyVE5XR1HSAacBQVVfeXFMTkp1T1JrcVZ1cFVnN3l2VUJYV1Ezc0pKenVWOUZaYVZRaDdIWlNHUWRnclA1V1BSSkliSW5NVWl2V0p5MS14OXo3Tlh0R1h2R3ZfS092WThLekQyclJqX1NxWjIxc1NETXJyOFBOb042eUVvWWlIVmVnVWFHOFRISURacWFmNmpaX2FsaHQxYTRxN1JyMTVYZVVYM0ZnZFhZZksxcXF5NGM</guid></item><item><title>用靶向PD-L1的融合蛋白工程化的用于局部IL-12递送的实体肿瘤CAR-T细胞-自然</title><link>https://www.nature.com/articles/s41551-025-01509-2</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div class="c-article-section__content" id="Sec10-content"&gt;&lt;h3 class="c-article__sub-heading" id="Sec11"&gt;Cell lines&lt;/h3&gt;&lt;p&gt;The mouse prostate cancer cell line PTEN&lt;sup&gt;−/−&lt;/sup&gt; &lt;i&gt;Kras&lt;/i&gt; (PTEN–&lt;i&gt;Kras&lt;/i&gt;) derived from 10-week K-&lt;i&gt;ras&lt;/i&gt; G12D;PTEN deletion mutant prostate cells was a kind gift from David Mulholland (The Icahn School of Medicine at Mount Sinai)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Mulholland, D. J. et al. Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. Cancer Res. 72, 1878–1889 (2012)." href="/articles/s41551-025-01509-2#ref-CR42" id="ref-link-section-d136417870e2233"&gt;42&lt;/a&gt;&lt;/sup&gt;. The Ras/Myc transformed prostate cancer line, RM9, was a kind gift from Timothy C. Thompson (MD Anderson Cancer Centre) and has been previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Murad, J. P. et al. Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity. Mol. Ther. 
                https://doi.org/10.1016/j.ymthe.2021.02.024
                
               (2021)." href="/articles/s41551-025-01509-2#ref-CR45" id="ref-link-section-d136417870e2238"&gt;45&lt;/a&gt;&lt;/sup&gt;. ID8, a cell line originated from C57BL/6 mouse ovarian surface epithelial cells, was a kind gift from Karen Aboody (City of Hope National Medical Center). Cell lines were cultured in complete Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Hyclone), 2 mM &lt;span class="u-small-caps"&gt;l&lt;/span&gt;-glutamine (Fisher Scientific) and 25 mM HEPES (Irvine Scientific) (cDMEM). PC3 human prostate cancer cell line (ATCC, CRL-1435) and PEO4 human ovarian cancer cell line (Sigma Aldrich, 10032309) were cultured in RPMI-1640 medium (Lonza) containing 10% FBS (Hyclone), 2 mM &lt;span class="u-small-caps"&gt;l&lt;/span&gt;-glutamine (Fisher Scientific) and 25 mM HEPES (Irvine Scientific) (complete (c)RPMI). Virus titres were checked with either HT1080 (ATCC; CCL-121, cDMEM) and/or Jurkat cells (ATCC TIB-152; clone E6-1, cRPMI). Human embryonic kidney cell line 293T (ATCC; CRL-3216) was cultured in cDMEM. To generate a more aggressive ID8 tumour line in vivo, the parental ID8 cells were engrafted in vivo in the peritoneal cavity of mice for ~30 days. Unsorted cells collected from murine ovarian model peritoneal ascites were processed for red blood cell (RBC) lysis and analysed immediately as described. Passaged ID8 cells were then engrafted into tumour-naïve mice confirming increased aggressiveness relative to parental cells.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec12"&gt;DNA constructs, lentiviral production and transduction, and retrovirus production&lt;/h3&gt;&lt;p&gt;Tumour cells were engineered to express firefly luciferase (&lt;i&gt;ffluc&lt;/i&gt;) by transduction with epHIV7 backbone lentivirus carrying the &lt;i&gt;ffluc&lt;/i&gt; gene under the control of the EF1α promoter. PTEN–&lt;i&gt;Kras&lt;/i&gt; cells were transduced to express human PSCA (hPSCA) (human &lt;i&gt;PSCA&lt;/i&gt;, accession no. &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005672.5"&gt;NM_005672.5&lt;/a&gt;), and ID8 and PEO4 cells were engineered to express tumour-associated glycoprotein-72 (TAG72) via transduction with epHIV7 lentivirus carrying the &lt;i&gt;St6galnac-I&lt;/i&gt; gene (STn; human, accession no. &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_018414.5"&gt;NM_018414.5&lt;/a&gt;, or murine mSTn, accession no. &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_011371"&gt;NM_011371&lt;/a&gt;), under the control of the EF1α promoter. STn is the unique sialyltransferase responsible for generating surface expression of aberrant glycosylation sialyl-Tn (TAG72)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 73" title="Ogawa, T. et al. ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway. Oncotarget 8, 112550–112564 (2017)." href="/articles/s41551-025-01509-2#ref-CR73" id="ref-link-section-d136417870e2293"&gt;73&lt;/a&gt;&lt;/sup&gt;. The single-chain variable fragment (scFv) sequence used in the TAG72–CAR construct was obtained from a murine monoclonal antibody clone CC49 that targets TAG72 (ref. &lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Murad, J. P. et al. Effective targeting of TAG72+ peritoneal ovarian tumors via regional delivery of CAR-engineered T cells. Front. Immunol. 
                https://doi.org/10.3389/fimmu.2018.02268
                
               (2018)." href="/articles/s41551-025-01509-2#ref-CR74" id="ref-link-section-d136417870e2297"&gt;74&lt;/a&gt;&lt;/sup&gt;). The extracellular spacer domain included the 129-amino acid middle-length CH2-deleted version (ΔCH2) of the murine IgG1 Fc spacer and a murine CD28 transmembrane domain&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Murad, J. P. et al. Effective targeting of TAG72+ peritoneal ovarian tumors via regional delivery of CAR-engineered T cells. Front. Immunol. 
                https://doi.org/10.3389/fimmu.2018.02268
                
               (2018)." href="/articles/s41551-025-01509-2#ref-CR74" id="ref-link-section-d136417870e2301"&gt;74&lt;/a&gt;&lt;/sup&gt;. The scFv sequence from the murine anti-hPSCA antibody (clone 1G8) was used to develop the murine PSCA–CAR construct. The extracellular spacer domain included the murine CD8 hinge region, followed by a murine CD8 transmembrane domain&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Murad, J. P. et al. Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity. Mol. Ther. 
                https://doi.org/10.1016/j.ymthe.2021.02.024
                
               (2021)." href="/articles/s41551-025-01509-2#ref-CR45" id="ref-link-section-d136417870e2306"&gt;45&lt;/a&gt;&lt;/sup&gt;. Both TAG72–CAR and PSCA–CAR had a 4-1BB intracellular co-stimulatory signalling domain. The murine CD3ζ cytolytic domain was previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Lee, E. H. J. et al. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. Nat. Commun. 14, 4737 (2023)." href="/articles/s41551-025-01509-2#ref-CR29" id="ref-link-section-d136417870e2310"&gt;29&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Murad, J. P. et al. Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity. Mol. Ther. 
                https://doi.org/10.1016/j.ymthe.2021.02.024
                
               (2021)." href="/articles/s41551-025-01509-2#ref-CR45" id="ref-link-section-d136417870e2313"&gt;45&lt;/a&gt;&lt;/sup&gt;. The CAR sequence was separated from a truncated murine CD19 gene (mCD19t) by a T2A ribosomal skip sequence and cloned in a pMYs retrovirus backbone under the control of a hybrid MMLV/MSCV promoter (Cell Biolabs) as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Lee, E. H. J. et al. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. Nat. Commun. 14, 4737 (2023)." href="/articles/s41551-025-01509-2#ref-CR29" id="ref-link-section-d136417870e2317"&gt;29&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Murad, J. P. et al. Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity. Mol. Ther. 
                https://doi.org/10.1016/j.ymthe.2021.02.024
                
               (2021)." href="/articles/s41551-025-01509-2#ref-CR45" id="ref-link-section-d136417870e2320"&gt;45&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Murad, J. P. et al. Effective targeting of TAG72+ peritoneal ovarian tumors via regional delivery of CAR-engineered T cells. Front. Immunol. 
                https://doi.org/10.3389/fimmu.2018.02268
                
               (2018)." href="/articles/s41551-025-01509-2#ref-CR74" id="ref-link-section-d136417870e2323"&gt;74&lt;/a&gt;&lt;/sup&gt;. Bifunctional fusion proteins or controls contain αPD-L1 scFv derived from Avelumab, or mutein non-PD-L1 binding variant (αPD-L1&lt;sup&gt;mut&lt;/sup&gt;) as described previously&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Martomo, S. A. et al. Single-dose anti–PD-L1/IL-15 fusion protein KD033 generates synergistic antitumor immunity with robust tumor-immune gene signatures and memory responses. Mol. Cancer Ther. 20, 347–356 (2021)." href="/articles/s41551-025-01509-2#ref-CR55" id="ref-link-section-d136417870e2329"&gt;55&lt;/a&gt;&lt;/sup&gt;. Sequences from full-length murine IL-12(p40p35) (murine &lt;i&gt;IL-12a&lt;/i&gt; and &lt;i&gt;IL-12b&lt;/i&gt;, NCBI accession nos. &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001159424.3"&gt;NM_001159424.3&lt;/a&gt;, &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001303244.1"&gt;NM_001303244.1&lt;/a&gt;)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Skrombolas, D., Wylie, I., Maharaj, S. &amp;amp; Frelinger, J. G. Characterization of an IL-12 p40/p35 truncated fusion protein that can inhibit the action of IL-12. J. Interferon Cytokine Res. 35, 690–697 (2015)." href="/articles/s41551-025-01509-2#ref-CR68" id="ref-link-section-d136417870e2354"&gt;68&lt;/a&gt;&lt;/sup&gt;, human IL-15/Ra (NCBI human &lt;i&gt;IL15&lt;/i&gt; and &lt;i&gt;IL15RA&lt;/i&gt;, accession nos. &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000585.5"&gt;NM_000585.5&lt;/a&gt;, &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001243539"&gt;NM_001243539&lt;/a&gt;)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Liu, B. et al. Bifunctional TGF-β trap/IL-15 protein complex elicits potent NK cell and CD8+ T cell immunity against solid tumors. Mol. Ther. 29, 2949–2962 (2021)." href="/articles/s41551-025-01509-2#ref-CR30" id="ref-link-section-d136417870e2379"&gt;30&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Martomo, S. A. et al. Single-dose anti–PD-L1/IL-15 fusion protein KD033 generates synergistic antitumor immunity with robust tumor-immune gene signatures and memory responses. Mol. Cancer Ther. 20, 347–356 (2021)." href="/articles/s41551-025-01509-2#ref-CR55" id="ref-link-section-d136417870e2382"&gt;55&lt;/a&gt;&lt;/sup&gt; and TGFβRII (US Patent US9676863B2)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Liu, B. et al. Bifunctional TGF-β trap/IL-15 protein complex elicits potent NK cell and CD8+ T cell immunity against solid tumors. Mol. Ther. 29, 2949–2962 (2021)." href="/articles/s41551-025-01509-2#ref-CR30" id="ref-link-section-d136417870e2386"&gt;30&lt;/a&gt;&lt;/sup&gt; were used to construct their respective fusions. Murine fusions contained linkers using a CH2-deleted version (ΔCH2) of human IgG1 Fc spacer (NCBI genomic DNA accession no. &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NG_001019.6"&gt;NG_001019.6&lt;/a&gt;) (Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01509-2#MOESM1"&gt;1a&lt;/a&gt;). Human bifunctional fusion proteins and controls contain αPD-L1 scFv derived from Avelumab (which is cross reactive with human and mouse). Human fusions contained linkers using a CH2-deleted version (ΔCH2) of human IgG4 Fc spacer (NCBI accession no. &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NG_001019.6"&gt;NG_001019.6&lt;/a&gt;). Sequences from full-length human IL-12(p35p40) (NCBI accession no. &lt;i&gt;IL-12A&lt;/i&gt;, &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000882.4"&gt;NM_000882.4&lt;/a&gt;; &lt;i&gt;IL-12B&lt;/i&gt;, &lt;a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_002187.3"&gt;NM_002187.3&lt;/a&gt;) were used, with the p40 subunit distal in all instances. All constructs were ordered as complete gene fragments (Genscript) and cloned into appropriate epHIV7 lentiviral or pMYs retroviral backbones as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Lee, E. H. J. et al. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. Nat. Commun. 14, 4737 (2023)." href="/articles/s41551-025-01509-2#ref-CR29" id="ref-link-section-d136417870e2428"&gt;29&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Murad, J. P. et al. Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity. Mol. Ther. 
                https://doi.org/10.1016/j.ymthe.2021.02.024
                
               (2021)." href="/articles/s41551-025-01509-2#ref-CR45" id="ref-link-section-d136417870e2431"&gt;45&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Murad, J. P. et al. Effective targeting of TAG72+ peritoneal ovarian tumors via regional delivery of CAR-engineered T cells. Front. Immunol. 
                https://doi.org/10.3389/fimmu.2018.02268
                
               (2018)." href="/articles/s41551-025-01509-2#ref-CR74" id="ref-link-section-d136417870e2434"&gt;74&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 75" title="Park, A. K. et al. Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors. Sci. Transl. Med. 
                https://doi.org/10.1126/scitranslmed.aaz1863
                
               (2020)." href="/articles/s41551-025-01509-2#ref-CR75" id="ref-link-section-d136417870e2437"&gt;75&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 76" title="Saul, P. et al. Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis. J. Immunother. Cancer 
                https://doi.org/10.1186/2051-1426-3-S2-P121
                
               (2015)." href="/articles/s41551-025-01509-2#ref-CR76" id="ref-link-section-d136417870e2440"&gt;76&lt;/a&gt;&lt;/sup&gt;. Bifunctional murine and human fusion and CAR construct illustrations are detailed in Supplementary Figs. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01509-2#MOESM1"&gt;1&lt;/a&gt; and &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01509-2#MOESM1"&gt;9&lt;/a&gt;. Amino acid sequences for murine CARs and bifunctional fusions (human and murine) are detailed in Supplementary Table &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01509-2#MOESM1"&gt;1&lt;/a&gt;, and human bifunctional fusions are also available in US Provisional Patent Application No. 63/772,399. Amino acid sequence for the human TAG72–CAR is detailed in US Patent US20210308184A1.&lt;/p&gt;&lt;p&gt;Retrovirus was produced by transfecting the ecotropic retroviral packaging cell line, PLAT-E (Cell Biolabs), with addition of murine PSCA–CAR and murine TAG72–CAR retrovirus backbone plasmid DNA using FuGENE HD transfection reagent (Promega). Viral supernatants were collected after 24, 36 and 48 h, pooled and stored at −80 °C in aliquots for future T cell transductions&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Murad, J. P. et al. Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity. Mol. Ther. 
                https://doi.org/10.1016/j.ymthe.2021.02.024
                
               (2021)." href="/articles/s41551-025-01509-2#ref-CR45" id="ref-link-section-d136417870e2457"&gt;45&lt;/a&gt;&lt;/sup&gt;. Lentivirus was generated by plating 293T cells in T-225 tissue culture flasks 1 day before transfection with packaging plasmids and desired CAR lentiviral backbone plasmid. Supernatants were collected after 3–4 days, filtered and centrifuged to remove cell debris, and incubated with 2 mM magnesium and 25 U ml&lt;sup&gt;−1&lt;/sup&gt; Benzonase endonuclease (EMD Millipore) to remove contaminating nucleic acids. Supernatants were combined and concentrated via high-speed centrifugation (6,080 × &lt;i&gt;g&lt;/i&gt;) overnight at 4 °C. Lentiviral pellets were then resuspended in phosphate-buffered saline (PBS)-lactose solution (4 g lactose per 100 ml PBS), aliquoted and stored at −80 °C for later use. Lentiviral titres were determined by transducing Jurkat or HT1080 cells. Flow cytometry was used to quantify expression of either intracellular αFc (fusion constructs) or surface CD19t (CAR+), respectively.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec13"&gt;Murine and human T cell isolation, transductions and ex vivo expansion&lt;/h3&gt;&lt;p&gt;Murine T cell activation and transduction was performed as described previously&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Lee, E. H. J. et al. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. Nat. Commun. 14, 4737 (2023)." href="/articles/s41551-025-01509-2#ref-CR29" id="ref-link-section-d136417870e2474"&gt;29&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 75" title="Park, A. K. et al. Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors. Sci. Transl. Med. 
                https://doi.org/10.1126/scitranslmed.aaz1863
                
               (2020)." href="/articles/s41551-025-01509-2#ref-CR75" id="ref-link-section-d136417870e2477"&gt;75&lt;/a&gt;&lt;/sup&gt;. Briefly, for murine studies, splenocytes were obtained by manual digestion of spleens from male heterozygous hPSCA-KI or female C57BL/6j mice. Enrichment of T cells was performed using the EasySep mouse negative T cell isolation kit following manufacturer protocol (StemCell Technologies). Murine PSCA–CAR or murine TAG72–CAR were achieved with single retrovirus transductions. Dual transduction required mixing of desired murine CAR retrovirus and secondary helper/fusion protein retrovirus to generate CAR-expressing fusion-positive T cells. Subsequent murine T cell expansion was performed as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Lee, E. H. J. et al. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. Nat. Commun. 14, 4737 (2023)." href="/articles/s41551-025-01509-2#ref-CR29" id="ref-link-section-d136417870e2481"&gt;29&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;&lt;p&gt;Human leukapheresis products were obtained from consenting healthy donors under City of Hope IRB-approved protocol no. 09025. Peripheral blood mononuclear cells (PBMCs) were isolated via Ficoll-Paque (GE Healthcare) density gradient centrifugation, washed in PBS/EDTA and cryopreserved in CryoStor (StemCell Technologies). T cell activation and transduction was performed in part as described previously&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Lee, E. H. J. et al. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. Nat. Commun. 14, 4737 (2023)." href="/articles/s41551-025-01509-2#ref-CR29" id="ref-link-section-d136417870e2488"&gt;29&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 76" title="Saul, P. et al. Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis. J. Immunother. Cancer 
                https://doi.org/10.1186/2051-1426-3-S2-P121
                
               (2015)." href="/articles/s41551-025-01509-2#ref-CR76" id="ref-link-section-d136417870e2491"&gt;76&lt;/a&gt;&lt;/sup&gt;. Briefly, thawed PBMCs (2.0 × 10&lt;sup&gt;6&lt;/sup&gt; CD3&lt;sup&gt;+&lt;/sup&gt;) were cultured in X-VIVO medium (Lonza) containing 100 U ml&lt;sup&gt;−1&lt;/sup&gt; recombinant human IL-2 (rhIL-2, BioTechne) and 0.5 ng ml&lt;sup&gt;−1&lt;/sup&gt; recombinant human IL-15 (rhIL-15, BioTechne). T cells were activated via CD3/CD28 TransAct (Miltenyi Biotec, 130-111-160) at 1:500 dilution, following manufacturer-suggested protocol, in 24-well tissue culture plates (Corning). Primary human TAG72–CAR transduction was performed in the presence of protamine sulfate (APP Pharmaceuticals), cytokines and human TAG72–CAR-T cell lentivirus as described previously&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Lee, E. H. J. et al. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. Nat. Commun. 14, 4737 (2023)." href="/articles/s41551-025-01509-2#ref-CR29" id="ref-link-section-d136417870e2504"&gt;29&lt;/a&gt;,&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 76" title="Saul, P. et al. Development of HER2-specific chimeric antigen receptor T cells for the treatment of breast-to-brain metastasis. J. Immunother. Cancer 
                https://doi.org/10.1186/2051-1426-3-S2-P121
                
               (2015)." href="/articles/s41551-025-01509-2#ref-CR76" id="ref-link-section-d136417870e2507"&gt;76&lt;/a&gt;&lt;/sup&gt;. Secondary transduction with human helper viruses (αPD-L1–Fc, αhIL-12–Fc or αPD-L1–Fc–hIL-12) involved restimulation with TransAct and cytokine replenishment 24 h following primary transduction. All viruses were used at an MOI of 1. Cells were continuously cultured with cytokine-enriched X-VIVO, refreshed every 2–3 days. At 10 days post transduction, CAR-T cell purity and phenotype were assessed by flow cytometry, detecting surface CAR (hCD3&lt;sup&gt;+&lt;/sup&gt;hCD19&lt;sup&gt;+&lt;/sup&gt;) and intracellular helper proteins via Fc-linker and hIL-12 expression. At day 14, cells were used for in vitro co-culture assays or cryopreserved in CryoStor CS5 for future use.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec14"&gt;Flow cytometry&lt;/h3&gt;&lt;p&gt;For flow cytometric analysis, cells were resuspended in FACS buffer (Hank’s balanced salt solution without Ca&lt;sup&gt;2+&lt;/sup&gt;, Mg&lt;sup&gt;2+&lt;/sup&gt; or phenol red (HBSS&lt;sup&gt;−/−&lt;/sup&gt;), Life Technologies) containing 2% FBS and 1× antibiotic-antimycotic (GIBCO, FACS buffer). Single-cell suspensions from mouse tissues or tumours were incubated for 20 min on ice with mouse Fc Block at a dilution of 1:50 (BD, 553140). Cells were then incubated with primary antibodies for 30 min at 4 °C in the dark with either Brilliant Violet 510 (BV510), Brilliant Violet 570 (BV570), Brilliant Violet 605 (BV605), Brilliant Violet 650 (BV650), fluorescein isothiocyanate (FITC), phycoerythrin (PE), peridinin chlorophyll protein complex (PerCP), PerCP-Cy5.5, PE-Cy7, allophycocyanin (APC), or APC-Cy7 (or APC-eFluor780), eFluor506, PE/Dazzle 594, PerCP-eFluor 710, BD Horizon Red 718 (R718), Alexa Fluor 488 (AF488), or PE-Cy5-conjugated antibodies. Antibodies against mouse CD3 (BD Biosciences, 563109, Clone: 17A2), mouse CD4 (ThermoFisher, 340443, Clone: RM4-5), mouse CD8a (BioLegend, 347313, Clone: 53-6.7), mouse CD19 (BD Biosciences, 557835, Clone: 1D3), mouse CD45 (BioLegend, 103145, Clone: 30-F11), mouse CD137 (ThermoFisher, 25-1371-82, Clone: 17B5), mouse NK1.1 (BioLegend, 108733, Clone: PK163), mouse PD-1 (BioLegend, 69-9985-80, Clone: J43), mouse LAG3 (BioLegend, 125227, Clone: C9B7W), mouse TIM-3 (BioLegend, 119704, Clone: RMT3-23), mouse CD11b (BioLegend, 101237, Clone: M1/70), CD44 (BD Biosciences, 103010, Clone: IM7), CD62L (BioLegend, 104412, Clone: MEL-14), CD80 (BD Biosciences, 740130, Clone: 16-10A1), mouse I-A/I-E (MHC Class II) (Biolegend, 64-5321-80, Clone: M5/114.15.2), mouse CD274 (PD-L1) (BioLegend, 124312, Clone: 10F.9G2), Ly6-C (BioLegend, 128029, Clone: HK1.4), mouse CD11c (BioLegend, 117316, Clone: N418), mouse Ly-6G (Biolegend, 127623, Clone: 1A8), mouse CD103 (BioLegend, 121426, Clone: 2E7), mouse F4/80 (BioLegend, 123127, Clone: BM8), mouse IL-12/IL-23 p40 (ThermoFisher, 12-7123-41, Clone: 17.8), human IL-15/Ra (R&amp;amp;D Systems, FAB10900R, Clone: 2639B, 1:20 dilution), human TGFβ Receptor II (BioLegend, 399703, Clone: W17055E), purified non-conjugated anti-human TGFβ Receptor II antibody (BioLegend, 399702, Clone: W17055E), anti-human CD45 (BD Biosciences, 563204; Clone: HI30), anti-human CD25 (Invitrogen, 46-0259-42, Clone: BC96), anti-human CD19 (BD Pharmigen, 557835, Clone: SJ25C1), purified APC anti-human PD-L1 antibody (BD Biosciences, 563741, Clone: MIH1) and PE mouse anti-human IL-12 (p40/p70) (BD Bioscienes, 554575, Clone: C11.5). All antibodies (anti-mouse and anti-human) used for flow cytometery were used at a dilution of 1:100 unless stated otherwise. Cell viability was determined using 4′, 6-diamidino-2-phenylindole (DAPI, Sigma). When necessary, secondary staining of cells was performed by washing twice before a 30-min incubation at 4 °C in the dark. Flow cytometry was performed on a MACSQuant Analyzer 16 (Miltenyi Biotec), and the data were analysed with FlowJo software (v.10.8). Representative flow cytometry gating strategy for lymphoid and myeloid populations can be found in Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01509-2#MOESM1"&gt;10&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;For intracellular flow cytometry, BD GolgiStop (51-2092KZ) was added to CAR-T cells for blocking intracellular protein transport and incubated for 3–4 h at 37 °C. Cells were transferred to a 96-well plate. Reagents and buffers for flow cytometry processing were pre-chilled on ice unless otherwise stated. Cells were washed with FACS buffer and then fixed in 1× BD Cytofix/Cytoperm (51-2090KZ) at 4 °C for 20 min. Following washing with 1× BD Perm/Wash buffer (51-2091KZ) twice, cells were stained with intracellular antibody: FITC polyclonal goat anti-human Fc (Jackson ImmunoResearch, 109-096-008) for 30 min at 4 °C. Data were acquired on a MACSQuant Analyzer 16 cytometer (Miltenyi) and analysed with FlowJo software (v.10.8).&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec15"&gt;In vitro PD-L1 binding, tumour killing and functional assays&lt;/h3&gt;&lt;p&gt;For murine PD-L1 blocking/binding experiments, PD-L1 expression was first induced on RM9 cells for 4 h via conditioned media collected from CAR-T cell:tumour cell co-cultures. PD-L1-induced tumours were then co-cultured for 1 h at room temperature with supernatants collected from supernatants of dual-transduced CAR-T cells engineered to secrete bifunctional fusion proteins (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41551-025-01509-2#Fig1"&gt;1d&lt;/a&gt;). Levels of PD-L1 blockade, from indicated CAR-T cell supernatants or relevant positive and negative controls, were measured in a flow cytometry-based competitive binding assay using a fluorescently conjugated competitively binding αPD-L1 antibody (BioLegend, Clone: 10F.9G2). Simultaneously, PD-L1-induced and fusion protein-blocked tumours were measured for detection of surface-bound fusion cytokines IL-15/Ra, IL-12 and TGFβRII. For TGFβRII detection, tumours were first blocked with cold unconjugated anti-TGFβRII antibody to remove tumour receptor background before adding CAR-T cell supernatants.&lt;/p&gt;&lt;p&gt;For human PD-L1 blocking/binding experiments, PD-L1 expression was first induced on PC3 prostate tumour cells overnight in 20 ng ml&lt;sup&gt;−1&lt;/sup&gt; recombinant human IFNγ (BioLegend, 570202). PD-L1-induced PC3 tumour cells were then co-cultured for 1 h at room temperature with supernatants collected from supernatants of transduced human Jurkat T cell tumour cells engineered to secrete human bifunctional fusion proteins or controls (Supplementary Fig. &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01509-2#MOESM1"&gt;9a&lt;/a&gt;). Levels of PD-L1 blockade, from indicated CAR-T cell supernatants or relevant positive and negative controls, were measured in a flow cytometry-based competitive binding assay using an APC fluorescently conjugated competitively binding anti-human PD-L1 antibody (BD Biosciences, 563741, Clone: MIH1; 1:100 dilution). Simultaneously, PD-L1-induced, αPLD1–Fc–IL-12 protein, single-sided controls or untransduced control Jurkat T cell supernatant blocked tumours, were measured for detection of surface-bound fusion cytokine human IL-12 (BD Bioscienes, Clone: C11.5; PE mouse anti-human IL-12 (p40/p70), 554575; 1:100 dilution) and/or Fc-linker protein using goat anti-human Fc-FITC (Jackson ImmunoResearch, 109-096-008; 1:100 dilution).&lt;/p&gt;&lt;p&gt;For mouse tumour cell killing assays, UTD or PSCA–CAR mouse T cells engineered with or without αPD-L1, αPD-L1–TGFβ&lt;sup&gt;trap&lt;/sup&gt;, αPD-L1&lt;sup&gt;mut&lt;/sup&gt;–IL-15, αPD-L1–IL-15, αPD-L1&lt;sup&gt;mut&lt;/sup&gt;–IL-12 or αPD-L1–IL-12 were co-cultured at a primary 1:2 E:T ratio against PTEN–&lt;i&gt;Kras&lt;/i&gt; hPSCA mouse prostate tumour cells in complete RPMI medium without cytokines in 96-well plates (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41551-025-01509-2#Fig1"&gt;1g&lt;/a&gt;). At indicated timepoints (every 48 h) co-cultures were analysed by flow cytometry as described. At these timepoints, replicate plates were rechallenged with an additional 20,000 PTEN–&lt;i&gt;Kras&lt;/i&gt; hPSCA tumour cells every 2 days for a total of 5 tumour challenges. For human tumour cell killing assays, UTD or TAG72–CAR-T cells engineered with or without human αPD-L1–Fc, hIL-12–Fc or αPD-L1–Fc–hIL-12 were co-cultured in triplicate at a primary 1:2 E:T ratio against PEO4-STn, human ovarian cancer cells transduced to express TAG72, in complete X-VIVO media without cytokines in 96-well plates (Fig. &lt;a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41551-025-01509-2#Fig1"&gt;1g&lt;/a&gt;). After 48 h, co-cultures were analysed by flow cytometry as described. For both murine and human co-culture assays, tumour cell killing by CAR-T cells was calculated by comparing CD45-negative DAPI-negative (viable) cell counts relative to targets co-cultured with UTD. In addition to flow cytometry measures of co-cultures, cell supernatants were collected from each timepoint to quantify IFNγ (human or mouse) by ELISA.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec16"&gt;ELISA cytokine assays&lt;/h3&gt;&lt;p&gt;Supernatants from tumour cell killing assays were collected at indicated times and frozen at −80 °C for future analysis. Supernatants from all timepoints were thawed and analysed for murine IFNγ using the murine IFNγ ELISA Ready-SET-GO! kit (mIFNγ; Invitrogen, 88-7314-88), or for human IFNγ using the human IFNγ ELISA kit (huIFNγ; Invitrogen, 88-7316-88) following manufacturer protocol. Mouse serum, plasma, peritoneal ascites or tumour CD45&lt;sup&gt;+&lt;/sup&gt; isolated cell supernatant cytokine levels of IFNγ and IL-12 were measured using murine IFNγ and IL-12 ELISA Ready-SET-GO! ELISA kits (IL-12; Invitrogen, BMS616), following manufacturer protocols. Plates were read at 450 nm using a Cytation3 imaging reader with Gen5 microplate software v.3.05 (BioTek). Mouse Luminex Discovery Assay kit (15-Plex; R&amp;amp;D Systems, LXSAMSM-15) was used to evaluate multiple analytes on collected peritoneal ascites from in vivo ovarian cancer models. Multiplex cytokine expression data were log&lt;sub&gt;2&lt;/sub&gt; transformed and displayed in balloon plots created using the gglot2 v.3.5.1 R package.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec17"&gt;RT–qPCR&lt;/h3&gt;&lt;p&gt;Complementary DNA was prepared from 1 μg of total RNA (matched from RNA-seq analyses) using SuperScript IV reverse transcriptase (ThermoFisher). Quantitative PCR was performed in triplicate using SsoAdvanced Universal SYBR Green Supermix (BioRad). Data were analysed using the comparative threshold method, and gene expression was normalized to murine GAPDH expression on a CFX RT-PCR instrument and CFX Maestro software (BioRad, v.2.3). Murine forward (F) and reverse (R) gene primers: murine &lt;i&gt;gapdh&lt;/i&gt; (F: GTCAAGCTCATTTCCTGGTATGACA, R: GTTGGGATAGGGCCTCTCTTG) and murine &lt;i&gt;tgf&lt;/i&gt;β (F: AGCTGCGCTTGCAGAGATTA, R: AGCCCTGTATTCCGTCTCCT) were used.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec18"&gt;In vivo studies&lt;/h3&gt;&lt;p&gt;All animal experiments were performed under protocols approved by the City of Hope Institutional Animal Care and Use Committee (protocol no. 21025). For all animal studies, mice were housed with 12 h light and 12 h dark cycle at a temperature range of 68–75 °F and humidity between 30–70%. For subcutaneous prostate tumour studies, PTEN–&lt;i&gt;Kras&lt;/i&gt; hPSCA cells (1.0 × 10&lt;sup&gt;6&lt;/sup&gt;) were prepared in a final volume of 100 μl HBSS&lt;sup&gt;−/−&lt;/sup&gt; and injected under the skin of the abdomen of 6–8-week-old male heterozygous hPSCA-KI C57BL/6J mice as previously described&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Murad, J. P. et al. Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity. Mol. Ther. 
                https://doi.org/10.1016/j.ymthe.2021.02.024
                
               (2021)." href="/articles/s41551-025-01509-2#ref-CR45" id="ref-link-section-d136417870e2618"&gt;45&lt;/a&gt;&lt;/sup&gt;. Tumour growth was measured using calipers (length × width × height = mm&lt;sup&gt;3&lt;/sup&gt;). For prostate tumour studies, mice were treated by i.p. administration with soluble murine recombinant IL-12 (sIL-12; 1 μg, PeproTech, 210-12) once daily for 5 days starting on the day of T cell treatment. For in vivo i.p. ovarian tumour studies, ID8-mStn (&lt;i&gt;ffluc&lt;/i&gt; expressing) cells (5.0 × 10&lt;sup&gt;6&lt;/sup&gt;) were prepared in a final volume of 400 μl HBSS&lt;sup&gt;−/−&lt;/sup&gt; and engrafted in &amp;gt;6-week-old female C57BL/6J (Jackson Laboratories) mice by i.p. injection. Tumour burden was measured via non-invasive bioluminescence imaging (LagoX, Spectral Imaging), and flux signals were analysed with Aura software (v.4.0, Spectral Imaging). Where indicated, mice were treated i.p. with 100 mg kg&lt;sup&gt;−1&lt;/sup&gt; cyclophosphamide (Cy). Mice received i.v. treatment with indicated T cells (1.0 × 10&lt;sup&gt;6&lt;/sup&gt; CAR+ T cells) in 100 μl final volume 24 h after Cy pre-conditioning. For ovarian tumour studies, mice were i.p. treated at 14 (or 35) days post tumour engraftment as indicated, with CAR+ T cells (3.0–5.0 × 10&lt;sup&gt;6&lt;/sup&gt;) in 400 μl final volume without Cy pre-conditioning. For indicated ovarian tumour studies, mice were co-treated i.p. with CAR-T cells and either soluble murine recombinant sIL-12 (0.5 μg i.p.) or with Avelumab (200 μg i.p.; anti-PD-L1, Bavencio, EMD Serono) every other day for a total of 3 doses starting on the day of T cell treatment. For all studies, mice were euthanized upon reaching s.c. tumour volumes exceeding 1,000 mm&lt;sup&gt;3&lt;/sup&gt; or i.p. tumours showing signs of distress such as a distended belly due to peritoneal ascites, laboured or difficulty breathing, apparent weight loss, impaired mobility or evidence of being moribund.&lt;/p&gt;&lt;p&gt;Peripheral blood was collected from isoflurane-anaesthetized mice by retro-orbital (r.o.) bleed through heparinized capillary tubes (Chase Scientific) into polystyrene tubes containing a heparin/PBS solution (1,000 units ml&lt;sup&gt;−1&lt;/sup&gt;, Sagent Pharmaceuticals). Total volume of each blood draw (~120 μl per mouse) was recorded. RBCs were lysed with 1× Red Cell Lysis buffer (Sigma) according to manufacturer protocol, and then washed, stained and analysed by flow cytometry as described above. When applicable, tumour, liver and spleen were collected from euthanized mice. Spleen weights were measured for analysis of splenomegaly. Serum from syngeneic prostate and ovarian cancer mouse studies was collected via r.o. bleed in non-heparinized capillary tubes as described above. Blood was kept at room temperature for 30 min, centrifuged at 6,000 × &lt;i&gt;g&lt;/i&gt; for 10 min at 4 °C, aliquoted and frozen at −80 °C until used for serum cytokine ELISA or chemistry analyses. Serum chemistry analysis was performed by running samples on a VETSCAN VS2 Chemistry Analyzer (Zoetis), using the phenobarbital chemistry panel rotor (Zoetis) for BUN, ALT and AST quantification as described in the manufacturer protocol. At pre-determined timepoints or at moribund status, mice were euthanized, and tissues and/or peritoneal ascites were collected and processed for flow cytometry and immunohistochemistry. Peritoneal ascites was centrifuged at 336 × &lt;i&gt;g&lt;/i&gt; for 10 min at 4 °C, aliquoted and frozen at −80 °C until used for cytokine ELISA or Mouse Luminex Discovery Assay multiplex analysis per manufacturer protocol (R&amp;amp;D Systems). For the study of immune cells collected from ovarian i.p. tumour masses, mice from each group were randomly selected and killed at day 6 or 7 post T cell injection. Peritoneal solid tumour masses were physically minced and enzymatically digested using a Miltenyi mouse tumour digestion kit, and CD45 positive selection was performed using magnetic mouse CD45 MicroBeads following manufacturer protocols (Miltenyi Biotec). Isolated CD45&lt;sup&gt;+&lt;/sup&gt; cells were analysed by flow cytometry, and individual replicate supernatants of overnight-cultured isolated CD45&lt;sup&gt;+&lt;/sup&gt; cells from each treatment group were measured for murine IFNγ secretion via ELISA as described above.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec19"&gt;Immunohistochemistry and Nanostring GeoMx digital spatial profiling (DSP) analysis&lt;/h3&gt;&lt;p&gt;Tumour tissues were fixed for up to 3 days in 4% paraformaldehyde (Boston BioProducts) and stored in 70% ethanol until further processing. Immunohistochemistry was performed by the solid tumour pathology core at City of Hope. Briefly, paraffin-embedded sections (10 μm) were stained with haematoxylin and eosin (H&amp;amp;E, Sigma Aldrich), CD3 (Ventana, Clone: SGV6), PD-L1 (Invitrogen, Clone: JJ08-95), CD4 (Abcam, Clone: EPR19514), CD8 (Cell Signaling, Clone: D4W22) and FOXP3 (Abcam, Clone: EPR22102-37). Images were obtained using the Nanozoomer 2.0HT digital slide scanner and the associated NDP.view2 software (Hamamatzu). For Nanostring GeoMx DSP, similarly prepared tissues and slides were sent for multiplex protein profiling with spatial context. The Nanostring GeoMx system-provided data centre software was used for generating the raw SNR data. Briefly, after quality control of the initial data, the segment and target data were filtered, followed by generation of SNR data for downstream analysis. SNR count protein expression data from 12 tumour ROIs per treatment group were processed and analysed using R v.4.4.0. The normality of data was assessed using the Shapiro–Wilk test. Protein expression values were &lt;i&gt;z&lt;/i&gt;-score transformed and displayed in heat maps using the ComplexHeatmap R package (v.2.20.0)&lt;sup&gt;&lt;a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 77" title="Gu, Z. Complex heatmap visualization. Imeta 1, e43 (2022)." href="/articles/s41551-025-01509-2#ref-CR77" id="ref-link-section-d136417870e2667"&gt;77&lt;/a&gt;&lt;/sup&gt;. ROIs from different treatment groups were clustered using complete-linkage hierarchical clustering on expression data of 39 proteins subgrouped by cell type or phenotype. The strength and direction of the relationship between the expression of defined pairs of proteins were evaluated using Spearman’s rank correlation method. Unless otherwise specified, a &lt;i&gt;P&lt;/i&gt;-value threshold of &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.05 was used to determine statistical significance.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec20"&gt;Statistical analysis&lt;/h3&gt;&lt;p&gt;In this study, we evaluated CAR-T cells for the treatment of solid tumours using in vitro T-cell functional assays, as well as syngeneic tumour models in mice. We engineered CAR-T cells to secrete bifunctional fusion proteins and evaluated therapeutic efficacy in these model systems. All in vitro assays were performed with at least duplicate samples and were repeated in at least two independent experiments. In vivo studies were performed using 6–8-week-old C57BL/6 or C57BL/6 background huPSCA-KI transgenic mice, using at least three mice per group for all in vivo studies to ensure statistical power. Mice were randomized on the basis of tumour volume or bioluminescence imaging to ensure evenly distributed average tumour sizes across each group. In vivo experiments were repeated at least twice. For subcutaneous tumour models, survival was based on the maximum tumour size allowed (~1,000 mm&lt;sup&gt;3&lt;/sup&gt; maximum volume). Excel (Microsoft, v.16.97) and GraphPad Prism 10 (GraphPad Software) were used to generate bar plots and graphs. Data are presented as mean ± s.e.m., unless otherwise stated. Unless otherwise indicated, &lt;i&gt;P&lt;/i&gt; values for pairwise comparisons were generated using an unpaired two-tailed Student’s &lt;i&gt;t&lt;/i&gt;-test with assumption of unequal variance, where *&lt;i&gt;P&lt;/i&gt; &amp;lt; 0.05, **&lt;i&gt;P&lt;/i&gt; &amp;lt; 0.01, ***&lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001 and ****&lt;i&gt;P&lt;/i&gt; &amp;lt; 0.0001.&lt;/p&gt;&lt;h3 class="c-article__sub-heading" id="Sec21"&gt;Reporting summary&lt;/h3&gt;&lt;p&gt;Further information on research design is available in the &lt;a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41551-025-01509-2#MOESM2"&gt;Nature Portfolio Reporting Summary&lt;/a&gt; linked to this article.&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Nature</author><pubDate>Wed, 01 Oct 2025 09:04:57 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMiX0FVX3lxTE5SRTU1dTZ0Y25tUnJtVUxadTEwZjduNUZldXJWeGF2VUtGblNkbjVaU2tBOTFoRnBRbUdockVZVXAwaWZkZmRWU0FUT2p0Y1lteXY5SHMzRWExQzNkdVo4</guid></item><item><title>告诉我们您患早发性癌症的经历。-《纽约时报》</title><link>https://www.nytimes.com/2025/10/01/well/tell-us-about-your-experience-with-early-onset-cancer.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;&lt;p id="cmsg"&gt;Please enable JS and disable any ad blocker&lt;/p&gt;&lt;/body&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The New York Times</author><pubDate>Wed, 01 Oct 2025 09:02:59 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMinwFBVV95cUxOYUpZM3Jwa0wtZC1oQTRZa19zMVlJdFVsNDRNT0dBR1hEYVdGZ1Nob0dHRzNOeGN4R0poT1ZKMTg2ZGU1WjlvZE1faExpek1HWkZ4YU9oZ3lUYnZpcVlSZTNhOUVkcVFSTmE4U2xtUDRsRE9CVzFScU9NQ3lNaWJtTnJvNmhoWTdTcnNGMFczYlE0QlhEQTlrRDdUOE9fZkk</guid></item><item><title>找出为什么更多年轻人罹患癌症的竞赛-《纽约时报》</title><link>https://www.nytimes.com/2025/10/01/well/cancer-young-people.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;&lt;p id="cmsg"&gt;Please enable JS and disable any ad blocker&lt;/p&gt;&lt;/body&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The New York Times</author><pubDate>Wed, 01 Oct 2025 09:01:01 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMickFVX3lxTE9hbk82bloxR05GMW0tOE4wMUJNNjg3R3Z6Qy1LSlpOaVpjSEpZVDZORVRNbmdmUWpiUVBWVExTblJmU21qUUQ2NkRPZmZYUTZucU9QbmRsZUJJNjh0QkVONTBuejlxREhuY09zWGlKS0swQQ</guid></item><item><title>自闭症谱系应该分开吗？ -《纽约时报》</title><link>https://www.nytimes.com/2025/10/01/health/autism-spectrum-neurodiversity-kennedy.html</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;body id="readabilityBody"&gt;&lt;p id="cmsg"&gt;Please enable JS and disable any ad blocker&lt;/p&gt;&lt;/body&gt;&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>The New York Times</author><pubDate>Wed, 01 Oct 2025 09:00:41 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMijgFBVV95cUxQV1VpX2Rod0Ixc1dITDYyQ2dFMTltQWt4ejNidFVFOEpoSW1LQU4zWnlaTkU2aUVrTVBRTExCMXVCLWNfaGFwMTY5bmt0Q2hwR0x5Zl90QjBSRnFwOWNtV05kclRKQ0tjM1EzenFHbWVHd1VQS05qWDFuYzctSjY3dFhXTlVqWFNJRTJFamFR</guid></item><item><title>“老实说，我对此一无所知” ：民意调查揭示了公众对在有意识的实验室培养的“迷你脑”上进行实验的不确定性- Live Science</title><link>https://www.livescience.com/health/i-honestly-am-not-sure-on-this-at-all-poll-reveals-public-uncertainty-over-experimenting-on-conscious-lab-grown-minibrains</link><description>&lt;html&gt;&lt;body&gt;&lt;div&gt;&lt;div id="article-body" class="text-copy bodyCopy auto paywall-locker"&gt;
&lt;p id="cc04568a-565e-40c2-8f53-3fbf66101a22"&gt;Scientists generally believe brain &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/minibrains-brain-organoids-explained" data-before-rewrite-localise="https://www.livescience.com/minibrains-brain-organoids-explained"&gt;&lt;u&gt;organoids&lt;/u&gt; —&lt;/a&gt; 3D aggregations of tissue that mimic some of the structures of the brain — are too simple to support consciousness. But as brain organoids become more sophisticated, there's a theoretical possibility that some may cross that threshold someday.&lt;/p&gt;&lt;p id="ad-unit-1" class="ad-unit"&gt;&lt;/p&gt;&lt;p&gt;The brain organoids that have been made so far typically represent just one part of the brain at a time. They are used to study brain development and diseases, as well as drug side effects, without requiring animals or human brains.&lt;/p&gt;&lt;a id="elk-seasonal" href="" data-url="" target="_blank" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;/a&gt;&lt;p id="cc04568a-565e-40c2-8f53-3fbf66101a22-2" class="paywall" aria-hidden="true"&gt;Now, some laboratory models have fused two or more brain organoids to form an "assembloid" that can mimic the cell-to-cell interactions between different brain regions. As a result, a group of researchers recently &lt;a data-analytics-id="inline-link" href="https://www.sciencedirect.com/science/article/pii/S2666389925002132" target="_blank" data-url="https://www.sciencedirect.com/science/article/pii/S2666389925002132" referrerpolicy="no-referrer-when-downgrade" data-hl-processed="none"&gt;&lt;u&gt;argued&lt;/u&gt;&lt;/a&gt; that the field must preemptively consider new ethical and regulatory frameworks if &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/tiny-brains-grown-in-the-lab-could-become-conscious-and-feel-pain-and-were-not-ready" data-before-rewrite-localise="https://www.livescience.com/health/neuroscience/tiny-brains-grown-in-the-lab-could-become-conscious-and-feel-pain-and-were-not-ready"&gt;&lt;u&gt;conscious organoids become a reality&lt;/u&gt;&lt;/a&gt;.&lt;/p&gt;&lt;p id="mid-article-leaderboard" class="ad-unit sm:hidden block"&gt;&lt;/p&gt;&lt;p id="8771fc59-1eef-4f48-a363-57278301a35b"&gt;In a Live Science poll, we asked readers if it would be OK to &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them" data-before-rewrite-localise="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them"&gt;&lt;u&gt;experiment on lab-grown "brains" if they were to become conscious&lt;/u&gt;&lt;/a&gt;. Approximately 657 readers responded before the poll closed.&lt;/p&gt;&lt;p id="ad-unit-2" class="ad-unit"&gt;&lt;/p&gt;&lt;p&gt;Around 25% of the respondents said they do not think we should experiment with conscious organoids but they are fine with using unconscious organoids with close monitoring. Another 23% believe there is no ethical way to experiment on them.&lt;/p&gt;&lt;p&gt;Meanwhile, 22% of readers said they would support the creation of new rules that consider the organoids' welfare, while another 19% believe no regulatory changes are needed. The remaining readers were undecided.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Related: &lt;/strong&gt;&lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/anatomy/could-mini-space-grown-organs-be-our-cancer-moonshot" data-before-rewrite-localise="https://www.livescience.com/health/anatomy/could-mini-space-grown-organs-be-our-cancer-moonshot"&gt;&lt;u&gt;&lt;strong&gt;Could mini space-grown organs be our 'cancer moonshot'?&lt;/strong&gt;&lt;/u&gt;&lt;/a&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/p&gt;&lt;div id="slice-container-newsletterForm-articleInbodyContent-HPfqBxJyycyKCFA73zPzSP" class="slice-container newsletter-inbodyContent-slice newsletterForm-articleInbodyContent-HPfqBxJyycyKCFA73zPzSP slice-container-newsletterForm"&gt;&lt;div data-hydrate="true" class="newsletter-form__wrapper newsletter-form__wrapper--inbodyContent"&gt;&lt;div class="newsletter-form__container"&gt;&lt;section class="newsletter-form__main-section"&gt;&lt;p class="newsletter-form__strapline"&gt;Get the world’s most fascinating discoveries delivered straight to your inbox.&lt;/p&gt;&lt;/section&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p&gt;Some readers warned that this research lacks foresight. "Do we have a road map where it would lead? Trapping conscious entities on a lab plate doesn't sound right," &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them?__vfz=medium%3Dcomment_share%7Csharer_uuid%3D00000000-0000-4000-8000-076968222c6f#vf-ccc1ceca-84de-44cd-91b6-b27eaecab5ba" data-before-rewrite-localise="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them?__vfz=medium%3Dcomment_share%7Csharer_uuid%3D00000000-0000-4000-8000-076968222c6f#vf-ccc1ceca-84de-44cd-91b6-b27eaecab5ba"&gt;&lt;u&gt;Duvidhameihaiaadmi&lt;/u&gt;&lt;/a&gt; wrote.&lt;/p&gt;&lt;p&gt;Some argued that the scientific benefits justify the risks. "If the benefits outweigh the moral conundrum, do it quick, make it as humane as possible, and make SURE that everyone knows this must be done or whatever life-changing breakthrough won't happen," &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them?__vfz=medium%3Dcomment_share%7Csharer_uuid%3D00000000-0000-4000-8000-076968222c6f#vf-c3d34ad1-9305-4140-aeb6-0b0f2858f4cd" data-before-rewrite-localise="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them?__vfz=medium%3Dcomment_share%7Csharer_uuid%3D00000000-0000-4000-8000-076968222c6f#vf-c3d34ad1-9305-4140-aeb6-0b0f2858f4cd"&gt;&lt;u&gt;GodParticle&lt;/u&gt;&lt;/a&gt; wrote. "I really don't see a breakthrough here worth the literal lives of these created beings once they gain consciousness. I have no mouth and I must scream…"&lt;/p&gt;&lt;p id="d9a26a99-e578-4cb8-87a1-e014c981a789"&gt;For others, the moral boundary seemed very clear. "Obviously if there's any sign of consciousness we have a moral imperative to stop experimenting," &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them?__vfz=medium%3Dcomment_share%7Csharer_uuid%3D00000000-0000-4000-8000-076968222c6f#vf-0a6642d6-73f2-4d36-bec6-1f3db1b5bfca" data-before-rewrite-localise="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them?__vfz=medium%3Dcomment_share%7Csharer_uuid%3D00000000-0000-4000-8000-076968222c6f#vf-0a6642d6-73f2-4d36-bec6-1f3db1b5bfca"&gt;&lt;u&gt;Toby&lt;/u&gt;&lt;/a&gt; commented, to which &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them?__vfz=medium%3Dcomment_share%7Csharer_uuid%3D00000000-0000-4000-8000-076968222c6f#vf-0a5047a1-3b44-422f-8e4e-45187e2b7408" data-before-rewrite-localise="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them?__vfz=medium%3Dcomment_share%7Csharer_uuid%3D00000000-0000-4000-8000-076968222c6f#vf-0a5047a1-3b44-422f-8e4e-45187e2b7408"&gt;&lt;u&gt;GodParticle&lt;/u&gt;&lt;/a&gt; responded, "we do, but we arent the scientists or their corporate/educational bosses…"&lt;/p&gt;&lt;p&gt;Still another user thought the dilemma sounded like a storyline straight out of "Star Trek: Next Generation." (STNG) "I honestly am not sure on this at all - the positive implications of experimentation are massive but I guess we need to work out where the humanity is in it… feels very STNG problem," &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them?__vfz=medium%3Dcomment_share%7Csharer_uuid%3D00000000-0000-4000-8000-076968222c6f#vf-9a484566-8e4b-4bc2-b9d7-d9ac82323a26" data-before-rewrite-localise="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them?__vfz=medium%3Dcomment_share%7Csharer_uuid%3D00000000-0000-4000-8000-076968222c6f#vf-9a484566-8e4b-4bc2-b9d7-d9ac82323a26"&gt;&lt;u&gt;Slater&lt;/u&gt;&lt;/a&gt; said.&lt;/p&gt;&lt;p&gt;One respondent highlighted what they saw as the inconsistency of our ethical concern for other entities. "It's touching — really — to see people cry over brain cells in a dish. But where does that saintly compassion go when monkeys are dissected alive, dogs poisoned, or billions of pigs ground in factory lines every year?" &lt;a data-analytics-id="inline-link" href="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them?__vfz=medium%3Dcomment_share%7Csharer_uuid%3D00000000-0000-4000-8000-076968222c6f#vf-3f06da18-c508-4e66-bd82-497478d12a7b" data-before-rewrite-localise="https://www.livescience.com/health/neuroscience/if-tiny-lab-grown-brains-became-conscious-would-it-still-be-ok-to-experiment-on-them?__vfz=medium%3Dcomment_share%7Csharer_uuid%3D00000000-0000-4000-8000-076968222c6f#vf-3f06da18-c508-4e66-bd82-497478d12a7b"&gt;&lt;u&gt;Asish&lt;/u&gt;&lt;/a&gt; wrote.&lt;/p&gt;&lt;p&gt;What do you think? Share your view in the comments below.&lt;/p&gt;&lt;hr id="605b65e6-ce43-47ff-94d9-2e37d28d4807"&gt;
&lt;/div&gt;
&lt;/div&gt;&lt;/body&gt;&lt;/html&gt;</description><author>Live Science</author><pubDate>Wed, 01 Oct 2025 09:00:00 GMT</pubDate><enclosure url="" length="10000" type="image/png"></enclosure><guid isPermaLink="true">CBMi7gFBVV95cUxNZkdEcUdOeHVWQzltd0duNUh4OXFvZ3RsWDM3T3BXQkpRVWd3T2ZtbnByeWVUWVJ1N3U2TU5DdXN6SEI0Rm9RMUc0cnpXbW1xLUw0NlR3cEVXQjhFNkE1YWQ2RkJCN0VVZW9HY3UwZ2tSS2pxNXR3d1R3dEN2VnFCR21sUWJTRjRhYUxJTTdhUHlzT0VzeldSUzhNTENVc01HY3l1bWY0ci1pT3Q0Y3hQR1JvUjhVVTZlX3pMRkZYRTNLQlZFM3R1WXVKRHI3V3Rpd3NVbW9TN1NEdUtGSkhCMWstLWo4SUlQUDhTVGJ3</guid></item></channel></rss>